Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
Line 1: Line 1:
−
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 
−
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
−
</div>
 
−
 
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
−
|-
+
|-!width="50"|Transcript ID
−
!width="50"|Name
+
!width="50"|Gene ID
−
!width="50"|Transcript ID
+
!width="50"|Symbol
−
!width="50"|Alias
+
!width="50"|Synonyms
−
!width="50"|Description
+
!width="50"|Functional Mechanism
 +
!width="50"|Biological Process
 
!width="50"|Disease
 
!width="50"|Disease
 
|-
 
|-
−
|''21A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501]
−
|[[NONHSAT128494]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141612 HSALNG0141612]
−
|ncRNA 21A
+
|HPVC1
−
|N/A
+
|PE5L,HPV18E5L
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''7SK''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605]
−
|[[NONHSAT113149]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141720 HSALNG0141720]
−
|"7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198"
+
|Alpha 250/ Alpha 280
−
|"RNA, 7SK small nuclear"
+
|NONHSAT104559,lnc-C9orf53-2:1
−
|colon adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632]
−
|[[lnc-LRR1-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096226 HSALNG0096226]
−
|"7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486"
+
|N4BP2L2-IT2
−
|"RNA, 7SL, cytoplasmic 1"
+
|CG030
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABALON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094]
−
|[[ABALON]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082161 HSALNG0082161]
−
|INXS
+
|LINC01150
−
|apoptotic BCL2L1-antisense long non-coding RNA
+
|2G7,TCONS_00019134
−
|renal cell carcinoma
+
|NA
 +
|pathogenic process
 +
|Wilms' tumor
 
|-
 
|-
−
|''AIRN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115]
−
|[[ENST00000609176.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032599 HSALNG0032599]
−
|"AIR, IGF2RAS"
+
|LINC01587
−
|Antisense of IGF2R non-protein coding RNA
+
|C4orf6,aC1
−
|Wilms’tumors
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''APOA1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105]
−
|[[ENST00000444200.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142220 HSALNG0142220]
−
|APOA1 antisense RNA
+
|NTT
−
|N/A
+
|NONHSAT115106
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''APTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234]
−
|[[NONHSAT121673]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053252 HSALNG0053252]
−
|Alu-mediated CDKN1A/p21
+
|RNF217-AS1
−
|N/A
+
|STL
−
|liver cirrhosis
+
|NA
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''BANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481]
−
|[[BANCR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0136795 HSALNG0136795]
−
|LINC00586
+
|INE2
−
|BRAF-activated non-protein coding RNA
+
|NCRNA00011
−
|gastric cancer, Non-small cell lung cancer(NSCLC), Osteosarcoma, Hepatocellular carcinoma, Malignant melanoma, Eosinophilic esophagitis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BDNF-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485]
−
|[[ENST00000499008.3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137683 HSALNG0137683]
−
|BDNF antisense RNA
+
|INE1
−
|"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049"
+
|NCRNA00010
−
|Alzheimer’s disease, Parkinson’s disease and Fragile X syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BLACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511]
−
|[[BLACAT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141622 HSALNG0141622]
−
|"linc-UBC1,LINC00912, onco-lncRNA-30"
+
|LINC01565
−
|bladder cancer associated transcript 1 (non-protein coding)
+
|C3orf27,GR6
−
|bladder cancer
+
|NA
 +
|pathogenic process
 +
|leukemia
 
|-
 
|-
−
|''CAHM''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068]
−
|[[ENST00000604200.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006924 HSALNG0006924]
−
|LINC00468
+
|LINC00869
−
|colon adenocarcinoma hypermethylated (non-protein coding)
+
|KIAA0493
−
|colorectal neoplasia.
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430]
−
|[[NONHSAT129210]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026312 HSALNG0026312]
−
|AK023948
+
|ERC2-IT1
−
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
+
|C1orf1,C3orf51,Po42
−
|thyroid carcinoma
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''BCYRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394]
−
|[[lnc-EPCAM-1:2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142509 HSALNG0142509]
−
|"BC200,BC200a, NCRNA00004, LINC00004"
+
|Y RNAs
−
|"BCYRN1, brain cytoplasmic RNA 1"
+
|lnc-PDIA4-1:1
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BPESC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195]
−
|[[ENST00000418282.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032409 HSALNG0032409]
−
|NCRNA00187
+
|NOP14-AS1
−
|"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)"
+
|C4orf10,RES4-24
−
|blepharophimosis syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYP4A22-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309]
−
|[[ENST00000444042.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142424 HSALNG0142424]
−
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
+
|TncRNA
−
|CYP4A22 antisense RNA 1
+
|NONHSAT022116,AF080092,TSU
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''CASC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243]
−
|[[ENST00000502056.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045080 HSALNG0045080]
−
|"LINC00860,CARLo-1"
+
|SMAD5-AS1
−
|cancer susceptibility candidate 8 (non-protein coding)
+
|SMAD5O,DAMS
−
|Colorectal Cancer,Lung Cancer
+
|NA
 +
|pathogenic process
 +
|malignant hematopoietic
 
|-
 
|-
−
|''CCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025]
−
|[[NONHSAT129017]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062672 HSALNG0062672]
−
|"CARLo-5, onco-lncRNA-40"
+
|LINC00244
−
|colon cancer associated transcript 1 (non-protein coding)
+
|C7orf4,NCRNA00244
−
|colorectal cancer,gastric cancer
+
|NA
 +
|pathogenic process
 +
|preaxial polydactyly
 
|-
 
|-
−
|''CCAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017]
−
|[[CCAT2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055219 HSALNG0055219]
−
|"NCCP1, LINC00873"
+
|KIF25-AS1
−
|colon cancer associated transcript 2 (non-protein coding)
+
|C6orf54,NCRNA00300,HGC6.1.1
−
|non-small cell lung cancer
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''CISTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332]
−
|[[NONHSAT028496]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055207 HSALNG0055207]
−
|"CISTR-ACT, CISTRACT, re52431"
+
|LINC01558
−
|chondrogenesis-associated transcript
+
|C6orf123,LINC01557,HGC6.2,dJ431P23.4
−
|brachydactyly
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''CRNDE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438]
−
|[[Lnc-IRX3-4:2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055209 HSALNG0055209]
−
|"LOC643911, LINC00180, CRNDEP"
+
|AFDN-AS1
−
|colorectal neoplasia differentially expressed (non-protein coding)
+
|C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''CYYR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232]
−
|[[ENST00000357401.3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135027 HSALNG0135027]
−
|cysteine and tyrosine rich 1 antisense RNA 1
+
|RFPL3S
−
|N/A
+
|RFPL3-AS1,RFPL3-A, NCRNA00005
−
|_
+
|NA
 +
|pathogenic process
 +
|opitz syndrome
 
|-
 
|-
−
|''DALIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393]
−
|[[DALIR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134830 HSALNG0134830]
−
|DALI
+
|RFPL1S
−
|DNMT1-associated long intergenic non-coding RNA
+
|RFPL1-AS1,RFPL1-A, NCRNA00006
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''DANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500]
−
|[[NONHSAT096369]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141611 HSALNG0141611]
−
|differentiation antagonizing non-protein coding RNA
+
|HCG4B
−
|"ANCR, AGU2, lncRNA-ANCR"
+
|HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
−
|bone diseases
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBET''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894]
−
|[[NONHSAT099821]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142009 HSALNG0142009]
−
|"DBE-T, DUX4L30"
+
|LINC00294
−
|D4Z4 binding element transcript (non-protein coding)
+
|NA
−
|Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DHFR upstream transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345]
−
|[[NONHSAT102417]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140599 HSALNG0140599]
−
|"DHFR minor transcript 5'-UTR, ENSG00000228716"
+
|LINC00893
−
|N/A
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hunter syndrome
 
|-
 
|-
−
|''DHRS4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133]
−
|[[NONHSAT035954]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142248 HSALNG0142248]
−
|DHRS4 antisense RNA 1
+
|PCBP3-OT1
−
|"PRO1488,AS1DHRS4"
+
|PCBP3-OT1,FLJ44028
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLEU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488]
−
|[[NONHSAT033797]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141599 HSALNG0141599]
−
|deleted in lymphocytic leukemia 1 (non-protein coding)
+
|BPESC1
−
|"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1"
+
|NCRNA00187
−
|chronic lymphocytic leukemia
+
|NA
 +
|pathogenic process
 +
|blepharophimosis syndrome
 
|-
 
|-
−
|''DLEU2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712]
−
|[[NONHSAT033821]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141827 HSALNG0141827]
−
|deleted in lymphocytic leukemia 2 (non-protein coding)
+
|COPG2IT1
−
|"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG"
+
|CIT1,NCRNA00170,COPG2AS
−
|chronic lymphocytic leukemia, lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DISC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040]
−
|[[NONHSAT010191]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128978 HSALNG0128978]
−
|"DISC1-AS1, DISC1OS, NCRNA00015"
+
|LINC00652
−
|disrupted in schizophrenia 2 (non-protein coding)
+
|HSPC072
−
|affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''EGOT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282]
−
|[[NONHSAT087635]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108689 HSALNG0108689]
−
|"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947"
+
|WASIR2
−
|Eosinophil granule ontogeny (EGO) RNA
+
|NCRNA00286A
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EMX2OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856]
−
|[[lnc-PDZD8-3:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119601 HSALNG0119601]
−
|"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847"
+
|LINC00470
−
|Emx2 opposite strand transcript.
+
|C18orf2
−
|_
+
|NA
 +
|pathogenic process
 +
|age-related macular degeneration
 
|-
 
|-
−
|''ERICD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507]
−
|[[Lnc-CHRAC1-2:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141618 HSALNG0141618]
−
|"TCONS_00014875, ERIC"
+
|LINC00588
−
|E2F1-regulated inhibitor of cell death (non-protein coding)
+
|C8orf71,DKFZP434F122
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ESRG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604]
−
|[[ENST00000583516.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134754 HSALNG0134754]
−
|HESRG
+
|TTC28-AS1
−
|embryonic stem cell related (non-protein coding)
+
|TTC28AS,TTC28-AS,KIAA1648
−
|embryonal carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Evf2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577]
−
|[[lnc-DLX5-3:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114754 HSALNG0114754]
−
|"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764"
+
|CDRT7
−
|_
+
|NCRNA00025,LINC00025
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FENDRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912]
−
|[[FENDRR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114755 HSALNG0114755]
−
|FOXF1 adjacent non-coding developmental regulatory RNA
+
|CDRT8
−
|"lincFOXF1, onco-lncRNA-21"
+
|NA
−
|Heart Failure
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FIRRE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048]
−
|[[ENST00000427391.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133887 HSALNG0133887]
−
|firre intergenic repeating RNA element
+
|CECR3
−
|LINC01200
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cat eye syndrome
 
|-
 
|-
−
|''FOXCUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915]
−
|[[Lnc-FOXC1-1:1]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133890 HSALNG0133890]
−
[[NONHSAT106529]]
+
|CECR9
−
|TCONS_00011636
+
|NA
−
|FOXC1 upstream transcript (non-protein coding)
+
|NA
−
|esophageal squamous cell carcinoma, basal-like breast cancer
+
|pathogenic process
 +
|cat eye syndrome
 
|-
 
|-
−
|''FTX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998]
−
|[[ENST00000602812.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133878 HSALNG0133878]
−
|"LINC00182,FLJ33139"
+
|HDHD5-AS1
−
|"FTX transcript, XIST regulator (non-protein coding)"
+
|CECR4,CECR5-AS1,NCRNA00017
−
|epatocellular carcinoma, colorectal cancer
+
|NA
 +
|pathogenic process
 +
|cat eye syndrome
 
|-
 
|-
−
|''GHET1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914]
−
|[[GHET1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133878 HSALNG0133878]
−
|lncRNA-GHET1
+
|CECR5-AS1
−
|gastric carcinoma proliferation enhancing transcript 1
+
|NCRNA00017
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|cat eye syndrome
 
|-
 
|-
−
|''GHRLOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919]
−
|[[NONHSAT087920]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029809 HSALNG0029809]
−
|"NCRNA00068,GHRL-AS1"
+
|CLRN1-AS1
−
|ghrelin opposite strand/antisense RNA
+
|CLRN1O,UCRP
 +
|NA
 +
|pathogenic process
 +
|usher syndrome type 3
 
|-
 
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082585 HSALNG0082585]
 +
|TMEM9B-AS1
 +
|C11orf18
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GPR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324]
−
|[[NONHSAT076558]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133586 HSALNG0133586]
−
|GPR1AS
+
|LINC01547
−
|GPR1 antisense RNA
+
|C21orf69,C21orf67
−
|_
+
|NA
 +
|pathogenic process
 +
|Down syndrome
 
|-
 
|-
−
|''HAGLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409]
−
|[[ENST00000416928.2]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131587 HSALNG0131587]
−
[[NONHSAT075638]]
+
|LINC00029
−
|Mdgt
+
|C20orf51,NCRNA00029,bA305P22.4
−
|HOXD antisense growth-associated long non-coding RNA
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 
|-
 
|-
−
|''HEIH''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336]
−
|[[HEIH]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141634 HSALNG0141634]
−
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
+
|LINC00529
−
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
+
|C8orf8
−
|hepatocelluar carcinoma
+
|NA
 +
|pathogenic process
 +
|keratolytic winter erythema
 
|-
 
|-
−
|''JADRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978]
−
|[[JADRR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010403 HSALNG0010403]
−
|lncRNA-JADE
+
|FLVCR1-AS1
−
|JADE1 adjacent regulatory RNA
+
|FLVCR1-DT,LQK1
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KANTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050]
−
|[[ENST00000604849.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114969 HSALNG0114969]
−
|KDM5C adjacent non-coding transcript
+
|SMCR2
−
|Spasm
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Smith-Magenis syndrome
 
|-
 
|-
−
|''LINC-PINT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401]
−
|[[NONHSAT123382]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114982 HSALNG0114982]
−
|"FLJ43663, PINT, LincRNA-Pint"
+
|SMCR5
−
|"long intergenic non-protein coding RNA, p53 induced transcript"
+
|NCRNA00034
−
|pancreatic cancer
+
|NA
 +
|pathogenic process
 +
|Smith-Magenis syndrome
 
|-
 
|-
−
|''LINC00163''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246]
−
|[[LINC00163]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142361 HSALNG0142361]
−
|"NLC1-A, NLC1A"
+
|SMCR6
−
|long intergenic non-protein coding RNA 163
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Smith-Magenis syndrome
 
|-
 
|-
−
|''LINC00312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626]
−
|[[NONHSAT087716]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133620 HSALNG0133620]
−
|"NAG7, NAG-7, ERR10, LMCD1DN, ERR-10"
+
|LINC00205
−
|long intergenic non-protein coding RNA 312
+
|C21orf86,NCRNA00205,
−
|nasopharyngeal carcinoma
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00850''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512]
−
|[[LINC00850]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132117 HSALNG0132117]
−
|KUCG1
+
|C21orf91-OT1
−
|long intergenic non-protein coding RNA 850
+
|NCRNA00285,D21S2089E
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01191''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596]
−
|[[ENST00000412690.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132582 HSALNG0132582]
−
|"VIN, lnc-ACTR3"
+
|LINC00307
−
|long intergenic non-protein coding RNA 1191
+
|NCRNA00307,D21S2091E
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LSINCT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502]
−
|[[LSINCT5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133549 HSALNG0133549]
−
|N/A
+
|TSPEAR-AS2
−
|long stress-induced non-coding transcript 5
+
|C21orf90
−
|gastric cancer,breast and ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807]
−
|[[ENST00000511918.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133721 HSALNG0133721]
−
|SCAL1
+
|MCM3AP-AS1
−
|lung cancer associated transcript 1 (non-protein coding)
+
|C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
−
|non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR22HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888]
−
|[[ENST00000574306.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133144 HSALNG0133144]
−
|"MGC14376, DKFZp686O06159, LOC554202"
+
|B3GALT5-AS1
−
|MIR22 host gene
+
|C21orf88
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR31HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898]
−
|[[NONHSAT130385]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133127 HSALNG0133127]
−
|LOC554202
+
|BRWD1-AS2
−
|MIR31 host gene
+
|C21orf87,NCRNA00257,BRWD1-IT2
−
|gastric cancer, pancreatic ductal adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR99AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031]
−
|[[ENST00000602580.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133621 HSALNG0133621]
−
|MONC
+
|LINC00315
−
|mir-99a-let-7c cluster host gene
+
|C21orf93,NCRNA00315
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR100HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033]
−
|[[ENST00000531381.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133612 HSALNG0133612]
−
|"AGD1, lncRNA-N2"
+
|LINC00334
−
|mir-100-let-7a-2 cluster host gene
+
|C21orf89,NCRNA00334
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR155HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322]
−
|[[NONHSAT081499]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132477 HSALNG0132477]
−
|"BIC, NCRNA00172"
+
|LINC00314
−
|MIR155 host gene
+
|C21orf94,NCRNA00314
−
|chronic lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR222HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821]
−
|[[ENST00000602507.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132261 HSALNG0132261]
−
|Lnc-Ang362
+
|LINC00308
−
|MIR222 host gene
+
|C21orf74,NCRNA00308,PRED16
−
|Ang II-associated cardiovascular disease
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''MIR503HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023]
−
|[[ENST00000414769.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132537 HSALNG0132537]
−
|"MGC16121, H19X"
+
|LINC00189
−
|MIR503 host gene
+
|C21orf109,NCRNA00189
−
|choriocarcinoma
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''MYCNUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375]
−
|[[ENST00000433810.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0042788 HSALNG0042788]
−
|lncUSMycN
+
|NCRUPAR
−
|MYCN upstream transcript (non-protein coding)
+
|ncR-uPAR,ncRuPAR,NCRNA00193
−
|neuroblastoma
+
|transcriptional regulation
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''NAMA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467]
−
|[[ENST00000604258.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133048 HSALNG0133048]
−
|N/A
+
|DSCR10
−
|"non-protein coding RNA, associated with MAP kinase pathway and growth arrest"
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480]
−
|[[ENST00000414795.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132984 HSALNG0132984]
−
|lncRNA-CMPK2
+
|DSCR9
−
|negative regulator of interferon response (non-protein coding)
+
|NCRNA00038
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OIP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051]
−
|[[ENST00000500949.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142166 HSALNG0142166]
−
|"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1"
+
|MDS2
−
|OIP5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|myelodysplastic syndrome
 
|-
 
|-
−
|''OVAAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810]
−
|[[ENST00000442621.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060777 HSALNG0060777]
−
|"LINC01131,OVAL"
+
|ST7-AS2
−
|ovarian adenocarcinoma amplified long non-coding RNA
+
|ST7OT2,ST7AS2
−
|ovarian cancer
+
|NA
 +
|pathogenic process
 +
|autism
 
|-
 
|-
−
|''PACERR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813]
−
|[[ENST00000608917.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060778 HSALNG0060778]
−
|"PACER, PTGS2-AS1"
+
|ST7-OT3
−
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
+
|ST7OT3,NCRNA00026
−
|inflammation and cancer
+
|NA
 +
|pathogenic process
 +
|autism
 
|-
 
|-
−
|''PART1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258]
−
|[[ENST00000506884.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142373 HSALNG0142373]
−
|"DKFZP586D0823, NCRNA00206"
+
|ST7-OT4
−
|prostate androgen-regulated transcript 1 (non-protein coding)
+
|NA
−
|prostate carcinogenesis
+
|NA
 +
|pathogenic process
 +
|autism
 
|-
 
|-
−
|''PAUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257]
−
|[[NONHSAT018635]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142372 HSALNG0142372]
−
|N/A
+
|ST7OT
−
|PAX6 upstream antisense RNA
+
|NONHSAT122926
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372]
−
|[[ENST00000412654.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074272 HSALNG0074272]
−
|"DD3, NCRNA00019, PCAT3"
+
|MIR600HG
−
|prostate cancer associated 3 (non-protein coding)
+
|C9orf45,NCRNA00287,GL012,FLJ22161
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239]
−
|[[ENST00000561978.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006325 HSALNG0006325]
−
|"PCAT-1, PCA1"
+
|ATP1A1-AS1
−
|prostate cancer associated transcript 1 (non-protein coding)
+
|C1orf203,ATP1A1OS,MGC16179
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563]
−
|[[ENST00000504263.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0022910 HSALNG0022910]
−
|"GDEP, PCAN1, PCA4"
+
|SPATA3-AS1
−
|prostate cancer associated transcript 4 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859]
−
|[[ENST00000452148.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0024100 HSALNG0024100]
−
|PCAN-R2
+
|LINC00852
−
|prostate cancer associated transcript 7 (non-protein coding)
+
|C3orf42,GHRLOS2,NAG73,GHRL-AS2
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRNCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395]
−
|[[NONHSAT129019]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0033002 HSALNG0033002]
−
|N/A
+
|LINC01096
−
|prostate cancer associated non-coding RNA 1
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367]
−
|[[ENST00000430058.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034486 HSALNG0034486]
−
|N/A
+
|LINC02260
−
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259]
−
|[[ENST00000556013.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036896 HSALNG0036896]
−
|N/A
+
|LINC01091
−
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PVT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480]
−
|[[ENST00000513868.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046004 HSALNG0046004]
−
|"NCRNA00079, LINC00079, onco-lncRNA-100"
+
|SAP30L-AS1
−
|Pvt1 oncogene (non-protein coding)
+
|FLJ38109,GALNT10-AS1
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558]
−
|[[NONHSAT040920]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046927 HSALNG0046927]
−
|NCRNA00198
+
|PRR7-AS1
−
|Prader-Willi region non-protein coding RNA 1
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356]
−
|[[NONHSAT040875]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0047338 HSALNG0047338]
−
|NCRNA00199
+
|LINC01622
−
|Prader-Willi region non-protein coding RNA 2
+
|TCONS_00011202
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RASSF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415]
−
|[[RASSF1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053588 HSALNG0053588]
−
|RASSF1 antisense RNA 1
+
|LINC01312
−
|ANRASSF1
+
|MGC34034
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCAANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652]
−
|[[SCAANT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0064240 HSALNG0064240]
−
|SCA7/ATXN7 antisense RNA 1
+
|EXTL3-AS1
−
|ATXN7-AS1
+
|C8orf50
−
|Spinocerebellar ataxia type 7
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCHLAP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253]
−
|[[NONHSAT075852]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065979 HSALNG0065979]
−
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
+
|C8orf34-AS1
−
|"SChLAP1,PCAT11"
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876]
−
|[[ENST00000526269.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074139 HSALNG0074139]
−
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
+
|PSMD5-AS1
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TARID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228]
−
|[[ENST00000607033.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0078227 HSALNG0078227]
−
|N/A
+
|LINC01553
−
|TCF21 antisense RNA inducing promoter demethylation
+
|C10orf40,AC023904.2
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WFDC21P''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689]
−
|[[Lnc-HEATR6-1:4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084463 HSALNG0084463]
−
|"WAP four-disulfide core domain 21, pseudogene"
+
|LINC00301
−
|"LOC645638, lnc-DC, LNCDC"
+
|C11orf64,NCRNA00301,MGC39681
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235]
−
|[[NONHSAT007663]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119722 HSALNG0119722]
−
|"SNHG2, ENSG00000234741"
+
|DLGAP1-AS3
−
|_
+
|NA
−
|autoimmune disease, breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIAT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200]
−
|[[lnc-CRYBA4-2:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0123001 HSALNG0123001]
−
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
+
|CIRBP-AS1
−
|myocardial infarction associated transcript (non-protein coding)
+
|C19orf23,MGC39338
−
|myocardial infarction
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''H19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335]
−
|[[NONHSAT017465]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124987 HSALNG0124987]
−
|"Q96MK8,ENSG00000130600"
+
|LINC01785
−
|"H19, imprinted maternally expressed transcript (non-protein coding)"
+
|NA
−
|bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582]
−
|[[lnc-BIRC7-2:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127139 HSALNG0127139]
−
|"HAR1F, ENSG00000238820"
+
|LINC01869
−
|highly accelerated region 1A
+
|MGC45922
−
|Huntington's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743]
−
|[[ENST00000447910.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131262 HSALNG0131262]
−
|"HAR1R, ENSG00000231133"
+
|LINC01711
−
|highly accelerated region 1B
+
|MGC4294
−
|Huntington's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468]
−
|[[NONHSAT028508]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141311 HSALNG0141311]
−
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
+
|FAM41AY1
−
|Hox antisense intergenic RNA
+
|FAM41AY
−
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIRM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899]
−
|[[lnc-EVX1-12:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045020 HSALNG0045020]
−
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
+
|C5orf66-AS2
−
|"HOXA transcript antisense RNA, myeloid-specific 1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTTIP''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922]
−
|[[NONHSAT119717]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083517 HSALNG0083517]
−
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
+
|CSTF3-AS1
−
|HOXA transcript at the distal tip
+
|CSTF3-DT
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|_
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923]
−
|''HOXA11-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014289 HSALNG0014289]
−
|[[NONHSAT119704]]
+
|CYP1B1-AS1
−
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
+
|C2orf58,MGC34824
−
|HOXA11 antisense RNA
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0025315 HSALNG0025315]
 +
|ENTPD3-AS1
 +
|FLJ36665
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970]
−
|[[NONHSAT119676]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071511 HSALNG0071511]
−
|"HOXA3as, ENSG00000253552"
+
|FAM27E3
−
|HOXA cluster antisense RNA 2
+
|MGC42630
−
|leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972]
−
|[[lnc-EVX1-9:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000046 HSALNG0000046]
−
|HOXA6as
+
|FAM41C
−
|HOXA cluster antisense RNA 3
+
|NA
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HULC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977]
−
|[[NONHSAT107640]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007223 HSALNG0007223]
−
|ENSG00000251164
+
|FLG-AS1
−
|hepatocellular carcinoma up-regulated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma, liver cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IPW''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983]
−
|[[NONHSAT041063]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105871 HSALNG0105871]
−
|NCRNA00002
+
|GABPB1-IT1
−
|imprinted in Prader-Willi syndrome
+
|FLJ10038
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JPX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010]
−
|[[lnc-ZCCHC13-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0123950 HSALNG0123950]
−
|"DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183"
+
|ILF3-AS1
−
|"JPX transcript, XIST activator (non-protein coding)"
+
|ILF3-DT
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNQ1OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034]
−
|[[NONHSAT017524]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097943 HSALNG0097943]
−
|"KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12"""
+
|LINC00347
−
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
+
|NA
−
|Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KRASP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039]
−
|[[NONHSAT113225]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004105 HSALNG0004105]
−
|ENSG00000220635
+
|LINC00466
−
|KRAS Pseudogene 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FALEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040]
−
|[[ENST00000416894.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0022951 HSALNG0022951]
−
|"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1"
+
|LINC00471
−
|focally amplified long non-coding RNA in epithelial cancer
+
|C2orf52,MGC43122
−
|ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''lincRNA-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044]
−
|[[NONHSAT059436]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119752 HSALNG0119752]
−
|"ROR, lincRNA-ST8SIA3, ENSG00000258609"
+
|LINC00526
−
|"long intergenic non-protein coding RNA, regulator of reprogramming"
+
|C18orf18,MGC17515,HsT959
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LOC100887755''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048]
−
|[[lnc-SNAI1-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106873 HSALNG0106873]
−
|"Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1"
+
|LINC00593
−
|translation regulatory long non-coding RNA 1
+
|C15orf50,MGC42951
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUSC7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050]
−
|[[NONHSAT091315]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0022320 HSALNG0022320]
−
|"LINC00902, LOC285194, ENSG00000243197"
+
|LINC00608
−
|tumor suppressor candidate 7 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RBM5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054]
−
|[[NONHSAT089783]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104144 HSALNG0104144]
−
|"LUCA-15-specific transcript, LUST, ENSG00000003756"
+
|LINC00638
−
|RBM5 antisense RNA 1
+
|MGC23270
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MALAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056]
−
|[[ENST00000534336.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124410 HSALNG0124410]
−
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
+
|LINC00661
−
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
+
|NA
−
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''mascRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057]
−
|[[lnc-SCYL1-1:5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0125113 HSALNG0125113]
−
|Malat1
+
|LINC00662
−
|mascRNA (MALAT1-associated small cytoplasmic RNA)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062]
−
|[[NONHSAT039745]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0024755 HSALNG0024755]
−
|"Gtl2, ENSG00000214548"
+
|LINC00692
−
|maternally expressed 3 (non-protein coding)
+
|NA
−
|Wilms' tumour,multiple myeloma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ncR-PAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064]
−
|[[NONHSAT102247]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075805 HSALNG0075805]
−
|"NCRUPAR, ENSG00000225407"
+
|LINC00705
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NDM29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067]
−
|[[lnc-C11orf16-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118878 HSALNG0118878]
−
|29A
+
|LINC00868
−
|"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))."
+
|C17orf52
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GNAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693]
−
|[[lnc-CTSZ-5:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062275 HSALNG0062275]
−
|"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590"
+
|LINC00996
−
|neuroendocrine secretory protein (Nesp) antisense.
+
|NA
−
|pseudohypoparathyroidism type Ib
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101]
−
|[[NONHSAT134764]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089327 HSALNG0089327]
−
|ENSG00000253079
+
|LINC01252
−
|"non-protein coding RNA, repressor of NFAT"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NTT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131]
−
|[[NONHSAT115106]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113283 HSALNG0113283]
−
|N/A
+
|LINC02135
−
|noncoding transcript in T cells.
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OTX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193]
−
|[[lnc-C14orf101-5:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018445 HSALNG0018445]
−
|"OTX2OS1, ENSG00000248550"
+
|NIFK-AS1
−
|OTX2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PANDAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244]
−
|[[lnc-CDKN1A-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008972 HSALNG0008972]
−
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
+
|SMG7-AS1
−
|promoter of CDKN1A antisense DNA damage activated RNA
+
|DKFZP564C196
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCGEM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326]
−
|[[NONHSAT076153]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113528 HSALNG0113528]
−
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
+
|SNAI3-AS1
−
|Prostate-specific transcript 1
+
|MGC23284
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00853''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205]
−
|[[ENST00000429328.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103442 HSALNG0103442]
−
|"PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805"
+
|SNHG10
−
|long intergenic non-protein coding RNA 853
+
|C14orf62,FLJ40557,NCRNA00063,LINC00063
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRINS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290]
−
|[[NONHSAT011777]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0109122 HSALNG0109122]
−
|ENSG00000238115
+
|ZNF205-AS1
−
|Psoriasis susceptibility-related RNA Gene Induced by Stress
+
|MGC3771
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTENP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294]
−
|[[NONHSAT130775]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009820 HSALNG0009820]
−
|"PTENpg1, PTEN2, ENSG00000237984"
+
|LINC00260
−
|PTEN Pseudogene 1
+
|C1orf217,NCRNA00260,MGC5457
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295]
−
|[[ENST00000553584.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000511 HSALNG0000511]
−
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
+
|LINC00337
−
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
+
|C1orf211,NCRNA00337,MGC40168
−
|Prader-Willi/Angelman syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00599''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298]
−
|[[lnc-TNKS-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0076905 HSALNG0076905]
−
|"retinal non-coding RNA 3, Rncr3, ENSG00000253230"
+
|WAC-AS1
−
|"Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAS-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299]
−
|[[NONHSAT015489]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077486 HSALNG0077486]
−
|"SAF, ENSG00000026103"
+
|LINC00839
−
|FAS antisense RNA 1
+
|NA
−
|B-cell lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATXN8OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303]
−
|[[NONHSAT034251]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089110 HSALNG0089110]
−
|"NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223"
+
|LINC00612
−
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
+
|C12orf33,MGC40170,FLJ41814
−
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312]
−
|[[NONHSAT021826]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124755 HSALNG0124755]
−
|"UHG, ENSG00000255717"
+
|LINC00663
−
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
+
|MGC39821
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320]
−
|[[lnc-OR10H5-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130611 HSALNG0130611]
−
|"U17HG, linc1343, ENSG00000242125"
+
|LINC00494
−
|Small nucleolar RNA host gene 3
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330]
−
|[[NONHSAT104072]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039733 HSALNG0039733]
−
|"U19H, ENSG00000200959"
+
|LINC01019
−
|Small nucleolar RNA host gene 4
+
|NA
−
|myelodysplastic syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333]
−
|[[NONHSAT054526]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057380 HSALNG0057380]
−
|"U50HG, ENSG00000203875"
+
|LINC00265
−
|Small nucleolar RNA host gene 5
+
|NCRNA00265,NCRNA00265-1
−
|lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334]
−
|[[lnc-TCF24-2:3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062824 HSALNG0062824]
−
|"U87HG, ENSG00000245910"
+
|LINC00689
−
|Small nucleolar RNA host gene 6
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SPRY4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337]
−
|[[lnc-NDFIP1-3:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068847 HSALNG0068847]
−
|"AK024556, ENSG00000274721"
+
|LINC01591
−
|SPRY4 intronic transcript 1 (non-protein coding)
+
|NA
−
|melanoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SRA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340]
−
|[[lnc-SRA1-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072666 HSALNG0072666]
−
|"SRA1, ENSG00000213523"
+
|LINC01501
−
|Steroid receptor RNA Activator
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TEA-ncRNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346]
−
|[[NONHSAT035776]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137712 HSALNG0137712]
−
|ENSG00000251002
+
|LINC01560
−
|T early alpha
+
|CXorf24
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IFNG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352]
−
|[[ENST00000538665.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045051 HSALNG0045051]
−
|"LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733"
+
|LINC01959
−
|IFNG antisense RNA 1
+
|NA
−
|multiple sclerosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TncRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353]
−
|[[NONHSAT022116]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0110333 HSALNG0110333]
−
|TSU
+
|LINC02175
−
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354]
−
|[[NONHSAT084827]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0064321 HSALNG0064321]
−
|ENSG00000253352
+
|LINC02209
−
|taurine up-regulated gene 1
+
|FAM183CP
−
|B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''UCA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359]
−
|[[lnc-OR10H5-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0107406 HSALNG0107406]
−
|"UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049"
+
|LINGO1-AS1
−
|urothelial cancer associated 1 (non-protein coding)
+
|NA
−
|bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma,  tongue squamous cell carcinomas
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNIP4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362]
−
|[[NONHSAT095745]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119342 HSALNG0119342]
−
|"non coding transcript UM9(5), UM9-5"
+
|MAFG-AS1
−
|KCNIP4 intronic transcript 1 (non-protein coding)
+
|MAFG-DT
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373]
−
|[[lnc-EIF3M-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0139326 HSALNG0139326]
−
|"WIT1, ENSG00000183242"
+
|MORF4L2-AS1
−
|WT1 (Wilms' tumor 1) antisense transcript
+
|NA
−
|gastric cancer, hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''XIST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381]
−
|[[NONHSAT137541]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029035 HSALNG0029035]
−
|ENSG00000229807
+
|NPHP3-AS1
−
|X inactive-specific transcript
+
|NCRNA00119
−
|Trisomy 21, bladder cancer, breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZEB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385]
−
|[[NONHSAT074775]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062543 HSALNG0062543]
−
|"Zeb2NAT, ENSG00000238057"
+
|PAXIP1-AS1
−
|Zeb2 natural antisense transcript
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZFAS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413]
−
|[[NONHSAT080206]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082091 HSALNG0082091]
−
|"Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410"
+
|TOLLIP-AS1
−
|ZNFX1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Zfhx2as''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416]
−
|[[ENST00000554403.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113198 HSALNG0113198]
−
|"Zfh-5AS, ENSG00000157306"
+
|LINC00311
−
|"zinc finger homeobox 2, antisense"
+
|TMEM148,NCRNA00311,MGC22001
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TMEM161B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422]
−
|[[lnc-RASA1-3:23]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069500 HSALNG0069500]
−
[[lnc-RASA1-3:25]]
+
|ZNF252P-AS1
−
|"AK082072,linc-POLR3G-8, ENSG00000247828"
+
|C8orf77
−
|TMEM161B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/ Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423]
−
|[[NONHSAT104559]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001624 HSALNG0001624]
−
[[lnc-NDST1-1:2]]
+
|ZNF436-AS1
−
|N/A
+
|C1orf213,FLJ90508
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''CDKN2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429]
−
|[[NONHSAT130421]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029047 HSALNG0029047]
−
[[lnc-C9orf53-2:1]]
+
|BFSP2-AS1
−
|"ANRIL, p15AS, ENSG00000240498"
+
|MGC2848
−
|CDKN2B antisense RNA 1
+
|NA
−
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
+
|NA
 +
|NA
 
|-
 
|-
−
|''BACE1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432]
−
|[[NONHSAT024403]],[[lnc-RNF214-1:2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032263 HSALNG0032263]
−
|"BACE1AS,NCRNA00177; FJ573250"
+
|CTBP1-AS1
−
|BACE1 antisense RNA
+
|C4orf42,CTBP1-DT,CTBP1-DT,MGC21675
−
|Alzheimer's disease,
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Beta-globin transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436]
−
|[[NONHSAT017676]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039444 HSALNG0039444]
−
[[NONHSAT017675]],
+
|EXOC3-AS1
−
[[NONHSAT017674]]
+
|C5orf55
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 
|-
 
|-
−
|''LINC00581''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441]
−
|[[lnc-PRL-6:2]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049246 HSALNG0049246]
−
[[lnc-PRL-6:1]]
+
|HCG27
−
|"BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678"
+
|bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
−
|long intergenic non-protein coding RNA 581
+
|NA
−
|West Syndrome
+
|NA
 +
|NA
 
|-
 
|-
−
|''CAR Intergenic 10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450]
−
|[[NONHSAT016928]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0067505 HSALNG0067505]
−
[[lnc-FANK1-3:1]]
+
|BAALC-AS2
−
|"Intergenic10, CR611911, AK055628"
+
|C8orf56,BAALCOS,MGC39526
−
|Chromatin Associated RNA 10
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''DIO3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453]
−
|[[NONHSAT040032]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062877 HSALNG0062877]
−
[[NONHSAT040039]]
+
|FAM87A
−
|"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498"
+
|NA
−
|DIO3 opposite strand/antisense RNA (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459]
−
|[[PCAT6]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0078365 HSALNG0078365]
−
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
+
|JMJD1C-AS1
−
|N/A
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00570''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465]
−
|[[ENST00000417473.2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0092957 HSALNG0092957]
−
|"KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177,"
+
|ATP2B1-AS1
−
|prostate cancer associated transcript 6 (non-protein coding)
+
|LINC00936
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NEAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466]
−
|[[ENST00000501122.2]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0093183 HSALNG0093183]
−
[[NONHSAT022111]]
+
|CEP83-AS1
−
|"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532"
+
|CEP83-DT
−
|Nuclear enriched abundant transcript 1.
+
|NA
−
|infertility
+
|NA
 +
|NA
 
|-
 
|-
−
|''ST7OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470]
−
|[[NONHSAT122926]],
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0107054 HSALNG0107054]
−
[[NONHSAT122918]],
+
|HEXA-AS1
−
[[NONHSAT122914]],
+
|C15orf34,FLJ13315
−
[[NONHSAT122932]]
+
|NA
−
|"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188"
+
|NA
−
|N/A
+
|NA
−
|_
 
 
|-
 
|-
−
|''snaR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487]
−
|[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141598 HSALNG0141598]
−
|small NF90-associated RNAs
+
|BIN3-IT1
−
|small NF90-associated RNAs
+
|FLJ14107
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Y RNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490]
−
|[[lnc-PDIA4-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141601 HSALNG0141601]
−
|N/A
+
|CSNK1G2-AS1
−
|N/A
+
|C19orf34,MGC39696
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PR antisense transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508]
−
|[[NONHSAT023851]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141619 HSALNG0141619]
−
|N/A
+
|LINC00634
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAM3D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510]
−
|[[FAM3D-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141621 HSALNG0141621]
−
|lnc-KCTD6-3
+
|LINC00685
−
|FAM3D antisense RNA 1
+
|CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
−
|head and neck squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SHANK2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515]
−
|[[SHANK2-AS3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141626 HSALNG0141626]
−
|N/A
+
|SHANK2-AS3
−
|SHANK2 antisense RNA 3
+
|C11orf76
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AATBC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073]
−
|[[AATBC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142188 HSALNG0142188]
−
|N/A
+
|NCBP2-AS2
−
|apoptosis associated transcript in bladder cancer
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502]
−
|[[ABHD11-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141613 HSALNG0141613]
−
|NCRNA00035
+
|KCNIP4-IT1
−
|ABHD11 antisense RNA 1 (tail to tail)
+
|NCRNA00099,UM9-5
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABHD15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856]
−
|[[ABHD15-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141971 HSALNG0141971]
−
|"linc-TP53I13, lnc-TP53I13"
+
|GTSCR1
−
|ABHD15 antisense RNA 1
+
|NA
−
|cardiometabolic diseases
+
|NA
 +
|pathogenic process
 +
|Gilles de la Tourette syndrome
 
|-
 
|-
−
|''ACTA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325]
−
|[[ACTA2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008917 HSALNG0008917]
−
|"uc001kfo.1, ZXF1"
+
|LINC00272
−
|ACTA2 antisense RNA 1
+
|C1orf120,NCRNA00272,RP1-223H12.3
−
|lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''ADAMTS9-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512]
−
|[[ADAMTS9-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141348 HSALNG0141348]
−
|N/A
+
|TTTY9B
−
|ADAMTS9 antisense RNA 2
+
|NCRNA00132
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ADORA2A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155]
−
|[[ADORA2A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142270 HSALNG0142270]
−
|FLJ34651
+
|Prion-associated RNAs
−
|ADORA2A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prion disease
 
|-
 
|-
−
|''AFAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444]
−
|[[AFAP1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062567 HSALNG0062567]
−
|MGC10981
+
|BLACE
−
|AFAP1 antisense RNA 1
+
|NA
−
|Barrett's esophagus and esophageal adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|acute B lymphoblastic leukemias
 
|-
 
|-
−
|''AGAP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411]
−
|[[AGAP2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0028877 HSALNG0028877]
−
|"LOC100130776, PUNISHER"
+
|H1FX-AS1
−
|AGAP2 antisense RNA 1
+
|C3orf47,FLJ34151
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668]
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089868 HSALNG0089868]
−
|N/A
+
|LINC00477
−
|N/A
+
|C12orf67,FLJ32894,FAM191B
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ANP32A-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096]
−
|[[ANP32A-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133923 HSALNG0133923]
−
|"FLJ11722, HsT18971"
+
|LINC00528
−
|ANP32A intronic transcript 1
+
|C22orf37,FLJ40542
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ARRDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824]
−
|[[ARRDC1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140941 HSALNG0140941]
−
|N/A
+
|ASMTL-AS1
−
|ARRDC1 antisense RNA 1
+
|CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASAP1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887]
−
|[[ASAP1-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106820 HSALNG0106820]
−
|"HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT"
+
|ANP32A-IT1
−
|ASAP1 intronic transcript 1
+
|C15orf28,NCRNA00321,FLJ11722,HsT18971
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASMTL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNT0289370]
−
|[[ASMTL-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010128 HSALNG0010128]
−
|FLJ13330
+
|MIR29B2CHG
−
|ASMTL antisense RNA 1
+
|C1orf132,FLJ35650
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATP1A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396]
−
|[[ATP1A1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007497 HSALNG0007497]
−
|MGC16179
+
|RUSC1-AS1
−
|ATP1A1 antisense RNA 1
+
|C1orf104,FLJ35976
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''B3GALT5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628]
−
|[[B3GALT5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0040236 HSALNG0040236]
−
|N/A
+
|LINC01194
−
|B3GALT5 antisense RNA 1
+
|CT49,TAG
−
|_
+
|NA
 +
|pathogenic process
 +
|melanoma
 
|-
 
|-
−
|''B4GALT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468]
−
|[[B4GALT1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103838 HSALNG0103838]
−
|N/A
+
|DIO3OS
−
|B4GALT1 antisense RNA 1
+
|C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BAALC-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060]
−
|[[BAALC-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057178 HSALNG0057178]
−
|MGC39526
+
|NPSR1-AS1
−
|BAALC antisense RNA 2
+
|AAA1,IMAGE:4827585
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370]
−
|[[BCAR4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035535 HSALNG0035535]
−
|N/A
+
|LINC00575
−
|breast cancer anti-estrogen resistance 4 (non-protein coding)
+
|C4orf11
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''BFSP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345]
−
|[[BFSP2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065537 HSALNG0065537]
−
|MGC2848
+
|LINC01602
−
|BFSP2 antisense RNA 1
+
|T1560
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''BGLT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433]
−
|[[BGLT3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035768 HSALNG0035768]
−
|"LINC01083, BGL3, lncRNA-BGL3"
+
|FAM13A-AS1
−
|beta globin locus transcript 3 (non-protein coding)
+
|FAM13A1OS,FAM13AOS,NCRNA00039
−
|Bcr-Abl-positive leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIN3-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186]
−
|[[BIN3-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072891 HSALNG0072891]
−
|FLJ14107
+
|MIRLET7DHG
−
|BIN3 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254]
−
|[[BIRC6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074353 HSALNG0074353]
−
|N/A
+
|MIR181A2HG
−
|BIRC6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283]
−
|[[BIRC6-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035624 HSALNG0035624]
−
|megamind
+
|WDFY3-AS2
−
|BIRC6 antisense RNA 2
+
|C4orf12,NCRNA00247,FBI4
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BISPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555]
−
|[[BISPR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073990 HSALNG0073990]
−
|N/A
+
|PAPPA-AS1
−
|BST2 interferon stimulated positive regulator (non-protein coding)
+
|PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BOK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307]
−
|[[BOK-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065020 HSALNG0065020]
−
|"NCRNA00151, NAToB"
+
|LINC00293
−
|BOK antisense RNA 1
+
|BEYLA
−
|testicular cancer
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''BRWD1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983]
−
|[[BRWD1-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014614 HSALNG0014614]
−
|N/A
+
|SIX3-AS1
−
|BRWD1 antisense RNA 2
+
|SIX3OS
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''C1QTNF9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503]
−
|[[C1QTNF9B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101546 HSALNG0101546]
−
|PCOTH
+
|OTX2-AS1
−
|C1QTNF9B antisense RNA 1
+
|OTX2OS1
−
|prostate cancer
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''C21orf91-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422]
−
|[[C21orf91-OT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0030360 HSALNG0030360]
−
|D21S2089E
+
|LINC01192
−
|C21orf91 overlapping transcript 1
+
|CT64
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C5orf66-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123]
−
|[[C5orf66-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104394 HSALNG0104394]
−
|"CTC-276P9.1, Epist"
+
|LINC01193
−
|C5orf66 antisense RNA 1
+
|CT60,LOC348120
−
|esophageal squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C5orf66-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664]
−
|[[C5orf66-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141779 HSALNG0141779]
−
|N/A
+
|C1QTNF9B-AS1
−
|C5orf66 antisense RNA 2
+
|PCOTH
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''C8orf34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623]
−
|[[C8orf34-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141738 HSALNG0141738]
−
|N/A
+
|ATP6V1G2-DDX39B
−
|C8orf34 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|dilated cardiomyopathy
 
|-
 
|-
−
|''CACNA1G-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498]
−
|[[CACNA1G-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141609 HSALNG0141609]
−
|N/A
+
|FAM226B
−
|CACNA1G antisense RNA 1
+
|CXorf50B,NCRNA00246B,LINC00246B
−
| keloid
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CAPN10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321]
−
|[[CAPN10-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133590 HSALNG0133590]
−
|locus959
+
|LINC00163
−
|CAPN10 antisense RNA 1 (head to head)
+
|C21orf134,NCRNA00163,NLC1-A,NLC1A
−
|_
+
|NA
 +
|pathogenic process
 +
|narcolepsy
 
|-
 
|-
−
|''CARD8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505]
−
|[[CARD8-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141616 HSALNG0141616]
−
|LOC100505812
+
|LINC00165
−
|CARD8 antisense RNA 1
+
|C21orf135,NCRNA00165,NLC1-B
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARMN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297]
−
|[[CARMN]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142412 HSALNG0142412]
−
|CARMEN
+
|TEA-ncRNAs
−
|cardiac mesoderm enhancer-associated non-coding RNA
+
|ENSG00000251002
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212]
−
|[[CASC11]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133403 HSALNG0133403]
−
|"TCONSN/A00014535, LINC00990, CARLo-7"
+
|LINC00322
−
|cancer susceptibility candidate 11 (non-protein coding)
+
|C21orf136,NCRNA00322,FLJ16545
−
|colorectal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741]
−
|[[CASC15]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141856 HSALNG0141856]
−
|N/A
+
|DHFR upstream transcripts
−
|cancer susceptibility candidate 15 (non-protein coding)
+
|DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
−
|metastatic melanoma, neuroblastoma
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527]
−
|[[CASC19]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141642 HSALNG0141642]
−
|CARLo-6
+
|21A
−
|cancer susceptibility candidate 19 (non-protein coding)
+
|ncRNA 21A,NONHSAT128494
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409]
−
|[[CASC2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0080181 HSALNG0080181]
−
|N/A
+
|TLX1NB
−
|cancer susceptibility candidate 2 (non-protein coding)
+
|TD1,TDI,APT-B7
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|leukemogenesis
 
|-
 
|-
−
|''CASC21''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662]
−
|[[CASC21]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141777 HSALNG0141777]
−
|CARLo-2
+
|C15orf2
−
|cancer susceptibility candidate 21 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Angelman syndrome
 
|-
 
|-
−
|''CASC22''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097]
−
|[[CASC22]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142212 HSALNG0142212]
−
|"TCONSN/A00024290, LincRNA-ENST00000515084"
+
|NPAP1
−
|cancer susceptibility candidate 22 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|Angelman syndrome
 
|-
 
|-
−
|''CASC9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406]
−
|[[CASC9]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104530 HSALNG0104530]
−
|"LINC00981, ESCCAL-1"
+
|PWRN2
−
|cancer susceptibility candidate 9 (non-protein coding)
+
|NCRNA00199
−
|predicted esophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome
 
|-
 
|-
−
|''CBR3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227]
−
|[[CBR3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104528 HSALNG0104528]
−
|PlncRNA-1
+
|PWRN1
−
|CBR3 antisense RNA 1
+
|NCRNA00198
−
|esophageal squamous carcinoma cell
+
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome
 
|-
 
|-
−
|''CCDC18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816]
−
|[[CCDC18-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127793 HSALNG0127793]
−
|ENST00000440778.1
+
|MIMT1
−
|CCDC18 antisense RNA 1
+
|MIM1,NCRNA00067,LINC00067
−
|Adolescent Idiopathic Scoliosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCDC26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180]
−
|[[CCDC26]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000682 HSALNG0000682]
−
|"MGC27434, RAM"
+
|MIR34AHG
−
|CCDC26 long non-coding RNA
+
|NA
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCEPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357]
−
|[[CCEPR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049203 HSALNG0049203]
−
|CCHE1
+
|LINC02570
−
|cervical carcinoma expressed PCNA regulatory lncRNA
+
|XXbac-BPG27H4.8
−
|cervical cancer
+
|NA
 +
|pathogenic process
 +
|MHC-associated diseases
 
|-
 
|-
−
|''CDKN1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177]
−
|[[CDKN1A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142292 HSALNG0142292]
−
|p21NAT
+
|RNY1
−
|CDKN1A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
 
|-
 
|-
−
|''CDR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378]
−
|[[CDR1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129114 HSALNG0129114]
−
|"CDR1NAT, ciRS-7, CDR1as"
+
|NKX2-2-AS1
−
|CDR1 antisense RNA
+
|NKX2-2AS
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''CDRT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151]
−
|[[CDRT7]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142266 HSALNG0142266]
−
|"NCRNA00025, LINC00025"
+
|PR antisense transcripts
−
|CMT1A duplicated region transcript 7 (non-protein coding)
+
|FJ515872.1,NONHSAT023851
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDRT8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290]
−
|[[CDRT8]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0086714 HSALNG0086714]
−
|N/A
+
|PGR-AS1,PR antisense transcripts
−
|CMT1A duplicated region transcript 8
+
|AT1,AT2,AT3
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607]
−
|[[CECR3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141722 HSALNG0141722]
−
|N/A
+
|anti-NOS2A
−
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|NA
 +
|pathogenic process
 +
|meningioma;glioblastoma
 
|-
 
|-
−
|''CECR5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687]
−
|[[CECR5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141802 HSALNG0141802]
−
|NCRNA00017
+
|CDKN1A-AS1
−
|CECR5 antisense RNA 1
+
|p21NAT
−
|cat eye syndrome
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNT0289166]
−
|[[CECR7]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103805 HSALNG0103805]
−
|SAHL1
+
|MEG9
−
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
+
|LINC00584
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668]
−
|[[CECR9]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055114 HSALNG0055114]
−
|N/A
+
|RPS6KA2-AS1
−
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''CEP83-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384]
−
|[[CEP83-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073983 HSALNG0073983]
−
|N/A
+
|PAPPA-AS2
−
|CEP83 antisense RNA 1 (head to head)
+
|AGU1
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CIRBP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802]
−
|[[CIRBP-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127785 HSALNG0127785]
−
|MGC39338
+
|ZIM2-AS1
−
|CIRBP antisense RNA 1
+
|ZIM2as
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CLRN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824]
−
|[[CLRN1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141939 HSALNG0141939]
−
|UCRP
+
|Evf2
−
|CLRN1 antisense RNA 1
+
|Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
−
|Usher syndrome type 3
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''COPG2IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481]
−
|[[COPG2IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134495 HSALNG0134495]
−
|"CIT1, NCRNA00170, COPG2AS"
+
|ADORA2A-AS1
−
|COPG2 imprinted transcript 1 (non-protein coding)
+
|C22orf45,FLJ34651
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CPS1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146]
−
|[[CPS1-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142261 HSALNG0142261]
−
|"PRO0132, CPS1-IT"
+
|POU5F1P4
−
|CPS1 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''CSNK1G2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033]
−
|[[CSNK1G2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142148 HSALNG0142148]
−
|MGC39696
+
|LSINCT1
−
|CSNK1G2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''CSTF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034]
−
|[[CSTF3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142149 HSALNG0142149]
−
|N/A
+
|LSINCT10
−
|CSTF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''CTBP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035]
−
|[[CTBP1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142150 HSALNG0142150]
−
|PCAT10
+
|LSINCT11
−
|CTBP1 antisense RNA
+
|NA
−
| prostate cancer
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''CTBP1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036]
−
|[[CTBP1-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142151 HSALNG0142151]
−
|MGC21675
+
|LSINCT12
−
|CTBP1 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''CYP1B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037]
−
|[[CYP1B1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142152 HSALNG0142152]
−
|MGC34824
+
|LSINCT2
−
|CYP1B1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''CYP51A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038]
−
|[[CYP51A1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142153 HSALNG0142153]
−
|"ENST00000453068, LRRD1-AS1"
+
|LSINCT3
−
|CYP51A1 antisense RNA 1
+
|NA
−
|renal cell carcinoma
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DACOR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039]
−
|[[DACOR1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142154 HSALNG0142154]
−
|TCONSN/A00023265
+
|LSINCT4
−
|DNMT1-associated colon cancer repressed lncRNA 1
+
|NA
−
|colon cancer
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041]
−
|[[DANT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142156 HSALNG0142156]
−
|N/A
+
|LSINCT6
−
|"DXZ4 associated non-coding transcript 1, proximal"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DANT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042]
−
|[[DANT2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142157 HSALNG0142157]
−
|N/A
+
|LSINCT7
−
|"DXZ4 associated non-coding transcript 2, distal"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DAOA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043]
−
|[[DAOA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142158 HSALNG0142158]
−
|G30
+
|LSINCT8
−
|DAOA antisense RNA 1
+
|NA
−
|bipolar illness,schizophrenia
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DAPK1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044]
−
|[[DAPK1-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142159 HSALNG0142159]
−
|N/A
+
|LSINCT9
−
|DAPK1 intronic transcript 1
+
|NA
−
| pancreatic cancer
+
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer
 
|-
 
|-
−
|''DBH-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676]
−
|[[DBH-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141791 HSALNG0141791]
−
|BPR
+
|CAR Intergenic 10
−
|DBH antisense RNA 1
+
|FLJ31066,NONHSAT016928,lnc-FANK1-3:1
−
|hepatocellular carcinoma
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032]
−
|[[DGCR10]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142147 HSALNG0142147]
−
|DGS-B
+
|LRRC3DN
−
|DiGeorge syndrome critical region gene 10 (non-protein coding)
+
|C21orf30,DKFZP434C128
−
|DiGeorge syndrome
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984]
−
|[[DGCR11]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129985 HSALNG0129985]
−
|DGS-D
+
|SNHG11
−
|DiGeorge syndrome critical region gene 11 (non-protein coding)
+
|C20orf198,LINC00101,NCRNA00101
−
|DiGeorge and velo-cardio-facial syndrome
+
|NA
 +
|pathogenic process
 +
|obesity
 
|-
 
|-
−
|''DGCR12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880]
−
|[[DGCR12]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141995 HSALNG0141995]
−
|DGS-E
+
|KRASP1
−
|DiGeorge syndrome critical region gene 12 (non-protein coding)
+
|NONHSAT113225,ENSG00000220635
−
|DiGeorge and velo-cardio-facial syndrome
+
|ceRNA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368]
−
|[[DGCR5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0003376 HSALNG0003376]
−
|"NCRNA00037, LINC00037"
+
|CYP4A22-AS1
−
|DiGeorge syndrome critical region gene 5 (non-protein coding)
+
|ncRNA-a3
−
|DiGeorge syndrome
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470]
−
|[[DGCR9]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0013045 HSALNG0013045]
−
|"DGS-A, POM121L5P"
+
|LINC00570
−
|DiGeorge syndrome critical region gene 9 (non-protein coding)
+
|ncRNA-a5
−
|DiGeorge syndrome
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DIAPH2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066]
−
|[[DIAPH2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0003381 HSALNG0003381]
−
|N/A
+
|LINC00853
−
|DIAPH2 antisense RNA 1
+
|PDZK1IP1-AS1,ncRNA-a4
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DISC1FP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936]
−
|[[DISC1FP1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142051 HSALNG0142051]
−
|N/A
+
|lincRNA-ROR
−
|DISC1 fusion partner 1 (non-protein coding)
+
|ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705]
−
|[[DLG2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141820 HSALNG0141820]
−
|"PSZA11q14, SZ-1"
+
|CHL1-AS2
−
|DLG2 antisense RNA 1
+
|NA
−
|schizophrenia
+
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis
 
|-
 
|-
−
|''DLGAP1-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084]
−
|[[DLGAP1-AS3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036316 HSALNG0036316]
−
|N/A
+
|SEC24B-AS1
−
|DLGAP1 antisense RNA 3
+
|1/2-SBSRNA4
−
|_
+
|siRNA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLX6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137]
−
|[[DLX6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142252 HSALNG0142252]
−
|"FLJ34048, Evf-2"
+
|PDZRN3-AS1
−
|DLX6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 
|-
 
|-
−
|''DNM3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237]
−
|[[DNM3OS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142352 HSALNG0142352]
−
|"MIR199A2HG, DNM3-AS1"
+
|SCAANT1
−
|DNM3 opposite strand/antisense RNA
+
|ATXN7-AS1
−
|Sézary syndrome
+
|transcriptional regulation
 +
|pathogenic process
 +
|spinocerebellar ataxia
 
|-
 
|-
−
|''DRAIC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594]
−
|[[DRAIC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141709 HSALNG0141709]
−
|N/A
+
|AK123790
−
|"downregulated RNA in cancer, inhibitor of cell invasion and migration"
+
|NA
−
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''DSCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911]
−
|[[DSCR10]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142026 HSALNG0142026]
−
|N/A
+
|LINC01451
−
|Down syndrome critical region 10 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''DSCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401]
−
|[[DSCR9]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142516 HSALNG0142516]
−
|NCRNA00038
+
|ZNF350-AS1
−
|Down syndrome critical region 9 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''DUBR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845]
−
|[[DUBR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141960 HSALNG0141960]
−
|N/A
+
|GADD45G
−
|DPPA2 upstream binding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|pituitary adenoma
 
|-
 
|-
−
|''EGFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410]
−
|[[EGFR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043357 HSALNG0043357]
−
|N/A
+
|TMEM161B-AS1
−
|EGFR antisense RNA 1
+
|AK082072,linc-POLR3G-8,ENSG00000247828
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ELFN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736]
−
|[[ELFN1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141851 HSALNG0141851]
−
|N/A
+
|DAPK1
−
|ELFN1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''ENTPD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048]
−
|[[ENTPD3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142163 HSALNG0142163]
−
|FLJ36665
+
|MAP3K14
−
|ENTPD3 antisense RNA 1
+
|MAP3K14
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''EPB41L4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150]
−
|[[EPB41L4A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142265 HSALNG0142265]
−
|TIGA1
+
|PPP3CB
−
|EPB41L4A antisense RNA 1
+
|NA
−
|cancer
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''EPB41L4A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531]
−
|[[EPB41L4A-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072477 HSALNG0072477]
−
|FLJ11235
+
|DAPK1-IT1
−
|EPB41L4A antisense RNA 2 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''ERC2-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990]
−
|[[ERC2-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041256 HSALNG0041256]
−
|Po42
+
|GDNF-AS1
−
|ERC2 intronic transcript 1
+
|GDNFOS
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''ERICH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702]
−
|[[ERICH1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014093 HSALNG0014093]
−
|N/A
+
|BIRC6-AS2
−
|ERICH1 antisense RNA 1
+
|megamind
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''EWSAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692]
−
|[[EWSAT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014085 HSALNG0014085]
−
|FLJ33768
+
|BIRC6-AS1
−
|Ewing sarcoma associated transcript 1
+
|NA
−
|Ewing sarcoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EXOC3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310]
−
|[[EXOC3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0116623 HSALNG0116623]
−
|N/A
+
|LINC00854
−
|EXOC3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EXTL3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332]
−
|[[EXTL3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142447 HSALNG0142447]
−
|N/A
+
|uc.73
−
|EXTL3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''F11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841]
−
|[[F11-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141956 HSALNG0141956]
−
|N/A
+
|FR0257520
−
|F11 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''FAM138A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104]
−
|[[FAM138A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142219 HSALNG0142219]
−
|F379
+
|NRG1
−
|family with sequence similarity 138 member A
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''FAM138B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689]
−
|[[FAM138B]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141804 HSALNG0141804]
−
|F379
+
|CDKN2B-AS11
−
|family with sequence similarity 138 member B
+
|NA
−
|_
+
|NA
 +
|pathogenic process;developmental process
 +
|stroke
 
|-
 
|-
−
|''FAM138C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690]
−
|[[FAM138C]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141805 HSALNG0141805]
−
|F379
+
|CDKN2B-AS12
−
|family with sequence similarity 138 member C
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''FAM138D''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691]
−
|[[FAM138D]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141806 HSALNG0141806]
−
|F379
+
|CDKN2B-AS13
−
|family with sequence similarity 138 member D
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|plexiform neurofibroma
 
|-
 
|-
−
|''FAM138E''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697]
−
|[[FAM138E]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141812 HSALNG0141812]
−
|F379
+
|CDKN2B-AS7
−
|family with sequence similarity 138 member E
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''FAM138F''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826]
−
|[[FAM138F]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141941 HSALNG0141941]
−
|F379
+
|FADS1
−
|family with sequence similarity 138 member F
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lipid metabolism disorder
 
|-
 
|-
−
|''FAM13A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698]
−
|[[FAM13A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141813 HSALNG0141813]
−
|NCRNA00039
+
|CDKN2B-AS8
−
|FAM13A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|melanoma
 
|-
 
|-
−
|''FAM201A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696]
−
|[[FAM201A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141811 HSALNG0141811]
−
|N/A
+
|CDKN2B-AS6
−
|family with sequence similarity 201 member A
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''FAM215A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699]
−
|[[FAM215A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141814 HSALNG0141814]
−
|"APR-2, LINC00530"
+
|CDKN2B-AS9
−
|family with sequence similarity 215 member A (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''FAM222A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688]
−
|[[FAM222A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141803 HSALNG0141803]
−
|N/A
+
|CDKN2B-AS10
−
|FAM222A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|stroke
 
|-
 
|-
−
|''FAM226A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950]
−
|[[FAM226A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031716 HSALNG0031716]
−
|MGC34827
+
|ENST00000456816
−
|family with sequence similarity 226 member A (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''FAM226B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021]
−
|[[FAM226B]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142136 HSALNG0142136]
−
|N/A
+
|LOC389332
−
|family with sequence similarity 226 member B (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''FAM27E3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306]
−
|[[FAM27E3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142421 HSALNG0142421]
−
|MGC42630
+
|TMEM72
−
|family with sequence similarity 27 member E3
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''FAM41AY1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641]
−
|[[FAM41AY1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141756 HSALNG0141756]
−
|N/A
+
|BC029135
−
|"family with sequence similarity 41 member A, Y-linked 1"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal clear cell cancer
 
|-
 
|-
−
|''FAM41C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374]
−
|[[FAM41C]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142489 HSALNG0142489]
−
|N/A
+
|X91348
−
|family with sequence similarity 41 member C
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal clear cell cancer
 
|-
 
|-
−
|''FAM66C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694]
−
|[[FAM66C]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141809 HSALNG0141809]
−
|N/A
+
|CDKN2B-AS4
−
|family with sequence similarity 66 member C
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cancer
 
|-
 
|-
−
|''FAM74A3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692]
−
|[[FAM74A3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141807 HSALNG0141807]
−
|OTTHUMG00000067149
+
|CDKN2B-AS2
−
|family with sequence similarity 74 member A3
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|coronary heart disease
 
|-
 
|-
−
|''FAM83H-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693]
−
|[[FAM83H-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141808 HSALNG0141808]
−
|onco-lncRNA-3
+
|CDKN2B-AS3
−
|FAM83H antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|intracranial aneurysm
 
|-
 
|-
−
|''FAM87A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695]
−
|[[FAM87A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141810 HSALNG0141810]
−
|N/A
+
|CDKN2B-AS5
−
|family with sequence similarity 87 member A
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 
|-
 
|-
−
|''FAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319]
−
|[[FAS-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142434 HSALNG0142434]
−
|SAF
+
|T-UCRs
−
|FAS antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''FGF10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530]
−
|[[FGF10-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141645 HSALNG0141645]
−
|RP11-473L15.2
+
|51A
−
|FGF10 antisense RNA 1
+
|NA
−
|_
+
|splicing regulation
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''FLG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163]
−
|[[FLG-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142278 HSALNG0142278]
−
|N/A
+
|RAB4B-EGLN2
−
|FLG antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cancer
 
|-
 
|-
−
|''FLVCR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167]
−
|[[FLVCR1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142282 HSALNG0142282]
−
|LQK1
+
|RERT
−
|FLVCR1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''FMR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263]
−
|[[FMR1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129088 HSALNG0129088]
−
|"ASFMR1, FMR4"
+
|LINC00237
−
|FMR1 antisense RNA 1
+
|NCRNA00237
−
|_
+
|NA
 +
|pathogenic process
 +
|macrocephaly;obesity
 
|-
 
|-
−
|''FOXC2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186]
−
|[[FOXC2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130081 HSALNG0130081]
−
|ODRUL
+
|LINC01370
−
|FOXC2 antisense RNA 1
+
|HI-LNC25,HILNC25
−
|osteosarcoma
+
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 
|-
 
|-
−
|''FOXG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114]
−
|[[FOXG1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046884 HSALNG0046884]
−
|FOXG1-AS
+
|LINC01574
−
|FOXG1 antisense RNA 1 (head to head)
+
|HI-LNC12,TCONS_00009551
−
|autism spectrum disorders
+
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 
|-
 
|-
−
|''FRGCA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159]
−
|[[FRGCA]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142274 HSALNG0142274]
−
|LncRNA-AP001631.9
+
|PTHLH
−
|"FOXM1-regulated, gastric cancer associated"
+
|NA
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|brachydactyly
 
|-
 
|-
−
|''GABPB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394]
−
|[[GABPB1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091306 HSALNG0091306]
−
|N/A
+
|CISTR
−
|GABPB1 antisense RNA 1
+
|CISTR-ACT,CISTRACT,re52431
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|brachydactyly
 
|-
 
|-
−
|''GACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862]
−
|[[ENST00000441383.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141977 HSALNG0141977]
−
|"LINC00876, AC096655.1-002"
+
|HELLPAR
−
|gastric cancer associated transcript 1 (non-protein coding)
+
|LINC-HELLP
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|HELLP syndrome
 
|-
 
|-
−
|''GACAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904]
−
|[[ENST00000579368.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142019 HSALNG0142019]
−
|HMlincRNA717
+
|LINC01125
−
|gastric cancer associated transcript 2 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|uremia
 
|-
 
|-
−
|''GACAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544]
−
|[[ENST00000426539.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141659 HSALNG0141659]
−
|lncRNA-AC130710
+
|AC002511.1
−
|gastric cancer associated transcript 3 (non-protein coding)
+
|LINC01531
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|enterovirus 71 infection
 
|-
 
|-
−
|''GAPLINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609]
−
|[[GAPLINC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141724 HSALNG0141724]
−
|TCONSN/A00026238
+
|AP000688.29
−
|"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA"
+
|AP000688.2
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|enterovirus 71 infection
 
|-
 
|-
−
|''GAS1RR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832]
−
|[[GAS1RR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141947 HSALNG0141947]
−
|LncRNA-Hh
+
|FFAR2
−
|GAS1 adjacent regulatory RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|enterovirus 71 infection
 
|-
 
|-
−
|''GAS6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222]
−
|[[GAS6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142337 HSALNG0142337]
−
|N/A
+
|RP4-620F22.3
−
|GAS6 antisense RNA 1
+
|AC099063.2
−
|_
+
|NA
 +
|pathogenic process
 +
|enterovirus 71 infection
 
|-
 
|-
−
|''GAS8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227]
−
|[[GAS8-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142342 HSALNG0142342]
−
|N/A
+
|RP5-843L14.1
−
|GAS8 antisense RNA 1
+
|LINC01716
−
|_
+
|NA
 +
|pathogenic process
 +
|enterovirus 71 infection
 
|-
 
|-
−
|''GATA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285]
−
|[[GATA3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140617 HSALNG0140617]
−
|N/A
+
|MAGEA8-AS1
−
|GATA3 antisense RNA 1
+
|RP5-869M20.2
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GATA6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019]
−
|[[GATA6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094159 HSALNG0094159]
−
|locus5689
+
|LHX5-AS1
−
|GATA6 antisense RNA 1 (head to head)
+
|locus4010
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GDNF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902]
−
|[[GDNF-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0023597 HSALNG0023597]
−
|GDNFOS
+
|CAPN10-AS1
−
|GDNF antisense RNA 1 (head to head)
+
|CAPN10-DT,locus959
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GLIDR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404]
−
|[[GLIDR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0076463 HSALNG0076463]
−
|"MGC21881, TCONSN/A00015562"
+
|STAM-AS1
−
|glioblastoma down-regulated RNA
+
|locus3182
−
| glioblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GLIS3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276]
−
|[[GLIS3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070806 HSALNG0070806]
−
|MGC16153
+
|PTENP1-AS
−
|GLIS3 antisense RNA 1
+
|PTENpg1-asRNA
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GNG12-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562]
−
|[[GNG12-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141677 HSALNG0141677]
−
|N/A
+
|AF116616
−
|GNG12 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''GTSCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589]
−
|[[GTSCR1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141704 HSALNG0141704]
−
|N/A
+
|AK094838
−
|"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''H1FX-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620]
−
|[[H1FX-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141735 HSALNG0141735]
−
|FLJ34151
+
|ASLNC00339
−
|H1FX antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HAND2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629]
−
|[[HAND2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141744 HSALNG0141744]
−
|"DEIN, NBLA00301, FLJ11539"
+
|BC002350
−
|HAND2 antisense RNA 1 (head to head)
+
|NA
−
|neuroblastoma
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HAS2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651]
−
|[[HAS2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141766 HSALNG0141766]
−
|"HASNT, NCRNA00077"
+
|BC091525
−
|HAS2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HCCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652]
−
|[[HCCAT5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141767 HSALNG0141767]
−
|"HTA, FJ222407"
+
|BE503655
−
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
+
|NA
−
| hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HCG27''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753]
−
|[[HCG27]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141868 HSALNG0141868]
−
|"bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123"
+
|ENO1
−
|HLA complex group 27 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HCG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835]
−
|[[HCG4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141950 HSALNG0141950]
−
|"HCGIV-10, HCGIV.9"
+
|FKBP10
−
|HLA complex group 4 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HCG4B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064]
−
|[[HCG4B]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142179 HSALNG0142179]
−
|"HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3"
+
|MYHAS
−
|HLA complex group 4B (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma
 
|-
 
|-
−
|''HCG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985]
−
|[[HCG9]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142100 HSALNG0142100]
−
|"PERB11, HCGIX, HCGIX4, HCGIX-4"
+
|LncRNA-LALR1
−
|HLA complex group 9 (non-protein coding)
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 
|-
 
|-
−
|''HCP5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNT0289934]
−
|[[HCP5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142049 HSALNG0142049]
−
|"D6S2650E, P5-1"
+
|lincRNA-LALR1
−
|HLA complex P5 (non-protein coding)
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''HELLPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577]
−
|[[HELLPAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043527 HSALNG0043527]
−
|LINC-HELLP
+
|NR2F1-AS1
−
|HELLP associated long non-coding RNA
+
|FLJ42709
−
|extravillous trophoblast
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HEXA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709]
−
|[[HEXA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141824 HSALNG0141824]
−
|FLJ13315
+
|CK19
−
|HEXA antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''HIF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943]
−
|[[HIF1A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142058 HSALNG0142058]
−
|5'aHIF-1A
+
|Llme23
−
|HIF1A antisense RNA 1
+
|NA
−
|kidney cancer
+
|NA
 +
|pathogenic process
 +
|melanoma
 
|-
 
|-
−
|''HIF1A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553]
−
|[[HIF1A-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141668 HSALNG0141668]
−
|"3'aHIF-1A, aHIF"
+
|AC096655.1
−
|HIF1A antisense RNA 2
+
|NA
−
| kidney cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''HNF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178]
−
|[[HNF1A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137593 HSALNG0137593]
−
|FLJ38690
+
|MIR222HG
−
|HNF1A antisense RNA 1
+
|Lnc-Ang362
−
|adenocarcinoma, oesophageal adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|Ang II-associated cardiovascular disease
 
|-
 
|-
−
|''HNF4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261]
−
|[[HNF4A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032541 HSALNG0032541]
−
|uc002xlx
+
|STX18-AS1
−
|HNF4A antisense RNA 1
+
|LOC100507266
−
|_
+
|NA
 +
|pathogenic process
 +
|atrial septal defect
 
|-
 
|-
−
|''HORMAD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849]
−
|[[HORMAD2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141964 HSALNG0141964]
−
|"MTMR3-AS1, NONHSAG033653"
+
|GHSR
−
|HORMAD2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''HPVC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNT0289850]
−
|[[HPVC1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141965 HSALNG0141965]
−
|"PE5L, HPV18E5L"
+
|GHSROS
−
|human papillomavirus (type 18) E5 central sequence-like 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''HTT-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210]
−
|[[HTT-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072923 HSALNG0072923]
−
|HTTAS
+
|PCAT7
−
|HTT antisense RNA (head to head)
+
|PCAN-R2
−
|Huntington's disease
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''HYMAI''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702]
−
|[[HYMAI]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141817 HSALNG0141817]
−
|NCRNA00020
+
|CES1P1
−
|hydatidiform mole associated and imprinted (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''IDI2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892]
−
|[[IDI2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142007 HSALNG0142007]
−
|"HT009, Em:AC022536.4"
+
|LINC00210
−
|IDI2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''IGF2-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006]
−
|[[IGF2-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142121 HSALNG0142121]
−
|"PEG8, IGF2-AS1"
+
|LOC100506974
−
|IGF2 antisense RNA
+
|NA
−
|hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''ILF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219]
−
|[[ILF3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142334 HSALNG0142334]
−
|N/A
+
|RP3-508I15.14
−
|ILF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''INE1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243]
−
|[[INE1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142358 HSALNG0142358]
−
|NCRNA00010
+
|SLC6A6
−
|inactivation escape 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''INE2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342]
−
|[[INE2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142457 HSALNG0142457]
−
|NCRNA00011
+
|uc003bgl.1
−
|inactivation escape 2 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''IRAIN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075]
−
|[[IRAIN]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008302 HSALNG0008302]
−
|IGF1R-AS
+
|LINC00970
−
|IGF1R antisense imprinted non-protein coding RNA
+
|NA
−
|_
+
|NA
−
|-
+
|pathogenic process
−
|''JMJD1C-AS1''
+
|non-small cell lung cancer
−
|[[JMJD1C-AS1]]
 
−
|N/A
 
−
|JMJD1C antisense RNA 1
 
−
|_
 
 
|-
 
|-
−
|''KCNK15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868]
−
|[[KCNK15-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101725 HSALNG0101725]
−
|RP11-445H22.4
+
|SALRNA1
−
|KCNK15 antisense RNA 1 (head to head)
+
|SAL-RNA1,XLOC_023166
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''KCNMB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267]
−
|[[KCNMB2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106957 HSALNG0106957]
−
|RP11-385J1.2
+
|SALRNA3
−
|KCNMB2 antisense RNA 1
+
|SAL-RNA3,XLOC_025918
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''KCNQ1DN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274]
−
|[[KCNQ1DN]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106960 HSALNG0106960]
−
|"BWRT, HSA404617"
+
|SALRNA2
−
|KCNQ1 downstream neighbor (non-protein coding)
+
|SAL-RNA2,XLOC_025931
−
|Wilms' tumor
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''KIAA1614-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428]
−
|[[KIAA1614-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021790 HSALNG0021790]
−
|RP11-46A10.4
+
|GPR1-AS
−
|KIAA1614 antisense RNA 1
+
|GPR1-AS1,GPR1AS
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KIF25-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207]
−
|[[KIF25-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108743 HSALNG0108743]
−
|HGC6.1.1
+
|LINC00235
−
|KIF25 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|anorexia nervosa
 
|-
 
|-
−
|''LAMP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526]
−
|[[LAMP5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141641 HSALNG0141641]
−
|N/A
+
|1B FGF-antisense transcripts
−
|LAMP5 antisense RNA 1
+
|NA
−
|leukemogenesis
+
|NA
 +
|pathogenic process
 +
|endometriosis
 
|-
 
|-
−
|''LBX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171]
−
|[[LBX2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142286 HSALNG0142286]
−
|N/A
+
|RNA polymerase III-dependent lncRNAs
−
|LBX2 antisense RNA 1
+
|NA
−
|renal cell carcinoma
+
|NA
 +
|pathogenic process
 +
|diffuse cerebral hypomyelination
 
|-
 
|-
−
|''LCAL1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168]
−
|[[LCAL1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142283 HSALNG0142283]
−
|onco-lncRNA-27
+
|REST/CoREST-regulated lncRNAs
−
|lung cancer associated lncRNA 1
+
|NA
−
| lung cancer
+
|NA
 +
|pathogenic process
 +
|Huntington disease
 
|-
 
|-
−
|''LHX5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606]
−
|[[LHX5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141721 HSALNG0141721]
−
|locus4010
+
|Alu lncRNAs
−
|LHX5 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|macular degeneration
 
|-
 
|-
−
|''LIFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358]
−
|[[LIFR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142473 HSALNG0142473]
−
|N/A
+
|UCH1LAS
−
|LIFR antisense RNA 1
+
|NA
−
|preterm birth
+
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 
|-
 
|-
−
|''LINC00029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244]
−
|[[LINC00029]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142359 HSALNG0142359]
−
|bA305P22.4
+
|SLC7A2-IT1A/B
−
|long intergenic non-protein coding RNA 29
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|progressive encephalopathy with severe infantile anorexia
 
|-
 
|-
−
|''LINC00052''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877]
−
|[[LINC00052]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141992 HSALNG0141992]
−
|FLJ31461
+
|Kcna2-AS
−
|long intergenic non-protein coding RNA 52
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|neuropathic pain
 
|-
 
|-
−
|''LINC00094''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191]
−
|[[LINC00094]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053305 HSALNG0053305]
−
|"FLJ35348, bA374P20.3"
+
|NCOA7-AS1
−
|long intergenic non-protein coding RNA 94
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00114''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020]
−
|[[LINC00114]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142135 HSALNG0142135]
−
|N/A
+
|LOC389023
−
|long intergenic non-protein coding RNA 114
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|psychiatric disease
 
|-
 
|-
−
|''LINC00115''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124]
−
|[[LINC00115]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084108 HSALNG0084108]
−
|FLJ22639
+
|PTPRJ-AS1
−
|long intergenic non-protein coding RNA 115
+
|NA
−
|
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654]
−
|[[LINC00152]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141769 HSALNG0141769]
−
|MGC4677
+
|BM742401
−
|long intergenic non-protein coding RNA 152
+
|NA
 +
|NA
 +
|pathogenic process
 
|gastric cancer
 
|gastric cancer
 
|-
 
|-
−
|''LINC00160''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331]
−
|[[LINC00160]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049950 HSALNG0049950]
−
|N/A
+
|LINC00951
−
|long intergenic non-protein coding RNA 160
+
|lincRNA-uc003opf.1,FLJ41649
−
|Breast Cancer
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''LINC00161''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130]
−
|[[LINC00161]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142245 HSALNG0142245]
−
|N/A
+
|PAWR
−
|long intergenic non-protein coding RNA 161
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''LINC00165''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264]
−
|[[LINC00165]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142379 HSALNG0142379]
−
|NLC1-B
+
|T-ALL-R-LncR1
−
|long intergenic non-protein coding RNA 165
+
|NA
−
| narcolepsy
+
|NA
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''LINC00189''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599]
−
|[[LINC00189]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141714 HSALNG0141714]
−
|N/A
+
|AK130977
−
|long intergenic non-protein coding RNA 189
+
|NA
−
|Breast Cancer
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00205''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625]
−
|[[LINC00205]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141740 HSALNG0141740]
−
|N/A
+
|AX746718
−
|long intergenic non-protein coding RNA 205
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00235''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738]
−
|[[LINC00235]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141853 HSALNG0141853]
−
|N/A
+
|DDR2
−
|long intergenic non-protein coding RNA 235
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00237''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003]
−
|[[LINC00237]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142118 HSALNG0142118]
−
|N/A
+
|LOC100131831
−
|long intergenic non-protein coding RNA 237
+
|NA
−
|macrosomia, obesity, macrocephaly, and ocular abnormalities
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00244''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144]
−
|[[LINC00244]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142259 HSALNG0142259]
−
|N/A
+
|POT1-AS1
−
|long intergenic non-protein coding RNA 244
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00261''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253]
−
|[[LINC00261]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142368 HSALNG0142368]
−
|"bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17"
+
|SNORA17B
−
|long intergenic non-protein coding RNA 261
+
|NA
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma
 
|-
 
|-
−
|''LINC00265''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421]
−
|[[LINC00265]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099625 HSALNG0099625]
−
|NCRNA00265-1
+
|GAS6-AS1
−
|long intergenic non-protein coding RNA 265
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''LINC00272''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838]
−
|[[LINC00272]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141953 HSALNG0141953]
−
|RP1-223H12.3
+
|FMR5
−
|long intergenic non-protein coding RNA 272
+
|NA
−
| prostate cancer region
+
|NA
 +
|pathogenic process
 +
|fragile X syndrome
 
|-
 
|-
−
|''LINC00293''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907]
−
|[[LINC00293]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100287 HSALNG0100287]
−
|BEYLA
+
|FOXG1-AS1
−
|long intergenic non-protein coding RNA 293
+
|FOXG1-AS
−
|_
+
|NA
 +
|pathogenic process
 +
|autism spectrum disorder
 
|-
 
|-
−
|''LINC00294''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263]
−
|[[LINC00294]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142378 HSALNG0142378]
−
|N/A
+
|SYNGAP1-AS1
−
|long intergenic non-protein coding RNA 294
+
|SYNGAP1-AS
−
|_
+
|NA
 +
|pathogenic process
 +
|autism spectrum disorder
 
|-
 
|-
−
|''LINC00299''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176]
−
|[[LINC00299]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142291 HSALNG0142291]
−
|FLJ45673
+
|RNase MRP
−
|long intergenic non-protein coding RNA 299
+
|NA
−
|Intellectual and developmental disability
+
|NA
 +
|pathogenic process
 +
|cartilage hair hypoplaisia
 
|-
 
|-
−
|''LINC00301''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469]
−
|[[LINC00301]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105872 HSALNG0105872]
−
|MGC39681
+
|GABPB1-AS1
−
|long intergenic non-protein coding RNA 301
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00302''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009]
−
|[[LINC00302]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075528 HSALNG0075528]
−
|XP33
+
|IDI2-AS1
−
|long intergenic non-protein coding RNA 302
+
|C10orf110,IDI2-A,HT009,Em:AC022536.4
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00305''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093]
−
|[[LINC00305]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044716 HSALNG0044716]
−
|"MGC39571, HsT1235"
+
|LINC01184
−
|long intergenic non-protein coding RNA 305
+
|FLJ33630
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00307''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108]
−
|[[LINC00307]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142223 HSALNG0142223]
−
|D21S2091E
+
|OGT
−
|long intergenic non-protein coding RNA 307
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC00308''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077]
−
|[[LINC00308]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142192 HSALNG0142192]
−
|PRED16
+
|ncNRFR
−
|long intergenic non-protein coding RNA 308
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC00310''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337]
−
|[[LINC00310]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142452 HSALNG0142452]
−
|N/A
+
|uc001lsz
−
|long intergenic non-protein coding RNA 310
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer;prostate cancer;liver cancer;lung cancer
 
|-
 
|-
−
|''LINC00311''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087]
−
|[[LINC00311]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021008 HSALNG0021008]
−
|MGC22001
+
|LINC01090
−
|long intergenic non-protein coding RNA 311
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|post-traumatic stress disorder
 
|-
 
|-
−
|''LINC00313''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNT0289746]
−
|[[LINC00313]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141861 HSALNG0141861]
−
|N/A
+
|DQ786227
−
|long intergenic non-protein coding RNA 313
+
|NA
 +
|NA
 +
|pathogenic process
 
|lung cancer
 
|lung cancer
 
|-
 
|-
−
|''LINC00314''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981]
−
|[[LINC00314]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142096 HSALNG0142096]
−
|N/A
+
|lncRNA-DQ786227
−
|long intergenic non-protein coding RNA 314
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''LINC00315''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876]
−
|[[LINC00315]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141991 HSALNG0141991]
−
|N/A
+
|JADRR
−
|long intergenic non-protein coding RNA 315
+
|LINC00915,lncRNA-JADE
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINC00320''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254]
−
|[[LINC00320]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142369 HSALNG0142369]
−
|"PRED14, FLJ37539"
+
|SOX2OT-S1
−
|long intergenic non-protein coding RNA 320
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''LINC00322''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNT0290404]
−
|[[LINC00322]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142519 HSALNG0142519]
−
|FLJ16545
+
|SOX2OT-S2
−
|long intergenic non-protein coding RNA 322
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00323''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870]
−
|[[LINC00323]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141985 HSALNG0141985]
−
|"PRED42, FLJ37173"
+
|HOXA13
−
|long intergenic non-protein coding RNA 323
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC00324''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946]
−
|[[LINC00324]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0037661 HSALNG0037661]
−
|"FLJ34790, MGC104931"
+
|SMAD1-AS1
−
|long intergenic non-protein coding RNA 324
+
|ENST00000513542
−
|_
+
|NA
 +
|pathogenic process
 +
|ventricular septal defects
 
|-
 
|-
−
|''LINC00334''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329]
−
|[[LINC00334]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041545 HSALNG0041545]
−
|N/A
+
|FGF10-AS1
−
|long intergenic non-protein coding RNA 334
+
|RP11-473L15.2
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|ventricular septal defects
 
|-
 
|-
−
|''LINC00337''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318]
−
|[[LINC00337]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142433 HSALNG0142433]
−
|MGC40168
+
|TUC339
−
|long intergenic non-protein coding RNA 337
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC00339''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819]
−
|[[LINC00339]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141934 HSALNG0141934]
−
|HSPC157
+
|ERICD
−
|long intergenic non-protein coding RNA 339
+
|LINC01130,TCONS_00014875,ERIC
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|retinoblastoma
 
|-
 
|-
−
|''LINC00342''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615]
−
|[[LINC00342]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141730 HSALNG0141730]
−
|N/A
+
|ARA
−
|long intergenic non-protein coding RNA 342
+
|NA
−
|Non-small cell lung cancer
+
|NA
 +
|pathogenic process
 +
|cancer
 
|-
 
|-
−
|''LINC00346''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822]
−
|[[LINC00346]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141937 HSALNG0141937]
−
|N/A
+
|ESCCAL-5
−
|long intergenic non-protein coding RNA 346
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''LINC00347''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074]
−
|[[LINC00347]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142189 HSALNG0142189]
−
|N/A
+
|ncC11orf49
−
|long intergenic non-protein coding RNA 347
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LINC00426''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076]
−
|[[LINC00426]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142191 HSALNG0142191]
−
|N/A
+
|ncHDAC5
−
|long intergenic non-protein coding RNA 426
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LINC00441''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078]
−
|[[LINC00441]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142193 HSALNG0142193]
−
|ncRNA-RB1
+
|ncRAB31
−
|long intergenic non-protein coding RNA 441
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LINC00461''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080]
−
|[[LINC00461]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142195 HSALNG0142195]
−
|"EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323"
+
|ncSRPK1
−
|long intergenic non-protein coding RNA 461
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LINC00466''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253]
−
|[[LINC00466]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008819 HSALNG0008819]
−
|N/A
+
|OVAAL
−
|long intergenic non-protein coding RNA 466
+
|LINC01131,OVAL
−
|_
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''LINC00467''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884]
−
|[[LINC00467]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141999 HSALNG0141999]
−
|MGC14801
+
|LALR
−
|long intergenic non-protein coding RNA 467
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC00470''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701]
−
|[[LINC00470]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141816 HSALNG0141816]
−
|N/A
+
|CEACAMP8
−
|long intergenic non-protein coding RNA 470
+
|CEACAMP8
−
|_
+
|NA
 +
|pathogenic process
 +
|pre-eclampsia
 
|-
 
|-
−
|''LINC00471''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018]
−
|[[LINC00471]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142133 HSALNG0142133]
−
|MGC43122
+
|LOC284100
−
|long intergenic non-protein coding RNA 471
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|pre-eclampsia
 
|-
 
|-
−
|''LINC00472''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023]
−
|[[LINC00472]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142138 HSALNG0142138]
−
|"dJ288M22.3, FLJ13189"
+
|LOC391533
−
|long intergenic non-protein coding RNA 472
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|pre-eclampsia
 
|-
 
|-
−
|''LINC00473''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558]
−
|[[LINC00473]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091365 HSALNG0091365]
−
|bA142J11.1
+
|LINC01154
−
|long intergenic non-protein coding RNA 473
+
|NA
−
|lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00477''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616]
−
|[[LINC00477]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094870 HSALNG0094870]
−
|"FLJ32894, FAM191B"
+
|THRIL
−
|long intergenic non-protein coding RNA 477
+
|BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|Kawasaki disease
 
|-
 
|-
−
|''LINC00491''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235]
−
|[[LINC00491]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0098080 HSALNG0098080]
−
|BC008363
+
|RNF219-AS1
−
|long intergenic non-protein coding RNA 491
+
|NA
−
|pancreatic ductal adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|blood pressure
 
|-
 
|-
−
|''LINC00493''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561]
−
|[[LINC00493]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141676 HSALNG0141676]
−
|LOC388789
+
|AF086415
−
|long intergenic non-protein coding RNA 493
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00494''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583]
−
|[[LINC00494]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141698 HSALNG0141698]
−
|N/A
+
|AK056098
−
|long intergenic non-protein coding RNA 494
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590]
−
|[[LINC00507]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141705 HSALNG0141705]
−
|N/A
+
|AK095147
−
|long intergenic non-protein coding RNA 507
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600]
−
|[[LINC00511]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141715 HSALNG0141715]
−
|onco-lncRNA-12
+
|AK294004
−
|long intergenic non-protein coding RNA 511
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00518''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612]
−
|[[LINC00518]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141727 HSALNG0141727]
−
|MGC40222
+
|AP5M1
−
|long intergenic non-protein coding RNA 518
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110]
−
|[[LINC00526]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142225 HSALNG0142225]
−
|"MGC17515, HsT959"
+
|ORAOV1
−
|long intergenic non-protein coding RNA 526
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00528''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210]
−
|[[LINC00528]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142325 HSALNG0142325]
−
|FLJ40542
+
|RP1-179N16.3
−
|long intergenic non-protein coding RNA 528
+
|Z95152.1
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC00529''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026]
−
|[[LINC00529]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017545 HSALNG0017545]
−
|N/A
+
|LINC01159
−
|long intergenic non-protein coding RNA 529
+
|linc-Brn1b
−
| keratolytic winter erythema
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''LINC00536''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014]
−
|[[LINC00536]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137988 HSALNG0137988]
−
|N/A
+
|KANTR
−
|long intergenic non-protein coding RNA 536
+
|KDM5C adjacent non-coding transcript
−
|_
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''LINC00538''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905]
−
|[[LINC00538]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142020 HSALNG0142020]
−
|"Yiya, PROX1UT"
+
|LINC01157
−
|long intergenic non-protein coding RNA 538
+
|TCONS_00010378,linc-Enc1
−
|cancers
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''LINC00575''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460]
−
|[[LINC00575]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0087416 HSALNG0087416]
−
|N/A
+
|APOA1-AS
−
|long intergenic non-protein coding RNA 575
+
|NA
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00588''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400]
−
|[[LINC00588]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142515 HSALNG0142515]
−
|DKFZP434F122
+
|ZNF300P1
−
|long intergenic non-protein coding RNA 588
+
|ZNF300P1
−
|_
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''LINC00593''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750]
−
|[[LINC00593]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141865 HSALNG0141865]
−
|MGC42951
+
|EEF1A1P9
−
|long intergenic non-protein coding RNA 593
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00598''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796]
−
|[[LINC00598]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141911 HSALNG0141911]
−
|TTL
+
|ENST00000318333
−
|long intergenic non-protein coding RNA 598
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00608''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797]
−
|[[LINC00608]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141912 HSALNG0141912]
−
|N/A
+
|ENST00000374520
−
|long intergenic non-protein coding RNA 608
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800]
−
|[[LINC00612]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141915 HSALNG0141915]
−
|"MGC40170, FLJ41814"
+
|ENST00000422362
−
|long intergenic non-protein coding RNA 612
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00620''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808]
−
|[[LINC00620]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141923 HSALNG0141923]
−
|N/A
+
|ENST00000455912
−
|long intergenic non-protein coding RNA 620
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00623''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809]
−
|[[LINC00623]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141924 HSALNG0141924]
−
|N/A
+
|ENST00000456007
−
|long intergenic non-protein coding RNA 623
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810]
−
|[[LINC00628]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141925 HSALNG0141925]
−
|N/A
+
|ENST00000456185
−
|long intergenic non-protein coding RNA 628
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00632''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817]
−
|[[LINC00632]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141932 HSALNG0141932]
−
|N/A
+
|EPOR
−
|long intergenic non-protein coding RNA 632
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00634''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913]
−
|[[LINC00634]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142028 HSALNG0142028]
−
|N/A
+
|LINC01550
−
|long intergenic non-protein coding RNA 634
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00635''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142]
−
|[[LINC00635]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142257 HSALNG0142257]
−
|N/A
+
|PMS2P5
−
|long intergenic non-protein coding RNA 635
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00636''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269]
−
|[[LINC00636]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142384 HSALNG0142384]
−
|N/A
+
|TCF7
−
|long intergenic non-protein coding RNA 636
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00638''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345]
−
|[[LINC00638]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142460 HSALNG0142460]
−
|MGC23270
+
|uc003jfz.2
−
|long intergenic non-protein coding RNA 638
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cardia adenocarcinoma
 
|-
 
|-
−
|''LINC00649''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095]
−
|[[LINC00649]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018112 HSALNG0018112]
−
|TCONSN/A00028768
+
|LINC01191
−
|long intergenic non-protein coding RNA 649
+
|VIN,lnc-ACTR3
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|influenza A virus
 
|-
 
|-
−
|''LINC00652''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976]
−
|[[LINC00652]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140165 HSALNG0140165]
−
|HSPC072
+
|FIRRE
−
|long intergenic non-protein coding RNA 652
+
|LINC01200
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00661''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097]
−
|[[LINC00661]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046284 HSALNG0046284]
−
|N/A
+
|LINC01202
−
|long intergenic non-protein coding RNA 661
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00662''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271]
−
|[[LINC00662]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142386 HSALNG0142386]
−
|N/A
+
|TCONS_00014512
−
|long intergenic non-protein coding RNA 662
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00663''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272]
−
|[[LINC00663]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142387 HSALNG0142387]
−
|MGC39821
+
|TCONS_00014978
−
|long intergenic non-protein coding RNA 663
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00667''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274]
−
|[[LINC00667]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142389 HSALNG0142389]
−
|N/A
+
|TCONS_00024647
−
|long intergenic non-protein coding RNA 667
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00668''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279]
−
|[[LINC00668]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142394 HSALNG0142394]
−
|N/A
+
|TCONS_00090092_MEG3
−
|long intergenic non-protein coding RNA 668
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00673''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280]
−
|[[LINC00673]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142395 HSALNG0142395]
−
|HI-LNC75
+
|TCONS_l2_00000179
−
|long intergenic non-protein coding RNA 673
+
|NA
−
|type 2 diabetes
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00675''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283]
−
|[[LINC00675]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142398 HSALNG0142398]
−
|N/A
+
|TCONS_l2_00004424
−
|long intergenic non-protein coding RNA 675
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00682''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284]
−
|[[LINC00682]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142399 HSALNG0142399]
−
|N/A
+
|TCONS_l2_00006843
−
|long intergenic non-protein coding RNA 682
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00685''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289]
−
|[[LINC00685]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142404 HSALNG0142404]
−
|OTTHUMT00000055574
+
|TCONS_l2_00014091
−
|long intergenic non-protein coding RNA 685
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00689''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291]
−
|[[LINC00689]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142406 HSALNG0142406]
−
|N/A
+
|TCONS_l2_00018070
−
|long intergenic non-protein coding RNA 689
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00692''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292]
−
|[[LINC00692]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142407 HSALNG0142407]
−
|N/A
+
|TCONS_l2_00020565
−
|long intergenic non-protein coding RNA 692
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00704''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293]
−
|[[LINC00704]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142408 HSALNG0142408]
−
|N/A
+
|TCONS_l2_00021262
−
|long intergenic non-protein coding RNA 704
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00705''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296]
−
|[[LINC00705]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142411 HSALNG0142411]
−
|N/A
+
|TCONS_l2_00030560
−
|long intergenic non-protein coding RNA 705
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|hepatoblastoma
 
|-
 
|-
−
|''LINC00839''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927]
−
|[[LINC00839]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142042 HSALNG0142042]
−
|N/A
+
|lincRNA1611
−
|long intergenic non-protein coding RNA 839
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''LINC00852''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149]
−
|[[LINC00852]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142264 HSALNG0142264]
−
|"NAG73, GHRL-AS2"
+
|Ppp3ca
−
|long intergenic non-protein coding RNA 852
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''LINC00854''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265]
−
|[[LINC00854]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142380 HSALNG0142380]
−
|N/A
+
|TC0100223
−
|long intergenic non-protein coding RNA 854
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 
|-
 
|-
−
|''LINC00857''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267]
−
|[[LINC00857]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142382 HSALNG0142382]
−
|N/A
+
|TC0101686
−
|long intergenic non-protein coding RNA 857
+
|NA
−
|lung cancer
+
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 
|-
 
|-
−
|''LINC00868''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268]
−
|[[LINC00868]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142383 HSALNG0142383]
−
|N/A
+
|TC1500845
−
|long intergenic non-protein coding RNA 868
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''LINC00869''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318]
−
|[[LINC00869]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128589 HSALNG0128589]
−
|KIAA0493
+
|LAMP5-AS1
−
|long intergenic non-protein coding RNA 869
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''LINC00880''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022]
−
|[[LINC00880]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0112916 HSALNG0112916]
−
|N/A
+
|LINC01228
−
|long intergenic non-protein coding RNA 880
+
|lincRNA-DYNLRB2-2
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00882''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654]
−
|[[LINC00882]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077963 HSALNG0077963]
−
|N/A
+
|SGMS1-AS1
−
|long intergenic non-protein coding RNA 882
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00887''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206]
−
|[[LINC00887]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0126202 HSALNG0126202]
−
|linc-ATP13A4-8
+
|PCAT19
−
|long intergenic non-protein coding RNA 887
+
|LOC100505495,LINC01190
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC00893''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521]
−
|[[LINC00893]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0115583 HSALNG0115583]
−
|N/A
+
|ABHD15-AS1
−
|long intergenic non-protein coding RNA 893
+
|linc-TP53I13,lnc-TP53I13
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiometabolic disease
 
|-
 
|-
−
|''LINC00901''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100]
−
|[[LINC00901]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069570 HSALNG0069570]
−
|"TCONSN/A00005428, BC040587"
+
|LINC01230
−
|long intergenic non-protein coding RNA 901
+
|linc-DMRT2,lnc-DRMT2,TCONS_00015639
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiometabolic disease
 
|-
 
|-
−
|''LINC00917''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183]
−
|[[LINC00917]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0120583 HSALNG0120583]
−
|N/A
+
|PCAT18
−
|long intergenic non-protein coding RNA 917
+
|LINC01092
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC00936''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029]
−
|[[LINC00936]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142144 HSALNG0142144]
−
|N/A
+
|LOC728606
−
|long intergenic non-protein coding RNA 936
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC00942''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
−
|[[LINC00942]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094171 HSALNG0094171]
−
|N/A
+
|ENST00000547963.1
−
|long intergenic non-protein coding RNA 942
+
|NA
−
|autism spectrum disorder
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''LINC00950''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802]
−
|[[LINC00950]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141917 HSALNG0141917]
−
|FP588
+
|ENST00000435885
−
|long intergenic non-protein coding RNA 950
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|oesophageal squamous cell cancer
 
|-
 
|-
−
|''LINC00951''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898]
−
|[[LINC00951]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0098920 HSALNG0098920]
−
|"lincRNA-uc003opf.1, FLJ41649"
+
|LINC01232
−
|long intergenic non-protein coding RNA 951
+
|FLJ41590,TCONS_00021520
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00961''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311]
−
|[[LINC00961]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124979 HSALNG0124979]
−
|N/A
+
|LINC01233
−
|long intergenic non-protein coding RNA 961
+
|XLOC_013014
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00963''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247]
−
|[[LINC00963]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088110 HSALNG0088110]
−
|N/A
+
|SENCR
−
|long intergenic non-protein coding RNA 963
+
|FLI1-AS1
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|vascular SMC phenotype
 
|-
 
|-
−
|''LINC00964''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296]
−
|[[LINC00964]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010286 HSALNG0010286]
−
|N/A
+
|LINC00467
−
|long intergenic non-protein coding RNA 964
+
|C1orf97,MGC14801
−
|_
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''LINC00970''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586]
−
|[[LINC00970]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068435 HSALNG0068435]
−
|N/A
+
|CASC21
−
|long intergenic non-protein coding RNA 970
+
|LINC01244,CARLo-2
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00974''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906]
−
|[[LINC00974]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068424 HSALNG0068424]
−
|N/A
+
|CASC19
−
|long intergenic non-protein coding RNA 974
+
|LINC01245,CARLo-6
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC00977''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754]
−
|[[LINC00977]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141869 HSALNG0141869]
−
|N/A
+
|ENSG00000135253.9
−
|long intergenic non-protein coding RNA 977
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC00982''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755]
−
|[[LINC00982]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141870 HSALNG0141870]
−
|FLJ42875
+
|ENSG00000147753.5
−
|long intergenic non-protein coding RNA 982
+
|NA
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC00993''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756]
−
|[[LINC00993]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141871 HSALNG0141871]
−
|N/A
+
|ENSG00000196096
−
|long intergenic non-protein coding RNA 993
+
|AC079610.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC00994''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757]
−
|[[LINC00994]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141872 HSALNG0141872]
−
|N/A
+
|ENSG00000197251.3
−
|long intergenic non-protein coding RNA 994
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC00996''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758]
−
|[[LINC00996]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141873 HSALNG0141873]
−
|N/A
+
|ENSG00000203325
−
|long intergenic non-protein coding RNA 996
+
|AL445248.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01016''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759]
−
|[[LINC01016]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141874 HSALNG0141874]
−
|N/A
+
|ENSG00000206129
−
|long intergenic non-protein coding RNA 1016
+
|AC006305.1
−
|Breast Cancer
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01018''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760]
−
|[[LINC01018]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141875 HSALNG0141875]
−
|N/A
+
|ENSG00000215231.3
−
|long intergenic non-protein coding RNA 1018
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01019''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761]
−
|[[LINC01019]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141876 HSALNG0141876]
−
|N/A
+
|ENSG00000215374.4
−
|long intergenic non-protein coding RNA 1019
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01020''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762]
−
|[[LINC01020]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141877 HSALNG0141877]
−
|N/A
+
|ENSG00000215808.2
−
|long intergenic non-protein coding RNA 1020
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01021''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763]
−
|[[LINC01021]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141878 HSALNG0141878]
−
|N/A
+
|ENSG00000226496.1
−
|long intergenic non-protein coding RNA 1021
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01024''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764]
−
|[[LINC01024]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141879 HSALNG0141879]
−
|MA-linc1
+
|ENSG00000229563.1
−
|long intergenic non-protein coding RNA 1024
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765]
−
|[[LINC01029]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141880 HSALNG0141880]
−
|N/A
+
|ENSG00000230133.1
−
|long intergenic non-protein coding RNA 1029
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01080''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766]
−
|[[LINC01080]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141881 HSALNG0141881]
−
|TCONSN/A00021856
+
|ENSG00000230544.1
−
|long intergenic non-protein coding RNA 1080
+
|NA
−
|Alzheimer's disease ;amnestic mild cognitive impairment
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01081''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767]
−
|[[LINC01081]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141882 HSALNG0141882]
−
|TCONSN/A00024764
+
|ENSG00000231133.1
−
|long intergenic non-protein coding RNA 1081
+
|NA
−
|alveolar capillary dysplasia ;misalignment of pulmonary veins
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01082''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768]
−
|[[LINC01082]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141883 HSALNG0141883]
−
|TCONSN/A00024492
+
|ENSG00000231185
−
|long intergenic non-protein coding RNA 1082
+
|AC010317.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01089''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769]
−
|[[LINC01089]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141884 HSALNG0141884]
−
|N/A
+
|ENSG00000232021.2
−
|long intergenic non-protein coding RNA 1089
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01090''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770]
−
|[[LINC01090]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141885 HSALNG0141885]
−
|N/A
+
|ENSG00000232046.1
−
|long intergenic non-protein coding RNA 1090
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01091''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771]
−
|[[LINC01091]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141886 HSALNG0141886]
−
|N/A
+
|ENSG00000232956.3
−
|long intergenic non-protein coding RNA 1091
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01096''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772]
−
|[[LINC01096]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141887 HSALNG0141887]
−
|N/A
+
|ENSG00000233154.1
−
|long intergenic non-protein coding RNA 1096
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01105''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773]
−
|[[LINC01105]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141888 HSALNG0141888]
−
|"FLJ30594, LOC150622"
+
|ENSG00000233251
−
|long intergenic non-protein coding RNA 1105
+
|AC007743.1
−
|predicted disease-related genes
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01108''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774]
−
|[[LINC01108]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141889 HSALNG0141889]
−
|LncRNA-ES1
+
|ENSG00000235285.1
−
|long intergenic non-protein coding RNA 1108
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01122''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775]
−
|[[LINC01122]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141890 HSALNG0141890]
−
|FLJ30838
+
|ENSG00000237036.3
−
|long intergenic non-protein coding RNA 1122
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01133''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776]
−
|[[LINC01133]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141891 HSALNG0141891]
−
|N/A
+
|ENSG00000237548.1
−
|long intergenic non-protein coding RNA 1133
+
|NA
−
|lung squamous cell cancer
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01139''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777]
−
|[[LINC01139]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141892 HSALNG0141892]
−
|N/A
+
|ENSG00000240453.1
−
|long intergenic non-protein coding RNA 1139
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01140''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778]
−
|[[LINC01140]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141893 HSALNG0141893]
−
|FLJ41676
+
|ENSG00000241269.1
−
|long intergenic non-protein coding RNA 1140
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01150''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779]
−
|[[LINC01150]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141894 HSALNG0141894]
−
|"2G7, TCONSN/A00019134"
+
|ENSG00000245910.3
−
|long intergenic non-protein coding RNA 1150
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780]
−
|[[LINC01152]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141895 HSALNG0141895]
−
|"TCONSN/A00025128, CMPD"
+
|ENSG00000248176
−
|long intergenic non-protein coding RNA 1152
+
|AC109349.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01154''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781]
−
|[[LINC01154]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141896 HSALNG0141896]
−
|N/A
+
|ENSG00000249364
−
|long intergenic non-protein coding RNA 1154
+
|AC112206.2
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01157''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782]
−
|[[LINC01157]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141897 HSALNG0141897]
−
|"TCONSN/A00010378, linc-Enc1"
+
|ENSG00000249772
−
|long intergenic non-protein coding RNA 1157
+
|AC026427.1
−
|brain development
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01158''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783]
−
|[[LINC01158]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141898 HSALNG0141898]
−
|linc-Brn1a
+
|ENSG00000250195
−
|long intergenic non-protein coding RNA 1158
+
|AC109927.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01159''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784]
−
|[[LINC01159]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141899 HSALNG0141899]
−
|linc-Brn1b
+
|ENSG00000250608
−
|long intergenic non-protein coding RNA 1159
+
|AC010210.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01184''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785]
−
|[[LINC01184]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141900 HSALNG0141900]
−
|FLJ33630
+
|ENSG00000254154
−
|long intergenic non-protein coding RNA 1184
+
|AL359075.2
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01185''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786]
−
|[[LINC01185]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141901 HSALNG0141901]
−
|FLJ16341
+
|ENSG00000255471
−
|long intergenic non-protein coding RNA 1185
+
|AP001528.2
−
|Psoriasis
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01192''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787]
−
|[[LINC01192]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141902 HSALNG0141902]
−
|N/A
+
|ENSG00000256218
−
|long intergenic non-protein coding RNA 1192
+
|AC007848.2
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01193''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788]
−
|[[LINC01193]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141903 HSALNG0141903]
−
|LOC348120
+
|ENSG00000259150.1
−
|long intergenic non-protein coding RNA 1193
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01194''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789]
−
|[[LINC01194]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141904 HSALNG0141904]
−
|TAG
+
|ENSG00000259334.1
−
|long intergenic non-protein coding RNA 1194
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01202''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790]
−
|[[LINC01202]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141905 HSALNG0141905]
−
|N/A
+
|ENSG00000259484.1
−
|long intergenic non-protein coding RNA 1202
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01207''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791]
−
|[[LINC01207]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141906 HSALNG0141906]
−
|N/A
+
|ENSG00000259758.1
−
|long intergenic non-protein coding RNA 1207
+
|NA
−
|Lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01225''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793]
−
|[[LINC01225]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141908 HSALNG0141908]
−
|N/A
+
|ENSG00000263753.1
−
|long intergenic non-protein coding RNA 1225
+
|NA
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01228''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794]
−
|[[LINC01228]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141909 HSALNG0141909]
−
|lincRNA-DYNLRB2-2
+
|ENSG00000264772
−
|long intergenic non-protein coding RNA 1228
+
|AC016876.2
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01230''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795]
−
|[[LINC01230]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141910 HSALNG0141910]
−
|"linc-DMRT2, lnc-DRMT2, TCONSN/A00015639"
+
|ENSG00000266952.1
−
|long intergenic non-protein coding RNA 1230
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01232''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828]
−
|[[LINC01232]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141943 HSALNG0141943]
−
|"FLJ41590, TCONSN/A00021520"
+
|FAM66B
−
|long intergenic non-protein coding RNA 1232
+
|FAM66E
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01233''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895]
−
|[[LINC01233]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142010 HSALNG0142010]
−
|XLOCN/A013014
+
|LINC00336
−
|long intergenic non-protein coding RNA 1233
+
|C6orf227,NCRNA00336
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01234''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899]
−
|[[LINC01234]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142014 HSALNG0142014]
−
|onco-lncRNA-32
+
|LINC00929
−
|long intergenic non-protein coding RNA 1234
+
|NA
−
|oesophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01252''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906]
−
|[[LINC01252]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142021 HSALNG0142021]
−
|N/A
+
|LINC01204
−
|long intergenic non-protein coding RNA 1252
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01262''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912]
−
|[[LINC01262]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142027 HSALNG0142027]
−
|"TCONSN/Al2N/A00021807, RP11-462G22.1"
+
|LINC01538
−
|long intergenic non-protein coding RNA 1262
+
|NA
−
|Parkinson's disease
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01264''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915]
−
|[[LINC01264]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142030 HSALNG0142030]
−
|RP11-124O11.2
+
|LINC01721
−
|long intergenic non-protein coding RNA 1264
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01268''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916]
−
|[[LINC01268]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142031 HSALNG0142031]
−
|LOC285758
+
|LINC01762
−
|long intergenic non-protein coding RNA 1268
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01296''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917]
−
|[[LINC01296]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142032 HSALNG0142032]
−
|FLJ39632
+
|LINC01798
−
|long intergenic non-protein coding RNA 1296
+
|NA
−
|prognostic biomarker
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247]
−
|[[LINC01312]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142362 HSALNG0142362]
−
|MGC34034
+
|SMIM2-IT1
−
|long intergenic non-protein coding RNA 1312
+
|C13orf44-IT1
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01317''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316]
−
|[[LINC01317]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142431 HSALNG0142431]
−
|N/A
+
|TTTY7
−
|long intergenic non-protein coding RNA 1317
+
|CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7
−
|_
+
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 
|-
 
|-
−
|''LINC01370''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNT0289872]
−
|[[LINC01370]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141987 HSALNG0141987]
−
|HI-LNC25
+
|HTTAS_v1
−
|long intergenic non-protein coding RNA 1370
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease
 
|-
 
|-
−
|''LINC01374''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175]
−
|[[LINC01374]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142290 HSALNG0142290]
−
|TCONSN/A00018278
+
|RNA-a
−
|long intergenic non-protein coding RNA 1374
+
|NA
−
|hepatocellular carcinoma
+
|transcriptional regulation
 +
|pathogenic process
 +
|Opitz-Kaveggia syndrome
 
|-
 
|-
−
|''LINC01405''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525]
−
|[[LINC01405]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141640 HSALNG0141640]
−
|N/A
+
|116HG
−
|long intergenic non-protein coding RNA 1405
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|Prader-Willi syndrome
 
|-
 
|-
−
|''LINC01411''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320]
−
|[[LINC01411]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142435 HSALNG0142435]
−
|RP11-267A15.1
+
|U1 spliceosomal lncRNA
−
|long intergenic non-protein coding RNA 1411
+
|NA
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 
|-
 
|-
−
|''LINC01420''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102]
−
|[[LINC01420]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039360 HSALNG0039360]
−
|N/A
+
|LINC01262
−
|long intergenic non-protein coding RNA 1420
+
|TCONS_l2_00021807,RP11-462G22.1
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|Parkinson's disease
 
|-
 
|-
−
|''LINC01433''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681]
−
|[[LINC01433]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141796 HSALNG0141796]
−
|LOC728228
+
|CCAT1-L
−
|long intergenic non-protein coding RNA 1433
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01435''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062]
−
|[[LINC01435]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142177 HSALNG0142177]
−
|"RP11-215N21.1, TCONSN/A00018040"
+
|MT-LIPCAR
−
|long intergenic non-protein coding RNA 1435
+
|uc022bqs.1,LIPCAR
−
|_
+
|NA
 +
|pathogenic process
 +
|heart disease
 
|-
 
|-
−
|''LINC01436''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941]
−
|[[LINC01436]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142056 HSALNG0142056]
−
|AP000688.8
+
|LIPCAR
−
|long intergenic non-protein coding RNA 1436
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|heart failure
 
|-
 
|-
−
|''LINC01468''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965]
−
|[[LINC01468]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096756 HSALNG0096756]
−
|lnc-MBL2-4
+
|TUSC8
−
|long intergenic non-protein coding RNA 1468
+
|LINC01071,XLOC_010588
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''LINC01478''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787]
−
|[[LINC01478]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077519 HSALNG0077519]
−
|N/A
+
|LINC01264
−
|long intergenic non-protein coding RNA 1478
+
|RP11-124O11.2
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINC01501''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733]
−
|[[LINC01501]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141848 HSALNG0141848]
−
|N/A
+
|D4Z4
−
|long intergenic non-protein coding RNA 1501
+
|NA
−
|_
+
|NA
 +
|pathogenic process;developmental process
 +
|facioscapulohumeral muscular dystrophy
 
|-
 
|-
−
|''LINC01503''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678]
−
|[[LINC01503]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141793 HSALNG0141793]
−
|lnc-PPP2R4-5
+
|CARL
−
|long intergenic non-protein coding RNA 1503
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|myocardial infarction
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142038 HSALNG0142038]
 +
|linc-CBR1-2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''LINC01507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354]
−
|[[LINC01507]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0117819 HSALNG0117819]
−
|XLOCN/A000303
+
|WFDC21P
−
|long intergenic non-protein coding RNA 1507
+
|WAP four-disulfide core domain 21,pseudogene
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|DC dysfunction
 
|-
 
|-
−
|''LINC01511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232]
−
|[[LINC01511]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142347 HSALNG0142347]
−
|RP11-325I22.2
+
|RUNX1
−
|long intergenic non-protein coding RNA 1511
+
|NA
−
|lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|acute myeloid leukemia
 
|-
 
|-
−
|''LINC01512''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234]
−
|[[LINC01512]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142349 HSALNG0142349]
−
|"LOC100132354, TCONSN/A00011120, HI-LNC77"
+
|RUNXOR
−
|long intergenic non-protein coding RNA 1512
+
|NA
−
|type 2 diabetes
+
|NA
 +
|pathogenic process
 +
|hematopoietic malignancies
 
|-
 
|-
−
|''LINC01513''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979]
−
|[[LINC01513]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142094 HSALNG0142094]
−
|"RP11-1C1.7, TCONSN/A00009352"
+
|lncRNA-CIR
−
|long intergenic non-protein coding RNA 1513
+
|NA
−
|lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|osteoarthritis
 
|-
 
|-
−
|''LINC01525''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368]
−
|[[LINC01525]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142483 HSALNG0142483]
−
|lnc-MAN1A2-1
+
|VIM2P
−
|long intergenic non-protein coding RNA 1525
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteoarthritis
 
|-
 
|-
−
|''LINC01526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879]
−
|[[LINC01526]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141994 HSALNG0141994]
−
|Lnc-FAM46A-1
+
|KRAS1P
−
|long intergenic non-protein coding RNA 1526
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cancer
 
|-
 
|-
−
|''LINC01527''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054]
−
|[[LINC01527]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142169 HSALNG0142169]
−
|lnc-SPRR2D-1
+
|MINA
−
|long intergenic non-protein coding RNA 1527
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer
 
|-
 
|-
−
|''LINC01537''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270]
−
|[[LINC01537]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0117279 HSALNG0117279]
−
|RP11-169D4.1-001
+
|TMEM92-AS1
−
|long intergenic non-protein coding RNA 1537
+
|RP11-893F2.9,lncRNA-508851,TCONS_00025237
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC01547''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900]
−
|[[LINC01547]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0054937 HSALNG0054937]
−
|N/A
+
|CAHM
−
|long intergenic non-protein coding RNA 1547
+
|LINC00468
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01553''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593]
−
|[[LINC01553]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141708 HSALNG0141708]
−
|AC023904.2
+
|AK123657
−
|long intergenic non-protein coding RNA 1553
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01558''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659]
−
|[[LINC01558]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141774 HSALNG0141774]
−
|"HGC6.2, dJ431P23.4"
+
|BX648207
−
|long intergenic non-protein coding RNA 1558
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01559''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660]
−
|[[LINC01559]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141775 HSALNG0141775]
−
|FLJ33810
+
|BX649059
−
|long intergenic non-protein coding RNA 1559
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01560''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846]
−
|[[LINC01560]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141961 HSALNG0141961]
−
|N/A
+
|GAS2L3
−
|long intergenic non-protein coding RNA 1560
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC01562''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633]
−
|[[LINC01562]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141748 HSALNG0141748]
−
|RP11-296A18.3
+
|BC011663
−
|long intergenic non-protein coding RNA 1562
+
|NA
−
|intervertebral disc degeneration
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01564''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867]
−
|[[LINC01564]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141982 HSALNG0141982]
−
|TCONSN/A00011314
+
|HIV1230
−
|long intergenic non-protein coding RNA 1564
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01565''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045]
−
|[[LINC01565]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142160 HSALNG0142160]
−
|GR6
+
|M14574
−
|long intergenic non-protein coding RNA 1565
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01574''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245]
−
|[[LINC01574]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142360 HSALNG0142360]
−
|"HI-LNC12, TCONSN/A00009551"
+
|SLCO5A1
−
|long intergenic non-protein coding RNA 1574
+
|NA
−
|type 2 diabetes
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01587''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326]
−
|[[LINC01587]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142441 HSALNG0142441]
−
|aC1
+
|uc.341
−
|long intergenic non-protein coding RNA 1587
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01589''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344]
−
|[[LINC01589]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142459 HSALNG0142459]
−
|"CTA-941F9.9, TCONSN/A00029353"
+
|uc003iqu
−
|long intergenic non-protein coding RNA 1589
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01591''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346]
−
|[[LINC01591]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142461 HSALNG0142461]
−
|N/A
+
|uc003tfx
−
|long intergenic non-protein coding RNA 1591
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01602''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950]
−
|[[LINC01602]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142065 HSALNG0142065]
−
|T1560
+
|lnc-AL355149.1-1
−
|long intergenic non-protein coding RNA 1602
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC01611''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001]
−
|[[LINC01611]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142116 HSALNG0142116]
−
|"RP1-90L14.1, TCONSN/Al2N/A00025430"
+
|lnc-ZNF674-1
−
|long intergenic non-protein coding RNA 1611
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''LINC01612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909]
−
|[[LINC01612]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140423 HSALNG0140423]
−
|"RP11-789C1.1, TCONSN/A00008319"
+
|LINC00632
−
|long intergenic non-protein coding RNA 1612
+
|NA
 +
|NA
 +
|pathogenic process
 
|gastric cancer
 
|gastric cancer
 
|-
 
|-
−
|''LINC01613''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105]
−
|[[LINC01613]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014134 HSALNG0014134]
−
|n341773
+
|LINC01317
−
|long intergenic non-protein coding RNA 1613
+
|NA
−
|idiopathic pulmonary fibrosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01614''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804]
−
|[[LINC01614]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113279 HSALNG0113279]
−
|"LCAL4, TCONSN/A00003105"
+
|LINC01081
−
|long intergenic non-protein coding RNA 1614
+
|TCONS_00024764
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|alveolar capillary dysplasia
 
|-
 
|-
−
|''LINC01616''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840]
−
|[[LINC01616]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141955 HSALNG0141955]
−
|n341006
+
|FOSB
−
|long intergenic non-protein coding RNA 1616
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01617''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587]
−
|[[LINC01617]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141702 HSALNG0141702]
−
|XLOCN/A006844
+
|AK093543
−
|long intergenic non-protein coding RNA 1617
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC01618''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732]
−
|[[LINC01618]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141847 HSALNG0141847]
−
|LOC152578
+
|D16366
−
|long intergenic non-protein coding RNA 1618
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC01622''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814]
−
|[[LINC01622]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141929 HSALNG0141929]
−
|TCONSN/A00011202
+
|ENST00000501583
−
|long intergenic non-protein coding RNA 1622
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC01627''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNT0290273]
−
|[[LINC01627]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142388 HSALNG0142388]
−
|RP11-397D12.4
+
|TCONS_00018278
−
|long intergenic non-protein coding RNA 1627
+
|NA
−
|NSCLC
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC01628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907]
−
|[[LINC01628]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142022 HSALNG0142022]
−
|AC007403.1
+
|LINC01374
−
|long intergenic non-protein coding RNA 1628
+
|TCONS_00018278
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''LINC01629''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106]
−
|[[LINC01629]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0111452 HSALNG0111452]
−
|linc-KIAA1737-2
+
|CASC22
−
|long intergenic non-protein coding RNA 1629
+
|LINC01373,TCONS_00024290,LincRNA-ENST00000515084
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINCMD1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246]
−
|[[LINCMD1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0027843 HSALNG0027843]
−
|N/A
+
|LINC00882
−
|"long intergenic non-protein coding RNA, muscle differentiation 1"
+
|NA
−
|Duchenne muscular dystrophy
+
|ceRNA
 +
|pathogenic process
 +
|airway diseases
 
|-
 
|-
−
|''LINGO1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288]
−
|[[LINGO1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008840 HSALNG0008840]
−
|N/A
+
|KIAA1614-AS1
−
|LINGO1 antisense RNA 1
+
|RP11-46A10.4
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|airway smooth muscle (ASM) disease
 
|-
 
|-
−
|''LMCD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310]
−
|[[LMCD1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0067913 HSALNG0067913]
−
|N/A
+
|LINC00536
−
|LMCD1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|trichorhinophalangeal syndrome
 
|-
 
|-
−
|''LOH12CR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200]
−
|[[LOH12CR2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0016063 HSALNG0016063]
−
|LOH2CR12
+
|LBX2-AS1
−
|"loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)"
+
|NA
−
|tumour suppressor
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LOXL1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799]
−
|[[LOXL1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071679 HSALNG0071679]
−
|N/A
+
|ENST00000414223
−
|LOXL1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LPP-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012]
−
|[[LPP-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142127 HSALNG0142127]
−
|N/A
+
|LOC105374631
−
|LPP antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LRP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305]
−
|[[LRP1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142420 HSALNG0142420]
−
|N/A
+
|TMEM179
−
|LRP1 antisense RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LRRC75A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315]
−
|[[LRRC75A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142430 HSALNG0142430]
−
|MGC40157
+
|TSPAN8
−
|LRRC75A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LUADT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334]
−
|[[LUADT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142449 HSALNG0142449]
−
|N/A
+
|uc001aka.2
−
|lung adenocarcinoma associated transcript 1
+
|NA
−
|lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''LUNAR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339]
−
|[[LUNAR1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142454 HSALNG0142454]
−
|N/A
+
|uc001vjj.1
−
|leukemia-associated non-coding IGF1R activator RNA 1
+
|NA
−
|leukemia
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''MAFA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343]
−
|[[MAFA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142458 HSALNG0142458]
−
|"RP11-909N17.3, TCONSN/A00014882"
+
|uc003erl.1
−
|MAFA antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''MAFG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354]
−
|[[MAFG-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142469 HSALNG0142469]
−
|N/A
+
|uc009wkz.1
−
|MAFG antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''MAFTRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893]
−
|[[MAFTRR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0013204 HSALNG0013204]
−
|linc-MAF-4
+
|MYCNUT
−
|MAF transcriptional regulator RNA
+
|MYCNUN,lncUSMycN
−
|_
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''MAGEA8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205]
−
|[[MAGEA8-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132900 HSALNG0132900]
−
|RP5-869M20.2
+
|LINC01436
−
|MAGEA8 antisense RNA 1 (head to head)
+
|AP000688.8
−
|_
+
|NA
 +
|pathogenic process
 +
|Down syndrome
 
|-
 
|-
−
|''MAPKAPK5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116]
−
|[[MAPKAPK5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129435 HSALNG0129435]
−
|FLJ39616
+
|MIR663AHG
−
|MAPKAPK5 antisense RNA 1
+
|RP3-410C9.1
−
|_
+
|NA
 +
|pathogenic process
 +
|turner syndrome
 
|-
 
|-
−
|''MCM3AP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108]
−
|[[MCM3AP-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0080498 HSALNG0080498]
−
|"FLJ10508, NCRNA00031"
+
|LINC01435
−
|MCM3AP antisense RNA 1
+
|RP11-215N21.1,TCONS_00018040
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''MDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674]
−
|[[MDC1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141789 HSALNG0141789]
−
|MDC1-AS
+
|CADM3-AS1
−
|MDC1 antisense RNA 1
+
|NA
−
| bladder cancer
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''MEF2C-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882]
−
|[[MEF2C-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141997 HSALNG0141997]
−
|N/A
+
|KRT19P3
−
|MEF2C antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''MEG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310]
−
|[[ENST00000553584.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142425 HSALNG0142425]
−
|LINC00584
+
|TNXA
−
|maternally expressed 9 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''MESTIT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750]
−
|[[MESTIT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004412 HSALNG0004412]
−
|"NCRNA00040, MEST-AS1"
+
|ZRANB2-AS2
−
|"MEST intronic transcript 1, antisense RNA"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MGAT3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745]
−
|[[MGAT3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141860 HSALNG0141860]
−
|TapSAKI
+
|DMTF1
−
|MGAT3 antisense RNA 1
+
|NA
−
|acute kidney injury
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MHRT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059]
−
|[[MHRT]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142174 HSALNG0142174]
−
|Myheart
+
|MRUL
−
|myosin heavy chain-associated RNA transcript
+
|NA
−
|heart pathological hypertrophy
+
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MIF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163]
−
|[[MIF-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089050 HSALNG0089050]
−
|LOC284889
+
|FAM66C
−
|MIF antisense RNA 1
+
|NA
−
|malaria susceptibility
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIMT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476]
−
|[[MIMT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132414 HSALNG0132414]
−
|"MIM1, NCRNA00067, LINC00067"
+
|CYYR1-AS1
−
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535]
−
|[[ENST00000517411.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141650 HSALNG0141650]
−
|TCONSN/A00015189
+
|AA174084
−
|MYC-induced long noncoding RNA
+
|NA
−
|Burkitt lymphoma
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MIR137HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298]
−
|[[MIR137HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129511 HSALNG0129511]
−
|N/A
+
|ABALON
−
|MIR137 host gene
+
|INXS
−
|schizophrenia
+
|splicing regulation
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''MIR17HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370]
−
|[[MIR17HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142485 HSALNG0142485]
−
|"FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048"
+
|VTRNA2-1
−
|miR-17-92a-1 cluster host gene
+
|CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a
−
|lymphoma, syndromic developmental defect
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MIR181A2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619]
−
|[[MIR181A2HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141734 HSALNG0141734]
−
|N/A
+
|ASK00420
−
|MIR181A2 host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR210HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749]
−
|[[MIR210HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141864 HSALNG0141864]
−
|N/A
+
|EBIC
−
|MIR210 host gene
+
|NA
−
|inflammatory renal epithelial injury
+
|transcriptional regulation
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR34AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299]
−
|[[MIR34AHG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142414 HSALNG0142414]
−
|N/A
+
|TI09485
−
|MIR34A host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR4435-2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300]
−
|[[MIR4435-2HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142415 HSALNG0142415]
−
|"LINC00978, AGD2, AK001796"
+
|TI10124
−
|MIR4435-2 host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR600HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301]
−
|[[MIR600HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142416 HSALNG0142416]
−
|"GL012, FLJ22161"
+
|TI13831
−
|MIR600 host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR663AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302]
−
|[[MIR663AHG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142417 HSALNG0142417]
−
|RP3-410C9.1
+
|TI18318
−
|MIR663A host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIR7-3HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303]
−
|[[MIR7-3HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142418 HSALNG0142418]
−
|"PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2"
+
|TI21327
−
|MIR7-3 host gene
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIRLET7BHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304]
−
|[[MIRLET7BHG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142419 HSALNG0142419]
−
|linc-Ppara
+
|TI22687
−
|MIRLET7B host gene
+
|NA
−
|asbestos exposure-related lung cancer
+
|NA
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MIRLET7DHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307]
−
|[[MIRLET7DHG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142422 HSALNG0142422]
−
|N/A
+
|TMPOP2
−
|MIRLET7D host gene
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|cervical cancer
 
|-
 
|-
−
|''MKRN3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570]
−
|[[MKRN3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141685 HSALNG0141685]
−
|"FNZ127, NCRNA00009, ZNF127-AS"
+
|AK021444
−
|MKRN3 antisense RNA 1
+
|NA
−
|Prader-Willi syndrome ;Angelman syndromes
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''MLK7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601]
−
|[[MLK7-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141716 HSALNG0141716]
−
|N/A
+
|AK307796
−
|MLK7 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''MLLT4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801]
−
|[[MLLT4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141916 HSALNG0141916]
−
|"HGC6.4, dJ431P23.3"
+
|ENST00000425785
−
|MLLT4 antisense RNA 1 (head to head)
+
|SEC63P1
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''MORF4L2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871]
−
|[[MORF4L2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141986 HSALNG0141986]
−
|N/A
+
|HOXB-AS3
−
|MORF4L2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''MT-LIPCAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367]
−
|[[MT-LIPCAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142482 HSALNG0142482]
−
|"uc022bqs.1, LIPCAR"
+
|URHC
−
|mitochondrially encoded long non-coding cardiac associated RNA
+
|NA
−
|heart failure
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''MYCNOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085]
−
|[[MYCNOS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0098166 HSALNG0098166]
−
|"NCYM, N-CYM, MYCN-AS1"
+
|LINC01080
−
|MYCN opposite strand
+
|TCONS_00021856
−
|neuroblastoma
+
|NA
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''N4BP2L2-IT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751]
−
|[[N4BP2L2-IT2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141866 HSALNG0141866]
−
|CG030
+
|EFNA3
−
|N4BPL2 intronic transcript 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''NALT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798]
−
|[[NALT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141913 HSALNG0141913]
−
|TCONSN/Al2N/A00029132
+
|ENST00000395084
−
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''NBAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829]
−
|[[NBAT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141944 HSALNG0141944]
−
|NBAT-1
+
|FAM83A-AS1
−
|neuroblastoma associated transcript 1
+
|NA
−
|Fighting Neuroblastomas ;breast cancer
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''NBR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164]
−
|[[NBR2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142279 HSALNG0142279]
−
|NCRNA00192
+
|RAD1
−
|neighbor of BRCA1 gene 2 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''NCBP2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585]
−
|[[NCBP2-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141700 HSALNG0141700]
−
|N/A
+
|AK056988
−
|NCBP2 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''NCOA7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638]
−
|[[NCOA7-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141753 HSALNG0141753]
−
|N/A
+
|BC017743
−
|NCOA7 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''NCRUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156]
−
|[[NCRUPAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142271 HSALNG0142271]
−
|"ncR-uPAR, ncRuPAR, NCRNA00193"
+
|PRR26
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|C10orf108
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''NFIA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349]
−
|[[NFIA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142464 HSALNG0142464]
−
|RP5-833A20.1
+
|uc003yqb.1
−
|NFIA antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''NIPBL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675]
−
|[[NIPBL-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141790 HSALNG0141790]
−
|NIPBL-AS
+
|CAI2
−
|NIPBL antisense RNA 1 (head to head)
+
|NA
−
| autism spectrum disorders
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''NKILA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNT0289673]
−
|[[NKILA]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141788 HSALNG0141788]
−
|N/A
+
|CADM1-AS1
−
|NF-kappaB interacting long non-coding RNA
+
|NA
−
| breast cancer
+
|transcriptional regulation
 +
|pathogenic process
 +
|renal clear cell cancer
 
|-
 
|-
−
|''NKX2-2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313]
−
|[[NKX2-2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142428 HSALNG0142428]
−
|NKX2-2AS
+
|TSLC1-AS1
−
|NKX2-2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''NOP14-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359]
−
|[[NOP14-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006378 HSALNG0006378]
−
|RES4-24
+
|LINC01525
−
|NOP14 antisense RNA 1
+
|lnc-MAN1A2-1
−
|Huntington disease
+
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 
|-
 
|-
−
|''NORAD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106]
−
|[[NORAD]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0051540 HSALNG0051540]
−
|N/A
+
|LINC01526
−
|non-coding RNA activated by DNA damage
+
|Lnc-FAM46A-1
−
|_
+
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 
|-
 
|-
−
|''NPHP3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774]
−
|[[NPHP3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0078013 HSALNG0078013]
−
|N/A
+
|LINC01468
−
|NPHP3 antisense RNA 1
+
|lnc-MBL2-4
−
|_
+
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 
|-
 
|-
−
|''NPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110]
−
|[[NPPA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074718 HSALNG0074718]
−
|N/A
+
|LINC01503
−
|NPPA antisense RNA 1
+
|lnc-PPP2R4-5
−
|_
+
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 
|-
 
|-
−
|''NPSR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968]
−
|[[NPSR1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142083 HSALNG0142083]
−
|"AAA1, IMAGE:4827585"
+
|lnc-MBL2-4:3
−
|NPSR1 antisense RNA 1
+
|NA
−
|cardiovascular disease
+
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 
|-
 
|-
−
|''NPTN-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993]
−
|[[NPTN-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142108 HSALNG0142108]
−
|lncRNA-LET
+
|lnc-STXBP5-1
−
|NPTN intronic transcript 1
+
|NA
−
|colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas
+
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 
|-
 
|-
−
|''NR2F1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563]
−
|[[NR2F1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141678 HSALNG0141678]
−
|FLJ42709
+
|AF118081
−
|NR2F1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''NRAV''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597]
−
|[[NRAV]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141712 HSALNG0141712]
−
|N/A
+
|AK124939
−
|negative regulator of antiviral response (non-protein coding)
+
|NA
−
|influenza A virus (IAV) infection
+
|NA
 +
|pathogenic process
 +
|pulmonary adenocarcinoma
 
|-
 
|-
−
|''OLMALINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153]
−
|[[OLMALINC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142268 HSALNG0142268]
−
|"bA34D15.5, FLJ12974, HI-LNC80"
+
|PRAS
−
|oligodendrocyte maturation-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249]
−
|[[PANCR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142364 HSALNG0142364]
−
|N/A
+
|SNAR-A1
−
|PITX2 adjacent non-coding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PAPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929]
−
|[[PAPPA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142044 HSALNG0142044]
−
|"PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156"
+
|lincRNA-BC2
−
|PAPPA antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''PAPPA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930]
−
|[[PAPPA-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142045 HSALNG0142045]
−
|AGU1
+
|lincRNA-BC4
−
|PAPPA antisense RNA 2
+
|NA
−
|stem cell differentiation
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''PARTICL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931]
−
|[[PARTICL]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142046 HSALNG0142046]
−
|PARTICLE
+
|lincRNA-BC5
−
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''PAXIP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932]
−
|[[PAXIP1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142047 HSALNG0142047]
−
|N/A
+
|lincRNA-BC8
−
|PAXIP1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''PCAT14''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
−
|[[PCAT14]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039551 HSALNG0039551]
−
|N/A
+
|LINC01511
−
|prostate cancer associated transcript 14 (non-protein coding)
+
|RP11-325I22.2
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCAT18''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026]
−
|[[PCAT18]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142141 HSALNG0142141]
−
|LINC01092
+
|LOC440905
−
|prostate cancer associated transcript 18 (non-protein coding)
+
|NA
−
| metastatic prostate cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCAT19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
−
|[[PCAT19]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039551 HSALNG0039551]
−
|LINC01190
+
|LINC01511
−
|prostate cancer associated transcript 19 (non-protein coding)
+
|RP11-325I22.2
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552]
−
|[[PCAT29]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141667 HSALNG0141667]
−
|N/A
+
|AC079776.2
−
|prostate cancer associated transcript 29 (non-protein coding)
+
|NA
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720]
−
|[[PCAT5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141835 HSALNG0141835]
−
|TPCAT-10-36067
+
|CTA-363E6.2
−
|prostate cancer associated transcript 5 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCBP2-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901]
−
|[[PCBP2-OT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142016 HSALNG0142016]
−
|TUC338
+
|LINC00987
−
|PCBP2 overlapping transcript 1
+
|NA
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCBP3-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185]
−
|[[PCBP3-OT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142300 HSALNG0142300]
−
|FLJ44028
+
|RP11-1C1.7
−
|PCBP3 overlapping transcript 1
+
|NA
−
|DNA damage
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCF11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197]
−
|[[PCF11-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142312 HSALNG0142312]
−
|ENST00000602322.1
+
|RP11-445K13.2
−
|PCF11 anstisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PCNA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199]
−
|[[PCNA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142314 HSALNG0142314]
−
|N/A
+
|RP11-473M20.11
−
|PCNA antisense RNA 1
+
|NA
−
|tumor
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PEG13''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213]
−
|[[PEG13]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142328 HSALNG0142328]
−
|N/A
+
|RP11-893F2.6
−
|paternally expressed 13
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PEG3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217]
−
|[[PEG3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142332 HSALNG0142332]
−
|"APEG3, NCRNA00155"
+
|RP13-514E23.1
−
|PEG3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PICSAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218]
−
|[[PICSAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142333 HSALNG0142333]
−
|"PRED74, NLC1-C"
+
|RP1-90D4.3
−
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
+
|NA
−
|Cutaneous Squamous Cell Carcinoma
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PINK1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220]
−
|[[PINK1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142335 HSALNG0142335]
−
|"FLJ00387, PINK1AS, naPINK1"
+
|RP4-575N6.5
−
|PINK1 antisense RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PISRT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226]
−
|[[PISRT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142341 HSALNG0142341]
−
|NCRNA00195
+
|RP5-826L7.1
−
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
+
|NA
−
|blepharophimosis syndrome
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PRKCQ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378]
−
|[[PRKCQ-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142493 HSALNG0142493]
−
|ENST00000414894.1
+
|XLOC_003286
−
|PRKCQ antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PRR7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379]
−
|[[PRR7-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142494 HSALNG0142494]
−
|N/A
+
|XLOC_003405
−
|PRR7 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PSMA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389]
−
|[[PSMA3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142504 HSALNG0142504]
−
|FLJ31306
+
|XLOC_012255
−
|PSMA3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''PSMD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056]
−
|[[PSMD5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142171 HSALNG0142171]
−
|N/A
+
|MIR21
−
|PSMD5 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 
|-
 
|-
−
|''PTENP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621]
−
|[[PTENP1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141736 HSALNG0141736]
−
|PTENpg1-asRNA
+
|ASncmtRNAs
−
|PTENP1 antisense RNA
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|cancer
 
|-
 
|-
−
|''PTPRJ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316]
−
|[[PTPRJ-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0022090 HSALNG0022090]
−
|N/A
+
|LINC01614
−
|PTPRJ antisense RNA 1
+
|LCAL4,TCONS_00003105
−
|_
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''PWAR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982]
−
|[[PWAR1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142097 HSALNG0142097]
−
|"PAR1, PAR-1"
+
|lncRNA-FER1L4
−
|Prader Willi/Angelman region RNA 1
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''PWAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016]
−
|[[PWAR4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142131 HSALNG0142131]
−
|"PAR4, PAR-4"
+
|LOC283177
−
|Prader Willi/Angelman region RNA 4
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 
|-
 
|-
−
|''PWAR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003]
−
|[[PWAR5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134860 HSALNG0134860]
−
|"PAR5, PAR-5"
+
|HORMAD2-AS1
−
|Prader Willi/Angelman region RNA 5
+
|MTMR3-AS1,NONHSAG033653
−
|_
+
|NA
 +
|pathogenic process
 +
|type 1 diabetes;bowel disease
 
|-
 
|-
−
|''PWARSN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372]
−
|[[PWARSN]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142487 HSALNG0142487]
−
|"PAR-SN, PARSN"
+
|WNT4
−
|"Prader Willi/Angelman region RNA, SNRPN neighbor"
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|pathogenic process
 +
|endometriosis
 
|-
 
|-
−
|''RAD51-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540]
−
|[[RAD51-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141655 HSALNG0141655]
−
|TODRA
+
|AB074278
−
|RAD51 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''RFPL1S''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166]
−
|[[RFPL1S]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142281 HSALNG0142281]
−
|"RFPL1-AS, NCRNA00006"
+
|RCCRT1
−
|RFPL1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal cell cancer
 
|-
 
|-
−
|''RGMB-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043]
−
|[[RGMB-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043862 HSALNG0043862]
−
|N/A
+
|LINC00491
−
|RGMB antisense RNA 1
+
|BC008363
−
|non-small cell lung cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''RHPN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNT0289632]
−
|[[RHPN1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141747 HSALNG0141747]
−
|MGC3113
+
|BC008363
−
|RHPN1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''RMST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858]
−
|[[RMST]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141973 HSALNG0141973]
−
|"NCRMS, NCRNA00054, LINC00054"
+
|H1.3
−
|rhabdomyosarcoma 2 associated transcript (non-protein coding)
+
|NA
−
|Rhabdomyosarcoma subtypes
+
|NA
 +
|pathogenic process
 +
|ovarian cancer
 
|-
 
|-
−
|''RNF217-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896]
−
|[[RNF217-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142011 HSALNG0142011]
−
|STL
+
|LINC00582
−
|RNF217 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''RNF219-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301]
−
|[[RNF219-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141635 HSALNG0141635]
−
|N/A
+
|LINC01537
−
|RNF219 antisense RNA 1
+
|RP11-169D4.1-001
−
|_
+
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 
|-
 
|-
−
|''RPL34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551]
−
|[[RPL34-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141666 HSALNG0141666]
−
|"FLJ37673, RP11-462C24.1"
+
|AC026166.2
−
|RPL34 antisense RNA 1 (head to head)
+
|MTCO1P5
−
|_
+
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 
|-
 
|-
−
|''RPS6KA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184]
−
|[[RPS6KA2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142299 HSALNG0142299]
−
|N/A
+
|RP11-169D4.1-001
−
|RPS6KA2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 
|-
 
|-
−
|''RUSC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545]
−
|[[RUSC1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141660 HSALNG0141660]
−
|FLJ35976
+
|AC006050.3
−
|RUSC1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 
|-
 
|-
−
|''SALRNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556]
−
|[[SALRNA1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141671 HSALNG0141671]
−
|"SAL-RNA1, XLOCN/A023166"
+
|AC138128.1
−
|senescence associated long non-coding RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''SALRNA2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818]
−
|[[SALRNA2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141933 HSALNG0141933]
−
|"SAL-RNA2, XLOCN/A025931"
+
|ERCC1
−
|senescence associated long non-coding RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''SALRNA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061]
−
|[[SALRNA3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142176 HSALNG0142176]
−
|"SAL-RNA3, XLOCN/A025918"
+
|MT1DP
−
|senescence associated long non-coding RNA 3
+
|MT1DP
−
|_
+
|NA
 +
|pathogenic process
 +
|liver cancer
 
|-
 
|-
−
|''SAMD12-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578]
−
|[[SAMD12-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141693 HSALNG0141693]
−
|N/A
+
|AK023096
−
|SAMD12 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Wilms’ tumor;uterine leiomyomas
 
|-
 
|-
−
|''SAMMSON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112]
−
|[[SAMMSON]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0003560 HSALNG0003560]
−
|N/A
+
|LINC01562
−
|survival associated mitochondrial melanoma specific oncogenic non-coding RNA
+
|RP11-296A18.3
−
|Melanoma
+
|transcriptional regulation
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''SAP30L-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567]
−
|[[SAP30L-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141682 HSALNG0141682]
−
|"FLJ38109, GALNT10-AS1"
+
|AK000974
−
|SAP30L antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SEC24B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579]
−
|[[SEC24B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141694 HSALNG0141694]
−
|1/2-SBSRNA4
+
|AK024118
−
|SEC24B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SGMS1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645]
−
|[[SGMS1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141760 HSALNG0141760]
−
|N/A
+
|BC040204
−
|SGMS1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SIRT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321]
−
|[[SIRT1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142436 HSALNG0142436]
−
|N/A
+
|U79277
−
|SIRT1 antisense RNA
+
|NA
−
|Hepatocellular Carcinoma
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SMAD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869]
−
|[[SMAD1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141984 HSALNG0141984]
−
|ENST00000513542
+
|HOST2
−
|SMAD1 antisense RNA 1
+
|NA
−
|Ventricular septal defects
+
|ceRNA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 
|-
 
|-
−
|''SMAD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368]
−
|[[SMAD5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135509 HSALNG0135509]
−
|DAMS
+
|MGAT3-AS1
−
|SMAD5 antisense RNA 1
+
|TapSAKI
−
|_
+
|NA
 +
|pathogenic process
 +
|acute kidney injury
 
|-
 
|-
−
|''SMCR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624]
−
|[[SMCR2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141739 HSALNG0141739]
−
|N/A
+
|ATXN7L3B
−
|"Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|spinocerebellar ataxia
 
|-
 
|-
−
|''SMCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990]
−
|[[SMCR5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142105 HSALNG0142105]
−
|NCRNA00034
+
|lnc-SCA7
−
|"Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)"
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|spinocerebellar ataxia
 
|-
 
|-
−
|''SMCR6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004]
−
|[[SMCR6]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142119 HSALNG0142119]
−
|N/A
+
|LOC100287482
−
|"Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)"
+
|NA
−
|Smith-Magenis syndrome
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''SMG7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383]
−
|[[SMG7-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142498 HSALNG0142498]
−
|DKFZP564C196
+
|XLOC_007697
−
|SMG7 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''SNAI3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384]
−
|[[SNAI3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142499 HSALNG0142499]
−
|MGC23284
+
|XLOC_008559
−
|SNAI3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''SNHG10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385]
−
|[[SNHG10]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142500 HSALNG0142500]
−
|"FLJ40557, NCRNA00063, LINC00063"
+
|XLOC_009911
−
|small nucleolar RNA host gene 10
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''SNHG11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813]
−
|[[SNHG11]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141928 HSALNG0141928]
−
|LINC00101
+
|ENST00000480739
−
|small nucleolar RNA host gene 11
+
|RPL13AP23
−
|obesity
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''SNHG12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111]
−
|[[SNHG12]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142226 HSALNG0142226]
−
|"PNAS-123, LINC00100, ASLNC04080"
+
|OS9
−
|small nucleolar RNA host gene 12
+
|NA
−
|osteosarcoma
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''SNHG14''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324]
−
|[[SNHG14]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142439 HSALNG0142439]
−
|"NCRNA00214, UBE3A-AS"
+
|uc.283-plus
−
|small nucleolar RNA host gene 14
+
|NA
−
| Prader-Willi
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''SNHG15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117]
−
|[[SNHG15]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0051652 HSALNG0051652]
−
|"FLJ38860, MYO1GUT, Linc-Myo1g"
+
|LINC01611
−
|small nucleolar RNA host gene 15
+
|RP1-90L14.1,TCONS_l2_00025430
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|diabetic retinopathy
 
|-
 
|-
−
|''SNHG16''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529]
−
|[[NONHSAT056039]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141644 HSALNG0141644]
−
|ncRAN
+
|2900055J20Rik
−
|small nucleolar RNA host gene 16
+
|2900055J20Rik
−
|bladder cancer, colorectal cancer
+
|NA
 +
|pathogenic process
 +
|left ventricular hypertrophy
 
|-
 
|-
−
|''SNHG20''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792]
−
|[[SNHG20]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141907 HSALNG0141907]
−
|"PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG"
+
|ENSG00000261777
−
|small nucleolar RNA host gene 20
+
|AC012184.3
−
|Hepatocellular Carcinoma
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''SNHG7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618]
−
|[[SNHG7]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141733 HSALNG0141733]
−
|"MGC16037, NCRNA00061"
+
|Asb3
−
|small nucleolar RNA host gene 7
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiovascular and renal disease
 
|-
 
|-
−
|''SNHG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703]
−
|[[SNHG8]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141818 HSALNG0141818]
−
|"NCRNA00060, LINC00060"
+
|Chac2
−
|small nucleolar RNA host gene 8
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiovascular and renal disease
 
|-
 
|-
−
|''SOCS2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139]
−
|[[SOCS2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142254 HSALNG0142254]
−
|N/A
+
|Pex11b
−
|SOCS2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiovascular and renal disease
 
|-
 
|-
−
|''SOX21-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255]
−
|[[SOX21-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142370 HSALNG0142370]
−
|N/A
+
|Sp5
−
|SOX21 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|cardiovascular and renal disease
 
|-
 
|-
−
|''SOX2-OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639]
−
|[[SOX2-OT]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101614 HSALNG0101614]
−
|"DKFZp761J1324, NCRNA00043"
+
|PSMA3-AS1
−
|SOX2 overlapping transcript
+
|FLJ31306
−
|Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''SPATA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319]
−
|[[SPATA3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141639 HSALNG0141639]
−
|N/A
+
|LINC00493
−
|SPATA3 antisense RNA 1 (head to head)
+
|LOC388789
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''ST7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903]
−
|[[ST7-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0126842 HSALNG0126842]
−
|ST7AS1
+
|CARD8-AS1
−
|ST7 antisense RNA 1
+
|LOC100505812
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|leukemia and neuroblastoma
 
|-
 
|-
−
|''ST7-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729]
−
|[[ST7-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0030929 HSALNG0030929]
−
|ST7AS2
+
|KCNMB2-AS1
−
|ST7 antisense RNA 2
+
|RP11-385J1.2
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''ST7-OT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548]
−
|[[ST7-OT3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141663 HSALNG0141663]
−
|NCRNA00026
+
|AC013264.2
−
|ST7 overlapping transcript 3
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''STAM-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857]
−
|[[STAM-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141972 HSALNG0141972]
−
|locus3182
+
|GUCY1B2
−
|STAM antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''STX18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190]
−
|[[STX18-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142305 HSALNG0142305]
−
|LOC100507266
+
|RP11-385J1.2
−
|STX18 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''TCL6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216]
−
|[[TCL6]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142331 HSALNG0142331]
−
|"TCL6e1, TNG2, TNG1"
+
|RP1-317E23.3
−
|T-cell leukemia/lymphoma 6 (non-protein coding)
+
|NA
−
|leukemia, lymphoma
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''TDRG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317]
−
|[[NONHSAT112472]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142432 HSALNG0142432]
−
|"LINC00532, lincRNA-NRN/A024015"
+
|TUBA4B
−
|testis development related 1 (non-protein coding)
+
|NA
−
|testicular cancer
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''TEX41''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375]
−
|[[TEX41]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142490 HSALNG0142490]
−
|"DKFZp686O1327, LINC00953"
+
|XLOC_000371
−
|testis expressed 41 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''TGFB2-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397]
−
|[[TGFB2-OT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142512 HSALNG0142512]
−
|FLJ11812
+
|Z82214.3
−
|TGFB2 overlapping transcript 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''TH2LCRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735]
−
|[[TH2LCRR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141850 HSALNG0141850]
−
|TH2-LCR
+
|DALIR
−
|T helper type 2 locus control region associated RNA
+
|DALI
−
|_
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''THRIL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376]
−
|[[Lnc-DHX37-1:1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142491 HSALNG0142491]
−
|"Linc1992, TCONSN/A00020260, BRI3BP-AS1"
+
|XLOC_000620
−
|TNF and HNRNPL related immunoregulatory long non-coding RNA
+
|NA
−
|Kawasaki disease
+
|NA
 +
|pathogenic process
 +
|H. pylori-related diseases
 
|-
 
|-
−
|''TINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380]
−
|[[ENST00000448587.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142495 HSALNG0142495]
−
|"FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16"
+
|XLOC_004122
−
|tissue differentiation-inducing non-protein coding RNA
+
|NA
−
|squamous cell carcinoma, gastric cancer
+
|NA
 +
|pathogenic process
 +
|H. pylori-related diseases
 
|-
 
|-
−
|''TLX1NB''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381]
−
|[[TLX1NB]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142496 HSALNG0142496]
−
|"TD1, TDI, APT-B7"
+
|XLOC_004562
−
|TLX1 neighbor
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|H. pylori-related diseases
 
|-
 
|-
−
|''TMEM92-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382]
−
|[[TMEM92-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142497 HSALNG0142497]
−
|"RP11-893F2.9, lncRNA-508851, TCONSN/A00025237"
+
|XLOC_005912
−
|TMEM92 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|H. pylori-related diseases
 
|-
 
|-
−
|''TMEM9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391]
−
|[[TMEM9B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142506 HSALNG0142506]
−
|N/A
+
|XLOC_014388
−
|TMEM9B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|H. pylori-related diseases
 
|-
 
|-
−
|''TOLLIP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028]
−
|[[TOLLIP-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142143 HSALNG0142143]
−
|N/A
+
|LOC652276
−
|TOLLIP antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''TP53COR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162]
−
|[[TP53COR1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142277 HSALNG0142277]
−
|"linc-p21, lincRNA-p21, Trp53cor1"
+
|R05532
−
|tumor protein p53 pathway corepressor 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''TP53TG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175]
−
|[[TP53TG1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046752 HSALNG0046752]
−
|"HN/ARG012D21.9, LINC00096"
+
|LINC01411
−
|TP53 target 1 (non-protein coding)
+
|RP11-267A15.1
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''TP73-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025]
−
|[[TP73-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142140 HSALNG0142140]
−
|PDAM
+
|LOC401317
−
|TP73 antisense RNA 1
+
|NA
−
|esophageal squamous cell carcinoma.
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''TRERNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726]
−
|[[TRERNA1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141841 HSALNG0141841]
−
|"ncRNA-a7, treRNA"
+
|CTD-2574D22.4
−
|translation regulatory long non-coding RNA 1
+
|AC120114.2
−
|_
+
|NA
 +
|pathogenic process
 +
|osteoarthritis
 
|-
 
|-
−
|''TRPM2-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141]
−
|[[TRPM2-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142256 HSALNG0142256]
−
|TRPM2-AS1
+
|PMS2L2
−
|TRPM2 antisense RNA
+
|NA
−
|cancer
+
|NA
 +
|pathogenic process
 +
|osteoarthritis
 
|-
 
|-
−
|''TSIX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974]
−
|[[TSIX]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142089 HSALNG0142089]
−
|"NCRNA00013, XIST-AS1, LINC00013"
+
|lncRNA-422
−
|"TSIX transcript, XIST antisense RNA"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''TSPEAR-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520]
−
|[[TSPEAR-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133454 HSALNG0133454]
−
|N/A
+
|AATBC
−
|TSPEAR antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''TTC28-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311]
−
|[[TTC28-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141637 HSALNG0141637]
−
|KIAA1648
+
|LINC00974
−
|TTC28 antisense RNA 1
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''TTTY15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943]
−
|[[TTTY15]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0042820 HSALNG0042820]
−
|"DKFZP434I143, NCRNA00138"
+
|ZBED3-AS1
−
|"testis-specific transcript, Y-linked 15 (non-protein coding)"
+
|NA
−
|prostate cancer sample
+
|NA
 +
|developmental process
 +
|NA
 
|-
 
|-
−
|''TTTY17A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116]
−
|[[TTTY17A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135958 HSALNG0135958]
−
|NCRNA00140
+
|LINC01589
−
|"testis-specific transcript, Y-linked 17A (non-protein coding)"
+
|CTA-941F9.9,TCONS_00029353
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''TTTY3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910]
−
|[[TTTY3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142025 HSALNG0142025]
−
|"TTY3, TTTY3A, LINC00121"
+
|LINC01426
−
|"testis-specific transcript, Y-linked 3 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''TTTY4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341]
−
|[[TTTY4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142456 HSALNG0142456]
−
|"TTY4, TTTY4A, LINC00123"
+
|uc002yug.2
−
|"testis-specific transcript, Y-linked 4 (non-protein coding)"
+
|NA
−
|_
+
|splicing regulation
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 
|-
 
|-
−
|''TTTY5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250]
−
|[[TTTY5]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142365 HSALNG0142365]
−
|"TTY5, LINC00126"
+
|SNCG
−
|"testis-specific transcript, Y-linked 5 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''TTTY6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNT0289949]
−
|[[TTTY6]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142064 HSALNG0142064]
−
|"TTY6, TTTY6A, LINC00127"
+
|lnc-AF085935
−
|"testis-specific transcript, Y-linked 6 (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TTTY9B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996]
−
|[[TTTY9B]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142111 HSALNG0142111]
−
|NCRNA00132
+
|lnc-uc003wbd
−
|"testis-specific transcript, Y-linked 9B (non-protein coding)"
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TUNAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559]
−
|[[TUNAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141674 HSALNG0141674]
−
|"TUNA, HI-LNC78"
+
|AF085935
−
|TCL1 upstream neural differentiation-associated RNA
+
|NA
−
|type 2 diabetes
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''TUSC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347]
−
|[[TUSC8]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142462 HSALNG0142462]
−
|XLOCN/A010588
+
|uc003wbd
−
|tumor suppressor candidate 8 (non-protein coding)
+
|NA
−
|cervical cancer
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''UMODL1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098]
−
|[[UMODL1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142213 HSALNG0142213]
−
|FLJ33471
+
|NR_001284
−
|UMODL1 antisense RNA 1
+
|TNXA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|chronic thromboembolic pulmonary hypertension
 
|-
 
|-
−
|''VLDLR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327]
−
|[[VLDLR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142442 HSALNG0142442]
−
|N/A
+
|uc.343
−
|VLDLR antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|osteoarthritis
 
|-
 
|-
−
|''WAC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196]
−
|[[WAC-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094525 HSALNG0094525]
−
|N/A
+
|NRAV
−
|WAC antisense RNA 1 (head to head)
+
|DYNLL1-AS1
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|influenza A virus
 
|-
 
|-
−
|''WASIR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140]
−
|[[WASIR2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142255 HSALNG0142255]
−
|N/A
+
|PLEC
−
|WASH and IL9R antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|chronic obstructive pulmonary disease
 
|-
 
|-
−
|''WDFY3-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172]
−
|[[WDFY3-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142287 HSALNG0142287]
−
|FBI4
+
|RNA44121|UCSC-2000-3182
−
|WDFY3 antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|chronic obstructive pulmonary disease
 
|-
 
|-
−
|''WSPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173]
−
|[[WSPAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142288 HSALNG0142288]
−
|"TCONSN/A00009511-XLOCN/A004555, lncTCF7"
+
|RNA50010|UCSC-9199-1005
−
|WNT signaling pathway activating non-coding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|chronic obstructive pulmonary disease
 
|-
 
|-
−
|''XACT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174]
−
|[[XACT]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142289 HSALNG0142289]
−
|N/A
+
|RNA58351|CombinedLit_316_550
−
|X active specific transcript (non-protein coding)
+
|NA
−
|chromosome inactivation
+
|NA
 +
|pathogenic process
 +
|chronic obstructive pulmonary disease
 
|-
 
|-
−
|''YAM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714]
−
|[[YAM1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141829 HSALNG0141829]
−
|Yam-1
+
|CR613944
−
|YY1-associated myogenesis RNA 1
+
|NA
−
|skeletal myogenesis
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''ZBED3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933]
−
|[[ZBED3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142048 HSALNG0142048]
−
|N/A
+
|lincRNA-CALCA
−
|ZBED3 antisense RNA 1
+
|NA
−
|chondrogenic differentiation
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''ZEB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200]
−
|[[ZEB1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142315 HSALNG0142315]
−
|N/A
+
|RP11-501G6.1
−
|ZEB1 antisense RNA 1
+
|NA
−
|hepatocellular carcinoma,  esophageal squamous cell carcinoma"
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''ZFAT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208]
−
|[[ZFAT-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142323 HSALNG0142323]
−
|"SAS-ZFAT, NCRNA00070"
+
|RP11-672F9.1
−
|ZFAT antisense RNA 1
+
|NA
−
|autoimmune thyroid disease
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''ZIM2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405]
−
|[[ZIM2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142520 HSALNG0142520]
−
|ZIM2as
+
|C14orf132
−
|ZIM2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''ZNF205-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937]
−
|[[ZNF205-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142052 HSALNG0142052]
−
|MGC3771
+
|lincRNA-TSPAN8
−
|ZNF205 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''ZNF252P-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225]
−
|[[ZNF252P-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142340 HSALNG0142340]
−
|N/A
+
|RP5-1014O16.1
−
|ZNF252P antisense RNA 1
+
|AC244098.1
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''ZNF436-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275]
−
|[[ZNF436-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142390 HSALNG0142390]
−
|FLJ90508
+
|TCONS_00026102
−
|ZNF436 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 
|-
 
|-
−
|''ZNF582-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277]
−
|[[ZNF582-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142392 HSALNG0142392]
−
|N/A
+
|TCONS_00032546
−
|ZNF582 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 
|-
 
|-
−
|''ZNF667-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037]
−
|[[ZNF667-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096978 HSALNG0096978]
−
|MORT
+
|LINC00441
−
|ZNF667 antisense RNA 1 (head to head)
+
|RB1-DT,ncRNA-RB1
−
|cancer
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''ZRANB2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661]
−
|[[ZRANB2-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141776 HSALNG0141776]
−
|N/A
+
|C1401f132
−
|ZRANB2 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039030 HSALNG0039030]
 +
|LINC02365
 +
|LVCAT8
 +
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''ADAMTS9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885]
−
|[[ADAMTS9-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0095161 HSALNG0095161]
−
|N/A
+
|ADGRD1-AS1
−
|ADAMTS9 antisense RNA 1
 
−
|epithelial ovarian cancer
 
−
|-
 
−
|''AFDN-AS1''
 
−
|[[AFDN-AS1]]
 
−
|C6orf124, MLLT4-AS1, HGC6.4, dJ431P23.3
 
−
|AFDN antisense RNA 1 (head to head)
 
−
|ovarian cancer
 
−
|-
 
−
|''ATP2C2-AS1''
 
−
|[[ATP2C2-AS1]]
 
−
|RP11-517C16.2-001
 
−
|ATP2C2 antisense RNA 1
 
−
|Botulinum Toxin Type A
 
−
|-
 
−
|''ADGRD1-AS1''
 
−
|[[ADGRD1-AS1]]
 
 
|LACAT8
 
|LACAT8
−
|ADGRD1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''ATP2B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142]
−
|[[ATP2B1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034152 HSALNG0034152]
−
|N/A
+
|LINC02475
−
|ATP2B1 antisense RNA 1
+
|LVCAT1
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BTG3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542]
−
|[[BTG3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141657 HSALNG0141657]
−
|ASBEL
+
|Abhd11os
−
|BTG3 antisense RNA 1
+
|NA
−
|Ovarian carcinoma
+
|NA
 +
|pathogenic process
 +
|neurodegenerative diseases
 
|-
 
|-
−
|''BRE-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895]
−
|[[BRE-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124521 HSALNG0124521]
−
|N/A
+
|BISPR
−
|BRE antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|virus infection
 
|-
 
|-
−
|''CCND2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975]
−
|[[CCND2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0112910 HSALNG0112910]
−
|N/A
+
|MAFTRR
−
|CCND2 antisense RNA 1
+
|linc-MAF-4
−
|glioma
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CD44-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058]
−
|[[CD44-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142173 HSALNG0142173]
−
|RP1-68D18.4
+
|MRAK052686
−
|CD44 antisense RNA 1
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|nonalcoholic fatty liver disease
 
|-
 
|-
−
|''CEBPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221]
−
|[[CEBPA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142336 HSALNG0142336]
−
|N/A
+
|RP4-583P15.10
−
|CEBPA antisense RNA 1 (head to head)
+
|AL121845.1
−
|Gastric cancer
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''CERNA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341]
−
|[[CERNA1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101470 HSALNG0101470]
−
|LOC100129973
+
|KTN1-AS1
−
|competing endogenous lncRNA 1 for miR-4707-5p and miR-4767
+
|C14orf33,MYCLo-3
−
|cardiovascular disease
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''CERNA2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752]
−
|[[CERNA2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129835 HSALNG0129835]
−
|HOST2
+
|DLGAP4-AS1
−
|competing endogenous lncRNA 2 for microRNA let-7b
+
|CCAT7
−
|Ovarian cancer, Hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''CERNA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682]
−
|[[CERNA3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141797 HSALNG0141797]
−
|CTA
+
|CCAT3
−
|competing endogenous lncRNA 3 for miR-645
+
|NA
−
|Osteosarcoma
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''CFLAR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684]
−
|[[CFLAR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141799 HSALNG0141799]
−
|ALS2CR10
+
|CCAT8
−
|CFLAR antisense RNA 1
+
|NA
−
|hypertrophic scar
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''CLMAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898]
−
|[[CLMAT3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142013 HSALNG0142013]
−
|SPARC-AS1
+
|LINC00659
−
|colorectal liver metastasis associated transcript 3
+
|NA
 +
|NA
 +
|pathogenic process
 
|colorectal cancer
 
|colorectal cancer
 
|-
 
|-
−
|''COL1A2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNT0289683]
−
|[[COL1A2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141798 HSALNG0141798]
−
|TCONS_00013888, lncRNA8975-1
+
|CCAT7
−
|COL1A2 antisense RNA 1
+
|NA
−
|
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''CSMD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627]
−
|[[CSMD2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141742 HSALNG0141742]
−
|ENST00000434181
+
|BALR-2
−
|CSMD2 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|B cell acute lymphoblastic leukemia
 
|-
 
|-
−
|''CYTOR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948]
−
|[[CYTOR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142063 HSALNG0142063]
−
|C2orf59, NCRNA00152, LINC00152, MGC4677
+
|lnc-ACACA-1
−
|cytoskeleton regulator RNA
+
|NA
−
|Breast cancer, Gastric cancer
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''CHMP1B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953]
−
|[[CHMP1B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142068 HSALNG0142068]
−
|N/A
+
|lnc-BMP2-2
−
|CHMP1B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''CLLU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955]
−
|[[CLLU1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142070 HSALNG0142070]
−
|N/A
+
|lnc-CPN2-1
−
|chronic lymphocytic leukemia up-regulated 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DLGAP4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958]
−
|[[DLGAP4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142073 HSALNG0142073]
−
|CCAT7
+
|lnc-FOXG1-2
−
|DLGAP4 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DM1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960]
−
|[[DM1-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142075 HSALNG0142075]
−
|N/A
+
|lnc-FZD1-2
−
|DM1 locus antisense RNA
+
|NA
−
|Myotonic dystrophy type 1
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DPYD-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962]
−
|[[DPYD-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142077 HSALNG0142077]
−
|N/A
+
|lnc-ITPR2-3
−
|DPYD antisense RNA 2
+
|NA
−
|Cervical squamous cancers
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DSCAM-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965]
−
|[[DSCAM-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142080 HSALNG0142080]
−
|M41
+
|lnc-LCP2-2
−
|DSCAM antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DSCR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988]
−
|[[DSCR4]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142103 HSALNG0142103]
−
|DCRB
+
|lnc-RP3-368B9
−
|Down syndrome critical region 4
+
|NA
−
|Down syndrome
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DSCR8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991]
−
|[[DSCR8]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142106 HSALNG0142106]
−
|C21orf65, MTAG2, CT25.1a, CT25.1b, MMA-1a, MMA-1b
+
|lnc-SLC30A4-1
−
|Down syndrome critical region 8 (non-protein coding)
+
|NA
−
|Down syndrome, melanoma
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DARS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992]
−
|[[DARS-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142107 HSALNG0142107]
−
|N/A
+
|lnc-SPAM1-6
−
|DARS antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DCST1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995]
−
|[[DCST1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142110 HSALNG0142110]
−
|RP11-307C12.11
+
|lnc-TTC34-3
−
|DCST1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 
|-
 
|-
−
|''DDN-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064]
−
|[[DDN-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106856 HSALNG0106856]
−
|CAT1507
+
|DRAIC
−
|DDN and PRKAG1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
 
|-
 
|-
−
|''DDX11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNT0005037]
−
|[[DDX11-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002618 HSALNG0002618]
−
|CONCR
+
|LINC01137
−
|DDX11 antisense RNA 1
+
|LOC728431
−
|_
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''DINOL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390]
−
|[[DINOL]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142505 HSALNG0142505]
−
|DINO
+
|XLOC_014172
−
|damage induced long noncoding RNA
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''DNAJB8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014]
−
|[[DNAJB8-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142129 HSALNG0142129]
−
|N/A
+
|LOC149086
−
|DNAJB8 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''ELF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183]
−
|[[ELF3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142298 HSALNG0142298]
−
|ENST00000415582
+
|RP11-160H22.5
−
|ELF3 antisense RNA 1
+
|AL121983.2
−
|Papillary Thyroid Cancer
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''FBXL19-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945]
−
|[[FBXL19-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142060 HSALNG0142060]
−
|NCRNA00095, MGC125469, MGC125470, MGC125472
+
|LNC00964-3
−
|FBXL19 antisense RNA 1 (head to head)
+
|NA
−
|Colorectal cancer
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''FAM30A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616]
−
|[[FAM30A]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141731 HSALNG0141731]
−
|HSPC053
+
|Arid2-IR
−
|family with sequence similarity 30 member A
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|renal inflammation
 
|-
 
|-
−
|''FEZF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716]
−
|[[FEZF1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141831 HSALNG0141831]
−
|N/A
+
|CR619813
−
|FEZF1 antisense RNA 1
+
|NA
−
|Colorectal carcinoma, Gastric cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FGF14-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739]
−
|[[FGF14-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141854 HSALNG0141854]
−
|N/A
+
|DDX6P1
−
|FGF14 antisense RNA 2
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FLICR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938]
−
|[[FLICR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142053 HSALNG0142053]
−
|N/A
+
|lincRNA-ZNF532
−
|FOXP3 regulating long intergenic non-coding RNA
+
|NA
−
|Autoimmune diabetes
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FLNC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011]
−
|[[FLNC-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142126 HSALNG0142126]
−
|N/A
+
|LOC105372753
−
|FLNC antisense RNA 1
+
|NA
−
|Cervical squamous cancers
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FOXD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013]
−
|[[FOXD2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142128 HSALNG0142128]
−
|MGC12982
+
|LOC105377769
−
|FOXD2 antisense RNA 1 (head to head)
+
|NA
−
|Lung cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FOXD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205]
−
|[[FOXD3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142320 HSALNG0142320]
−
|pasFOXD3
+
|RP11-58D2.1
−
|FOXD3 antisense RNA 1 (head to head)
+
|NA
−
|glioma
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''FOXP4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946]
−
|[[FOXP4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105101 HSALNG0105101]
−
|N/A
+
|ENST00000434223
−
|FOXP4 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''G2E3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947]
−
|[[G2E3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082178 HSALNG0082178]
−
|CAT1647
+
|ENST00000442037
−
|G2E3 antisense RNA 1
+
|NA
−
|Bladder cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''GCASPC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953]
−
|[[GCASPC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088449 HSALNG0088449]
−
|TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1
+
|ENST00000540136
−
|gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA
+
|NA
−
|gallbladder cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''GABPB1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103]
−
|[[GABPB1-IT1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142218 HSALNG0142218]
−
|FLJ10038
+
|NR_038125
−
|GABPB1 intronic transcript
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''GPRC5D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136]
−
|[[GPRC5D-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142251 HSALNG0142251]
−
|RP11-392P7.6
+
|PDLIM3
−
|GPRC5D and HEBP1 antisense RNA 1
+
|NA
−
|Colorectal cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''GSEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335]
−
|[[GSEC]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142450 HSALNG0142450]
−
|ST3GAL4-AS1, DCPS-AS1, FLJ39051
+
|uc001gch.1
−
|G-quadruplex forming sequence containing lncRNA
+
|NA
−
|colon cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''HCG11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336]
−
|[[HCG11]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142451 HSALNG0142451]
−
|bK14H9.3, FLJ14049, FLJ30357
+
|uc001gzl.3
−
|HLA complex group 11 (non-protein coding)
+
|NA
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''HDAC2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351]
−
|[[HDAC2-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142466 HSALNG0142466]
−
|ENST00000421891
+
|uc004bbl.1
−
|HDAC2 and HS3ST5 antisense RNA 2
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''HOXC-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369]
−
|[[HOXC-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142484 HSALNG0142484]
−
|N/A
+
|VNN2
−
|HOXC cluster antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''HDHD5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577]
−
|[[HDHD5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141692 HSALNG0141692]
−
|CECR4, CECR5-AS1, NCRNA00017
+
|AK022798
−
|HDHD5 antisense RNA 1
+
|NA
−
|cat eye syndrome
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''HMMR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663]
−
|[[HMMR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141778 HSALNG0141778]
−
|N/A
+
|C1orf74
−
|HMMR antisense RNA 1
+
|NA
−
|basal-like breast cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''HSD17B3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602]
−
|[[HSD17B3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141717 HSALNG0141717]
−
|ENST00000448857
+
|AKR7L
−
|HSD17B3 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''IL21R-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711]
−
|[[IL21R-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141826 HSALNG0141826]
−
|N/A
+
|COL3A1
−
|IL21R antisense RNA 1
+
|NA
−
|coronary artery disease
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''INHBA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878]
−
|[[INHBA-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141993 HSALNG0141993]
−
|N/A
+
|KCNE2
−
|INHBA antisense RNA 1
+
|NA
−
|Gastric cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''ITFG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636]
−
|[[ITFG2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141751 HSALNG0141751]
−
|N/A
+
|BC015134
−
|ITFG2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''INO80-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713]
−
|[[INO80-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141828 HSALNG0141828]
−
|ENST00000560178
+
|CR594506
−
|INO80 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''INTS9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928]
−
|[[INTS9-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142043 HSALNG0142043]
−
|ENST00000520055
+
|lincRNA-BBOX1-2
−
|INTS9 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''KIAA0087''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719]
−
|[[KIAA0087]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132223 HSALNG0132223]
−
|N/A
+
|LINC00320
−
|KIAA0087 lncRNA
+
|PRED14,FLJ37539
−
|endometrial carcinoma
+
|NA
 +
|pathogenic process;developmental process
 +
|cortical white matter
 
|-
 
|-
−
|''KRT7-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823]
−
|[[KRT7-AS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141938 HSALNG0141938]
−
|N/A
+
|EVADR
−
|KRT7 antisense RNA 1
+
|NA
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer;lung cancer;colorectal cancer;rectal cancer
 
|-
 
|-
−
|''KTN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNT0289944]
−
|[[KTN1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142059 HSALNG0142059]
−
|C14orf33, MYCLo-3
+
|Lnc_bc060912
−
|KTN1 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''LEF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952]
−
|[[LEF1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142067 HSALNG0142067]
−
|N/A
+
|lnc-bc060912
−
|LEF1 antisense RNA 1
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|lung cancer
 
|-
 
|-
−
|''LIF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613]
−
|[[LIF-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141728 HSALNG0141728]
−
|Lnc-LIF-AS
+
|APF
−
|LIF antisense RNA 1
+
|NA
−
|Cervical squamous cancers
+
|ceRNA
 +
|pathogenic process
 +
|myocardial infarction
 
|-
 
|-
−
|''LINC00260''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617]
−
|[[LINC00260]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141732 HSALNG0141732]
−
|MGC5457
+
|AS Uchl1
−
|long intergenic non-protein coding RNA 260
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 
|-
 
|-
−
|''LINC00513''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104]
−
|[[LINC00513]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099739 HSALNG0099739]
−
|AC016831.7
+
|LINC01296
−
|long intergenic non-protein coding RNA 513
+
|FLJ39632
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC00665''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403]
−
|[[LINC00665]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142518 HSALNG0142518]
−
|N/A
+
|ZXF2
−
|long intergenic non-protein coding RNA 665
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 
|-
 
|-
−
|''LINC00680''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113]
−
|[[LINC00680]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142228 HSALNG0142228]
−
|N/A
+
|P14695
−
|long intergenic non-protein coding RNA 680
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC00909''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114]
−
|[[LINC00909]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142229 HSALNG0142229]
−
|N/A
+
|P16984
−
|long intergenic non-protein coding RNA 909
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC00969''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115]
−
|[[LINC00969]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142230 HSALNG0142230]
−
|ENST00000453324
+
|P19780
−
|long intergenic non-protein coding RNA 969
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01505''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116]
−
|[[LINC01505]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142231 HSALNG0142231]
−
|RP11-308N19.1
+
|P23099
−
|long intergenic non-protein coding RNA 1505
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01689''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117]
−
|[[LINC01689]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142232 HSALNG0142232]
−
|AP000469.2
+
|P24363
−
|long intergenic non-protein coding RNA 1689
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01711''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118]
−
|[[LINC01711]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142233 HSALNG0142233]
−
|MGC4294
+
|P28210
−
|long intergenic non-protein coding RNA 1711
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01785''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120]
−
|[[LINC01785]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142235 HSALNG0142235]
−
|N/A
+
|P33863
−
|long intergenic non-protein coding RNA 1785
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01826''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121]
−
|[[LINC01826]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142236 HSALNG0142236]
−
|lnc-MKI67IP-3
+
|P4091
−
|long intergenic non-protein coding RNA 1826
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01869''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122]
−
|[[LINC01869]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142237 HSALNG0142237]
−
|MGC45922
+
|P6391
−
|long intergenic non-protein coding RNA 1869
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC01959''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123]
−
|[[LINC01959]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142238 HSALNG0142238]
−
|N/A
+
|P6488
−
|long intergenic non-protein coding RNA 1959
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02001''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124]
−
|[[LINC02001]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142239 HSALNG0142239]
−
|RP11-1094M14.11
+
|P700
−
|long intergenic non-protein coding RNA 2001
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02135''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125]
−
|[[LINC02135]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142240 HSALNG0142240]
−
|N/A
+
|P8611
−
|long intergenic non-protein coding RNA 2135
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02158''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126]
−
|[[LINC02158]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142241 HSALNG0142241]
−
|N/A
+
|P8725
−
|long intergenic non-protein coding RNA 2158
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02175''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127]
−
|[[LINC02175]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142242 HSALNG0142242]
−
|N/A
+
|P8860
−
|long intergenic non-protein coding RNA 2175
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02179''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128]
−
|[[LINC02179]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142243 HSALNG0142243]
−
|RP11-189E14.4
+
|P9745
−
|long intergenic non-protein coding RNA 2179
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02209''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269]
−
|[[LINC02209]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044864 HSALNG0044864]
−
|N/A
+
|TH2LCRR
−
|long intergenic non-protein coding RNA 2209
+
|TH2-LCR
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|allergic asthma
 
|-
 
|-
−
|''LINC02224''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964]
−
|[[LINC02224]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142079 HSALNG0142079]
−
|BRCAT107, ENST00000505706
+
|lnc-LCE5A-1
−
|long intergenic non-protein coding RNA 2224
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|laryngeal cancer;head and neck squamous cell cancer
 
|-
 
|-
−
|''LINC02232''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198]
−
|[[LINC02232]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026441 HSALNG0026441]
−
|RP11-707A18.1
+
|FAM3D-AS1
−
|long intergenic non-protein coding RNA 2232
+
|lnc-KCTD6-3
−
|_
+
|NA
 +
|pathogenic process
 +
|tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer
 
|-
 
|-
−
|''LINC02233''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843]
−
|[[LINC02233]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141958 HSALNG0141958]
−
|RP11-6C14.1
+
|FRLnc1
−
|long intergenic non-protein coding RNA 2233
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC02234''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005]
−
|[[LINC02234]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0117109 HSALNG0117109]
−
|RP11-455B3.1
+
|ENST00000575202
−
|long intergenic non-protein coding RNA 2234
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02235''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952]
−
|[[LINC02235]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089220 HSALNG0089220]
−
|RP11-354A14.1
+
|ENST00000539009
−
|long intergenic non-protein coding RNA 2235
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02236''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954]
−
|[[LINC02236]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089242 HSALNG0089242]
−
|RP11-332J15.1
+
|ENST00000544591
−
|long intergenic non-protein coding RNA 2236
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02237''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752]
−
|[[LINC02237]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141867 HSALNG0141867]
−
|RP11-1101K5.1
+
|EHHADH-AS1
−
|long intergenic non-protein coding RNA 2237
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02260''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812]
−
|[[LINC02260]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141927 HSALNG0141927]
−
|N/A
+
|ENST00000468960
−
|long intergenic non-protein coding RNA 2260
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02365''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276]
−
|[[LINC02365]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142391 HSALNG0142391]
−
|LVCAT8
+
|TCONS_00026506
−
|long intergenic non-protein coding RNA 2365
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02475''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952]
−
|[[LINC02475]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091595 HSALNG0091595]
−
|LVCAT1
+
|LRP1-AS
−
|long intergenic non-protein coding RNA 2475
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''LINC02487''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045]
−
|[[LINC02487]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015125 HSALNG0015125]
−
|N/A
+
|LINC01122
−
|long intergenic non-protein coding RNA 2487
+
|FLJ30838,AC007092.1
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC02488''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565]
−
|[[LINC02488]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141680 HSALNG0141680]
−
|CTD-2316B1
+
|AI364715
−
|long intergenic non-protein coding RNA 2488
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC02551''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921]
−
|[[LINC02551]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142036 HSALNG0142036]
−
|RP11-890B15.2
+
|LINC0949
−
|long intergenic non-protein coding RNA 2551
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|systemic lupus erythematosus
 
|-
 
|-
−
|''LINC02560''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680]
−
|[[LINC02560]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141795 HSALNG0141795]
−
|CTD-2619J13.13
+
|CCAL
−
|long intergenic non-protein coding RNA 2560
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''LINC02561''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079]
−
|[[LINC02561]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077354 HSALNG0077354]
−
|RP11-445P17.8
+
|LINC00993
−
|long intergenic non-protein coding RNA 2561
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINC-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811]
−
|[[LINC-ROR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141926 HSALNG0141926]
−
|lincRNA-RoR, lincRNA-ST8SIA3, ROR
+
|ENST00000460164
−
|long intergenic non-protein coding RNA, regulator of reprogramming
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 
|-
 
|-
−
|''LNCPRESS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282]
−
|[[LNCPRESS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142397 HSALNG0142397]
−
|lncPRESS1
+
|TCONS_l2_00003938
−
|lncRNA p53 regulated and ESC associated 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 
|-
 
|-
−
|''LNCPRESS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888]
−
|[[LNCPRESS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142003 HSALNG0142003]
−
|lncPRESS2
+
|LGALS3
−
|lncRNA p53 regulated and ESC associated 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LRRC3DN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963]
−
|[[LRRC3DN]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142078 HSALNG0142078]
−
|DKFZP434C128
+
|lnc-KCMF1-2:1
−
|LRRC3 downstream neighbor (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LUARIS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967]
−
|[[LUARIS]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142082 HSALNG0142082]
−
|lncRNA#32
+
|lnc-LLPH-2:1
−
|lncRNA upregulator of antiviral response interferon signaling
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LILRB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971]
−
|[[LILRB1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142086 HSALNG0142086]
−
|AC009892.10
+
|lnc-PLA2R1-1:1
−
|LILRB1 antisense RNA 1
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00226''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972]
−
|[[LINC00226]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142087 HSALNG0142087]
−
|C14orf97, NCRNA00226
+
|lnc-PSD4-1:14
−
|long intergenic non-protein coding RNA 226
+
|NA
−
|Pancreatic ductal adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00240''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066]
−
|[[LINC00240]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142181 HSALNG0142181]
−
|C6orf41, NCRNA00240, bA373D17.1
+
|n335550
−
|long intergenic non-protein coding RNA 240
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00365''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070]
−
|[[LINC00365]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142185 HSALNG0142185]
−
|N/A
+
|n340790
−
|long intergenic non-protein coding RNA 365
+
|NA
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00460''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072]
−
|[[LINC00460]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142187 HSALNG0142187]
−
|N/A
+
|n386477
−
|long intergenic non-protein coding RNA 460
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00520''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286]
−
|[[LINC00520]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142401 HSALNG0142401]
−
|C14orf34
+
|TCONS_l2_00010365
−
|long intergenic non-protein coding RNA 520
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 
|-
 
|-
−
|''LINC00578''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNT0288944]
−
|[[LINC00578]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129184 HSALNG0129184]
−
|N/A
+
|ENST00000422494
−
|long intergenic non-protein coding RNA 578
+
|NA
−
|major depressive disorder
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00672''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118]
−
|[[LINC00672]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0038513 HSALNG0038513]
−
|N/A
+
|LINC01612
−
|long intergenic non-protein coding RNA 672
+
|RP11-789C1.1,TCONS_00008319
−
|Endometrial cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC00862''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610]
−
|[[LINC00862]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141725 HSALNG0141725]
−
|C1orf98, SMIM16
+
|AP001439.2
−
|long intergenic non-protein coding RNA 862
+
|NA
−
|Cystic Fibrosis
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC00888''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671]
−
|[[LINC00888]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141786 HSALNG0141786]
−
|N/A
+
|CACNAICAS3
−
|long intergenic non-protein coding RNA 888
+
|NA
−
|Melanoma tumorigenesis
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC00890''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853]
−
|[[LINC00890]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141968 HSALNG0141968]
−
|N/A
+
|GS1-5L10.1
−
|long intergenic non-protein coding RNA 890
+
|NA
−
|Leiomyoma
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC00998''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNT0289875]
−
|[[LINC00998]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141990 HSALNG0141990]
−
|N/A
+
|INTS7
−
|long intergenic non-protein coding RNA 998
+
|NA
−
|major depressive disorder
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01116''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065]
−
|[[LINC01116]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142180 HSALNG0142180]
−
|TALNEC2
+
|MYLK-AS1
−
|long intergenic non-protein coding RNA 1116
+
|NA
−
|Prostate cancer, GBM
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01138''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157]
−
|[[LINC01138]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142272 HSALNG0142272]
−
|LINC00875, FLJ39739
+
|PRSS21
−
|long intergenic non-protein coding RNA 1138
+
|NA
−
|prostate cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01186''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202]
−
|[[LINC01186]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142317 HSALNG0142317]
−
|N/A
+
|RP11-528G1.2
−
|long intergenic non-protein coding RNA 1186
+
|NA
−
|Lung cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01198''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207]
−
|[[LINC01198]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142322 HSALNG0142322]
−
|N/A
+
|RP11-643M14.1
−
|long intergenic non-protein coding RNA 1198
+
|NA
−
|anaplastic gliomas
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01554''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209]
−
|[[LINC01554]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142324 HSALNG0142324]
−
|C5orf27, FLJ38821, FIS
+
|RP11-789C1.1
−
|long intergenic non-protein coding RNA 1554
+
|LINC01612
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01630''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314]
−
|[[LINC01630]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142429 HSALNG0142429]
−
|LOC100287225
+
|TSNAX-DISC1
−
|long intergenic non-protein coding RNA 1630
+
|NA
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01671''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386]
−
|[[LINC01671]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142501 HSALNG0142501]
−
|BC041455
+
|XLOC_010235
−
|long intergenic non-protein coding RNA 1671
+
|NA
−
|Breast cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''LINC01684''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558]
−
|[[LINC01684]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141673 HSALNG0141673]
−
|lnc-JAM2-6
+
|AF075041
−
|long intergenic non-protein coding RNA 1684
+
|NA
−
|Nonalcoholic fatty liver disease
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01772''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564]
−
|[[ENST00000457898.1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141679 HSALNG0141679]
−
|ENSG00000226029
+
|AF339813
−
|long intergenic non-protein coding RNA 1772
+
|NA
−
|alzheimer's disease, ovarian cancer, pancreatic cancer,gastric cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01833''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575]
−
|[[LINC01833]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141690 HSALNG0141690]
−
|RP11-89, K21.1
+
|AK022029
−
|long intergenic non-protein coding RNA 1833
+
|NA
−
|lung adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01844''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576]
−
|[[LINC01844]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141691 HSALNG0141691]
−
|LOC101926975
+
|AK022159
−
|long intergenic non-protein coding RNA 1844
+
|NA
−
|Hirschsprung Disease
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01852''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604]
−
|[[LINC01852]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141719 HSALNG0141719]
−
|ENST00000434223
+
|AL389956
−
|long intergenic non-protein coding RNA 1852
+
|NA
−
|non-small cell lung cancer
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01857''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640]
−
|[[LINC01857]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141755 HSALNG0141755]
−
|AC079767.4
+
|BC023629
−
|long intergenic non-protein coding RNA 1857
+
|NA
−
|Tuberculosis
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''LINC01929''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096]
−
|[[LINC01929]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142211 HSALNG0142211]
−
|CTD-2171N6.1
+
|NONHSAT125629
−
|long intergenic non-protein coding RNA 1929
+
|NA
−
|Papillary thyroid cancer
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINC01930''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393]
−
|[[LINC01930]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142508 HSALNG0142508]
−
|EU358092
+
|XR_250621.1
−
|long intergenic non-protein coding RNA 1930
+
|NA
−
|schizophrenia
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''LINC01952''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951]
−
|[[LINC01952]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0033002 HSALNG0033002]
−
|AC004854.4
+
|ENST00000503938
−
|long intergenic non-protein coding RNA 1952
+
|NA
−
|recurrent miscarriage
+
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 
|-
 
|-
−
|''LINC02055''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085]
−
|[[LINC02055]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142200 HSALNG0142200]
−
|RP1130-1
+
|NONHSAT012762
−
|long intergenic non-protein coding RNA 2055
+
|NA
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 
|-
 
|-
−
|''LINC02081''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151]
−
|[[LINC02081]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0023952 HSALNG0023952]
−
|CTD-2357A8.3, XLOC_012582
+
|LMCD1-AS1
−
|long intergenic non-protein coding RNA 2081
+
|NA
−
|Esophageal Cancer, Tuberculosis
+
|NA
 +
|pathogenic process
 +
|acute kidney injury
 
|-
 
|-
−
|''LINC02098''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926]
−
|[[LINC02098]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142041 HSALNG0142041]
−
|RP11-702B10.1
+
|linc-PXN-1
−
|long intergenic non-protein coding RNA 2098
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02099''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281]
−
|[[LINC02099]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142396 HSALNG0142396]
−
|AC145110.1
+
|TCONS_l2_00001418
−
|long intergenic non-protein coding RNA 2099
+
|NA
−
|Breast cancer
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02151''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285]
−
|[[LINC02151]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142400 HSALNG0142400]
−
|TCONS_00019174
+
|TCONS_l2_00008237
−
|long intergenic non-protein coding RNA 2151
+
|NA
−
|Major Depressive Disorder
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287]
−
|[[LINC02152]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142402 HSALNG0142402]
−
|ENST00000566208
+
|TCONS_l2_00011130
−
|long intergenic non-protein coding RNA 2152
+
|NA
−
|Major Depressive Disorder
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02153''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288]
−
|[[LINC02153]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142403 HSALNG0142403]
−
|ENST00000517573
+
|TCONS_l2_00013175
−
|long intergenic non-protein coding RNA 2153
+
|NA
−
|Major Depressive Disorder
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02154''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294]
−
|[[LINC02154]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142409 HSALNG0142409]
−
|GS1-600G8.5
+
|TCONS_l2_00022611
−
|long intergenic non-protein coding RNA 2154
+
|NA
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02155''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295]
−
|[[LINC02155]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142410 HSALNG0142410]
−
|RP11-705O24.1
+
|TCONS_l2_00022670
−
|long intergenic non-protein coding RNA 2155
+
|NA
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 
|-
 
|-
−
|''LINC02156''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352]
−
|[[LINC02156]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142467 HSALNG0142467]
−
|RP1-90J4.1
+
|uc004bdv.3
−
|long intergenic non-protein coding RNA 2156
+
|NA
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02157''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363]
−
|[[LINC02157]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142478 HSALNG0142478]
−
|RP11-327J17.1
+
|ULK4P2
−
|long intergenic non-protein coding RNA 2157
+
|NA
−
|Esophageal Cancer
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''LINC02231''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942]
−
|[[LINC02231]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142057 HSALNG0142057]
−
|RP11-766N7.4
+
|LK4P2
−
|long intergenic non-protein coding RNA 2231
+
|NA
−
|Esophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LINC02238''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538]
−
|[[LINC02238]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141653 HSALNG0141653]
−
|RP4-788P17.1
+
|AB019562
−
|long intergenic non-protein coding RNA 2238
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|hypopharyngeal squamous cell cancer
 
|-
 
|-
−
|''LINC02243''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661]
−
|[[LINC02243]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043585 HSALNG0043585]
−
|ENST00000441841
+
|ENST00000503710
−
|long intergenic non-protein coding RNA 2243
+
|NA
−
|Lung squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02245''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806]
−
|[[LINC02245]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141921 HSALNG0141921]
−
|lnc-SERTAD2-3
+
|ENST00000445734
−
|long intergenic non-protein coding RNA 2245
+
|NA
−
|epithelial ovarian cancer
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02246''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807]
−
|[[LINC02246]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141922 HSALNG0141922]
−
|ENST00000418954
+
|ENST00000448093
−
|long intergenic non-protein coding RNA 2246
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02247''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815]
−
|[[LINC02247]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141930 HSALNG0141930]
−
|ENST00000417135
+
|ENST00000502941
−
|long intergenic non-protein coding RNA 2247
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02258''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340]
−
|[[LINC02258]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142455 HSALNG0142455]
−
|RP11-248E9.5
+
|uc002nbr.3
−
|long intergenic non-protein coding RNA 2258
+
|NA
−
|pneumonia
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02402''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNT0290348]
−
|[[LINC02402]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142463 HSALNG0142463]
−
|ENST00000550337.1
+
|uc003xut.
−
|long intergenic non-protein coding RNA 2402
+
|NA
−
|Pre-Diabetes, Type 2 Diabetes Mellitus
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02489''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356]
−
|[[LINC02489]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142471 HSALNG0142471]
−
|CTD-2589M5
+
|uc021re1.1
−
|long intergenic non-protein coding RNA 2489
+
|NA
−
|Osteosarcoma
+
|NA
 +
|pathogenic process
 +
|endometrial cancer
 
|-
 
|-
−
|''LINC02490''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549]
−
|[[LINC02490]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141664 HSALNG0141664]
−
|RP11-209E8
+
|AC016745.3
−
|long intergenic non-protein coding RNA 2490
+
|AC016745.1
−
|Osteosarcoma
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''LINC02555''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180]
−
|[[LINC02555]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142295 HSALNG0142295]
−
|AC079630.2
+
|RP11-128A17.1
−
|long intergenic non-protein coding RNA 2555
+
|AC078909.1
−
|Papillary thyroid cancer
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''LINC02562''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377]
−
|[[LINC02562]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142492 HSALNG0142492]
−
|RP11-44F21.5
+
|XLOC_001711
−
|long intergenic non-protein coding RNA 2562
+
|NA
−
|Squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|glioma
 
|-
 
|-
−
|''LINP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975]
−
|[[LINP1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142090 HSALNG0142090]
−
|N/A
+
|lncRNA-AK058003
−
|lncRNA in non-homologous end joining pathway 1
+
|NA
 +
|NA
 +
|pathogenic process
 
|breast cancer
 
|breast cancer
 
|-
 
|-
−
|''LIVAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061]
−
|[[LIVAR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034072 HSALNG0034072]
−
|lnc18q22.2
+
|LINC00682
−
|liver cell viability associated lncRNA
+
|NA
−
|Non-alcoholic steatohepatitis
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''LNCSRLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305]
−
|[[LNCSRLR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089456 HSALNG0089456]
−
|lncRNA-SRLR
+
|LINC01559
−
|lncRNA sorafenib resistance in renal cell carcinoma associated
+
|FLJ33810
−
|renal cell carcinoma
+
|NA
 +
|pathogenic process
 +
|Huntington disease
 
|-
 
|-
−
|''MAGI2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854]
−
|[[MAGI2-AS3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141969 HSALNG0141969]
−
|ENST00000414797
+
|GSTT1-AS1
−
|MAGI2 antisense RNA 3
+
|NA
−
|early-onset preeclampsia
+
|transcriptional regulation
 +
|pathogenic process
 +
|mycobacterium tuberculosis infection
 
|-
 
|-
−
|''MAPT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978]
−
|[[MAPT-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142093 HSALNG0142093]
−
|N/A
+
|lncRNA-CD244
−
|MAPT antisense RNA 1
+
|NA
−
|Parkinson's Disease
+
|transcriptional regulation
 +
|pathogenic process
 +
|tuberculosis infection
 
|-
 
|-
−
|''MDS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237]
−
|[[MDS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068014 HSALNG0068014]
−
|N/A
+
|SAMD12-AS1
−
|myelodysplastic syndrome 2 translocation associated
+
|NA
−
|myelodysplastic syndrome
+
|NA
 +
|pathogenic process
 +
|neuroblastoma
 
|-
 
|-
−
|''MEF2C-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179]
−
|[[MEF2C-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142294 HSALNG0142294]
−
|CTC-467M3.1
+
|RP11-119F7.4
−
|MEF2C antisense RNA 2
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MELTF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278]
−
|[[MELTF-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142393 HSALNG0142393]
−
|MFI2-AS1
+
|TCONS_00068220
−
|MELTF antisense RNA 1
+
|NA
−
|osteosarcoma
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MHENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573]
−
|[[MHENCR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0139654 HSALNG0139654]
−
|N/A
+
|DANT1
−
|melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489
+
|NA
−
|Melanoma
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR200CHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926]
−
|[[MIR200CHG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0139662 HSALNG0139662]
−
|U47924.27
+
|DANT2
−
|MIR200C and MIR141 host gene
+
|NA
−
|Melanoma tumorigenesis
+
|transcriptional regulation
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR2052HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399]
−
|[[MIR2052HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142514 HSALNG0142514]
−
|N/A
+
|ZMAT1
−
|MIR2052 host gene
+
|NA
−
|breast cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MAP3K20-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554]
−
|[[MAP3K20-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141669 HSALNG0141669]
−
|N/A
+
|AC100865.1
−
|MAP3K20 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|coronary artery disease
 
|-
 
|-
−
|''MYOSLID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228]
−
|[[MYOSLID]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105273 HSALNG0105273]
−
|N/A
+
|RAD51-AS1
−
|myocardin-induced smooth muscle lncRNA, inducer of differentiation
+
|TODRA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''MIR3936HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743]
−
|[[MIR3936HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141858 HSALNG0141858]
−
|LOC553103, SLC22A5-AS1
+
|DKFZP434K028
−
|MIR3936 host gene
+
|NA
−
|nasopharyngeal carcinoma, gastric cancer  
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MIR4422HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630]
−
|[[MIR4422HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141745 HSALNG0141745]
−
|RP11-101C11.1
+
|BC002811
−
|MIR4422 host gene
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|astrocytoma
 
|-
 
|-
−
|''MIR4713HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387]
−
|[[MIR4713HG]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142502 HSALNG0142502]
−
|RP11-108K3.1
+
|XLOC_010967
−
|MIR4713 host gene
+
|NA
−
|Colorectal adenocarcinoma
+
|NA
 +
|pathogenic process
 +
|astrocytoma
 
|-
 
|-
−
|''MMP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955]
−
|[[MMP2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084672 HSALNG0084672]
−
|ENST00000569037
+
|ENST00000545440
−
|MMP2 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|pediatric acute myeloid leukemia
 
|-
 
|-
−
|''MNX1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981]
−
|[[MNX1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133391 HSALNG0133391]
−
|CCAT5, LOC645249
+
|FRGCA
−
|MNX1 antisense RNA 1 (head to head)
+
|LncRNA-AP001631.9
−
|Ovarian Cancer
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''MNX1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289611 HSALNT0289611]
−
|[[MNX1-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141726 HSALNG0141726]
−
|ENST00000429228
+
|AP001631.9
−
|MNX1 antisense RNA 2
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''NCF4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976]
−
|[[NCF4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142091 HSALNG0142091]
−
|CTA-833B7.2
+
|LncRNA-AP001631.9
−
|NCF4 antisense RNA 1
+
|NA
−
|recurrent miscarriage
+
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''NIFK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686]
−
|[[NIFK-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141801 HSALNG0141801]
−
|N/A
+
|CD99P1
−
|NIFK antisense RNA 1
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 
|-
 
|-
−
|''NEXN-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119]
−
|[[NEXN-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074097 HSALNG0074097]
−
|C1orf118, FLJ90637
+
|LINC01613
−
|NEXN antisense RNA 1
+
|n341773
−
|lung cancer
+
|NA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 
|-
 
|-
−
|''NNT-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844]
−
|[[NNT-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141959 HSALNG0141959]
−
|N/A
+
|FTH1P3
−
|NNT antisense RNA 1
+
|FTH1P3
−
|colorectal cancer cells
+
|NA
 +
|pathogenic process
 +
|oral squamous cell cancer
 
|-
 
|-
−
|''PAX8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855]
−
|[[PAX8-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141970 HSALNG0141970]
−
|N/A
+
|GTF2IRD2P1
−
|PAX8 antisense RNA 1
+
|GTF2IRD2P1
−
|cervical cancer
+
|NA
 +
|pathogenic process
 +
|oral squamous cell cancer
 
|-
 
|-
−
|''P4HA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135]
−
|[[P4HA3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142250 HSALNG0142250]
−
|N/A
+
|PDIA3F
−
|P4HA3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|oral squamous cell cancer
 
|-
 
|-
−
|''PCSK6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329]
−
|[[PCSK6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026562 HSALNG0026562]
−
|N/A
+
|LINC00994
−
|PCSK6 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|inflammatory bowel disease
 
|-
 
|-
−
|''PGR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208]
−
|[[PGR-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077290 HSALNG0077290]
−
|AT1, AT2, AT3
+
|PCAT5
−
|PGR antisense RNA 1
+
|LINC01452,TPCAT-10-36067
−
|_
+
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0054158 HSALNG0054158]
 +
|LUADT1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0107133 HSALNG0107133]
 +
|LOXL1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|exfoliation syndrome
 
|-
 
|-
−
|''POC1B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734]
−
|[[POC1B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141849 HSALNG0141849]
−
|RP11-734K2.4
+
|DACOR1
−
|POC1B antisense RNA 1
+
|TCONS_00023265
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PPP1R12A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060]
−
|[[PPP1R12A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114548 HSALNG0114548]
−
|R12A-AS1
+
|LINC00675
−
|PPP1R12A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 
|-
 
|-
−
|''PRNT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889]
−
|[[PRNT]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070759 HSALNG0070759]
−
|M8
+
|B4GALT1-AS1
−
|prion locus lncRNA, testis expressed
+
|NA
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''PINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348]
−
|[[PINCR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083371 HSALNG0083371]
−
|N/A
+
|LINC01616
−
|p53-induced noncoding RNA
+
|n341006
−
|Colorectal cancer
+
|NA
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''PLUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068]
−
|[[PLUT]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142183 HSALNG0142183]
−
|PDX1-AS1, PLUTO, HI-LNC71
+
|n336934
−
|PDX1 associated lncRNA, upregulator of transcription
+
|NA
−
|Type 2 diabetes
+
|NA
 +
|pathogenic process
 +
|Alzheimer's disease
 
|-
 
|-
−
|''PRAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240]
−
|[[PRAL]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142355 HSALNG0142355]
−
|lncRNA-PRAL
+
|SIRT1-AS
−
|p53 regulation associated lncRNA
+
|NA
−
|Hepatocellular carcinoma, Lung Cancer
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''PRKCZ-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198]
−
|[[PRKCZ-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142313 HSALNG0142313]
−
|RP11-181G12.2
+
|RP11-457M11.2
−
|PRKCZ antisense RNA 1
+
|NA
 +
|ceRNA
 +
|pathogenic process
 
|lung adenocarcinoma
 
|lung adenocarcinoma
 
|-
 
|-
−
|''PRKG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768]
−
|[[PRKG1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072141 HSALNG0072141]
−
|RP11-573I11.2
+
|LINC01507
−
|PRKG1 antisense RNA 1
+
|XLOC_000303
−
|rheumatoid arthritis
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PSMD6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903]
−
|[[PSMD6-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142018 HSALNG0142018]
−
|ENST00000462717, lnc00462717
+
|LINC01057
−
|PSMD6 antisense RNA 1
+
|NA
−
|Papillary Thyroid Cancer, GBM
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PSORS1C3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914]
−
|[[PSORS1C3]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142029 HSALNG0142029]
−
|NCRNA00196
+
|LINC01617
−
|psoriasis susceptibility 1 candidate 3 (non-protein coding)
+
|C8orf23,NCRNA00249,XLOC_006844
−
|rheumatoid arthritis
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''PSPC1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015]
−
|[[PSPC1-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142130 HSALNG0142130]
−
|RP11-523H24.3
+
|LOC152578
−
|PSPC1 antisense RNA 2
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|pathogenic process
 +
|colorectal cancer
 
|-
 
|-
−
|''RAMP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252]
−
|[[RAMP2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034426 HSALNG0034426]
−
|N/A
+
|LINC01618
−
|RAMP2 antisense RNA 1
+
|LOC152578
−
|glioblastoma
+
|NA
 +
|pathogenic process
 +
|NA
 
|-
 
|-
−
|''RASGRF2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870]
−
|[[RASGRF2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075266 HSALNG0075266]
−
|CTC-459I6.1
+
|NALT1
−
|RASGRF2 antisense RNA 1
+
|MIR4674HG,LINC01573,TCONS_l2_00029132
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 
|-
 
|-
−
|''RFPL3S''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083]
−
|[[RFPL3S]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045290 HSALNG0045290]
−
|RFPL3-AS, NCRNA00005
+
|MALINC1
−
|RFPL3 antisense
+
|LINC01024,MA-linc1
−
|_
+
|NA
 +
|pathogenic process
 +
|human breast and lung cancer
 
|-
 
|-
−
|''RNASEH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902]
−
|[[RNASEH1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142017 HSALNG0142017]
−
|LOC100506054
+
|LINC01024
−
|RNASEH1 antisense RNA 1
+
|MA-linc1
−
|_
+
|NA
 +
|pathogenic process
 +
|osteosarcoma;lung cancer
 
|-
 
|-
−
|''SATB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120]
−
|[[SATB2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071043 HSALNG0071043]
−
|N/A
+
|LINC01627
−
|SATB2 antisense RNA 1
+
|RP11-397D12.4
−
|Osteosarcoma
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''SKAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121]
−
|[[SKAP1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015617 HSALNG0015617]
−
|RP11-456D7.1
+
|LINC01628
−
|SKAP1 antisense RNA 1
+
|AC007403.1
−
|pneumonia
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''SIX3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820]
−
|[[SIX3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141935 HSALNG0141935]
−
|SIX3OS
+
|ERICH1-AS1
−
|SIX3 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''SLC12A9-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193]
−
|[[SLC12A9-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142308 HSALNG0142308]
−
|RP11-126L15
+
|RP11-397D12.4
−
|SLC12A9 antisense RNA 1
+
|LINC01627
−
|_
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 
|-
 
|-
−
|''SLC9A3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122]
−
|[[SLC9A3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0102605 HSALNG0102605]
−
|UC011CLY.2
+
|LINC01629
−
|SLC9A3 antisense RNA 1
+
|linc-KIAA1737-2
−
|_
+
|transcriptional regulation
 +
|pathogenic process
 +
|hypoxic and inflammatory renal epithelial injury
 
|-
 
|-
−
|''SMILR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161]
−
|[[SMILR]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142276 HSALNG0142276]
−
|N/A
+
|PTPRG-AS1
−
|smooth muscle induced lncRNA, enhancer of proliferation
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SPRY4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980]
−
|[[SPRY4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142095 HSALNG0142095]
−
|THCAT68
+
|lncRNA-DLEU1
−
|SPRY4 antisense RNA 1
+
|NA
−
|_
+
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SLC12A5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983]
−
|[[SLC12A5-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142098 HSALNG0142098]
−
|RP11-465L10.10
+
|lncRNA-Hh
−
|SLC12A5 and MMP9 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SLC16A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986]
−
|[[SLC16A1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072437 HSALNG0072437]
−
|ENST00000421157.1
+
|GAS1RR
−
|SLC16A1 antisense RNA 1
+
|LncRNA-Hh
−
|Acute myocardial infarction
+
|NA
 +
|pathogenic process
 +
|breast cancer
 
|-
 
|-
−
|''SLC25A25-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908]
−
|[[SLC25A25-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005250 HSALNG0005250]
−
|N/A
+
|CCDC18-AS1
−
|SLC25A25 antisense RNA 1
+
|ENST00000440778.1
−
|colorectal cancer
+
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis
 
|-
 
|-
−
|''SLC5A4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055]
−
|[[SLC5A4-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132813 HSALNG0132813]
−
|RP1-90G24.10
+
|LINC00649
−
|SLC5A4 antisense RNA 1
+
|TCONS_00028768
−
|gastric cancer
+
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis
 
|-
 
|-
−
|''SLC7A11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219]
−
|[[SLC7A11-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075966 HSALNG0075966]
−
|ENST00000512786
+
|PRKCQ-AS1
−
|SLC7A11 antisense RNA 1
+
|ENST00000414894.1
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis
 
|-
 
|-
−
|''SMIM10L2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203]
−
|[[SMIM10L2B-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142318 HSALNG0142318]
−
|ENST00000453528
+
|RP11-567G11.1
−
|SMIM10L2B antisense RNA 1
+
|LINC02041
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 
|-
 
|-
−
|''SNHG18''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805]
−
|[[SNHG18]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141920 HSALNG0141920]
−
|N/A
+
|ENST00000438550
−
|small nucleolar RNA host gene 18
+
|RPS24P1
−
|glioma
+
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 
|-
 
|-
−
|''SNHG26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083]
−
|[[SNHG26]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142198 HSALNG0142198]
−
|AC005682.5
+
|NONHSAG011351
−
|small nucleolar RNA host gene 26
+
|NA
−
|Bladder urothelial carcinoma
+
|NA
 +
|pathogenic process
 +
|type 1 diabetes
 
|-
 
|-
−
|''SPINT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049]
−
|[[SPINT1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142164 HSALNG0142164]
−
|RP11-532F12.5
+
|MCHR2-AS1
−
|SPINT1 antisense RNA 1
+
|NA
−
|Melanoma tumorigenesis
+
|NA
 +
|pathogenic process
 +
|psychiatric disease
 
|-
 
|-
−
|''SPON1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799]
−
|[[SPON1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141914 HSALNG0141914]
−
|RP11-21, L19.1
+
|ENST00000414355
−
|SPON1 antisense RNA 1
+
|NA
−
|B cell lymphoma
+
|NA
 +
|pathogenic process
 +
|cadmium toxicology
 
|-
 
|-
−
|''STK32A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241]
−
|[[STK32A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142356 HSALNG0142356]
−
|CTC-255N20
+
|SKP2
−
|STK32A antisense RNA 1
+
|NA
−
|Osteosarcoma
+
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141952 HSALNG0141952]
 +
|FLJ90757
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142132 HSALNG0142132]
 +
|LOC283663
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142134 HSALNG0142134]
 +
|LOC338651
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142247 HSALNG0142247]
 +
|PCATs
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041277 HSALNG0041277]
 +
|EGFLAM-AS1
 +
|lncRNA-LOWEG
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142146 HSALNG0142146]
 +
|LOWEG
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 
|-
 
|-
−
|''SVIL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635]
−
|[[SVIL-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141750 HSALNG0141750]
−
|RP11-534G20.3
+
|BC014579
−
|SVIL antisense RNA 1
+
|NA
−
|rheumatoid arthritis
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TGFB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721]
−
|[[TGFB2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141836 HSALNG0141836]
−
|NR_046268
+
|CTB-167B5.2
−
|TGFB2 antisense RNA 1 (head to head)
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TGFB3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863]
−
|[[TGFB3-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141978 HSALNG0141978]
−
|ENST00000553732
+
|HELLS
−
|TGFB3 antisense RNA 1
+
|NA
−
|early-onset preeclampsia
+
|NA
 +
|pathogenic process
 +
|leukemia
 
|-
 
|-
−
|''TDRKH-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195]
−
|[[TDRKH-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142310 HSALNG0142310]
−
|RP11-98D18
+
|RP11-401P9.4
−
|TDRKH antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TFAP2A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252]
−
|[[TFAP2A-AS2]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142367 HSALNG0142367]
−
|HIPSTR
+
|SNHG19
−
|TFAP2A antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 
|-
 
|-
−
|''TRAM2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557]
−
|[[TRAM2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141672 HSALNG0141672]
−
|N/A
+
|AF070632
−
|TRAM2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''TMEM132D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569]
−
|[[TMEM132D-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141684 HSALNG0141684]
−
|LOC283352
+
|AK021443
−
|TMEM132D antisense RNA 1
+
|NA
−
|Botulinum Toxin Type A
+
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 
|-
 
|-
−
|''TNFRSF10A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728]
−
|[[TNFRSF10A-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141843 HSALNG0141843]
−
|RP11-1149O23.2
+
|CTD-3080P12.3
−
|TNFRSF10A antisense RNA 1
+
|NA
 +
|ceRNA
 +
|pathogenic process
 
|gastric cancer
 
|gastric cancer
 
|-
 
|-
−
|''TNFRSF14-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987]
−
|[[TNFRSF14-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142102 HSALNG0142102]
−
|ENST00000416860.2
+
|lncRNA-n336928
−
|TNFRSF14 antisense RNA 1
+
|NA
−
|Acute myocardial infarction
+
|NA
 +
|pathogenic process
 +
|bladder cancer
 
|-
 
|-
−
|''TPT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723]
−
|[[TPT1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141838 HSALNG0141838]
−
|N/A
+
|CTC-523E23.5
−
|TPT1 antisense RNA 1
+
|AC008555.2
−
|anaplastic gliomas
+
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''TRIM52-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724]
−
|[[TRIM52-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141839 HSALNG0141839]
−
|N/A
+
|CTD-2246P4.1
−
|TRIM52 antisense RNA 1 (head to head)
+
|NA
−
|renal cell carcinoma
+
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''VPS9D1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055]
−
|[[VPS9D1-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142170 HSALNG0142170]
−
|MYU
+
|MIR132
−
|VPS9D1 antisense RNA 1
+
|MIRN132,miRNA132,mir-132
−
|_
+
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142304 HSALNG0142304]
 +
|RP11-363G2.4
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''WWOX-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191]
−
|[[WWOX-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142306 HSALNG0142306]
−
|RP11-190D6.2
+
|RP11-38F22.1
−
|WWOX antisense RNA 1
+
|LINC02424
−
|Epithelial ovarian cancer
+
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''ZNF674-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223]
−
|[[ZNF674-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142338 HSALNG0142338]
−
|N/A
+
|RP4-639J15.1
−
|ZNF674 antisense RNA 1 (head to head)
+
|AC006967.2
−
|hepatocellular carcinoma
+
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration
 
|-
 
|-
−
|''ZNF710-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233]
−
|[[ZNF710-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142348 HSALNG0142348]
−
|ENST00000558334
+
|RUNX1-IT1
−
|ZNF710 antisense RNA 1
+
|C21orf96
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053446 HSALNG0053446]
 +
|ENST00000415964
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|pediatric acute myeloid leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142124 HSALNG0142124]
 +
|LOC101927497
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142071 HSALNG0142071]
 +
|lnc-CYP4A22-2/3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|clear cell renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142114 HSALNG0142114]
 +
|lnc-ZNF180-2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal clear cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142201 HSALNG0142201]
 +
|NONHSAT037832
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141773 HSALNG0141773]
 +
|BX647187
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNT0288920]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017086 HSALNG0017086]
 +
|CNNM3-DT
 +
|LOC100506036
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141699 HSALNG0141699]
 +
|AK056155
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Loeys-Dietz syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142172 HSALNG0142172]
 +
|MR1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Loeys-Dietz syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141658 HSALNG0141658]
 +
|AC002454.1
 +
|AC002454.1
 +
|NA
 +
|pathogenic process
 +
|endometriosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142024 HSALNG0142024]
 +
|LINC01420
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|systemic lupus erythematosus
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141646 HSALNG0141646]
 +
|53BP1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142216 HSALNG0142216]
 +
|NR_024118
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142354 HSALNG0142354]
 +
|SGO1-AS1
 +
|SGOL1-AS1
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127764 HSALNG0127764]
 +
|ZNF667-AS1
 +
|MORT
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142099 HSALNG0142099]
 +
|lncRNA-HIF2PUT
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018617 HSALNG0018617]
 +
|ENST00000433673
 +
|AC068282.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008353 HSALNG0008353]
 +
|ENST00000454271
 +
|AL021940.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141606 HSALNG0141606]
 +
|ENST00000432431
 +
|AC023128.1
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142033 HSALNG0142033]
 +
|LINC01828
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142503 HSALNG0142503]
 +
|XLOC_011402
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141988 HSALNG0141988]
 +
|ICAM-1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNT0289668]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141783 HSALNG0141783]
 +
|C5T1lncRNA
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNT0289667]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141782 HSALNG0141782]
 +
|C5T1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141781 HSALNG0141781]
 +
|C5-OT1
 +
|C5T1lncRNA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141741 HSALNG0141741]
 +
|AX800134
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142453 HSALNG0142453]
 +
|uc001ncr
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142445 HSALNG0142445]
 +
|uc.48+
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diabetic neuropathic pain
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0038313 HSALNG0038313]
 +
|LINC01207
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141743 HSALNG0141743]
 +
|BALR-6
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|B-lymphoblastic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142137 HSALNG0142137]
 +
|LOC389641
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141840 HSALNG0141840]
 +
|CTD-2541M15
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142055 HSALNG0142055]
 +
|LINK-A
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|triple-negative breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142222 HSALNG0142222]
 +
|NUTF2P3
 +
|NUTF2P3
 +
|NA
 +
|pathogenic process
 +
|pancreatic cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142210 HSALNG0142210]
 +
|NONHSAT123350
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal clear cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142477 HSALNG0142477]
 +
|UHRF1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142481 HSALNG0142481]
 +
|UPAT
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114404 HSALNG0114404]
 +
|LINC00324
 +
|FLJ34790,MGC104931
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142084 HSALNG0142084]
 +
|lnc-MX1-1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142139 HSALNG0142139]
 +
|LOC400891
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141998 HSALNG0141998]
 +
|LA16c-313D11.11
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142307 HSALNG0142307]
 +
|RP11-395G23.3
 +
|AC027031.2
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNT0289742]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141857 HSALNG0141857]
 +
|DILC
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNT0289957]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142072 HSALNG0142072]
 +
|lnc-DILC
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141696 HSALNG0141696]
 +
|AK027294
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142486 HSALNG0142486]
 +
|WISP1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099020 HSALNG0099020]
 +
|FGF14-AS2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142246 HSALNG0142246]
 +
|PCAT2
 +
|CARLo-4,PCA2,TCONS_00015167
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141643 HSALNG0141643]
 +
|2700086A05Rik
 +
|2700086A05Rik
 +
|NA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142366 HSALNG0142366]
 +
|SNED1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Idiopathic pulmonary fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142448 HSALNG0142448]
 +
|uc.77
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|idiopathic pulmonary fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141931 HSALNG0141931]
 +
|ENST00000537266
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141975 HSALNG0141975]
 +
|HAGLROS
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141996 HSALNG0141996]
 +
|KRT18P55
 +
|KRT18P55
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0110450 HSALNG0110450]
 +
|IL21R-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|coronary artery disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142227 HSALNG0142227]
 +
|OTTHUMT00000387022
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|coronary artery disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000226 HSALNG0000226]
 +
|PRKCZ-AS1
 +
|RP11-181G12.2
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014612 HSALNG0014612]
 +
|LINC01833
 +
|RP11-89,K21.1
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142329 HSALNG0142329]
 +
|RP11-89K21
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0079188 HSALNG0079188]
 +
|LINC00857
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142224 HSALNG0142224]
 +
|OR3A4
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142161 HSALNG0142161]
 +
|MAGI1-IT1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142357 HSALNG0142357]
 +
|SLC26A4-AS1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141636 HSALNG0141636]
 +
|KRT7-AS
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105101 HSALNG0105101]
 +
|LINC01852
 +
|ENST00000434223
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142293 HSALNG0142293]
 +
|RP11-1008C21.2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141707 HSALNG0141707]
 +
|AK123072
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141688 HSALNG0141688]
 +
|AK021954
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atherosclerosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105961 HSALNG0105961]
 +
|CERNA1
 +
|LOC100129973
 +
|ceRNA
 +
|pathogenic process
 +
|cardiovascular disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008959 HSALNG0008959]
 +
|LAMC1-AS1
 +
|lnc-LAMC2-1:1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142202 HSALNG0142202]
 +
|NONHSAT040387
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142207 HSALNG0142207]
 +
|NONHSAT098586
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108626 HSALNG0108626]
 +
|PCSK6-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141752 HSALNG0141752]
 +
|BC016831
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141989 HSALNG0141989]
 +
|IGKV
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142311 HSALNG0142311]
 +
|RP11-434D9.1
 +
|AC112206.2
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142000 HSALNG0142000]
 +
|LCAL6
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141765 HSALNG0141765]
 +
|BC088254
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|myocardial hypertrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141711 HSALNG0141711]
 +
|AK124454
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141846 HSALNG0141846]
 +
|CYP4B1-PS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diabetic nephropathy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094020 HSALNG0094020]
 +
|LINC01405
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142374 HSALNG0142374]
 +
|ST8SIA6-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0047244 HSALNG0047244]
 +
|TRIM52-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141749 HSALNG0141749]
 +
|BC012900
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ulcerative colitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133283 HSALNG0133283]
 +
|UMODL1-AS1
 +
|FLJ33471
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075449 HSALNG0075449]
 +
|ARRDC1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071200 HSALNG0071200]
 +
|FAM74A3
 +
|OTTHUMG00000067149
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141949 HSALNG0141949]
 +
|FH
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Fumarase deficiency
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142076 HSALNG0142076]
 +
|lnc-HOXC4-3:1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142109 HSALNG0142109]
 +
|lnc-TEAD4-1:1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142385 HSALNG0142385]
 +
|TCONS_00003876
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNT0289825]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141940 HSALNG0141940]
 +
|EVI1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142350 HSALNG0142350]
 +
|SARCC
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142475 HSALNG0142475]
 +
|ucoo2kmd.1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001020 HSALNG0001020]
 +
|KAZN-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141837 HSALNG0141837]
 +
|CTB-89H12.4
 +
|AC021078.1
 +
|ceRNA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141607 HSALNG0141607]
 +
|EPB41L4A-AS2
 +
|FLJ11235
 +
|NA
 +
|pathogenic process
 +
|lung cancer;breast cancer;kidney cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004554 HSALNG0004554]
 +
|LINC02567
 +
|ENST00000427806
 +
|NA
 +
|pathogenic process
 +
|attention deficit hyperactivity disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141948 HSALNG0141948]
 +
|FGFR3-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141822 HSALNG0141822]
 +
|CILinc01
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141823 HSALNG0141823]
 +
|CILinc02
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140235 HSALNG0140235]
 +
|LINC00629
 +
|LINC00629AB,LINC00629C,LINC00629D,LINC00629
 +
|NA
 +
|pathogenic process
 +
|choriocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141780 HSALNG0141780]
 +
|C2dat1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ischemic brain injury
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057357 HSALNG0057357]
 +
|POU6F2-AS2
 +
|FLJ12971
 +
|protein localization
 +
|pathogenic process
 +
|oesophageal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142061 HSALNG0142061]
 +
|lnc13
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|celiac disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141844 HSALNG0141844]
 +
|CTD903
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142208 HSALNG0142208]
 +
|NONHSAT104436
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141665 HSALNG0141665]
 +
|AC024560.2
 +
|AC024560.1
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134219 HSALNG0134219]
 +
|ENST00000436681
 +
|AP000552.1
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141651 HSALNG0141651]
 +
|AA584040
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141652 HSALNG0141652]
 +
|AA709223
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141772 HSALNG0141772]
 +
|BX478947
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|congenital heart defect
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119819 HSALNG0119819]
 +
|LINC00668
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141834 HSALNG0141834]
 +
|CRNDE-h
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068121 HSALNG0068121]
 +
|SMILR
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular pathologies
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142511 HSALNG0142511]
 +
|Z38
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0095037 HSALNG0095037]
 +
|LINC00507
 +
|NA
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113270 HSALNG0113270]
 +
|LINC01082
 +
|TCONSNA00024492
 +
|NA
 +
|pathogenic process
 +
|alveolar capillary dysplasia with misalignment of pulmonary veins
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015253 HSALNG0015253]
 +
|LINC01185
 +
|FLJ16341
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142275 HSALNG0142275]
 +
|PTPRD-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142301 HSALNG0142301]
 +
|RP11-254I22.1
 +
|MIR583HG
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142319 HSALNG0142319]
 +
|RP11-57P19.1
 +
|AC009432.1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142326 HSALNG0142326]
 +
|RP11-80H5.7
 +
|AL157400.4
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142330 HSALNG0142330]
 +
|RP1-223E5.4
 +
|AL441883.1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142339 HSALNG0142339]
 +
|RP4-799P18.3
 +
|AL122008.4
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045514 HSALNG0045514]
 +
|LINC01844
 +
|LOC101926975
 +
|NA
 +
|pathogenic process
 +
|hirschsprung disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142062 HSALNG0142062]
 +
|Lnc34a
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075977 HSALNG0075977]
 +
|LINP1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142066 HSALNG0142066]
 +
|lncARSR
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005967 HSALNG0005967]
 +
|RBM15-AS1
 +
|AS-RBM15
 +
|translational control
 +
|pathogenic process
 +
|acute megakaryocytic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142204 HSALNG0142204]
 +
|NONHSAT073641
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142142 HSALNG0142142]
 +
|LOC572558
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141697 HSALNG0141697]
 +
|AK033210
 +
|NA
 +
|NA
 +
|pathogenic process;developmental process
 +
|bronchopulmonary dysplasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141963 HSALNG0141963]
 +
|GClnc1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141687 HSALNG0141687]
 +
|AK021630
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141718 HSALNG0141718]
 +
|AL049437
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Parkinson's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142122 HSALNG0142122]
 +
|LOC100507661
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122663 HSALNG0122663]
 +
|LINC01029
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cognitive functions and neuronal plasticity
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142284 HSALNG0142284]
 +
|RMEL3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142074 HSALNG0142074]
 +
|lnc-FRG2C-3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142081 HSALNG0142081]
 +
|lnc-LIN54-1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142112 HSALNG0142112]
 +
|lnc-USP50-2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142115 HSALNG0142115]
 +
|lnc-ZNF354A-1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ankylosing spondylitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017887 HSALNG0017887]
 +
|ENST00000455309
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142035 HSALNG0142035]
 +
|LINC02384
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142113 HSALNG0142113]
 +
|Lnc-UTS2D-1:1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142182 HSALNG0142182]
 +
|n336161
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142184 HSALNG0142184]
 +
|n340599
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142214 HSALNG0142214]
 +
|NR_002712
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142405 HSALNG0142405]
 +
|TCONS_l2_00014794
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142285 HSALNG0142285]
 +
|RMRP
 +
|CHH,NME1R,RRP2,RMRP
 +
|ceRNA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142015 HSALNG0142015]
 +
|LINC00961
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068551 HSALNG0068551]
 +
|LINC00977
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary spontaneous pneumothorax
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141675 HSALNG0141675]
 +
|AF085995
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141681 HSALNG0141681]
 +
|AK000053
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141686 HSALNG0141686]
 +
|AK021595
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141689 HSALNG0141689]
 +
|AK022024
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141710 HSALNG0141710]
 +
|AK124307
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141754 HSALNG0141754]
 +
|BC020384
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141757 HSALNG0141757]
 +
|BC030759
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141830 HSALNG0141830]
 +
|CR615992
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142069 HSALNG0142069]
 +
|lnc-CC3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141729 HSALNG0141729]
 +
|APOC1P1-3
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142480 HSALNG0142480]
 +
|UNMIBC
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142438 HSALNG0142438]
 +
|uc.167
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ventricular septal defects
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142327 HSALNG0142327]
 +
|RP11-838N2.4
 +
|GAPLINC
 +
|ceRNA
 +
|pathogenic process
 +
|glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0121223 HSALNG0121223]
 +
|LINC01478
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|blood pressure
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0016990 HSALNG0016990]
 +
|LINC00342
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141792 HSALNG0141792]
 +
|CAR10
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141638 HSALNG0141638]
 +
|MAPT-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Parkinson's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141794 HSALNG0141794]
 +
|CAT104
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142375 HSALNG0142375]
 +
|STXBP5-AS1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141976 HSALNG0141976]
 +
|HAR1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Huntington disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142474 HSALNG0142474]
 +
|UCHL1-AS1
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|Parkinson's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142353 HSALNG0142353]
 +
|SCAANT1-AS
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|spinocerebellar ataxia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141763 HSALNG0141763]
 +
|BC041488
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142303 HSALNG0142303]
 +
|RP11-359E19.2
 +
|AC022733.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNT0289669]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141784 HSALNG0141784]
 +
|C6orf176-TV1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNT0289670]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141785 HSALNG0141785]
 +
|C6orf176-TV2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141966 HSALNG0141966]
 +
|GIHCG
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141764 HSALNG0141764]
 +
|BC087858
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142468 HSALNG0142468]
 +
|uc004cov.4
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypertrophic cardiomyopathy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142472 HSALNG0142472]
 +
|uc022bqu.1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypertrophic cardiomyopathy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060796 HSALNG0060796]
 +
|CFTR-AS1
 +
|BGas
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021858 HSALNG0021858]
 +
|MYOSLID
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|vascular smooth muscle cell (VSMC) contractile phenotype
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142446 HSALNG0142446]
 +
|uc.63
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142221 HSALNG0142221]
 +
|numb
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|uveal melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141962 HSALNG0141962]
 +
|GCASPC
 +
|TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141683 HSALNG0141683]
 +
|AK001094
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141703 HSALNG0141703]
 +
|AK093735
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141746 HSALNG0141746]
 +
|BC003519
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142215 HSALNG0142215]
 +
|NR_003573
 +
|ANXA2P2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142234 HSALNG0142234]
 +
|P2RX7-V3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|uveal melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142423 HSALNG0142423]
 +
|TMSB4
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|osteoarthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090163 HSALNG0090163]
 +
|DDX11-AS1
 +
|CONCR
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142167 HSALNG0142167]
 +
|MELOE
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142346 HSALNG0142346]
 +
|RSU1P2
 +
|RSU1P2
 +
|ceRNA
 +
|pathogenic process
 +
|cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142280 HSALNG0142280]
 +
|RBMY2FP
 +
|RBMY2FP
 +
|NA
 +
|NA
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142186 HSALNG0142186]
 +
|n375709
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141863 HSALNG0141863]
 +
|DUXAP8
 +
|DUXAP8
 +
|NA
 +
|NA
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142145 HSALNG0142145]
 +
|LOC729966
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142258 HSALNG0142258]
 +
|POIR
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|periodontitis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031988 HSALNG0031988]
 +
|MELTF-AS1
 +
|MFI2-AS1,AC068302.3
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142168 HSALNG0142168]
 +
|MFI2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142037 HSALNG0142037]
 +
|linc-223
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|acute myeloid leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006859 HSALNG0006859]
 +
|LINC01138
 +
|LINC00875,FLJ39739
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142377 HSALNG0142377]
 +
|SUZ12P1
 +
|SUZ12P1
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142120 HSALNG0142120]
 +
|LOC100505976
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142507 HSALNG0142507]
 +
|XLOC_l2_010636
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043014 HSALNG0043014]
 +
|RASGRF2-AS1
 +
|CTC-459I6.1
 +
|NA
 +
|pathogenic process
 +
|sepsis-induced endothelial dysfunction
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141967 HSALNG0141967]
 +
|GPC3-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091321 HSALNG0091321]
 +
|HOXC-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|atherosclerosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057557 HSALNG0057557]
 +
|LUARIS
 +
|lncRNA#32
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044828 HSALNG0044828]
 +
|MIR3936HG
 +
|LOC553103,SLC22A5-AS1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;nasopharyngeal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142263 HSALNG0142263]
 +
|Ppp1r1b
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|congenital heart defect
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099182 HSALNG0099182]
 +
|LINC00460
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142309 HSALNG0142309]
 +
|RP1-13P20.6
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142479 HSALNG0142479]
 +
|Unigene56159
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142470 HSALNG0142470]
 +
|uc009yby.1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048011 HSALNG0048011]
 +
|TFAP2A-AS2
 +
|HIPSTR
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141819 HSALNG0141819]
 +
|Chaer
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cardiac hypertrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNT0289865]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141980 HSALNG0141980]
 +
|HIF-2α
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101489 HSALNG0101489]
 +
|LINC00520
 +
|C14orf34
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041561 HSALNG0041561]
 +
|MRPS30-DT
 +
|BRCAT54
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0092662 HSALNG0092662]
 +
|PPP1R12A-AS1
 +
|R12A-AS1
 +
|translational control
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088600 HSALNG0088600]
 +
|ITFG2-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142203 HSALNG0142203]
 +
|NONHSAT041499
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142206 HSALNG0142206]
 +
|NONHSAT089447
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142085 HSALNG0142085]
 +
|lnc-NKX2-3-1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142104 HSALNG0142104]
 +
|lnc-RTN4R-1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141936 HSALNG0141936]
 +
|ERL
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Marek's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0092867 HSALNG0092867]
 +
|LINC02258
 +
|RP11-248E9.5
 +
|NA
 +
|pathogenic process
 +
|pneumonia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0117085 HSALNG0117085]
 +
|SKAP1-AS1
 +
|RP11-456D7.1
 +
|NA
 +
|pathogenic process
 +
|pneumonia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049760 HSALNG0049760]
 +
|DINOL
 +
|DINO
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000547 HSALNG0000547]
 +
|CAMTA1-DT
 +
|lncCAMTA1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142443 HSALNG0142443]
 +
|uc.345
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142175 HSALNG0142175]
 +
|MSNP1AS
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|autism spectrum disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004596 HSALNG0004596]
 +
|NEXN-AS1
 +
|C1orf118,FLJ90637
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088083 HSALNG0088083]
 +
|LINC02098
 +
|RP11-702B10.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0095473 HSALNG0095473]
 +
|PSPC1-AS2
 +
|RP11-523H24.3
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0114857 HSALNG0114857]
 +
|LRRC75A-AS1
 +
|C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077999 HSALNG0077999]
 +
|PRKG1-AS1
 +
|RP11-573I11.2
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0076970 HSALNG0076970]
 +
|SVIL-AS1
 +
|RP11-534G20.3
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108169 HSALNG0108169]
 +
|VPS33B-DT
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141919 HSALNG0141919]
 +
|ENST00000438399
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142343 HSALNG0142343]
 +
|RPKG1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142465 HSALNG0142465]
 +
|uc004afb.1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135015 HSALNG0135015]
 +
|SLC5A4-AS1
 +
|RP1-90G24.10
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0063964 HSALNG0063964]
 +
|TNFRSF10A-AS1
 +
|RP11-1149O23.2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141842 HSALNG0141842]
 +
|CTD-2616J11.14
 +
|AC008750.7
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142297 HSALNG0142297]
 +
|RP11-150O12.3
 +
|AC124067.4
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141845 HSALNG0141845]
 +
|CXCL1P1
 +
|CXCL1P1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141918 HSALNG0141918]
 +
|ENST00000438347
 +
|CCND3P1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142012 HSALNG0142012]
 +
|LINC00601
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141614 HSALNG0141614]
 +
|KIAA0087
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141942 HSALNG0141942]
 +
|FAM212B-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142125 HSALNG0142125]
 +
|LOC102723552
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142296 HSALNG0142296]
 +
|RP11-140I24
 +
|LINC01568
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142316 HSALNG0142316]
 +
|RP11-501O2
 +
|LINC02046
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142321 HSALNG0142321]
 +
|RP11-600K151
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142199 HSALNG0142199]
 +
|NONHSAG051968
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142205 HSALNG0142205]
 +
|NONHSAT076747
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142209 HSALNG0142209]
 +
|NONHSAT122730
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0066240 HSALNG0066240]
 +
|MIR2052HG
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096884 HSALNG0096884]
 +
|LINC01198
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096821 HSALNG0096821]
 +
|TPT1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142039 HSALNG0142039]
 +
|linc-cdh4-2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068878 HSALNG0068878]
 +
|LINC02055
 +
|RP1130-1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141852 HSALNG0141852]
 +
|DBCCR1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141662 HSALNG0141662]
 +
|AC012065.7
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|chronic lymphocytic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0116565 HSALNG0116565]
 +
|RAMP2-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141706 HSALNG0141706]
 +
|AK098081
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141759 HSALNG0141759]
 +
|BC037331
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141761 HSALNG0141761]
 +
|BC040303
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141832 HSALNG0141832]
 +
|CR749831
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0040073 HSALNG0040073]
 +
|SNHG18
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050030 HSALNG0050030]
 +
|FOXP4-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0012584 HSALNG0012584]
 +
|RNASEH1-AS1
 +
|LOC100506054
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088026 HSALNG0088026]
 +
|GSEC
 +
|ST3GAL4-AS1,DCPS-AS1,FLJ39051
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0028799 HSALNG0028799]
 +
|DNAJB8-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0120059 HSALNG0120059]
 +
|CHMP1B-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010602 HSALNG0010602]
 +
|TGFB2-AS1
 +
|NR_046268
 +
|NA
 +
|pathogenic process
 
|early-onset preeclampsia
 
|early-onset preeclampsia
 
|-
 
|-
−
|''ZFHX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323]
−
|[[ZFHX2-AS1]]
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0037356 HSALNG0037356]
−
|N/A
+
|SLC7A11-AS1
−
|ZFHX2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0064248 HSALNG0064248]
 +
|INTS9-AS1
 +
|ENST00000520055
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0111641 HSALNG0111641]
 +
|MMP2-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130456 HSALNG0130456]
 +
|SLC12A5-AS1
 +
|RP11-465L10.10
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002415 HSALNG0002415]
 +
|CSMD2-AS1
 +
|ENST00000434181
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0052934 HSALNG0052934]
 +
|HDAC2-AS2
 +
|ENST00000421891
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105327 HSALNG0105327]
 +
|INO80-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075065 HSALNG0075065]
 +
|LINC02247
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0059170 HSALNG0059170]
 +
|MAGI2-AS3
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062699 HSALNG0062699]
 +
|MNX1-AS2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140277 HSALNG0140277]
 +
|SMIM10L2B-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0102543 HSALNG0102543]
 +
|TGFB3-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073036 HSALNG0073036]
 +
|HSD17B3-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142034 HSALNG0142034]
 +
|LINC02246
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100050 HSALNG0100050]
 +
|ZNF710-AS1
 +
|ENST00000558334
 +
|NA
 +
|pathogenic process
 +
|early-onset preeclampsia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007188 HSALNG0007188]
 +
|TDRKH-AS1
 +
|RP11-98D18.9
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057684 HSALNG0057684]
 +
|LINC01952
 +
|AC004854.4
 +
|NA
 +
|pathogenic process
 +
|recurrent miscarriage
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142190 HSALNG0142190]
 +
|NCF4-AS1
 +
|CTA-833B7.2
 +
|NA
 +
|pathogenic process
 +
|recurrent miscarriage
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029603 HSALNG0029603]
 +
|LNCSRLR
 +
|lncRNA-SRLR
 +
|transcriptional regulation
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021529 HSALNG0021529]
 +
|CFLAR-AS1
 +
|ALS2CR10
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141825 HSALNG0141825]
 +
|COL1A2-AS1
 +
|TCONS_00013888,lncRNA8975-1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypertrophic scar
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035847 HSALNG0035847]
 +
|LNCPRESS2
 +
|lncPRESS2
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005432 HSALNG0005432]
 +
|LINC01930
 +
|EU358092
 +
|NA
 +
|pathogenic process
 +
|schizophrenia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046325 HSALNG0046325]
 +
|HMMR-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|basal-like breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088703 HSALNG0088703]
 +
|CCND2-AS1
 +
|CCND2-AS2
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0030884 HSALNG0030884]
 +
|LINC00578
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026576 HSALNG0026576]
 +
|ADAMTS9-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0038152 HSALNG0038152]
 +
|FAM198B-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048820 HSALNG0048820]
 +
|LINC00240
 +
|C6orf41,NCRNA00240,bA373D17.1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122453 HSALNG0122453]
 +
|LINC00909
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141620 HSALNG0141620]
 +
|LINC00680
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0061394 HSALNG0061394]
 +
|LINC00513
 +
|AC016831.7
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0115960 HSALNG0115960]
 +
|LINC02001
 +
|RP11-1094M14.11
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0092950 HSALNG0092950]
 +
|POC1B-AS1
 +
|RP11-734K2.4
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060049 HSALNG0060049]
 +
|SLC12A9-AS1
 +
|RP11-126L15.4
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050617 HSALNG0050617]
 +
|TRAM2-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001176 HSALNG0001176]
 +
|LINC01772
 +
|ENSG00000226029
 +
|ceRNA
 +
|pathogenic process
 +
|oesophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009693 HSALNG0009693]
 +
|ELF3-AS1
 +
|ENST00000415582
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0025450 HSALNG0025450]
 +
|LINC02158
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133329 HSALNG0133329]
 +
|LINC01671
 +
|BC041455
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132343 HSALNG0132343]
 +
|LINC01684
 +
|lnc-JAM2-6
 +
|NA
 +
|pathogenic process
 +
|nonalcoholic fatty liver disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096092 HSALNG0096092]
 +
|LINC00365
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043625 HSALNG0043625]
 +
|LINC01554
 +
|C5orf27,FLJ38821,FIS
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0136701 HSALNG0136701]
 +
|LINC02154
 +
|GS1-600G8.5
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065704 HSALNG0065704]
 +
|LINC02155
 +
|RP11-705O24.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108398 HSALNG0108398]
 +
|LINC02157
 +
|RP11-327J17.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090758 HSALNG0090758]
 +
|LINC02156
 +
|RP1-90J4.1
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0063832 HSALNG0063832]
 +
|LINC02153
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0087394 HSALNG0087394]
 +
|LINC02151
 +
|TCONS_00019174
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0109385 HSALNG0109385]
 +
|LINC02152
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0013844 HSALNG0013844]
 +
|BRE-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056623 HSALNG0056623]
 +
|SNHG26
 +
|AC005682.5
 +
|NA
 +
|pathogenic process
 +
|bladder urothelial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122284 HSALNG0122284]
 +
|LIVAR
 +
|lnc18q22.2
 +
|NA
 +
|pathogenic process
 +
|nonalcoholic steatohepatiti
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031832 HSALNG0031832]
 +
|LINC00969
 +
|ENST00000453324
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140259 HSALNG0140259]
 +
|LINC02243
 +
|ENST00000441841
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039449 HSALNG0039449]
 +
|SLC9A3-AS1
 +
|UC011CLY.2
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0126602 HSALNG0126602]
 +
|DM1-AS
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|myotonic dystrophy type 1
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004475 HSALNG0004475]
 +
|LINC02238
 +
|RP4-788P17.1
 +
|NA
 +
|pathogenic process
 +
|B cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043374 HSALNG0043374]
 +
|MEF2C-AS2
 +
|CTC-467M3.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0003824 HSALNG0003824]
 +
|MIR4422HG
 +
|RP11-101C11.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082800 HSALNG0082800]
 +
|SPON1-AS1
 +
|RP11-21,L19.1
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083610 HSALNG0083610]
 +
|CD44-AS1
 +
|RP1-68D18.4
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127560 HSALNG0127560]
 +
|LILRB1-AS1
 +
|AC009892.10
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289546 HSALNT0289546]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141661 HSALNG0141661]
 +
|AC009892.10
 +
|LILRB1-AS1
 +
|NA
 +
|NA
 +
|B cell lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137635 HSALNG0137635]
 +
|LINC01186
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131657 HSALNG0131657]
 +
|MHENCR
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034801 HSALNG0034801]
 +
|LINC02232
 +
|RP11-707A18.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0038220 HSALNG0038220]
 +
|LINC02233
 +
|RP11-6C14.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039930 HSALNG0039930]
 +
|LINC02236
 +
|RP11-332J15.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043678 HSALNG0043678]
 +
|LINC02234
 +
|RP11-455B3.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0066607 HSALNG0066607]
 +
|LINC02235
 +
|RP11-354A14.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0067779 HSALNG0067779]
 +
|LINC02237
 +
|RP11-1101K5.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0111295 HSALNG0111295]
 +
|LINC02179
 +
|RP11-189E14.4
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132340 HSALNG0132340]
 +
|LINC01689
 +
|AP000469.2
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091963 HSALNG0091963]
 +
|LINC02231
 +
|RP11-766N7.4
 +
|NA
 +
|pathogenic process
 +
|Esophageal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105903 HSALNG0105903]
 +
|MIR4713HG
 +
|RP11-108K3.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0037858 HSALNG0037858]
 +
|FAM160A1-DT
 +
|RP11-610P16.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021423 HSALNG0021423]
 +
|SATB2-AS1
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141623 HSALNG0141623]
 +
|LINC01826
 +
|lnc-MKI67IP-3
 +
|ceRNA
 +
|pathogenic process
 +
|atherosclerosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104253 HSALNG0104253]
 +
|LINC00226
 +
|C14orf97,NCRNA00226
 +
|NA
 +
|pathogenic process
 +
|pancreatic ductaladenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039173 HSALNG0039173]
 +
|F11-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105295 HSALNG0105295]
 +
|SPINT1-AS1
 +
|RP11-532F12.5
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088950 HSALNG0088950]
 +
|MIR200CHG
 +
|U47924.27
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031153 HSALNG0031153]
 +
|LINC00888
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0116205 HSALNG0116205]
 +
|LINC00672
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0085691 HSALNG0085691]
 +
|P4HA3-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|parkinson's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0095075 HSALNG0095075]
 +
|TMEM132D-AS1
 +
|LOC283352
 +
|NA
 +
|pathogenic process
 +
|human dermal fibroblasts
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113128 HSALNG0113128]
 +
|ATP2C2-AS1
 +
|RP11-517C16.2-001
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0112863 HSALNG0112863]
 +
|WWOX-AS1
 +
|RP11-190D6.2
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0061246 HSALNG0061246]
 +
|FLNC-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142004 HSALNG0142004]
 +
|LIF-AS1
 +
|Lnc-LIF-AS
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005428 HSALNG0005428]
 +
|DPYD-AS2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical squamous cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141951 HSALNG0141951]
 +
|FLICR
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|autoimmune diabete
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090563 HSALNG0090563]
 +
|LINC02402
 +
|ENST00000550337.1
 +
|NA
 +
|pathogenic process
 +
|diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065453 HSALNG0065453]
 +
|CERNA3
 +
|CTA
 +
|ceRNA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043312 HSALNG0043312]
 +
|LINC02488
 +
|CTD-2316B1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083979 HSALNG0083979]
 +
|LINC02489
 +
|CTD-2589M5
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105991 HSALNG0105991]
 +
|LINC02490
 +
|RP11-209E8
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045650 HSALNG0045650]
 +
|STK32A-AS1
 +
|CTC-255N20
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055190 HSALNG0055190]
 +
|LINC02487
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045503 HSALNG0045503]
 +
|SPRY4-AS1
 +
|THCAT68
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090908 HSALNG0090908]
 +
|DDN-AS1
 +
|CAT1507
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006150 HSALNG0006150]
 +
|SLC16A1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000276 HSALNG0000276]
 +
|TNFRSF14-AS1
 +
|ENST00000416860.2
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0125745 HSALNG0125745]
 +
|LINC00665
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0019085 HSALNG0019085]
 +
|DARS-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|renal disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0125425 HSALNG0125425]
 +
|CEBPA-AS1
 +
|CEBPA-DT
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057479 HSALNG0057479]
 +
|INHBA-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0067472 HSALNG0067472]
 +
|GASAL1
 +
|GASL1
 +
|NA
 +
|pathogenic process
 +
|liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021881 HSALNG0021881]
 +
|LINC01857
 +
|AC079767.4
 +
|NA
 +
|pathogenic process
 +
|tuberculosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004949 HSALNG0004949]
 +
|LINC01140
 +
|FLJ41676
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137521 HSALNG0137521]
 +
|PINCR
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0139543 HSALNG0139543]
 +
|LINC00890
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|leiomyoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009573 HSALNG0009573]
 +
|LINC00862
 +
|C1orf98,SMIM16
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035237 HSALNG0035237]
 +
|LINC02562
 +
|RP11-44F21.5
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127961 HSALNG0127961]
 +
|LINC02560
 +
|CTD-2619J13.13
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088252 HSALNG0088252]
 +
|LINC02551
 +
|RP11-890B15.2
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0078773 HSALNG0078773]
 +
|DDIT4-AS1
 +
|RP11-442H21.2
 +
|NA
 +
|pathogenic process
 +
|cystic Fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089423 HSALNG0089423]
 +
|GPRC5D-AS1
 +
|RP11-392P7.6
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015768 HSALNG0015768]
 +
|PCBP1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044141 HSALNG0044141]
 +
|STARD4-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097004 HSALNG0097004]
 +
|LINC00462
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099453 HSALNG0099453]
 +
|SOX1-OT
 +
|LINC00403
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001107 HSALNG0001107]
 +
|SLC25A34-AS1
 +
|RP11-169K16.4
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075163 HSALNG0075163]
 +
|PPP1R26-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0064310 HSALNG0064310]
 +
|LINC00589
 +
|C8orf75,TSLNC8
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141627 HSALNG0141627]
 +
|TPM1-AS
 +
|TPM1-AS1
 +
|splicing regulation
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141631 HSALNG0141631]
 +
|LINC01101
 +
|FLJ14816
 +
|NA
 +
|pathogenic process
 +
|HPV-induced cervical neoplasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018748 HSALNG0018748]
 +
|LINC02572
 +
|AC079776.2
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0046188 HSALNG0046188]
 +
|LINC02202
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0027511 HSALNG0027511]
 +
|LINC00973
 +
|CTD-2021J15.2
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141401 HSALNG0141401]
 +
|TTTY10
 +
|NCRNA00133
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133418 HSALNG0133418]
 +
|LINC00319
 +
|C21orf125,NCRNA00319,PRED49,FLJ38036
 +
|ceRNA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007394 HSALNG0007394]
 +
|IL6R-AS1
 +
|RP11-350G8.5
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043020 HSALNG0043020]
 +
|CKMT2-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006203 HSALNG0006203]
 +
|HIPK1-AS1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050214 HSALNG0050214]
 +
|POLH-AS1
 +
|RP3-337H4.8
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053237 HSALNG0053237]
 +
|TRDN-AS1
 +
|HRAT13
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069213 HSALNG0069213]
 +
|LY6E-DT
 +
|LOC100133669
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNT0289434]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0040409 HSALNG0040409]
 +
|BASP1-AS1
 +
|LOC285696
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069691 HSALNG0069691]
 +
|GLIS3-AS1
 +
|C9orf70,MGC16153
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070213 HSALNG0070213]
 +
|BNC2-AS1
 +
|RP11-62F24.2
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0078947 HSALNG0078947]
 +
|ZNF503-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|age-related macular degeneration
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0076434 HSALNG0076434]
 +
|VIM-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0011058 HSALNG0011058]
 +
|ACBD3-AS1
 +
|RP11-275I14.4
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005074 HSALNG0005074]
 +
|LRRC8C-DT
 +
|FLJ27354
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0058889 HSALNG0058889]
 +
|ELN-AS1
 +
|CTB-51J22.1
 +
|NA
 +
|pathogenic process
 +
|endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036645 HSALNG0036645]
 +
|LINC02264
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044495 HSALNG0044495]
 +
|LINC02201
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132198 HSALNG0132198]
 +
|LINC02573
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015785 HSALNG0015785]
 +
|LINC01816
 +
|LOC100133985
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091335 HSALNG0091335]
 +
|LINC02381
 +
|LOC400043
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029874 HSALNG0029874]
 +
|MBNL1-AS1
 +
|LOC401093
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141624 HSALNG0141624]
 +
|MIR4697HG
 +
|LINC00947,LOC283174
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065480 HSALNG0065480]
 +
|LINC00968
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053963 HSALNG0053963]
 +
|NMBR-AS1
 +
|RP11-137J7.2
 +
|NA
 +
|pathogenic process
 +
|non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077499 HSALNG0077499]
 +
|LINC01518
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002009 HSALNG0002009]
 +
|LINC02574
 +
|RP11-288L9.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNT0032721]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015486 HSALNG0015486]
 +
|LINC02579
 +
|AC007365.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0014519 HSALNG0014519]
 +
|LINC02580
 +
|AC093609.1
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNT0032808]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015519 HSALNG0015519]
 +
|LINC02576
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060386 HSALNG0060386]
 +
|LINC02577
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074062 HSALNG0074062]
 +
|LINC02578
 +
|RP11-127L21.1
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084388 HSALNG0084388]
 +
|FAM111A-DT
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133545 HSALNG0133545]
 +
|LINC02575
 +
|AP001065.15
 +
|transcriptional regulation
 +
|pathogenic process
 +
|UVB-irradiated KC & non-melanoma skin cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNT0025249]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0012143 HSALNG0012143]
 +
|KIF26B-AS1
 +
|RP11-62I21.1
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0085146 HSALNG0085146]
 +
|RPS6KB2-AS1
 +
|AP003419.16
 +
|NA
 +
|pathogenic process
 +
|aging‑associated idiopathic pulmonary fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090150 HSALNG0090150]
 +
|LINC00941
 +
|lncRNA-MUF
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075045 HSALNG0075045]
 +
|LINC00094
 +
|FLJ35348,bA374P20.3
 +
|NA
 +
|pathogenic process
 +
|lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053894 HSALNG0053894]
 +
|FILNC1
 +
|NA
 +
|translational control
 +
|pathogenic process
 +
|renal tumor
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128600 HSALNG0128600]
 +
|PARAL1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|obesity
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244832 HSALNT0244832]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118528 HSALNG0118528]
 +
|SOX9-AS1
 +
|FLJ37644
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNT0289236]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118528 HSALNG0118528]
 +
|ROCR
 +
|LINC02095
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0027060 HSALNG0027060]
 +
|LINC02027
 +
|LOC728290
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNT0289424]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141124 HSALNG0141124]
 +
|TTTY22
 +
|NCRNA00147
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0030090 HSALNG0030090]
 +
|LINC00880
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122396 HSALNG0122396]
 +
|LINC02582
 +
|CTD-2354A18.1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097712 HSALNG0097712]
 +
|LINC00364
 +
|LncRNA00364
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029189 HSALNG0029189]
 +
|NCK1-DT
 +
|NCK1-AS1,SLC35G2-AS1
 +
|ceRNA
 +
|pathogenic process
 +
|cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0067505 HSALNG0067505]
 +
|BAALC-AS1
 +
|lncFZD6,FZD6-DT
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021972 HSALNG0021972]
 +
|CPS1-IT1
 +
|CPS1-IT,CPS1IT,CPS1IT1,PRO0132
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0059740 HSALNG0059740]
 +
|DLX6-AS1
 +
|DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048
 +
|transcriptional regulation
 +
|pathogenic process
 +
|split hand/split foot malformation disorder;lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142006 HSALNG0142006]
 +
|LINC00114
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0138601 HSALNG0138601]
 +
|TSIX
 +
|LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|systemic sclerosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104503 HSALNG0104503]
 +
|MKRN3-AS1
 +
|ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142371 HSALNG0142371]
 +
|SRA
 +
|lnc-SRA1-1:1,SRA1,ENSG00000213523
 +
|transcriptional regulation
 +
|pathogenic process
 +
|nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049271 HSALNG0049271]
 +
|HCP5
 +
|6S2650E,D6S2650E,P5-1
 +
|NA
 +
|pathogenic process
 +
|AIDS
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083476 HSALNG0083476]
 +
|WT1-AS
 +
|WIT1,WIT-1,WT1A, WT1-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082235 HSALNG0082235]
 +
|KCNQ1OT1
 +
|KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128372 HSALNG0128372]
 +
|PCNA-AS1
 +
|PCNAA, PCNA-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049107 HSALNG0049107]
 +
|HCG9
 +
|PERB11,HCGIX,HCGIX4,HCGIX-4
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103448 HSALNG0103448]
 +
|TCL6
 +
|TCL6e1,TNG2,TNG1
 +
|NA
 +
|pathogenic process;developmental process
 +
|renal cell cancer;leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0072040 HSALNG0072040]
 +
|PCA3
 +
|DD3,NCRNA00019,PCAT3
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082178 HSALNG0082178]
 +
|H19
 +
|ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2
 +
|transcriptional regulation;ceRNA
 +
|developmental process;pathogenic process
 +
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097105 HSALNG0097105]
 +
|DLEU1
 +
|BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141604 HSALNG0141604]
 +
|DBH-AS1
 +
|NCRNA00118,BPR
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0042101 HSALNG0042101]
 +
|PART1
 +
|DKFZP586D0823,NCRNA00206
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082197 HSALNG0082197]
 +
|IGF2-AS
 +
|IGF2A,PEG8,IGF2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131285 HSALNG0131285]
 +
|GNAS-AS1
 +
|GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;pseudohypoparathyroidism type Ib
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0051709 HSALNG0051709]
 +
|SNHG5
 +
|C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;lymphoma;melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0011462 HSALNG0011462]
 +
|DISC2
 +
|DISC1-AS1,DISC1O, NCRNA00015
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097806 HSALNG0097806]
 +
|ATXN8OS
 +
|SCA8,KLHL1A,NCRNA00003
 +
|transcriptional regulation
 +
|pathogenic process
 +
|spinocerebellar ataxia;spinocerebellar ataxia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142427 HSALNG0142427]
 +
|TRAF3IP2-AS1
 +
|C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|schizophrenia;cocaine abuse
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0054049 HSALNG0054049]
 +
|HYMAI
 +
|NCRNA00020
 +
|NA
 +
|pathogenic process
 +
|transient neonatal diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071146 HSALNG0071146]
 +
|FAM201A
 +
|C9orf122
 +
|NA
 +
|pathogenic process
 +
|leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0093910 HSALNG0093910]
 +
|FAM222A-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0138575 HSALNG0138575]
 +
|FAM226A
 +
|CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141608 HSALNG0141608]
 +
|FAM215A
 +
|C17orf88,APR-2,LINC00530
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0025991 HSALNG0025991]
 +
|RBM5-AS1
 +
|LUST
 +
|transcriptional regulation
 +
|pathogenic process
 +
|tumor
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001554 HSALNG0001554]
 +
|LINC00339
 +
|NCRNA00339,HSPC157
 +
|NA
 +
|pathogenic process;developmental process
 +
|Pancreatic ductal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068615 HSALNG0068615]
 +
|ASAP1-IT1
 +
|ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0021208 HSALNG0021208]
 +
|PCGEM1
 +
|NCRNA00071,LINC00071,PCAT9
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteoarthritis;prostate cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082243 HSALNG0082243]
 +
|KCNQ1DN
 +
|BWRT,HSA404617
 +
|NA
 +
|pathogenic process
 +
|aging;Wilms' tumor
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0097101 HSALNG0097101]
 +
|DLEU2
 +
|DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104558 HSALNG0104558]
 +
|PWAR4
 +
|PAR4,PAR-4
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103778 HSALNG0103778]
 +
|MEG8
 +
|SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome;temple syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133856 HSALNG0133856]
 +
|CECR7
 +
|SAHL1
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;cat eye syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0035451 HSALNG0035451]
 +
|PCAT4
 +
|GDEP,PCAN1,PCA4
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0029318 HSALNG0029318]
 +
|PISRT1
 +
|NCRNA00195
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|blepharophimosis syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0092137 HSALNG0092137]
 +
|IFNG-AS1
 +
|Tmevpg1,LincR-Ifng-3'A, NEST
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018067 HSALNG0018067]
 +
|FAM138B
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069515 HSALNG0069515]
 +
|FAM138C
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000006 HSALNG0000006]
 +
|FAM138A
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088434 HSALNG0088434]
 +
|FAM138D
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108677 HSALNG0108677]
 +
|FAM138E
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122829 HSALNG0122829]
 +
|FAM138F
 +
|F379
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141632 HSALNG0141632]
 +
|LINC00312
 +
|LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN
 +
|transcriptional regulation
 +
|pathogenic process
 +
|nasopharyngeal cancer;bladder cancer;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0054798 HSALNG0054798]
 +
|AIRN
 +
|AIR,NCRNA00088,IGF2RA, IGF2R-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0123415 HSALNG0123415]
 +
|MIR7-3HG
 +
|C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2
 +
|NA
 +
|pathogenic process
 +
|liver cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0089375 HSALNG0089375]
 +
|LOH12CR2
 +
|LOH2CR12
 +
|NA
 +
|pathogenic process
 +
|pre-B acute lymphoblastic leukaemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133055 HSALNG0133055]
 +
|DSCR8
 +
|C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b
 +
|NA
 +
|pathogenic process
 +
|Down syndrome;melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133422 HSALNG0133422]
 +
|LINC00313
 +
|C21orf84,NCRNA00313,
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132830 HSALNG0132830]
 +
|LINC00310
 +
|C21orf82,NCRNA00310
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132500 HSALNG0132500]
 +
|LINC00161
 +
|C21orf100,NCRNA00161
 +
|ceRNA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132027 HSALNG0132027]
 +
|MIR99AHG
 +
|C21orf35,FLJ38295,C21orf34,LINC00478,MONC
 +
|NA
 +
|pathogenic process
 +
|myeloid leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056865 HSALNG0056865]
 +
|HOXA11-AS
 +
|HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076
 +
|ceRNA
 +
|pathogenic process
 +
|uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0093342 HSALNG0093342]
 +
|RMST
 +
|NCRM, NCRNA00054,LINC00054
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|breast cancer;rhabdomyosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142194 HSALNG0142194]
 +
|ncR-PAR
 +
|NCRUPAR,ENSG00000225407
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0061370 HSALNG0061370]
 +
|MESTIT1
 +
|MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS
 +
|NA
 +
|pathogenic process
 +
|Silver-Russell syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133168 HSALNG0133168]
 +
|DSCAM-AS1
 +
|M41
 +
|NA
 +
|pathogenic process
 +
|adolescent idiopathic scoliosis;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104546 HSALNG0104546]
 +
|PWARSN
 +
|PAR-SN,PARSN
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060774 HSALNG0060774]
 +
|ST7-AS1
 +
|ST7OT1,ST7AS1
 +
|NA
 +
|pathogenic process
 +
|glioma;autism
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0099122 HSALNG0099122]
 +
|DAOA-AS1
 +
|DAOAA, DAOA-A,G30
 +
|NA
 +
|pathogenic process
 +
|panic disorder;schizophrenia;bipolar disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0080104 HSALNG0080104]
 +
|OLMALINC
 +
|C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80
 +
|NA
 +
|pathogenic process
 +
|type 2 diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0012802 HSALNG0012802]
 +
|LINC00299
 +
|C2orf46,NCRNA00299,FLJ45673
 +
|NA
 +
|pathogenic process;developmental process
 +
|intellectual and developmental disability;neurodevelopmental disabilities
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039816 HSALNG0039816]
 +
|LINC01020
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048016 HSALNG0048016]
 +
|LINC00518
 +
|C6orf218,MGC40222
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0039909 HSALNG0039909]
 +
|LINC01018
 +
|SRHC
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031463 HSALNG0031463]
 +
|LPP-AS2
 +
|MYCLo-5,MYCLo-6
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068292 HSALNG0068292]
 +
|LINC00964
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094063 HSALNG0094063]
 +
|MAPKAPK5-AS1
 +
|C12orf47,FLJ39616
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0027872 HSALNG0027872]
 +
|LINC00635
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141633 HSALNG0141633]
 +
|LINC00636
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127758 HSALNG0127758]
 +
|ZNF582-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000022 HSALNG0000022]
 +
|LINC00115
 +
|NCRNA00115,FLJ22639
 +
|ceRNA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075291 HSALNG0075291]
 +
|SNHG7
 +
|MGC16037,NCRNA00061
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0020412 HSALNG0020412]
 +
|MAP3K20-AS1
 +
|MLK7-AS1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069280 HSALNG0069280]
 +
|RHPN1-AS1
 +
|C8orf51,MGC3113
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0138602 HSALNG0138602]
 +
|XIST
 +
|DXS399E,NCRNA00001,DXS1089,swd66,LINC00001
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128330 HSALNG0128330]
 +
|PRNT
 +
|M8
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0080912 HSALNG0080912]
 +
|EMX2OS
 +
|NCRNA00045,EMX2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096546 HSALNG0096546]
 +
|LINC00598
 +
|TTL
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141628 HSALNG0141628]
 +
|TTTY17A
 +
|NCRNA00140
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0013206 HSALNG0013206]
 +
|MYCNOS
 +
|NCYM,N-CYM,MYCN-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0022192 HSALNG0022192]
 +
|DIRC3
 +
|FLJ14199
 +
|NA
 +
|pathogenic process
 +
|familial renal cell cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084905 HSALNG0084905]
 +
|MALAT1
 +
|PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA
 +
|splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141859 HSALNG0141859]
 +
|DLG2-AS1
 +
|DLG2A, DLG2-A,PSZA11q14,SZ-1
 +
|NA
 +
|pathogenic process
 +
|schizophrenia;myotonic dystrophy type 1;heart failure
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103778 HSALNG0103778]
 +
|MEG3
 +
|FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1
 +
|translational control;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142413 HSALNG0142413]
 +
|TERC
 +
|DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;dyskeratosis congenita;lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0080948 HSALNG0080948]
 +
|CASC2
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0098601 HSALNG0098601]
 +
|MIR17HG
 +
|C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;syndromic developmental defect;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141456 HSALNG0141456]
 +
|TTTY6
 +
|TTY6,TTTY6A,LINC00127
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141468 HSALNG0141468]
 +
|TTTY4
 +
|TTY4,TTTY4A,LINC00123
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141548 HSALNG0141548]
 +
|TTTY3
 +
|TTY3,TTTY3A,LINC00121
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141450 HSALNG0141450]
 +
|TTTY5
 +
|TTY5,LINC00126
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036656 HSALNG0036656]
 +
|SNHG8
 +
|NCRNA00060,LINC00060
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;malignant pleural mesothelioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141597 HSALNG0141597]
 +
|BCYRN1
 +
|BC200,BC200a,NCRNA00004,LINC00004
 +
|splicing regulation;translational control
 +
|pathogenic process
 +
|aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068805 HSALNG0068805]
 +
|ZFAT-AS1
 +
|ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070
 +
|NA
 +
|pathogenic process
 +
|autoimmune disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0077083 HSALNG0077083]
 +
|ZEB1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135987 HSALNG0135987]
 +
|MIRLET7BHG
 +
|linc-Ppara
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0116616 HSALNG0116616]
 +
|NBR2
 +
|NCRNA00192
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;breast cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134930 HSALNG0134930]
 +
|TUG1
 +
|FLJ20618,NCRNA00080,LINC00080
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0079552 HSALNG0079552]
 +
|FAS-AS1
 +
|FASA, FAS-A,SAF
 +
|transcriptional regulation
 +
|pathogenic process
 +
|ataxia telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068110 HSALNG0068110]
 +
|HAS2-AS1
 +
|HAS2A, HAS2-A,HASNT,NCRNA00077
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049245 HSALNG0049245]
 +
|PSORS1C3
 +
|NCRNA00196
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis;psoriasis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141983 HSALNG0141983]
 +
|HLA-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|psoriasis;liver injury;multiple sclerosis;AIDS
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142269 HSALNG0142269]
 +
|PRINS
 +
|NCRNA00074
 +
|transcriptional regulation
 +
|pathogenic process
 +
|psoriasis;prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0127790 HSALNG0127790]
 +
|PEG3-AS1
 +
|PEG3AS,PEG3-AS,APEG3,NCRNA00155
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141648 HSALNG0141648]
 +
|7SL
 +
|7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1
 +
|protein localization
 +
|pathogenic process
 +
|AIDS;Leishmaniasis;dermatomyositis;polymyositis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142196 HSALNG0142196]
 +
|NDM29
 +
|29A,lnc-C11orf16-1:1
 +
|NA
 +
|pathogenic process
 +
|neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074439 HSALNG0074439]
 +
|NRON
 +
|NCRNA00194
 +
|NA
 +
|pathogenic process
 +
|AIDS;Down syndrome;HIV
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0065926 HSALNG0065926]
 +
|SNHG6
 +
|U87HG,HBII-276HG,NCRNA00058
 +
|translational control;ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141768 HSALNG0141768]
 +
|Beta-globin transcript
 +
|AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142513 HSALNG0142513]
 +
|Zfhx2as
 +
|Zfh-5AS,ENSG00000157306,ENST00000554403.1
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0005433 HSALNG0005433]
 +
|MIR137HG
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|schizophrenia;lung cancer;malignant lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056858 HSALNG0056858]
 +
|HOXA-AS3
 +
|HOXA6as
 +
|NA
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068551 HSALNG0068551]
 +
|CCDC26
 +
|MGC27434,RAM
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142008 HSALNG0142008]
 +
|LINC00271
 +
|C6orf217,NCRNA00271
 +
|NA
 +
|pathogenic process
 +
|type 2 diabetes;schizophrenia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0109621 HSALNG0109621]
 +
|BCAR4
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142005 HSALNG0142005]
 +
|LINC00032
 +
|C9orf14,NCRNA00032
 +
|NA
 +
|pathogenic process
 +
|narcolepsy;melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133591 HSALNG0133591]
 +
|PICSAR
 +
|C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74
 +
|transcriptional regulation
 +
|pathogenic process
 +
|testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0124398 HSALNG0124398]
 +
|UCA1
 +
|CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36
 +
|transcriptional regulation;ceRNA
 +
|developmental process;pathogenic process
 +
|oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNT0003871]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002066 HSALNG0002066]
 +
|SNHG3
 +
|NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131591 HSALNG0131591]
 +
|HAR1A
 +
|HAR1F,NCRNA00064,LINC00064
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131589 HSALNG0131589]
 +
|HAR1B
 +
|HAR1R,NCRNA00065,LINC00065
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044150 HSALNG0044150]
 +
|EPB41L4A-AS1
 +
|C5orf26,NCRNA00219,TIGA1
 +
|NA
 +
|pathogenic process
 +
|lung cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134655 HSALNG0134655]
 +
|MIAT
 +
|C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT
 +
|splicing regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0047947 HSALNG0047947]
 +
|HULC
 +
|NCRNA00078,LINC00078,HCCAT1
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0023880 HSALNG0023880]
 +
|EGOT
 +
|EGO,NCRNA00190
 +
|NA
 +
|pathogenic process;developmental process
 +
|prostate cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001461 HSALNG0001461]
 +
|PINK1-AS
 +
|PINK1-AS1,FLJ00387,PINK1A, naPINK1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|glucose metabolism disorder;Parkinson's disease;diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068477 HSALNG0068477]
 +
|PVT1
 +
|NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT
 +
|transcriptional regulation;translational control
 +
|pathogenic process
 +
|murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073233 HSALNG0073233]
 +
|NAMA
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119442 HSALNG0119442]
 +
|NARF-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070397 HSALNG0070397]
 +
|CDKN2B-AS1
 +
|CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12
 +
|siRNA;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0024099 HSALNG0024099]
 +
|GHRLOS
 +
|NCRNA00068,GHRL-AS1
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026279 HSALNG0026279]
 +
|ESRG
 +
|HESRG
 +
|NA
 +
|pathogenic process
 +
|embryonal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140560 HSALNG0140560]
 +
|FMR1-AS1
 +
|FMR1A, FMR1-A,ASFMR1,FMR4
 +
|transcriptional regulation
 +
|pathogenic process
 +
|fragile X syndrome;neurological disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141610 HSALNG0141610]
 +
|HCG4
 +
|HCGIV-10,HCGIV.9
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0038609 HSALNG0038609]
 +
|HAND2-AS1
 +
|DEIN,NBLA00301,FLJ11539
 +
|NA
 +
|pathogenic process
 +
|neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0019362 HSALNG0019362]
 +
|ZEB2-AS1
 +
|ZEB2A, ZEB2-A,ZEB2NAT
 +
|splicing regulation
 +
|pathogenic process
 +
|bladder cancer;hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008545 HSALNG0008545]
 +
|GAS5
 +
|SNHG2,NCRNA00030
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0087449 HSALNG0087449]
 +
|BACE1-AS
 +
|BACE1A,FJ573250,NCRNA00177,BACE1-AS1
 +
|translational control;transcriptional regulation
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133533 HSALNG0133533]
 +
|TRPM2-AS
 +
|TRPM2-AS1
 +
|NA
 +
|pathogenic process
 +
|melanoma;prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008462 HSALNG0008462]
 +
|DNM3OS
 +
|DNM3-AS1,MIR199A2HG
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133982 HSALNG0133982]
 +
|DGCR5
 +
|NCRNA00037,LINC00037
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083307 HSALNG0083307]
 +
|BDNF-AS
 +
|BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS
 +
|siRNA;transcriptional regulation
 +
|developmental process;pathogenic process
 +
|Huntington disease;schizophrenia;psychiatric disease;obesity
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056850 HSALNG0056850]
 +
|HOTAIRM1
 +
|HOXA-AS1,NCRNA00179,HOXA1-AS1
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142273 HSALNG0142273]
 +
|PTCSC1
 +
|PTCSC,AK023948,NCRNA00197
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091318 HSALNG0091318]
 +
|HOTAIR
 +
|HOXC-AS4,HOXC11-AS1,NCRNA00072
 +
|siRNA;transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084892 HSALNG0084892]
 +
|NEAT1
 +
|NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045213 HSALNG0045213]
 +
|SNHG4
 +
|U19H,NCRNA00059
 +
|NA
 +
|pathogenic process
 +
|myelodysplastic syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118855 HSALNG0118855]
 +
|SNHG16
 +
|ncRAN,Nbla12061,Nbla10727
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;bladder cancer;colorectal cancer;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0023698 HSALNG0023698]
 +
|BOK-AS1
 +
|BOKA,NCRNA00151,NAToB
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;testicular cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141647 HSALNG0141647]
 +
|7SK
 +
|7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017872 HSALNG0017872]
 +
|MIR4435-2HG
 +
|MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0016500 HSALNG0016500]
 +
|PARTICL
 +
|PARTICLE
 +
|transcriptional regulation
 +
|pathogenic process
 +
|low-dose irradiation
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069266 HSALNG0069266]
 +
|MINCR
 +
|LINC01604,TCONS_00015189
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;Burkitt lymphoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000905 HSALNG0000905]
 +
|NPPA-AS1
 +
|NPPAA, NPPA-AS
 +
|splicing regulation
 +
|pathogenic process
 +
|cardiovascular disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142345 HSALNG0142345]
 +
|RRP1B
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|spinocerebellar ataxia;laryngeal squamous cell cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0093062 HSALNG0093062]
 +
|CLLU1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0087764 HSALNG0087764]
 +
|MIR100HG
 +
|AGD1,lncRNA-N2,linc-NeD125
 +
|NA
 +
|developmental process;pathogenic process
 +
|myeloid leukemia;myopia;cervical cancer;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0028235 HSALNG0028235]
 +
|TUSC7
 +
|LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141762 HSALNG0141762]
 +
|BC040587
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0028242 HSALNG0028242]
 +
|LINC00901
 +
|LSAMP-AS4,TCONS_00005428,BC040587
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;gastric cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0112604 HSALNG0112604]
 +
|HCCAT5
 +
|HTA,FJ222407
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142155 HSALNG0142155]
 +
|LSINCT5
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0086377 HSALNG0086377]
 +
|DISC1FP1
 +
|Boymaw
 +
|transcriptional regulation
 +
|pathogenic process
 +
|schizophrenia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104567 HSALNG0104567]
 +
|SNHG14
 +
|115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS
 +
|ceRNA
 +
|pathogenic process
 +
|Angelman syndrome;cerebral infarction;Prader-Willi syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000343 HSALNG0000343]
 +
|TP73-AS1
 +
|KIAA0495,PDAM
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142426 HSALNG0142426]
 +
|TP53COR1
 +
|Trp53cor1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068414 HSALNG0068414]
 +
|PRNCR1
 +
|CARLo-3,PCAT8
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;prostate cancer;glioma;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009743 HSALNG0009743]
 +
|PCAT6
 +
|KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;triple-negative breast cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130723 HSALNG0130723]
 +
|TRERNA1
 +
|LINC00651,ncRNA-a7,treRNA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007045 HSALNG0007045]
 +
|FALEC
 +
|LINC00568,ncRNA-a1,FAL1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|ovarian cancer;thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142123 HSALNG0142123]
 +
|LOC100887755
 +
|Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142363 HSALNG0142363]
 +
|snaR
 +
|EU035784.1,lnc-BSPH1-1:1
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0138609 HSALNG0138609]
 +
|JPX
 +
|NCRNA00183,ENOX,LINC00183,DCBALD06
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNT0289231]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0001716 HSALNG0001716]
 +
|RCAN3AS
 +
|TCONS_00001428
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069631 HSALNG0069631]
 +
|VLDLR-AS1
 +
|lincRNA-VLDLR
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0138614 HSALNG0138614]
 +
|FTX
 +
|NCRNA00182,MIR374AHG,LINC00182,FLJ33139
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043383 HSALNG0043383]
 +
|MEF2C-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;Prader-Willi syndrome and Angelman syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091277 HSALNG0091277]
 +
|PCBP2-OT1
 +
|TUC338
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;tongue squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142488 HSALNG0142488]
 +
|WRAP53
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;cancer;dyskeratosis congenita
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049949 HSALNG0049949]
 +
|TDRG1
 +
|LINC00532,lincRNA-NRNA024015
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132382 HSALNG0132382]
 +
|MIR155HG
 +
|MIRHG2,BIC,NCRNA00172
 +
|NA
 +
|pathogenic process
 +
|B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0024293 HSALNG0024293]
 +
|LINC00620
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056871 HSALNG0056871]
 +
|HOTTIP
 +
|NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130661 HSALNG0130661]
 +
|ZFAS1
 +
|C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045502 HSALNG0045502]
 +
|SPRY4-IT1
 +
|SPRIGHTLY
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049759 HSALNG0049759]
 +
|PANDAR
 +
|PANDA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032415 HSALNG0032415]
 +
|HTT-AS
 +
|HTT-AS1,HTTAS
 +
|NA
 +
|pathogenic process
 +
|Huntington disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0047200 HSALNG0047200]
 +
|HEIH
 +
|LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0107117 HSALNG0107117]
 +
|NPTN-IT1
 +
|lncRNA-LET
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141862 HSALNG0141862]
 +
|DQ786243
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|crohn's disease;colorectal cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068414 HSALNG0068414]
 +
|PCAT1
 +
|PCAT-1,PCA1
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134403 HSALNG0134403]
 +
|PCAT14
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101780 HSALNG0101780]
 +
|HIF1A-AS2
 +
|3'aHIF-1A,aHIF
 +
|translational control
 +
|pathogenic process
 +
|bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0101776 HSALNG0101776]
 +
|HIF1A-AS1
 +
|5'aHIF-1A,5'aHIF1alpha
 +
|NA
 +
|pathogenic process
 +
|acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031034 HSALNG0031034]
 +
|SOX2-OT
 +
|SOX2OT,DKFZp761J1324,NCRNA00043
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141815 HSALNG0141815]
 +
|CDR1-AS
 +
|CDR1NAT,ciRS-7,CDR1as
 +
|ceRNA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050599 HSALNG0050599]
 +
|LINCMD1
 +
|MIR133BHG,LINC-MD1
 +
|ceRNA
 +
|developmental process;pathogenic process
 +
|Duchenne muscular dystrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0082362 HSALNG0082362]
 +
|BGLT3
 +
|LINC01083,BGL3,lncRNA-BGL3
 +
|ceRNA
 +
|pathogenic process
 +
|chronic myeloid leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055058 HSALNG0055058]
 +
|LINC00473
 +
|C6orf176,bA142J11.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048223 HSALNG0048223]
 +
|LINC01108
 +
|LncRNA-ES1
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0103465 HSALNG0103465]
 +
|TUNAR
 +
|LINC00617,TUNA,HI-LNC78
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0105343 HSALNG0105343]
 +
|OIP5-AS1
 +
|cyrano,linc-OIP5
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048515 HSALNG0048515]
 +
|LINC00581
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|West Syndrome;West syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141771 HSALNG0141771]
 +
|BX118339
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|West syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010465 HSALNG0010465]
 +
|LINC00538
 +
|Yiya,PROX1UT
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132926 HSALNG0132926]
 +
|CBR3-AS1
 +
|PlncRNA-1,PlncRNA1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;hepatocellular cancer;prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070363 HSALNG0070363]
 +
|MIR31HG
 +
|LOC554202,hsa-lnc-31,LncHIFCAR
 +
|ceRNA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0034419 HSALNG0034419]
 +
|DANCR
 +
|KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142444 HSALNG0142444]
 +
|uc.388
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141957 HSALNG0141957]
 +
|FR0348383
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141211 HSALNG0141211]
 +
|TTTY15
 +
|DKFZP434I143,NCRNA00138
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141833 HSALNG0141833]
 +
|CRNDE
 +
|LOC643911,LINC00180,CRNDEP
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141800 HSALNG0141800]
 +
|CCND1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|tumor;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142050 HSALNG0142050]
 +
|lincRNA-p21
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|lung cancer;cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142249 HSALNG0142249]
 +
|PCNCR1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141603 HSALNG0141603]
 +
|DBET
 +
|DBE-T,DUX4L30
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|facioscapulohumeral muscular dystrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071734 HSALNG0071734]
 +
|BANCR
 +
|LINC00586
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100636 HSALNG0100636]
 +
|PTCSC3
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|papillary thyroid cancer;thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290063 HSALNT0290063]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142178 HSALNG0142178]
 +
|MVIH
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0052921 HSALNG0052921]
 +
|LINC01268
 +
|LOC285758
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0031716 HSALNG0031716]
 +
|LINC00887
 +
|linc-ATP13A4-8,HEIRCC
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypoxic and inflammatory renal epithelial injury;renal clear cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100075 HSALNG0100075]
 +
|DHRS4-AS1
 +
|C14orf167,PRO1488,AS1DHRS4
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113304 HSALNG0113304]
 +
|FENDRR
 +
|FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21
 +
|transcriptional regulation
 +
|developmental process;pathogenic process
 +
|osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050235 HSALNG0050235]
 +
|LINC01512
 +
|LOC100132354,TCONS_00011120,HI-LNC77
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;type 2 diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118547 HSALNG0118547]
 +
|LINC00673
 +
|HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0128306 HSALNG0128306]
 +
|LINC01433
 +
|LOC728228
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068424 HSALNG0068424]
 +
|CCAT1
 +
|CARLo-5,onco-lncRNA-40
 +
|ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0123467 HSALNG0123467]
 +
|TINCR
 +
|ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16
 +
|translational control
 +
|pathogenic process;developmental process
 +
|bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060113 HSALNG0060113]
 +
|LNCPRESS1
 +
|lncPRESS1
 +
|translational control
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075843 HSALNG0075843]
 +
|LINC02561
 +
|RP11-445P17.8
 +
|NA
 +
|pathogenic process
 +
|cystic fibrosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140616 HSALNG0140616]
 +
|LINC00850
 +
|KUCG1
 +
|NA
 +
|pathogenic process
 +
|Duchenne muscular dystrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0032699 HSALNG0032699]
 +
|AFAP1-AS1
 +
|AFAP1A, AFAP1-A,MGC10981
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141630 HSALNG0141630]
 +
|XACT
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0120344 HSALNG0120344]
 +
|GATA6-AS1
 +
|locus5689,BM742401
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;chronic lymphocytic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073144 HSALNG0073144]
 +
|PTCSC2
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141770 HSALNG0141770]
 +
|BTG3-AS1
 +
|ASBEL
 +
|translational control
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070801 HSALNG0070801]
 +
|PTENP1
 +
|NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142244 HSALNG0142244]
 +
|PAN
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Kaposi's sarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142054 HSALNG0142054]
 +
|LINC-ROR
 +
|lincRNA-RoR,lincRNA-ST8SIA3,ROR
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142437 HSALNG0142437]
 +
|UBE3A-ATS
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Angelman syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043367 HSALNG0043367]
 +
|LINC00461
 +
|EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323
 +
|NA
 +
|pathogenic process;developmental process
 +
|retinal and visual function
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141602 HSALNG0141602]
 +
|CTBP1-AS
 +
|PCAT10
 +
|transcriptional regulation
 +
|pathogenic process
 +
|chronic hepatitis C;prostate cancer;polycystic ovary syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017694 HSALNG0017694]
 +
|GACAT1
 +
|LINC00876,AC096655.1-002
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0056854 HSALNG0056854]
 +
|HOXA-AS2
 +
|HOXA3as
 +
|transcriptional regulation
 +
|pathogenic process
 +
|promyelocytic leukemia;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043441 HSALNG0043441]
 +
|LUCAT1
 +
|SCAL1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009941 HSALNG0009941]
 +
|BLACAT1
 +
|linc-UBC1,LINC00912,onco-lncRNA-30
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071221 HSALNG0071221]
 +
|GLIDR
 +
|LINC01172,MGC21881,TCONS_00015562
 +
|NA
 +
|pathogenic process
 +
|glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104548 HSALNG0104548]
 +
|PWAR5
 +
|PAR5,PAR-5
 +
|NA
 +
|pathogenic process
 +
|glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0059377 HSALNG0059377]
 +
|TP53TG1
 +
|TP53AP1,H_RG012D21.9,LINC00096
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;ataxia telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141713 HSALNG0141713]
 +
|AK126698
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104558 HSALNG0104558]
 +
|IPW
 +
|NCRNA00002
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Prader-Willi syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068443 HSALNG0068443]
 +
|CCAT2
 +
|NCCP1,LINC00873
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129180 HSALNG0129180]
 +
|LINC00261
 +
|C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17
 +
|NA
 +
|pathogenic process
 +
|pancreatic cancer;non-small cell lung cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0000303 HSALNG0000303]
 +
|LINC00982
 +
|FLJ42875
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142197 HSALNG0142197]
 +
|NEAT1_2
 +
|NEAT1_2
 +
|protein localization
 +
|pathogenic process
 +
|amyotrophic lateral sclerosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0076040 HSALNG0076040]
 +
|GATA3-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004297 HSALNG0004297]
 +
|GNG12-AS1
 +
|NA
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142510 HSALNG0142510]
 +
|YAM1
 +
|Yam-1
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|skeletal myogenesis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018036 HSALNG0018036]
 +
|PAX8-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|malignant pleural mesothelioma;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026023 HSALNG0026023]
 +
|RASSF1-AS1
 +
|ANRASSF1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142376 HSALNG0142376]
 +
|SUMO1P3
 +
|SUMO1P3
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094549 HSALNG0094549]
 +
|HNF1A-AS1
 +
|C12orf27,NCRNA00262,FLJ38690,HAS1
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041218 HSALNG0041218]
 +
|NIPBL-AS1
 +
|NIPBL-DT,NIPBL-AS
 +
|NA
 +
|pathogenic process
 +
|autism spectrum disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0057702 HSALNG0057702]
 +
|SNHG15
 +
|C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113835 HSALNG0113835]
 +
|MIR22HG
 +
|C17orf91,MGC14376,DKFZp686O06159
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113835 HSALNG0113835]
 +
|MIR22HG
 +
|C17orf91,MGC14376,DKFZp686O06159
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119881 HSALNG0119881]
 +
|GACAT2
 +
|MTCL1-AS1,HMlincRNA717
 +
|NA
 +
|pathogenic process
 +
|pancreatic cancer;non-small cell lung cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0134448 HSALNG0134448]
 +
|MIF-AS1
 +
|LOC284889,MIF-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|malaria;nephrolithiasis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0061385 HSALNG0061385]
 +
|LINC-PINT
 +
|MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer;heart failure
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0020769 HSALNG0020769]
 +
|SCHLAP1
 +
|LINC00913,SChLAP1,PCAT11
 +
|transcriptional regulation
 +
|pathogenic process
 +
|bladder cancer;prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0093119 HSALNG0093119]
 +
|SOCS2-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0066261 HSALNG0066261]
 +
|CASC9
 +
|ESCCAL-1,ESSCAL1,LINC00981
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130306 HSALNG0130306]
 +
|HNF4A-AS1
 +
|uc002xlx
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0131196 HSALNG0131196]
 +
|NKILA
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer;breast cancer;tongue squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0088539 HSALNG0088539]
 +
|LINC00942
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;autism spectrum disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062700 HSALNG0062700]
 +
|MNX1-AS1
 +
|CCAT5,LOC645249
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141629 HSALNG0141629]
 +
|VPS9D1-AS1
 +
|MYU
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142381 HSALNG0142381]
 +
|TC0101441
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009856 HSALNG0009856]
 +
|ERLNC1
 +
|TC0101441,ElncRNA1
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142165 HSALNG0142165]
 +
|Mdgt
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0020594 HSALNG0020594]
 +
|HAGLR
 +
|HOXD-AS1,Mdgt
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0017541 HSALNG0017541]
 +
|LINC01158
 +
|PANTR1,linc-Brn1a,linc-POU3F3
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|esophageal squamous cell cancer;gastric cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0062110 HSALNG0062110]
 +
|GHET1
 +
|lncRNA-GHET1
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;gastric cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141625 HSALNG0141625]
 +
|PEG13
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|intellectual disabilities
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0140233 HSALNG0140233]
 +
|MIR503HG
 +
|MGC16121,H19X
 +
|NA
 +
|pathogenic process
 +
|choriocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0083445 HSALNG0083445]
 +
|PAUPAR
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process;developmental process
 +
|uveal melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094171 HSALNG0094171]
 +
|LINC01234
 +
|LCAL84,onco-lncRNA-32
 +
|ceRNA
 +
|pathogenic process
 +
|oesophageal squamous cell cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0016642 HSALNG0016642]
 +
|CYTOR
 +
|C2orf59,NCRNA00152,MGC4677
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141821 HSALNG0141821]
 +
|CHRF
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|cardiac hypertrophy;silicosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068436 HSALNG0068436]
 +
|CASC8
 +
|LINC00860,CARLo-1
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0068465 HSALNG0068465]
 +
|CASC11
 +
|TCONS_00014535,LINC00990,CARLo-7,ENST00000518376
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133191 HSALNG0133191]
 +
|LINC00323
 +
|PRED42,FLJ37173
 +
|NA
 +
|pathogenic process
 +
|breast cancer;hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0011845 HSALNG0011845]
 +
|LINC01139
 +
|LINK-A,TCONS_00000027
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036270 HSALNG0036270]
 +
|LEF1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119753 HSALNG0119753]
 +
|LINC00667
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142260 HSALNG0142260]
 +
|POU3F3
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|esophageal squamous cell cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0096112 HSALNG0096112]
 +
|LINC00426
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|primary Sjögren's syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074744 HSALNG0074744]
 +
|LINC00963
 +
|MetaLnc9
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0086124 HSALNG0086124]
 +
|PCF11-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;adolescent idiopathic scoliosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141649 HSALNG0141649]
 +
|91H
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0055679 HSALNG0055679]
 +
|ELFN1-AS1
 +
|MYCLo-2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0079547 HSALNG0079547]
 +
|ACTA2-AS1
 +
|uc001kfo.1,ZXF1
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0059132 HSALNG0059132]
 +
|APTR
 +
|RSBN1L-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|liver fibrosis;glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142101 HSALNG0142101]
 +
|lncRNA-MVIH
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142092 HSALNG0142092]
 +
|lncRNA-ATB
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141737 HSALNG0141737]
 +
|ATB
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141701 HSALNG0141701]
 +
|AK057054
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0135702 HSALNG0135702]
 +
|LINC01315
 +
|lnc-C22orf32-1,C22orf32-1
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026583 HSALNG0026583]
 +
|ADAMTS9-AS2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|non-small cell lung cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009103 HSALNG0009103]
 +
|PACERR
 +
|PACER,PTGS2-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|osteosarcoma;osteoarthritis;inflammation and cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0010604 HSALNG0010604]
 +
|TGFB2-OT1
 +
|FLJ11812
 +
|ceRNA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0027860 HSALNG0027860]
 +
|DUBR
 +
|LINC00883
 +
|ceRNA
 +
|pathogenic process
 +
|asthma and chronic obstructive pulmonary disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNT0290147]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142262 HSALNG0142262]
 +
|POXCUT
 +
|TCONS_00011636
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0047407 HSALNG0047407]
 +
|FOXCUT
 +
|LINC01379,TCONS_00011636
 +
|transcriptional regulation
 +
|pathogenic process
 +
|esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0059521 HSALNG0059521]
 +
|CYP51A1-AS1
 +
|ENST00000453068,LRRD1-AS1
 +
|NA
 +
|pathogenic process
 +
|renal cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036288 HSALNG0036288]
 +
|RPL34-AS1
 +
|FLJ37673,RP11-462C24.1
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045015 HSALNG0045015]
 +
|C5orf66-AS1
 +
|CTC-276P9.1,Epist
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0006924 HSALNG0006924]
 +
|LINC00623
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|nasopharyngeal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141946 HSALNG0141946]
 +
|FER1L4
 +
|FER1L4
 +
|ceRNA
 +
|pathogenic process
 +
|gastric cancer;endometrial cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0013215 HSALNG0013215]
 +
|GACAT3
 +
|LINC01458,lncRNA-AC130710
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0058863 HSALNG0058863]
 +
|ABHD11-AS1
 +
|WBSCR26,LINC00035,NCRNA00035
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;mutant huntingtin
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0137651 HSALNG0137651]
 +
|ZNF674-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106864 HSALNG0106864]
 +
|PCAT29
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141787 HSALNG0141787]
 +
|CADM1
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007253 HSALNG0007253]
 +
|LINC01527
 +
|lnc-SPRR2D-1,RP1-13P20.6
 +
|NA
 +
|pathogenic process
 +
|squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108520 HSALNG0108520]
 +
|LUNAR1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141945 HSALNG0141945]
 +
|FAR2P1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0053580 HSALNG0053580]
 +
|TARID
 +
|EYA4-AS1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|kidney clear cell sarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069286 HSALNG0069286]
 +
|MAFA-AS1
 +
|RP11-909N17.3,TCONS_00014882
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142344 HSALNG0142344]
 +
|RPLP0P2
 +
|RPLP0P2
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133273 HSALNG0133273]
 +
|ZNF295-AS1
 +
|C21orf121,NCRNA00318,PRED87
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0040150 HSALNG0040150]
 +
|LINC01513
 +
|RP11-1C1.7,TCONS_00009352
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0108507 HSALNG0108507]
 +
|IRAIN
 +
|IGF1R-AS
 +
|transcriptional regulation
 +
|pathogenic process
 +
|pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142517 HSALNG0142517]
 +
|ZNRD1-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141615 HSALNG0141615]
 +
|LCAL1
 +
|onco-lncRNA-27
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100038 HSALNG0100038]
 +
|MHRT
 +
|Myheart
 +
|transcriptional regulation
 +
|pathogenic process
 +
|heart hypertrophy;acute myocardial infarction
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141974 HSALNG0141974]
 +
|HA117
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hirschsprung disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0012722 HSALNG0012722]
 +
|NRIR
 +
|lncRNA-CMPK2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|chronic hepatitis C;HCV
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142002 HSALNG0142002]
 +
|LET
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004023 HSALNG0004023]
 +
|NFIA-AS1
 +
|RP5-833A20.1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|atherosclerosis;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119710 HSALNG0119710]
 +
|GAPLINC
 +
|LINC01540,TCONS_00026238,lncRNA-uc002kmd.1
 +
|siRNA
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0079313 HSALNG0079313]
 +
|CERNA2
 +
|HOST2,lncRNA-HOST2
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;epithelial ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0050689 HSALNG0050689]
 +
|LINC01564
 +
|TCONS_00011314
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0012685 HSALNG0012685]
 +
|LINC01105
 +
|FLJ30594,LOC150622
 +
|NA
 +
|pathogenic process
 +
|gastric cancer;leukemia and neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0091650 HSALNG0091650]
 +
|AGAP2-AS1
 +
|LOC100130776,PUNISHER
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;glioma;leukemia and neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0106834 HSALNG0106834]
 +
|EWSAT1
 +
|TMEM84,NCRNA00277,LINC00277,FLJ33768
 +
|transcriptional regulation
 +
|pathogenic process
 +
|Ewing sarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0074573 HSALNG0074573]
 +
|SLC25A25-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0130331 HSALNG0130331]
 +
|KCNK15-AS1
 +
|RP11-445H22.4
 +
|NA
 +
|pathogenic process
 +
|osteoarthritis;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141979 HSALNG0141979]
 +
|HIF2PUT
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0019370 HSALNG0019370]
 +
|TEX41
 +
|DKFZp686O1327,LINC00953
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142476 HSALNG0142476]
 +
|UFC1
 +
|NA
 +
|transcriptional regulation;ceRNA
 +
|pathogenic process
 +
|osteoarthritis;hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142001 HSALNG0142001]
 +
|LEIGC
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049188 HSALNG0049188]
 +
|MDC1-AS1
 +
|MDC1-AS
 +
|NA
 +
|pathogenic process
 +
|bladder cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048542 HSALNG0048542]
 +
|NBAT1
 +
|CASC14,NBAT-1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|breast cancer;renal clear cell cancer;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113287 HSALNG0113287]
 +
|LINC00917
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094327 HSALNG0094327]
 +
|LINC00173
 +
|NCRNA00173,FLJ42957
 +
|NA
 +
|pathogenic process
 +
|HIV-1-infected;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142253 HSALNG0142253]
 +
|PEG10
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|diffuse large B-cell lymphoma;esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041549 HSALNG0041549]
 +
|LINC02224
 +
|BRCAT107,ENST00000505706
 +
|NA
 +
|pathogenic process
 +
|active tuberculosis
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141981 HSALNG0141981]
 +
|HIT
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002075 HSALNG0002075]
 +
|SNHG12
 +
|ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma;endometrial cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0002236 HSALNG0002236]
 +
|LINC01225
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142162 HSALNG0142162]
 +
|MALAT2
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0084672 HSALNG0084672]
 +
|SNHG1
 +
|LINC00057,NCRNA00057,U22HG,UHG,lncRNA16
 +
|NA
 +
|pathogenic process
 +
|astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0044933 HSALNG0044933]
 +
|WSPAR
 +
|TCONS_00009511-XLOC_004555,lncTCF7
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;liver cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118552 HSALNG0118552]
 +
|LINC00511
 +
|onco-lncRNA-12
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0069321 HSALNG0069321]
 +
|FAM83H-AS1
 +
|onco-lncRNA-3
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0051162 HSALNG0051162]
 +
|LINC00472
 +
|C6orf155,dJ288M22.3,FLJ13189
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142040 HSALNG0142040]
 +
|linc-ITGB1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007801 HSALNG0007801]
 +
|LINC01133
 +
|lncRNA-PAGBC
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer;colorectal cancer;lung squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141600 HSALNG0141600]
 +
|CCEPR
 +
|CCHE1,lncRNA-CCHE1
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;cervical cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0098682 HSALNG0098682]
 +
|SOX21-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;oral squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048533 HSALNG0048533]
 +
|CASC15
 +
|LINC00340,lnc-SOX4-1
 +
|NA
 +
|pathogenic process
 +
|basal cell cancer;melanoma;neuroblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141670 HSALNG0141670]
 +
|AC104699.1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045923 HSALNG0045923]
 +
|CLMAT3
 +
|SPARC-AS1
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0043698 HSALNG0043698]
 +
|RGMB-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|lung adenocarcinoma;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142023 HSALNG0142023]
 +
|LINC01419
 +
|LVCAT7,TCONS_00014497
 +
|NA
 +
|pathogenic process
 +
|hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141656 HSALNG0141656]
 +
|AB209630
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hypopharyngeal squamous cell cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141723 HSALNG0141723]
 +
|AOC4P
 +
|AOC4P
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer;hepatocelluar cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0040781 HSALNG0040781]
 +
|PURPL
 +
|LINC01021,LOC643401,RP11-46C20.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0094605 HSALNG0094605]
 +
|LINC01089
 +
|LIMT
 +
|NA
 +
|pathogenic process
 +
|breast cancer;astrocytoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0058166 HSALNG0058166]
 +
|EGFR-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141654 HSALNG0141654]
 +
|AB073614
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0117322 HSALNG0117322]
 +
|CACNA1G-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|keloid
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0081992 HSALNG0081992]
 +
|MIR210HG
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hypoxic and inflammatory stress
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113319 HSALNG0113319]
 +
|FOXC2-AS1
 +
|ODRUL
 +
|NA
 +
|pathogenic process
 +
|osteosarcoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0132865 HSALNG0132865]
 +
|LINC00160
 +
|C21orf52,NCRNA00160
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0049582 HSALNG0049582]
 +
|LINC01016
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0045753 HSALNG0045753]
 +
|CARMN
 +
|MIR143HG,CARMEN
 +
|transcriptional regulation
 +
|pathogenic process
 +
|cardiac differentiation
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0121579 HSALNG0121579]
 +
|LINC01630
 +
|LOC100287225
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104253 HSALNG0104253]
 +
|FAM30A
 +
|C14orf110,KIAA0125,HSPC053
 +
|NA
 +
|pathogenic process
 +
|gallbladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141617 HSALNG0141617]
 +
|LINC00346
 +
|C13orf29,NCRNA00346
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141758 HSALNG0141758]
 +
|BC032469
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141695 HSALNG0141695]
 +
|AK024171
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|intervertebral disc degeneration;gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142302 HSALNG0142302]
 +
|RP11-284N8.3.1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141954 HSALNG0141954]
 +
|FMR6
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|fragile X syndrome;fragile X-associated premature ovarian insufficiency
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142267 HSALNG0142267]
 +
|PRAL
 +
|lncRNA-PRAL
 +
|NA
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0129818 HSALNG0129818]
 +
|NORAD
 +
|LINC00657
 +
|transcriptional regulation;translational control
 +
|pathogenic process
 +
|breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041283 HSALNG0041283]
 +
|LIFR-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|preterm
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0036373 HSALNG0036373]
 +
|PANCR
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|atrial fibrillation
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060982 HSALNG0060982]
 +
|FEZF1-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0115230 HSALNG0115230]
 +
|CCDC144NL-AS1
 +
|NA
 +
|ceRNA
 +
|pathogenic process
 +
|ovarian cancer;cardiac hypertrophy
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142217 HSALNG0142217]
 +
|NR_026689
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075559 HSALNG0075559]
 +
|ADARB2-AS1
 +
|C10orf109,NCRNA00168,bA466B20.1
 +
|NA
 +
|pathogenic process
 +
|breast cancer;pancreatic ductal adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0018139 HSALNG0018139]
 +
|DPP10-AS1
 +
|BC032913
 +
|NA
 +
|pathogenic process
 +
|breast cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0113682 HSALNG0113682]
 +
|GAS8-AS1
 +
|C16orf3
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0075802 HSALNG0075802]
 +
|MANCR
 +
|LINC00704
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026715 HSALNG0026715]
 +
|SAMMSON
 +
|LINC01212
 +
|NA
 +
|pathogenic process
 +
|melanoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007238 HSALNG0007238]
 +
|LINC00302
 +
|C1orf46,NCRNA00302,XP33
 +
|NA
 +
|developmental process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118895 HSALNG0118895]
 +
|SNHG20
 +
|C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0007463 HSALNG0007463]
 +
|DCST1-AS1
 +
|RP11-307C12.11
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0071682 HSALNG0071682]
 +
|PGM5-AS1
 +
|FAM233A,LOC572558
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142351 HSALNG0142351]
 +
|SBF2-AS1
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142440 HSALNG0142440]
 +
|uc.338
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|hepatocellular cancer;lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNT0289973]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142088 HSALNG0142088]
 +
|LNCRI
 +
|lnc-RI
 +
|ceRNA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0142117 HSALNG0142117]
 +
|LOC100130476
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cardia adenocarcinoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0063356 HSALNG0063356]
 +
|LINC00599
 +
|Rncr3
 +
|NA
 +
|pathogenic process
 +
|diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0009871 HSALNG0009871]
 +
|LINC00628
 +
|NA
 +
|transcriptional regulation
 +
|pathogenic process
 +
|gastric cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133031 HSALNG0133031]
 +
|DSCR4
 +
|DCRB
 +
|NA
 +
|pathogenic process
 +
|Down syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0008546 HSALNG0008546]
 +
|GAS5-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|oral submucous fibrosis;non-small cell lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0048782 HSALNG0048782]
 +
|HCG11
 +
|bK14H9.3,FLJ14049,FLJ30357
 +
|NA
 +
|pathogenic process
 +
|prostate cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0064314 HSALNG0064314]
 +
|LINC02099
 +
|AC145110.1
 +
|NA
 +
|pathogenic process
 +
|rheumatoid arthritis;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0100348 HSALNG0100348]
 +
|G2E3-AS1
 +
|CAT1647
 +
|NA
 +
|pathogenic process
 +
|bladder cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0015506 HSALNG0015506]
 +
|LINC02245
 +
|lnc-SERTAD2-3,AC007386.2
 +
|NA
 +
|pathogenic process
 +
|ovarian cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0004109 HSALNG0004109]
 +
|FOXD3-AS1
 +
|pasFOXD3
 +
|transcriptional regulation
 +
|pathogenic process
 +
|glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0060638 HSALNG0060638]
 +
|LINC00998
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|major depression disorder
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0041522 HSALNG0041522]
 +
|NNT-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0026555 HSALNG0026555]
 +
|PSMD6-AS1
 +
|ENST00000462717,lnc00462717
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer;glioma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0119047 HSALNG0119047]
 +
|LINC02081
 +
|CTD-2357A8.3,XLOC_012582
 +
|NA
 +
|pathogenic process
 +
|esophageal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0107939 HSALNG0107939]
 +
|LINC00052
 +
|TMEM83,NCRNA00052,FLJ31461
 +
|ceRNA
 +
|pathogenic process
 +
|hepatocellular cancer;breast cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0095970 HSALNG0095970]
 +
|PLUT
 +
|PDX1-AS1,PLUTO,HI-LNC71
 +
|transcriptional regulation
 +
|pathogenic process
 +
|type 2 diabetes
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0073476 HSALNG0073476]
 +
|LINC01505
 +
|RP11-308N19.1
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0020625 HSALNG0020625]
 +
|LINC01116
 +
|TALNEC2
 +
|transcriptional regulation
 +
|pathogenic process
 +
|prostate cancer;glioblastoma
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0003395 HSALNG0003395]
 +
|FOXD2-AS1
 +
|MGC12982
 +
|NA
 +
|pathogenic process
 +
|lung cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0122085 HSALNG0122085]
 +
|LINC00305
 +
|C18orf20,NCRNA00305,MGC39571,HsT1235
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0110794 HSALNG0110794]
 +
|FBXL19-AS1
 +
|NCRNA00095,MGC125469,MGC125470,MGC125472
 +
|NA
 +
|pathogenic process
 +
|colorectal cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0090479 HSALNG0090479]
 +
|LINC02555
 +
|AC079630.2
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0121679 HSALNG0121679]
 +
|LINC01929
 +
|CTD-2171N6.1
 +
|NA
 +
|pathogenic process
 +
|papillary thyroid cancer
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0118529 HSALNG0118529]
 +
|LINC01152
 +
|TCONS_00025128,CMPD
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0139113 HSALNG0139113]
 +
|DIAPH2-AS1
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Hodgkin's disease
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0104558 HSALNG0104558]
 +
|PWAR1
 +
|PAR1,PAR-1
 +
|NA
 +
|pathogenic process
 +
|Prader-Willi syndrome and Angelman syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0070961 HSALNG0070961]
 +
|LINC00950
 +
|FP588
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141855 HSALNG0141855]
 +
|DGCR12
 +
|DGS-E
 +
|NA
 +
|pathogenic process;developmental process
 +
|DiGeorge syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133987 HSALNG0133987]
 +
|DGCR9
 +
|DGS-A,POM121L5P
 +
|NA
 +
|pathogenic process
 +
|DiGeorge syndrome
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0133982 HSALNG0133982]
 +
|DGCR10
 +
|DGS-B
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494]
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNG0141605 HSALNG0141605]
 +
|DGCR11
 +
|DGS-D
 +
|NA
 +
|pathogenic process
 +
|NA
 +
|-
 
|}
 
|}

Revision as of 05:57, 26 August 2019

Gene ID Symbol Synonyms Functional Mechanism Biological Process Disease
HSALNT0289501 HSALNG0141612 HPVC1 PE5L,HPV18E5L NA pathogenic process NA
HSALNT0289605 HSALNG0141720 Alpha 250/ Alpha 280 NONHSAT104559,lnc-C9orf53-2:1 NA NA NA
HSALNT0199632 HSALNG0096226 N4BP2L2-IT2 CG030 NA NA NA
HSALNT0171094 HSALNG0082161 LINC01150 2G7,TCONS_00019134 NA pathogenic process Wilms' tumor
HSALNT0289115 HSALNG0032599 LINC01587 C4orf6,aC1 NA pathogenic process neuroblastoma
HSALNT0290105 HSALNG0142220 NTT NONHSAT115106 NA NA NA
HSALNT0289234 HSALNG0053252 RNF217-AS1 STL NA pathogenic process acute lymphoblastic leukemia
HSALNT0280481 HSALNG0136795 INE2 NCRNA00011 NA NA NA
HSALNT0289485 HSALNG0137683 INE1 NCRNA00010 NA NA NA
HSALNT0289511 HSALNG0141622 LINC01565 C3orf27,GR6 NA pathogenic process leukemia
HSALNT0289068 HSALNG0006924 LINC00869 KIAA0493 NA NA NA
HSALNT0289430 HSALNG0026312 ERC2-IT1 C1orf1,C3orf51,Po42 NA pathogenic process NA
HSALNT0290394 HSALNG0142509 Y RNAs lnc-PDIA4-1:1 NA NA NA
HSALNT0289195 HSALNG0032409 NOP14-AS1 C4orf10,RES4-24 NA NA NA
HSALNT0290309 HSALNG0142424 TncRNA NONHSAT022116,AF080092,TSU NA developmental process NA
HSALNT0289243 HSALNG0045080 SMAD5-AS1 SMAD5O,DAMS NA pathogenic process malignant hematopoietic
HSALNT0289025 HSALNG0062672 LINC00244 C7orf4,NCRNA00244 NA pathogenic process preaxial polydactyly
HSALNT0289017 HSALNG0055219 KIF25-AS1 C6orf54,NCRNA00300,HGC6.1.1 NA pathogenic process ovarian cancer
HSALNT0289332 HSALNG0055207 LINC01558 C6orf123,LINC01557,HGC6.2,dJ431P23.4 NA pathogenic process ovarian cancer
HSALNT0289438 HSALNG0055209 AFDN-AS1 C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 NA pathogenic process NA
HSALNT0289232 HSALNG0135027 RFPL3S RFPL3-AS1,RFPL3-A, NCRNA00005 NA pathogenic process opitz syndrome
HSALNT0289393 HSALNG0134830 RFPL1S RFPL1-AS1,RFPL1-A, NCRNA00006 NA pathogenic process NA
HSALNT0289500 HSALNG0141611 HCG4B HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 NA NA NA
HSALNT0289894 HSALNG0142009 LINC00294 NA NA NA NA
HSALNT0289345 HSALNG0140599 LINC00893 NA NA pathogenic process hunter syndrome
HSALNT0290133 HSALNG0142248 PCBP3-OT1 PCBP3-OT1,FLJ44028 NA NA NA
HSALNT0289488 HSALNG0141599 BPESC1 NCRNA00187 NA pathogenic process blepharophimosis syndrome
HSALNT0289712 HSALNG0141827 COPG2IT1 CIT1,NCRNA00170,COPG2AS NA NA NA
HSALNT0265040 HSALNG0128978 LINC00652 HSPC072 NA developmental process NA
HSALNT0289282 HSALNG0108689 WASIR2 NCRNA00286A NA NA NA
HSALNT0246856 HSALNG0119601 LINC00470 C18orf2 NA pathogenic process age-related macular degeneration
HSALNT0289507 HSALNG0141618 LINC00588 C8orf71,DKFZP434F122 NA NA NA
HSALNT0276604 HSALNG0134754 TTC28-AS1 TTC28AS,TTC28-AS,KIAA1648 NA NA NA
HSALNT0237577 HSALNG0114754 CDRT7 NCRNA00025,LINC00025 NA NA NA
HSALNT0288912 HSALNG0114755 CDRT8 NA NA NA NA
HSALNT0275048 HSALNG0133887 CECR3 NA NA pathogenic process cat eye syndrome
HSALNT0288915 HSALNG0133890 CECR9 NA NA pathogenic process cat eye syndrome
HSALNT0288998 HSALNG0133878 HDHD5-AS1 CECR4,CECR5-AS1,NCRNA00017 NA pathogenic process cat eye syndrome
HSALNT0288914 HSALNG0133878 CECR5-AS1 NCRNA00017 NA pathogenic process cat eye syndrome
HSALNT0288919 HSALNG0029809 CLRN1-AS1 CLRN1O,UCRP NA pathogenic process usher syndrome type 3
HSALNT0289271 HSALNG0082585 TMEM9B-AS1 C11orf18 NA NA NA
HSALNT0289324 HSALNG0133586 LINC01547 C21orf69,C21orf67 NA pathogenic process Down syndrome
HSALNT0270409 HSALNG0131587 LINC00029 C20orf51,NCRNA00029,bA305P22.4 NA NA NA
HSALNT0289336 HSALNG0141634 LINC00529 C8orf8 NA pathogenic process keratolytic winter erythema
HSALNT0288978 HSALNG0010403 FLVCR1-AS1 FLVCR1-DT,LQK1 NA NA NA
HSALNT0238050 HSALNG0114969 SMCR2 NA NA pathogenic process Smith-Magenis syndrome
HSALNT0289401 HSALNG0114982 SMCR5 NCRNA00034 NA pathogenic process Smith-Magenis syndrome
HSALNT0290246 HSALNG0142361 SMCR6 NA NA pathogenic process Smith-Magenis syndrome
HSALNT0274626 HSALNG0133620 LINC00205 C21orf86,NCRNA00205, NA pathogenic process NA
HSALNT0271512 HSALNG0132117 C21orf91-OT1 NCRNA00285,D21S2089E NA NA NA
HSALNT0272596 HSALNG0132582 LINC00307 NCRNA00307,D21S2091E NA NA NA
HSALNT0274502 HSALNG0133549 TSPEAR-AS2 C21orf90 NA NA NA
HSALNT0274807 HSALNG0133721 MCM3AP-AS1 C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 NA NA NA
HSALNT0288888 HSALNG0133144 B3GALT5-AS1 C21orf88 NA NA NA
HSALNT0288898 HSALNG0133127 BRWD1-AS2 C21orf87,NCRNA00257,BRWD1-IT2 NA NA NA
HSALNT0289031 HSALNG0133621 LINC00315 C21orf93,NCRNA00315 NA NA NA
HSALNT0289033 HSALNG0133612 LINC00334 C21orf89,NCRNA00334 NA NA NA
HSALNT0289322 HSALNG0132477 LINC00314 C21orf94,NCRNA00314 NA NA NA
HSALNT0271821 HSALNG0132261 LINC00308 C21orf74,NCRNA00308,PRED16 NA pathogenic process NA
HSALNT0289023 HSALNG0132537 LINC00189 C21orf109,NCRNA00189 NA pathogenic process NA
HSALNT0289375 HSALNG0042788 NCRUPAR ncR-uPAR,ncRuPAR,NCRNA00193 transcriptional regulation developmental process NA
HSALNT0273467 HSALNG0133048 DSCR10 NA NA NA NA
HSALNT0289480 HSALNG0132984 DSCR9 NCRNA00038 NA NA NA
HSALNT0290051 HSALNG0142166 MDS2 NA NA pathogenic process myelodysplastic syndrome
HSALNT0127810 HSALNG0060777 ST7-AS2 ST7OT2,ST7AS2 NA pathogenic process autism
HSALNT0127813 HSALNG0060778 ST7-OT3 ST7OT3,NCRNA00026 NA pathogenic process autism
HSALNT0290258 HSALNG0142373 ST7-OT4 NA NA pathogenic process autism
HSALNT0290257 HSALNG0142372 ST7OT NONHSAT122926 NA NA NA
HSALNT0289372 HSALNG0074272 MIR600HG C9orf45,NCRNA00287,GL012,FLJ22161 NA NA NA
HSALNT0013239 HSALNG0006325 ATP1A1-AS1 C1orf203,ATP1A1OS,MGC16179 NA NA NA
HSALNT0048563 HSALNG0022910 SPATA3-AS1 NA NA NA NA
HSALNT0050859 HSALNG0024100 LINC00852 C3orf42,GHRLOS2,NAG73,GHRL-AS2 NA NA NA
HSALNT0069395 HSALNG0033002 LINC01096 NA NA NA NA
HSALNT0072367 HSALNG0034486 LINC02260 NA NA NA NA
HSALNT0077259 HSALNG0036896 LINC01091 NA NA NA NA
HSALNT0096480 HSALNG0046004 SAP30L-AS1 FLJ38109,GALNT10-AS1 NA NA NA
HSALNT0098558 HSALNG0046927 PRR7-AS1 NA NA NA NA
HSALNT0099356 HSALNG0047338 LINC01622 TCONS_00011202 NA NA NA
HSALNT0113415 HSALNG0053588 LINC01312 MGC34034 NA NA NA
HSALNT0134652 HSALNG0064240 EXTL3-AS1 C8orf50 NA NA NA
HSALNT0138253 HSALNG0065979 C8orf34-AS1 NA NA NA NA
HSALNT0154876 HSALNG0074139 PSMD5-AS1 NA NA NA NA
HSALNT0163228 HSALNG0078227 LINC01553 C10orf40,AC023904.2 NA NA NA
HSALNT0175689 HSALNG0084463 LINC00301 C11orf64,NCRNA00301,MGC39681 NA NA NA
HSALNT0247235 HSALNG0119722 DLGAP1-AS3 NA NA NA NA
HSALNT0254200 HSALNG0123001 CIRBP-AS1 C19orf23,MGC39338 NA NA NA
HSALNT0257335 HSALNG0124987 LINC01785 NA NA NA NA
HSALNT0261582 HSALNG0127139 LINC01869 MGC45922 NA NA NA
HSALNT0269743 HSALNG0131262 LINC01711 MGC4294 NA NA NA
HSALNT0288468 HSALNG0141311 FAM41AY1 FAM41AY NA NA NA
HSALNT0288899 HSALNG0045020 C5orf66-AS2 NA NA NA NA
HSALNT0288922 HSALNG0083517 CSTF3-AS1 CSTF3-DT NA NA NA
HSALNT0288923 HSALNG0014289 CYP1B1-AS1 C2orf58,MGC34824 NA NA NA
HSALNT0288957 HSALNG0025315 ENTPD3-AS1 FLJ36665 NA NA NA
HSALNT0288970 HSALNG0071511 FAM27E3 MGC42630 NA NA NA
HSALNT0288972 HSALNG0000046 FAM41C NA NA NA NA
HSALNT0288977 HSALNG0007223 FLG-AS1 NA NA NA NA
HSALNT0288983 HSALNG0105871 GABPB1-IT1 FLJ10038 NA NA NA
HSALNT0289010 HSALNG0123950 ILF3-AS1 ILF3-DT NA NA NA
HSALNT0289034 HSALNG0097943 LINC00347 NA NA NA NA
HSALNT0289039 HSALNG0004105 LINC00466 NA NA NA NA
HSALNT0289040 HSALNG0022951 LINC00471 C2orf52,MGC43122 NA NA NA
HSALNT0289044 HSALNG0119752 LINC00526 C18orf18,MGC17515,HsT959 NA NA NA
HSALNT0289048 HSALNG0106873 LINC00593 C15orf50,MGC42951 NA NA NA
HSALNT0289050 HSALNG0022320 LINC00608 NA NA NA NA
HSALNT0289054 HSALNG0104144 LINC00638 MGC23270 NA NA NA
HSALNT0289056 HSALNG0124410 LINC00661 NA NA NA NA
HSALNT0289057 HSALNG0125113 LINC00662 NA NA NA NA
HSALNT0289062 HSALNG0024755 LINC00692 NA NA NA NA
HSALNT0289064 HSALNG0075805 LINC00705 NA NA NA NA
HSALNT0289067 HSALNG0118878 LINC00868 C17orf52 NA NA NA
HSALNT0130693 HSALNG0062275 LINC00996 NA NA NA NA
HSALNT0289101 HSALNG0089327 LINC01252 NA NA NA NA
HSALNT0289131 HSALNG0113283 LINC02135 NA NA NA NA
HSALNT0289193 HSALNG0018445 NIFK-AS1 NA NA NA NA
HSALNT0289244 HSALNG0008972 SMG7-AS1 DKFZP564C196 NA NA NA
HSALNT0235326 HSALNG0113528 SNAI3-AS1 MGC23284 NA NA NA
HSALNT0215205 HSALNG0103442 SNHG10 C14orf62,FLJ40557,NCRNA00063,LINC00063 NA NA NA
HSALNT0289290 HSALNG0109122 ZNF205-AS1 MGC3771 NA NA NA
HSALNT0289294 HSALNG0009820 LINC00260 C1orf217,NCRNA00260,MGC5457 NA NA NA
HSALNT0289295 HSALNG0000511 LINC00337 C1orf211,NCRNA00337,MGC40168 NA NA NA
HSALNT0289298 HSALNG0076905 WAC-AS1 NA NA NA NA
HSALNT0289299 HSALNG0077486 LINC00839 NA NA NA NA
HSALNT0289303 HSALNG0089110 LINC00612 C12orf33,MGC40170,FLJ41814 NA NA NA
HSALNT0289312 HSALNG0124755 LINC00663 MGC39821 NA NA NA
HSALNT0289320 HSALNG0130611 LINC00494 NA NA NA NA
HSALNT0289330 HSALNG0039733 LINC01019 NA NA NA NA
HSALNT0289333 HSALNG0057380 LINC00265 NCRNA00265,NCRNA00265-1 NA NA NA
HSALNT0289334 HSALNG0062824 LINC00689 NA NA NA NA
HSALNT0289337 HSALNG0068847 LINC01591 NA NA NA NA
HSALNT0289340 HSALNG0072666 LINC01501 NA NA NA NA
HSALNT0289346 HSALNG0137712 LINC01560 CXorf24 NA NA NA
HSALNT0289352 HSALNG0045051 LINC01959 NA NA NA NA
HSALNT0289353 HSALNG0110333 LINC02175 NA NA NA NA
HSALNT0289354 HSALNG0064321 LINC02209 FAM183CP NA NA NA
HSALNT0289359 HSALNG0107406 LINGO1-AS1 NA NA NA NA
HSALNT0289362 HSALNG0119342 MAFG-AS1 MAFG-DT NA NA NA
HSALNT0289373 HSALNG0139326 MORF4L2-AS1 NA NA NA NA
HSALNT0289381 HSALNG0029035 NPHP3-AS1 NCRNA00119 NA NA NA
HSALNT0289385 HSALNG0062543 PAXIP1-AS1 NA NA NA NA
HSALNT0289413 HSALNG0082091 TOLLIP-AS1 NA NA NA NA
HSALNT0289416 HSALNG0113198 LINC00311 TMEM148,NCRNA00311,MGC22001 NA NA NA
HSALNT0289422 HSALNG0069500 ZNF252P-AS1 C8orf77 NA NA NA
HSALNT0289423 HSALNG0001624 ZNF436-AS1 C1orf213,FLJ90508 NA NA NA
HSALNT0289429 HSALNG0029047 BFSP2-AS1 MGC2848 NA NA NA
HSALNT0289432 HSALNG0032263 CTBP1-AS1 C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 NA NA NA
HSALNT0289436 HSALNG0039444 EXOC3-AS1 C5orf55 NA NA NA
HSALNT0289441 HSALNG0049246 HCG27 bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 NA NA NA
HSALNT0289450 HSALNG0067505 BAALC-AS2 C8orf56,BAALCOS,MGC39526 NA NA NA
HSALNT0289453 HSALNG0062877 FAM87A NA NA NA NA
HSALNT0289459 HSALNG0078365 JMJD1C-AS1 NA NA NA NA
HSALNT0289465 HSALNG0092957 ATP2B1-AS1 LINC00936 NA NA NA
HSALNT0289466 HSALNG0093183 CEP83-AS1 CEP83-DT NA NA NA
HSALNT0289470 HSALNG0107054 HEXA-AS1 C15orf34,FLJ13315 NA NA NA
HSALNT0289487 HSALNG0141598 BIN3-IT1 FLJ14107 NA NA NA
HSALNT0289490 HSALNG0141601 CSNK1G2-AS1 C19orf34,MGC39696 NA NA NA
HSALNT0289508 HSALNG0141619 LINC00634 NA NA NA NA
HSALNT0289510 HSALNG0141621 LINC00685 CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 NA NA NA
HSALNT0289515 HSALNG0141626 SHANK2-AS3 C11orf76 NA NA NA
HSALNT0290073 HSALNG0142188 NCBP2-AS2 NA NA NA NA
HSALNT0289502 HSALNG0141613 KCNIP4-IT1 NCRNA00099,UM9-5 NA NA NA
HSALNT0289856 HSALNG0141971 GTSCR1 NA NA pathogenic process Gilles de la Tourette syndrome
HSALNT0289325 HSALNG0008917 LINC00272 C1orf120,NCRNA00272,RP1-223H12.3 NA pathogenic process prostate cancer
HSALNT0288512 HSALNG0141348 TTTY9B NCRNA00132 NA NA NA
HSALNT0290155 HSALNG0142270 Prion-associated RNAs NA NA pathogenic process prion disease
HSALNT0289444 HSALNG0062567 BLACE NA NA pathogenic process acute B lymphoblastic leukemias
HSALNT0060411 HSALNG0028877 H1FX-AS1 C3orf47,FLJ34151 NA NA NA
HSALNT0186668 HSALNG0089868 LINC00477 C12orf67,FLJ32894,FAM191B NA NA NA
HSALNT0275096 HSALNG0133923 LINC00528 C22orf37,FLJ40542 NA NA NA
HSALNT0287824 HSALNG0140941 ASMTL-AS1 CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 NA NA NA
HSALNT0288887 HSALNG0106820 ANP32A-IT1 C15orf28,NCRNA00321,FLJ11722,HsT18971 NA NA NA
HSALNT0289370 HSALNG0010128 MIR29B2CHG C1orf132,FLJ35650 NA NA NA
HSALNT0289396 HSALNG0007497 RUSC1-AS1 C1orf104,FLJ35976 NA NA NA
HSALNT0084628 HSALNG0040236 LINC01194 CT49,TAG NA pathogenic process melanoma
HSALNT0289468 HSALNG0103838 DIO3OS C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 NA NA NA
HSALNT0121060 HSALNG0057178 NPSR1-AS1 AAA1,IMAGE:4827585 NA NA NA
HSALNT0074370 HSALNG0035535 LINC00575 C4orf11 NA pathogenic process NA
HSALNT0137345 HSALNG0065537 LINC01602 T1560 NA pathogenic process NA
HSALNT0289433 HSALNG0035768 FAM13A-AS1 FAM13A1OS,FAM13AOS,NCRNA00039 NA NA NA
HSALNT0289186 HSALNG0072891 MIRLET7DHG NA NA NA NA
HSALNT0155254 HSALNG0074353 MIR181A2HG NA NA NA NA
HSALNT0289283 HSALNG0035624 WDFY3-AS2 C4orf12,NCRNA00247,FBI4 NA NA NA
HSALNT0154555 HSALNG0073990 PAPPA-AS1 PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 NA NA NA
HSALNT0136307 HSALNG0065020 LINC00293 BEYLA NA developmental process NA
HSALNT0030983 HSALNG0014614 SIX3-AS1 SIX3OS NA developmental process NA
HSALNT0211503 HSALNG0101546 OTX2-AS1 OTX2OS1 NA developmental process NA
HSALNT0063422 HSALNG0030360 LINC01192 CT64 NA NA NA
HSALNT0217123 HSALNG0104394 LINC01193 CT60,LOC348120 NA NA NA
HSALNT0289664 HSALNG0141779 C1QTNF9B-AS1 PCOTH NA pathogenic process prostate cancer
HSALNT0289623 HSALNG0141738 ATP6V1G2-DDX39B NA NA pathogenic process dilated cardiomyopathy
HSALNT0289498 HSALNG0141609 FAM226B CXorf50B,NCRNA00246B,LINC00246B NA NA NA
HSALNT0289321 HSALNG0133590 LINC00163 C21orf134,NCRNA00163,NLC1-A,NLC1A NA pathogenic process narcolepsy
HSALNT0289505 HSALNG0141616 LINC00165 C21orf135,NCRNA00165,NLC1-B NA NA NA
HSALNT0290297 HSALNG0142412 TEA-ncRNAs ENSG00000251002 NA NA NA
HSALNT0274212 HSALNG0133403 LINC00322 C21orf136,NCRNA00322,FLJ16545 NA NA NA
HSALNT0289741 HSALNG0141856 DHFR upstream transcripts DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 transcriptional regulation NA NA
HSALNT0289527 HSALNG0141642 21A ncRNA 21A,NONHSAT128494 NA NA NA
HSALNT0289409 HSALNG0080181 TLX1NB TD1,TDI,APT-B7 NA pathogenic process leukemogenesis
HSALNT0289662 HSALNG0141777 C15orf2 NA NA pathogenic process Angelman syndrome
HSALNT0290097 HSALNG0142212 NPAP1 NA NA pathogenic process Angelman syndrome
HSALNT0217406 HSALNG0104530 PWRN2 NCRNA00199 NA pathogenic process Prader-Willi syndrome
HSALNT0289227 HSALNG0104528 PWRN1 NCRNA00198 NA pathogenic process Prader-Willi syndrome
HSALNT0262816 HSALNG0127793 MIMT1 MIM1,NCRNA00067,LINC00067 NA NA NA
HSALNT0289180 HSALNG0000682 MIR34AHG NA NA NA NA
HSALNT0289357 HSALNG0049203 LINC02570 XXbac-BPG27H4.8 NA pathogenic process MHC-associated diseases
HSALNT0290177 HSALNG0142292 RNY1 NA NA pathogenic process cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
HSALNT0289378 HSALNG0129114 NKX2-2-AS1 NKX2-2AS transcriptional regulation pathogenic process NA
HSALNT0290151 HSALNG0142266 PR antisense transcripts FJ515872.1,NONHSAT023851 transcriptional regulation NA NA
HSALNT0180290 HSALNG0086714 PGR-AS1,PR antisense transcripts AT1,AT2,AT3 NA NA NA
HSALNT0289607 HSALNG0141722 anti-NOS2A NA NA pathogenic process meningioma;glioblastoma
HSALNT0289687 HSALNG0141802 CDKN1A-AS1 p21NAT transcriptional regulation NA NA
HSALNT0289166 HSALNG0103805 MEG9 LINC00584 NA NA NA
HSALNT0116668 HSALNG0055114 RPS6KA2-AS1 NA NA pathogenic process breast cancer
HSALNT0289384 HSALNG0073983 PAPPA-AS2 AGU1 NA NA NA
HSALNT0262802 HSALNG0127785 ZIM2-AS1 ZIM2as NA NA NA
HSALNT0289824 HSALNG0141939 Evf2 Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 transcriptional regulation NA NA
HSALNT0289481 HSALNG0134495 ADORA2A-AS1 C22orf45,FLJ34651 NA NA NA
HSALNT0290146 HSALNG0142261 POU5F1P4 NA NA pathogenic process prostate cancer
HSALNT0290033 HSALNG0142148 LSINCT1 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290034 HSALNG0142149 LSINCT10 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290035 HSALNG0142150 LSINCT11 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290036 HSALNG0142151 LSINCT12 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290037 HSALNG0142152 LSINCT2 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290038 HSALNG0142153 LSINCT3 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290039 HSALNG0142154 LSINCT4 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290041 HSALNG0142156 LSINCT6 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290042 HSALNG0142157 LSINCT7 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290043 HSALNG0142158 LSINCT8 NA NA pathogenic process lung cancer;breast cancer
HSALNT0290044 HSALNG0142159 LSINCT9 NA NA pathogenic process lung cancer;breast cancer
HSALNT0289676 HSALNG0141791 CAR Intergenic 10 FLJ31066,NONHSAT016928,lnc-FANK1-3:1 transcriptional regulation NA NA
HSALNT0290032 HSALNG0142147 LRRC3DN C21orf30,DKFZP434C128 transcriptional regulation NA NA
HSALNT0266984 HSALNG0129985 SNHG11 C20orf198,LINC00101,NCRNA00101 NA pathogenic process obesity
HSALNT0289880 HSALNG0141995 KRASP1 NONHSAT113225,ENSG00000220635 ceRNA NA NA
HSALNT0006368 HSALNG0003376 CYP4A22-AS1 ncRNA-a3 transcriptional regulation NA NA
HSALNT0027470 HSALNG0013045 LINC00570 ncRNA-a5 transcriptional regulation NA NA
HSALNT0289066 HSALNG0003381 LINC00853 PDZK1IP1-AS1,ncRNA-a4 transcriptional regulation NA NA
HSALNT0289936 HSALNG0142051 lincRNA-ROR ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 NA NA NA
HSALNT0289705 HSALNG0141820 CHL1-AS2 NA NA pathogenic process adolescent idiopathic scoliosis
HSALNT0076084 HSALNG0036316 SEC24B-AS1 1/2-SBSRNA4 siRNA NA NA
HSALNT0290137 HSALNG0142252 PDZRN3-AS1 NA NA pathogenic process type 2 diabetes
HSALNT0290237 HSALNG0142352 SCAANT1 ATXN7-AS1 transcriptional regulation pathogenic process spinocerebellar ataxia
HSALNT0289594 HSALNG0141709 AK123790 NA NA pathogenic process hepatocelluar cancer
HSALNT0289911 HSALNG0142026 LINC01451 NA NA pathogenic process hepatocelluar cancer
HSALNT0290401 HSALNG0142516 ZNF350-AS1 NA NA pathogenic process hepatocelluar cancer
HSALNT0289845 HSALNG0141960 GADD45G NA NA pathogenic process pituitary adenoma
HSALNT0289410 HSALNG0043357 TMEM161B-AS1 AK082072,linc-POLR3G-8,ENSG00000247828 NA NA NA
HSALNT0289736 HSALNG0141851 DAPK1 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290048 HSALNG0142163 MAP3K14 MAP3K14 NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290150 HSALNG0142265 PPP3CB NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0151531 HSALNG0072477 DAPK1-IT1 NA NA pathogenic process NA
HSALNT0288990 HSALNG0041256 GDNF-AS1 GDNFOS transcriptional regulation pathogenic process Alzheimer's disease
HSALNT0029702 HSALNG0014093 BIRC6-AS2 megamind NA developmental process NA
HSALNT0029692 HSALNG0014085 BIRC6-AS1 NA NA NA NA
HSALNT0289310 HSALNG0116623 LINC00854 NA NA NA NA
HSALNT0290332 HSALNG0142447 uc.73 NA NA pathogenic process colorectal cancer
HSALNT0289841 HSALNG0141956 FR0257520 NA NA pathogenic process prostate cancer
HSALNT0290104 HSALNG0142219 NRG1 NA NA pathogenic process lung cancer
HSALNT0289689 HSALNG0141804 CDKN2B-AS11 NA NA pathogenic process;developmental process stroke
HSALNT0289690 HSALNG0141805 CDKN2B-AS12 NA NA pathogenic process glioma
HSALNT0289691 HSALNG0141806 CDKN2B-AS13 NA NA pathogenic process plexiform neurofibroma
HSALNT0289697 HSALNG0141812 CDKN2B-AS7 NA NA pathogenic process acute lymphoblastic leukemia
HSALNT0289826 HSALNG0141941 FADS1 NA NA pathogenic process lipid metabolism disorder
HSALNT0289698 HSALNG0141813 CDKN2B-AS8 NA NA pathogenic process melanoma
HSALNT0289696 HSALNG0141811 CDKN2B-AS6 NA NA pathogenic process neuroblastoma
HSALNT0289699 HSALNG0141814 CDKN2B-AS9 NA NA pathogenic process prostate cancer
HSALNT0289688 HSALNG0141803 CDKN2B-AS10 NA NA pathogenic process stroke
HSALNT0288950 HSALNG0031716 ENST00000456816 NA NA pathogenic process clear cell renal cell cancer
HSALNT0290021 HSALNG0142136 LOC389332 NA NA pathogenic process clear cell renal cell cancer
HSALNT0290306 HSALNG0142421 TMEM72 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289641 HSALNG0141756 BC029135 NA NA pathogenic process renal clear cell cancer
HSALNT0290374 HSALNG0142489 X91348 NA NA pathogenic process renal clear cell cancer
HSALNT0289694 HSALNG0141809 CDKN2B-AS4 NA NA pathogenic process cancer
HSALNT0289692 HSALNG0141807 CDKN2B-AS2 NA NA pathogenic process coronary heart disease
HSALNT0289693 HSALNG0141808 CDKN2B-AS3 NA NA pathogenic process intracranial aneurysm
HSALNT0289695 HSALNG0141810 CDKN2B-AS5 NA NA pathogenic process type 2 diabetes
HSALNT0290319 HSALNG0142434 T-UCRs NA NA pathogenic process neuroblastoma
HSALNT0289530 HSALNG0141645 51A NA splicing regulation pathogenic process Alzheimer's disease
HSALNT0290163 HSALNG0142278 RAB4B-EGLN2 NA NA pathogenic process cancer
HSALNT0290167 HSALNG0142282 RERT NA NA pathogenic process hepatocellular cancer
HSALNT0265263 HSALNG0129088 LINC00237 NCRNA00237 NA pathogenic process macrocephaly;obesity
HSALNT0267186 HSALNG0130081 LINC01370 HI-LNC25,HILNC25 NA pathogenic process type 2 diabetes
HSALNT0289114 HSALNG0046884 LINC01574 HI-LNC12,TCONS_00009551 NA pathogenic process type 2 diabetes
HSALNT0290159 HSALNG0142274 PTHLH NA NA pathogenic process brachydactyly
HSALNT0189394 HSALNG0091306 CISTR CISTR-ACT,CISTRACT,re52431 transcriptional regulation pathogenic process brachydactyly
HSALNT0289862 HSALNG0141977 HELLPAR LINC-HELLP NA pathogenic process HELLP syndrome
HSALNT0289904 HSALNG0142019 LINC01125 NA NA pathogenic process uremia
HSALNT0289544 HSALNG0141659 AC002511.1 LINC01531 NA pathogenic process enterovirus 71 infection
HSALNT0289609 HSALNG0141724 AP000688.29 AP000688.2 NA pathogenic process enterovirus 71 infection
HSALNT0289832 HSALNG0141947 FFAR2 NA NA pathogenic process enterovirus 71 infection
HSALNT0290222 HSALNG0142337 RP4-620F22.3 AC099063.2 NA pathogenic process enterovirus 71 infection
HSALNT0290227 HSALNG0142342 RP5-843L14.1 LINC01716 NA pathogenic process enterovirus 71 infection
HSALNT0287285 HSALNG0140617 MAGEA8-AS1 RP5-869M20.2 NA NA NA
HSALNT0289019 HSALNG0094159 LHX5-AS1 locus4010 NA NA NA
HSALNT0288902 HSALNG0023597 CAPN10-AS1 CAPN10-DT,locus959 NA NA NA
HSALNT0289404 HSALNG0076463 STAM-AS1 locus3182 NA NA NA
HSALNT0148276 HSALNG0070806 PTENP1-AS PTENpg1-asRNA transcriptional regulation NA NA
HSALNT0289562 HSALNG0141677 AF116616 NA NA pathogenic process osteosarcoma
HSALNT0289589 HSALNG0141704 AK094838 NA NA pathogenic process osteosarcoma
HSALNT0289620 HSALNG0141735 ASLNC00339 NA NA pathogenic process osteosarcoma
HSALNT0289629 HSALNG0141744 BC002350 NA NA pathogenic process osteosarcoma
HSALNT0289651 HSALNG0141766 BC091525 NA NA pathogenic process osteosarcoma
HSALNT0289652 HSALNG0141767 BE503655 NA NA pathogenic process osteosarcoma
HSALNT0289753 HSALNG0141868 ENO1 NA NA pathogenic process osteosarcoma
HSALNT0289835 HSALNG0141950 FKBP10 NA NA pathogenic process osteosarcoma
HSALNT0290064 HSALNG0142179 MYHAS NA NA pathogenic process osteosarcoma
HSALNT0289985 HSALNG0142100 LncRNA-LALR1 NA transcriptional regulation pathogenic process liver cancer
HSALNT0289934 HSALNG0142049 lincRNA-LALR1 NA transcriptional regulation pathogenic process NA
HSALNT0091577 HSALNG0043527 NR2F1-AS1 FLJ42709 NA NA NA
HSALNT0289709 HSALNG0141824 CK19 NA NA pathogenic process breast cancer
HSALNT0289943 HSALNG0142058 Llme23 NA NA pathogenic process melanoma
HSALNT0289553 HSALNG0141668 AC096655.1 NA NA pathogenic process gastric cancer
HSALNT0289178 HSALNG0137593 MIR222HG Lnc-Ang362 NA pathogenic process Ang II-associated cardiovascular disease
HSALNT0289261 HSALNG0032541 STX18-AS1 LOC100507266 NA pathogenic process atrial septal defect
HSALNT0289849 HSALNG0141964 GHSR NA NA pathogenic process non-small cell lung cancer
HSALNT0289850 HSALNG0141965 GHSROS NA NA pathogenic process non-small cell lung cancer
HSALNT0289210 HSALNG0072923 PCAT7 PCAN-R2 NA pathogenic process prostate cancer
HSALNT0289702 HSALNG0141817 CES1P1 NA NA pathogenic process non-small cell lung cancer
HSALNT0289892 HSALNG0142007 LINC00210 NA NA pathogenic process non-small cell lung cancer
HSALNT0290006 HSALNG0142121 LOC100506974 NA NA pathogenic process non-small cell lung cancer
HSALNT0290219 HSALNG0142334 RP3-508I15.14 NA NA pathogenic process non-small cell lung cancer
HSALNT0290243 HSALNG0142358 SLC6A6 NA NA pathogenic process non-small cell lung cancer
HSALNT0290342 HSALNG0142457 uc003bgl.1 NA NA pathogenic process non-small cell lung cancer
HSALNT0289075 HSALNG0008302 LINC00970 NA NA pathogenic process non-small cell lung cancer
HSALNT0211868 HSALNG0101725 SALRNA1 SAL-RNA1,XLOC_023166 NA developmental process NA
HSALNT0222267 HSALNG0106957 SALRNA3 SAL-RNA3,XLOC_025918 NA developmental process NA
HSALNT0222274 HSALNG0106960 SALRNA2 SAL-RNA2,XLOC_025931 NA developmental process NA
HSALNT0289428 HSALNG0021790 GPR1-AS GPR1-AS1,GPR1AS transcriptional regulation NA NA
HSALNT0226207 HSALNG0108743 LINC00235 NA NA pathogenic process anorexia nervosa
HSALNT0289526 HSALNG0141641 1B FGF-antisense transcripts NA NA pathogenic process endometriosis
HSALNT0290171 HSALNG0142286 RNA polymerase III-dependent lncRNAs NA NA pathogenic process diffuse cerebral hypomyelination
HSALNT0290168 HSALNG0142283 REST/CoREST-regulated lncRNAs NA NA pathogenic process Huntington disease
HSALNT0289606 HSALNG0141721 Alu lncRNAs NA NA pathogenic process macular degeneration
HSALNT0290358 HSALNG0142473 UCH1LAS NA NA pathogenic process Parkinson's disease
HSALNT0290244 HSALNG0142359 SLC7A2-IT1A/B NA NA pathogenic process progressive encephalopathy with severe infantile anorexia
HSALNT0289877 HSALNG0141992 Kcna2-AS NA NA pathogenic process neuropathic pain
HSALNT0289191 HSALNG0053305 NCOA7-AS1 NA NA pathogenic process NA
HSALNT0290020 HSALNG0142135 LOC389023 NA transcriptional regulation pathogenic process psychiatric disease
HSALNT0175124 HSALNG0084108 PTPRJ-AS1 NA transcriptional regulation NA NA
HSALNT0289654 HSALNG0141769 BM742401 NA NA pathogenic process gastric cancer
HSALNT0289331 HSALNG0049950 LINC00951 lincRNA-uc003opf.1,FLJ41649 NA pathogenic process esophageal squamous cell cancer
HSALNT0290130 HSALNG0142245 PAWR NA NA pathogenic process acute lymphoblastic leukemia
HSALNT0290264 HSALNG0142379 T-ALL-R-LncR1 NA NA pathogenic process acute lymphoblastic leukemia
HSALNT0289599 HSALNG0141714 AK130977 NA NA pathogenic process malignant pleural mesothelioma
HSALNT0289625 HSALNG0141740 AX746718 NA NA pathogenic process malignant pleural mesothelioma
HSALNT0289738 HSALNG0141853 DDR2 NA NA pathogenic process malignant pleural mesothelioma
HSALNT0290003 HSALNG0142118 LOC100131831 NA NA pathogenic process malignant pleural mesothelioma
HSALNT0290144 HSALNG0142259 POT1-AS1 NA NA pathogenic process malignant pleural mesothelioma
HSALNT0290253 HSALNG0142368 SNORA17B NA NA pathogenic process malignant pleural mesothelioma
HSALNT0207421 HSALNG0099625 GAS6-AS1 NA NA pathogenic process non-small cell lung cancer
HSALNT0289838 HSALNG0141953 FMR5 NA NA pathogenic process fragile X syndrome
HSALNT0208907 HSALNG0100287 FOXG1-AS1 FOXG1-AS NA pathogenic process autism spectrum disorder
HSALNT0290263 HSALNG0142378 SYNGAP1-AS1 SYNGAP1-AS NA pathogenic process autism spectrum disorder
HSALNT0290176 HSALNG0142291 RNase MRP NA NA pathogenic process cartilage hair hypoplaisia
HSALNT0289469 HSALNG0105872 GABPB1-AS1 NA NA pathogenic process NA
HSALNT0289009 HSALNG0075528 IDI2-AS1 C10orf110,IDI2-A,HT009,Em:AC022536.4 NA NA NA
HSALNT0289093 HSALNG0044716 LINC01184 FLJ33630 NA NA NA
HSALNT0290108 HSALNG0142223 OGT NA NA pathogenic process colorectal cancer
HSALNT0290077 HSALNG0142192 ncNRFR NA transcriptional regulation pathogenic process colorectal cancer
HSALNT0290337 HSALNG0142452 uc001lsz NA NA pathogenic process gastric cancer;prostate cancer;liver cancer;lung cancer
HSALNT0289087 HSALNG0021008 LINC01090 NA NA pathogenic process post-traumatic stress disorder
HSALNT0289746 HSALNG0141861 DQ786227 NA NA pathogenic process lung cancer
HSALNT0289981 HSALNG0142096 lncRNA-DQ786227 NA NA pathogenic process lung cancer
HSALNT0289876 HSALNG0141991 JADRR LINC00915,lncRNA-JADE transcriptional regulation pathogenic process breast cancer
HSALNT0290254 HSALNG0142369 SOX2OT-S1 NA NA pathogenic process esophageal squamous cell cancer
HSALNT0290404 HSALNG0142519 SOX2OT-S2 NA NA pathogenic process NA
HSALNT0289870 HSALNG0141985 HOXA13 NA NA pathogenic process hepatocelluar cancer
HSALNT0078946 HSALNG0037661 SMAD1-AS1 ENST00000513542 NA pathogenic process ventricular septal defects
HSALNT0087329 HSALNG0041545 FGF10-AS1 RP11-473L15.2 transcriptional regulation pathogenic process ventricular septal defects
HSALNT0290318 HSALNG0142433 TUC339 NA NA pathogenic process hepatocellular cancer
HSALNT0289819 HSALNG0141934 ERICD LINC01130,TCONS_00014875,ERIC transcriptional regulation pathogenic process retinoblastoma
HSALNT0289615 HSALNG0141730 ARA NA NA pathogenic process cancer
HSALNT0289822 HSALNG0141937 ESCCAL-5 NA NA pathogenic process esophageal squamous cell cancer
HSALNT0290074 HSALNG0142189 ncC11orf49 NA NA pathogenic process renal cell cancer
HSALNT0290076 HSALNG0142191 ncHDAC5 NA NA pathogenic process renal cell cancer
HSALNT0290078 HSALNG0142193 ncRAB31 NA NA pathogenic process renal cell cancer
HSALNT0290080 HSALNG0142195 ncSRPK1 NA NA pathogenic process renal cell cancer
HSALNT0018253 HSALNG0008819 OVAAL LINC01131,OVAL NA pathogenic process ovarian cancer
HSALNT0289884 HSALNG0141999 LALR NA transcriptional regulation pathogenic process hepatocelluar cancer
HSALNT0289701 HSALNG0141816 CEACAMP8 CEACAMP8 NA pathogenic process pre-eclampsia
HSALNT0290018 HSALNG0142133 LOC284100 NA NA pathogenic process pre-eclampsia
HSALNT0290023 HSALNG0142138 LOC391533 NA NA pathogenic process pre-eclampsia
HSALNT0189558 HSALNG0091365 LINC01154 NA NA NA NA
HSALNT0196616 HSALNG0094870 THRIL BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 transcriptional regulation pathogenic process Kawasaki disease
HSALNT0289235 HSALNG0098080 RNF219-AS1 NA NA pathogenic process blood pressure
HSALNT0289561 HSALNG0141676 AF086415 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289583 HSALNG0141698 AK056098 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289590 HSALNG0141705 AK095147 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289600 HSALNG0141715 AK294004 NA transcriptional regulation pathogenic process nasopharyngeal cancer
HSALNT0289612 HSALNG0141727 AP5M1 NA NA pathogenic process nasopharyngeal cancer
HSALNT0290110 HSALNG0142225 ORAOV1 NA NA pathogenic process nasopharyngeal cancer
HSALNT0290210 HSALNG0142325 RP1-179N16.3 Z95152.1 NA pathogenic process nasopharyngeal cancer
HSALNT0037026 HSALNG0017545 LINC01159 linc-Brn1b NA developmental process NA
HSALNT0289014 HSALNG0137988 KANTR KDM5C adjacent non-coding transcript NA developmental process NA
HSALNT0289905 HSALNG0142020 LINC01157 TCONS_00010378,linc-Enc1 NA developmental process NA
HSALNT0289460 HSALNG0087416 APOA1-AS NA transcriptional regulation NA NA
HSALNT0290400 HSALNG0142515 ZNF300P1 ZNF300P1 NA pathogenic process ovarian cancer
HSALNT0289750 HSALNG0141865 EEF1A1P9 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289796 HSALNG0141911 ENST00000318333 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289797 HSALNG0141912 ENST00000374520 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289800 HSALNG0141915 ENST00000422362 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289808 HSALNG0141923 ENST00000455912 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289809 HSALNG0141924 ENST00000456007 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289810 HSALNG0141925 ENST00000456185 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289817 HSALNG0141932 EPOR NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289913 HSALNG0142028 LINC01550 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0290142 HSALNG0142257 PMS2P5 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0290269 HSALNG0142384 TCF7 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0290345 HSALNG0142460 uc003jfz.2 NA NA pathogenic process gastric cardia adenocarcinoma
HSALNT0289095 HSALNG0018112 LINC01191 VIN,lnc-ACTR3 transcriptional regulation pathogenic process influenza A virus
HSALNT0288976 HSALNG0140165 FIRRE LINC01200 transcriptional regulation NA NA
HSALNT0289097 HSALNG0046284 LINC01202 NA NA NA NA
HSALNT0290271 HSALNG0142386 TCONS_00014512 NA NA pathogenic process hepatoblastoma
HSALNT0290272 HSALNG0142387 TCONS_00014978 NA NA pathogenic process hepatoblastoma
HSALNT0290274 HSALNG0142389 TCONS_00024647 NA NA pathogenic process hepatoblastoma
HSALNT0290279 HSALNG0142394 TCONS_00090092_MEG3 NA NA pathogenic process hepatoblastoma
HSALNT0290280 HSALNG0142395 TCONS_l2_00000179 NA NA pathogenic process hepatoblastoma
HSALNT0290283 HSALNG0142398 TCONS_l2_00004424 NA NA pathogenic process hepatoblastoma
HSALNT0290284 HSALNG0142399 TCONS_l2_00006843 NA NA pathogenic process hepatoblastoma
HSALNT0290289 HSALNG0142404 TCONS_l2_00014091 NA NA pathogenic process hepatoblastoma
HSALNT0290291 HSALNG0142406 TCONS_l2_00018070 NA NA pathogenic process hepatoblastoma
HSALNT0290292 HSALNG0142407 TCONS_l2_00020565 NA NA pathogenic process hepatoblastoma
HSALNT0290293 HSALNG0142408 TCONS_l2_00021262 NA NA pathogenic process hepatoblastoma
HSALNT0290296 HSALNG0142411 TCONS_l2_00030560 NA NA pathogenic process hepatoblastoma
HSALNT0289927 HSALNG0142042 lincRNA1611 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290149 HSALNG0142264 Ppp3ca NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290265 HSALNG0142380 TC0100223 NA NA pathogenic process epithelial ovarian cancer
HSALNT0290267 HSALNG0142382 TC0101686 NA NA pathogenic process epithelial ovarian cancer
HSALNT0290268 HSALNG0142383 TC1500845 NA NA pathogenic process ovarian cancer
HSALNT0289318 HSALNG0128589 LAMP5-AS1 NA NA pathogenic process acute lymphoblastic leukemia
HSALNT0234022 HSALNG0112916 LINC01228 lincRNA-DYNLRB2-2 NA pathogenic process NA
HSALNT0162654 HSALNG0077963 SGMS1-AS1 NA NA pathogenic process NA
HSALNT0289206 HSALNG0126202 PCAT19 LOC100505495,LINC01190 NA pathogenic process prostate cancer
HSALNT0289521 HSALNG0115583 ABHD15-AS1 linc-TP53I13,lnc-TP53I13 NA pathogenic process cardiometabolic disease
HSALNT0289100 HSALNG0069570 LINC01230 linc-DMRT2,lnc-DRMT2,TCONS_00015639 NA pathogenic process cardiometabolic disease
HSALNT0249183 HSALNG0120583 PCAT18 LINC01092 NA pathogenic process prostate cancer
HSALNT0290029 HSALNG0142144 LOC728606 NA NA pathogenic process prostate cancer
HSALNT0288956 HSALNG0094171 ENST00000547963.1 NA NA pathogenic process esophageal squamous cell cancer
HSALNT0289802 HSALNG0141917 ENST00000435885 NA NA pathogenic process oesophageal squamous cell cancer
HSALNT0205898 HSALNG0098920 LINC01232 FLJ41590,TCONS_00021520 NA pathogenic process NA
HSALNT0257311 HSALNG0124979 LINC01233 XLOC_013014 NA pathogenic process NA
HSALNT0183247 HSALNG0088110 SENCR FLI1-AS1 NA pathogenic process vascular SMC phenotype
HSALNT0289296 HSALNG0010286 LINC00467 C1orf97,MGC14801 NA pathogenic process neuroblastoma
HSALNT0143586 HSALNG0068435 CASC21 LINC01244,CARLo-2 NA pathogenic process NA
HSALNT0288906 HSALNG0068424 CASC19 LINC01245,CARLo-6 NA pathogenic process NA
HSALNT0289754 HSALNG0141869 ENSG00000135253.9 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289755 HSALNG0141870 ENSG00000147753.5 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289756 HSALNG0141871 ENSG00000196096 AC079610.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289757 HSALNG0141872 ENSG00000197251.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289758 HSALNG0141873 ENSG00000203325 AL445248.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289759 HSALNG0141874 ENSG00000206129 AC006305.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289760 HSALNG0141875 ENSG00000215231.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289761 HSALNG0141876 ENSG00000215374.4 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289762 HSALNG0141877 ENSG00000215808.2 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289763 HSALNG0141878 ENSG00000226496.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289764 HSALNG0141879 ENSG00000229563.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289765 HSALNG0141880 ENSG00000230133.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289766 HSALNG0141881 ENSG00000230544.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289767 HSALNG0141882 ENSG00000231133.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289768 HSALNG0141883 ENSG00000231185 AC010317.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289769 HSALNG0141884 ENSG00000232021.2 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289770 HSALNG0141885 ENSG00000232046.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289771 HSALNG0141886 ENSG00000232956.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289772 HSALNG0141887 ENSG00000233154.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289773 HSALNG0141888 ENSG00000233251 AC007743.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289774 HSALNG0141889 ENSG00000235285.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289775 HSALNG0141890 ENSG00000237036.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289776 HSALNG0141891 ENSG00000237548.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289777 HSALNG0141892 ENSG00000240453.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289778 HSALNG0141893 ENSG00000241269.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289779 HSALNG0141894 ENSG00000245910.3 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289780 HSALNG0141895 ENSG00000248176 AC109349.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289781 HSALNG0141896 ENSG00000249364 AC112206.2 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289782 HSALNG0141897 ENSG00000249772 AC026427.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289783 HSALNG0141898 ENSG00000250195 AC109927.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289784 HSALNG0141899 ENSG00000250608 AC010210.1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289785 HSALNG0141900 ENSG00000254154 AL359075.2 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289786 HSALNG0141901 ENSG00000255471 AP001528.2 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289787 HSALNG0141902 ENSG00000256218 AC007848.2 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289788 HSALNG0141903 ENSG00000259150.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289789 HSALNG0141904 ENSG00000259334.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289790 HSALNG0141905 ENSG00000259484.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289791 HSALNG0141906 ENSG00000259758.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289793 HSALNG0141908 ENSG00000263753.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289794 HSALNG0141909 ENSG00000264772 AC016876.2 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289795 HSALNG0141910 ENSG00000266952.1 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289828 HSALNG0141943 FAM66B FAM66E NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289895 HSALNG0142010 LINC00336 C6orf227,NCRNA00336 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289899 HSALNG0142014 LINC00929 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289906 HSALNG0142021 LINC01204 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289912 HSALNG0142027 LINC01538 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289915 HSALNG0142030 LINC01721 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289916 HSALNG0142031 LINC01762 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289917 HSALNG0142032 LINC01798 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0290247 HSALNG0142362 SMIM2-IT1 C13orf44-IT1 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0290316 HSALNG0142431 TTTY7 CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289872 HSALNG0141987 HTTAS_v1 NA transcriptional regulation pathogenic process Huntington disease
HSALNT0290175 HSALNG0142290 RNA-a NA transcriptional regulation pathogenic process Opitz-Kaveggia syndrome
HSALNT0289525 HSALNG0141640 116HG NA transcriptional regulation pathogenic process Prader-Willi syndrome
HSALNT0290320 HSALNG0142435 U1 spliceosomal lncRNA NA NA pathogenic process Parkinson's disease
HSALNT0289102 HSALNG0039360 LINC01262 TCONS_l2_00021807,RP11-462G22.1 ceRNA pathogenic process Parkinson's disease
HSALNT0289681 HSALNG0141796 CCAT1-L NA transcriptional regulation pathogenic process colorectal cancer
HSALNT0290062 HSALNG0142177 MT-LIPCAR uc022bqs.1,LIPCAR NA pathogenic process heart disease
HSALNT0289941 HSALNG0142056 LIPCAR NA NA pathogenic process heart failure
HSALNT0200965 HSALNG0096756 TUSC8 LINC01071,XLOC_010588 NA pathogenic process cervical cancer
HSALNT0161787 HSALNG0077519 LINC01264 RP11-124O11.2 NA pathogenic process breast cancer
HSALNT0289733 HSALNG0141848 D4Z4 NA NA pathogenic process;developmental process facioscapulohumeral muscular dystrophy
HSALNT0289678 HSALNG0141793 CARL NA ceRNA pathogenic process myocardial infarction
HSALNT0289923 HSALNG0142038 linc-CBR1-2 NA NA pathogenic process lung cancer
HSALNT0243354 HSALNG0117819 WFDC21P WAP four-disulfide core domain 21,pseudogene transcriptional regulation pathogenic process DC dysfunction
HSALNT0290232 HSALNG0142347 RUNX1 NA NA pathogenic process acute myeloid leukemia
HSALNT0290234 HSALNG0142349 RUNXOR NA NA pathogenic process hematopoietic malignancies
HSALNT0289979 HSALNG0142094 lncRNA-CIR NA NA pathogenic process osteoarthritis
HSALNT0290368 HSALNG0142483 VIM2P NA NA pathogenic process osteoarthritis
HSALNT0289879 HSALNG0141994 KRAS1P NA NA pathogenic process cancer
HSALNT0290054 HSALNG0142169 MINA NA NA pathogenic process esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer
HSALNT0289270 HSALNG0117279 TMEM92-AS1 RP11-893F2.9,lncRNA-508851,TCONS_00025237 NA pathogenic process hepatocellular cancer
HSALNT0288900 HSALNG0054937 CAHM LINC00468 NA pathogenic process colorectal cancer
HSALNT0289593 HSALNG0141708 AK123657 NA NA pathogenic process colorectal cancer
HSALNT0289659 HSALNG0141774 BX648207 NA NA pathogenic process colorectal cancer
HSALNT0289660 HSALNG0141775 BX649059 NA NA pathogenic process colorectal cancer
HSALNT0289846 HSALNG0141961 GAS2L3 NA NA pathogenic process colorectal cancer
HSALNT0289633 HSALNG0141748 BC011663 NA NA pathogenic process gastric cancer
HSALNT0289867 HSALNG0141982 HIV1230 NA NA pathogenic process gastric cancer
HSALNT0290045 HSALNG0142160 M14574 NA NA pathogenic process gastric cancer
HSALNT0290245 HSALNG0142360 SLCO5A1 NA NA pathogenic process gastric cancer
HSALNT0290326 HSALNG0142441 uc.341 NA NA pathogenic process gastric cancer
HSALNT0290344 HSALNG0142459 uc003iqu NA NA pathogenic process gastric cancer
HSALNT0290346 HSALNG0142461 uc003tfx NA NA pathogenic process gastric cancer
HSALNT0289950 HSALNG0142065 lnc-AL355149.1-1 NA NA pathogenic process nasopharyngeal cancer
HSALNT0290001 HSALNG0142116 lnc-ZNF674-1 NA NA pathogenic process nasopharyngeal cancer
HSALNT0286909 HSALNG0140423 LINC00632 NA NA pathogenic process gastric cancer
HSALNT0289105 HSALNG0014134 LINC01317 NA NA NA NA
HSALNT0234804 HSALNG0113279 LINC01081 TCONS_00024764 transcriptional regulation pathogenic process alveolar capillary dysplasia
HSALNT0289840 HSALNG0141955 FOSB NA NA pathogenic process hepatocelluar cancer
HSALNT0289587 HSALNG0141702 AK093543 NA NA pathogenic process hepatocellular cancer
HSALNT0289732 HSALNG0141847 D16366 NA NA pathogenic process hepatocellular cancer
HSALNT0289814 HSALNG0141929 ENST00000501583 NA NA pathogenic process hepatocellular cancer
HSALNT0290273 HSALNG0142388 TCONS_00018278 NA NA pathogenic process hepatocellular cancer
HSALNT0289907 HSALNG0142022 LINC01374 TCONS_00018278 NA pathogenic process NA
HSALNT0231106 HSALNG0111452 CASC22 LINC01373,TCONS_00024290,LincRNA-ENST00000515084 NA pathogenic process breast cancer
HSALNT0058246 HSALNG0027843 LINC00882 NA ceRNA pathogenic process airway diseases
HSALNT0018288 HSALNG0008840 KIAA1614-AS1 RP11-46A10.4 ceRNA pathogenic process airway smooth muscle (ASM) disease
HSALNT0142310 HSALNG0067913 LINC00536 NA NA pathogenic process trichorhinophalangeal syndrome
HSALNT0034200 HSALNG0016063 LBX2-AS1 NA NA pathogenic process renal cell cancer
HSALNT0149799 HSALNG0071679 ENST00000414223 NA NA pathogenic process renal cell cancer
HSALNT0290012 HSALNG0142127 LOC105374631 NA NA pathogenic process renal cell cancer
HSALNT0290305 HSALNG0142420 TMEM179 NA NA pathogenic process renal cell cancer
HSALNT0290315 HSALNG0142430 TSPAN8 NA NA pathogenic process renal cell cancer
HSALNT0290334 HSALNG0142449 uc001aka.2 NA NA pathogenic process renal cell cancer
HSALNT0290339 HSALNG0142454 uc001vjj.1 NA NA pathogenic process renal cell cancer
HSALNT0290343 HSALNG0142458 uc003erl.1 NA NA pathogenic process renal cell cancer
HSALNT0290354 HSALNG0142469 uc009wkz.1 NA NA pathogenic process renal cell cancer
HSALNT0027893 HSALNG0013204 MYCNUT MYCNUN,lncUSMycN NA pathogenic process neuroblastoma
HSALNT0273205 HSALNG0132900 LINC01436 AP000688.8 NA pathogenic process Down syndrome
HSALNT0266116 HSALNG0129435 MIR663AHG RP3-410C9.1 NA pathogenic process turner syndrome
HSALNT0289108 HSALNG0080498 LINC01435 RP11-215N21.1,TCONS_00018040 NA pathogenic process NA
HSALNT0289674 HSALNG0141789 CADM3-AS1 NA NA pathogenic process bladder cancer
HSALNT0289882 HSALNG0141997 KRT19P3 NA NA pathogenic process bladder cancer
HSALNT0290310 HSALNG0142425 TNXA NA NA pathogenic process bladder cancer
HSALNT0008750 HSALNG0004412 ZRANB2-AS2 NA NA NA NA
HSALNT0289745 HSALNG0141860 DMTF1 NA NA pathogenic process gastric cancer
HSALNT0290059 HSALNG0142174 MRUL NA transcriptional regulation pathogenic process gastric cancer
HSALNT0185163 HSALNG0089050 FAM66C NA NA NA NA
HSALNT0289476 HSALNG0132414 CYYR1-AS1 NA NA NA NA
HSALNT0289535 HSALNG0141650 AA174084 NA NA pathogenic process gastric cancer
HSALNT0266298 HSALNG0129511 ABALON INXS splicing regulation pathogenic process renal cell cancer
HSALNT0290370 HSALNG0142485 VTRNA2-1 CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a NA pathogenic process gastric cancer
HSALNT0289619 HSALNG0141734 ASK00420 NA NA pathogenic process cervical cancer
HSALNT0289749 HSALNG0141864 EBIC NA transcriptional regulation pathogenic process cervical cancer
HSALNT0290299 HSALNG0142414 TI09485 NA NA pathogenic process cervical cancer
HSALNT0290300 HSALNG0142415 TI10124 NA NA pathogenic process cervical cancer
HSALNT0290301 HSALNG0142416 TI13831 NA NA pathogenic process cervical cancer
HSALNT0290302 HSALNG0142417 TI18318 NA NA pathogenic process cervical cancer
HSALNT0290303 HSALNG0142418 TI21327 NA NA pathogenic process cervical cancer
HSALNT0290304 HSALNG0142419 TI22687 NA NA pathogenic process cervical cancer
HSALNT0290307 HSALNG0142422 TMPOP2 NA transcriptional regulation pathogenic process cervical cancer
HSALNT0289570 HSALNG0141685 AK021444 NA NA pathogenic process colorectal cancer
HSALNT0289601 HSALNG0141716 AK307796 NA NA pathogenic process colorectal cancer
HSALNT0289801 HSALNG0141916 ENST00000425785 SEC63P1 NA pathogenic process colorectal cancer
HSALNT0289871 HSALNG0141986 HOXB-AS3 NA NA pathogenic process colorectal cancer
HSALNT0290367 HSALNG0142482 URHC NA NA pathogenic process hepatocellular cancer
HSALNT0289085 HSALNG0098166 LINC01080 TCONS_00021856 NA pathogenic process Alzheimer's disease
HSALNT0289751 HSALNG0141866 EFNA3 NA NA pathogenic process breast cancer
HSALNT0289798 HSALNG0141913 ENST00000395084 NA NA pathogenic process hepatocelluar cancer
HSALNT0289829 HSALNG0141944 FAM83A-AS1 NA NA pathogenic process hepatocelluar cancer
HSALNT0290164 HSALNG0142279 RAD1 NA NA pathogenic process hepatocelluar cancer
HSALNT0289585 HSALNG0141700 AK056988 NA NA pathogenic process hepatocellular cancer
HSALNT0289638 HSALNG0141753 BC017743 NA NA pathogenic process hepatocellular cancer
HSALNT0290156 HSALNG0142271 PRR26 C10orf108 NA pathogenic process hepatocellular cancer
HSALNT0290349 HSALNG0142464 uc003yqb.1 NA NA pathogenic process hepatocellular cancer
HSALNT0289675 HSALNG0141790 CAI2 NA NA pathogenic process neuroblastoma
HSALNT0289673 HSALNG0141788 CADM1-AS1 NA transcriptional regulation pathogenic process renal clear cell cancer
HSALNT0290313 HSALNG0142428 TSLC1-AS1 NA NA pathogenic process glioma
HSALNT0013359 HSALNG0006378 LINC01525 lnc-MAN1A2-1 NA pathogenic process squamous cell cancer
HSALNT0109106 HSALNG0051540 LINC01526 Lnc-FAM46A-1 NA pathogenic process squamous cell cancer
HSALNT0162774 HSALNG0078013 LINC01468 lnc-MBL2-4 NA pathogenic process squamous cell cancer
HSALNT0289110 HSALNG0074718 LINC01503 lnc-PPP2R4-5 NA pathogenic process tongue squamous cell cancer
HSALNT0289968 HSALNG0142083 lnc-MBL2-4:3 NA NA pathogenic process tongue squamous cell cancer
HSALNT0289993 HSALNG0142108 lnc-STXBP5-1 NA NA pathogenic process tongue squamous cell cancer
HSALNT0289563 HSALNG0141678 AF118081 NA NA pathogenic process lung cancer
HSALNT0289597 HSALNG0141712 AK124939 NA NA pathogenic process pulmonary adenocarcinoma
HSALNT0290153 HSALNG0142268 PRAS NA NA pathogenic process colorectal cancer
HSALNT0290249 HSALNG0142364 SNAR-A1 NA NA pathogenic process colorectal cancer
HSALNT0289929 HSALNG0142044 lincRNA-BC2 NA NA pathogenic process breast cancer
HSALNT0289930 HSALNG0142045 lincRNA-BC4 NA NA pathogenic process breast cancer
HSALNT0289931 HSALNG0142046 lincRNA-BC5 NA NA pathogenic process breast cancer
HSALNT0289932 HSALNG0142047 lincRNA-BC8 NA NA pathogenic process breast cancer
HSALNT0083190 HSALNG0039551 LINC01511 RP11-325I22.2 NA pathogenic process lung adenocarcinoma
HSALNT0290026 HSALNG0142141 LOC440905 NA NA pathogenic process lung adenocarcinoma
HSALNT0083190 HSALNG0039551 LINC01511 RP11-325I22.2 NA NA NA
HSALNT0289552 HSALNG0141667 AC079776.2 NA NA pathogenic process lung adenocarcinoma
HSALNT0289720 HSALNG0141835 CTA-363E6.2 NA NA pathogenic process lung adenocarcinoma
HSALNT0289901 HSALNG0142016 LINC00987 NA NA pathogenic process lung adenocarcinoma
HSALNT0290185 HSALNG0142300 RP11-1C1.7 NA NA pathogenic process lung adenocarcinoma
HSALNT0290197 HSALNG0142312 RP11-445K13.2 NA NA pathogenic process lung adenocarcinoma
HSALNT0290199 HSALNG0142314 RP11-473M20.11 NA NA pathogenic process lung adenocarcinoma
HSALNT0290213 HSALNG0142328 RP11-893F2.6 NA NA pathogenic process lung adenocarcinoma
HSALNT0290217 HSALNG0142332 RP13-514E23.1 NA NA pathogenic process lung adenocarcinoma
HSALNT0290218 HSALNG0142333 RP1-90D4.3 NA NA pathogenic process lung adenocarcinoma
HSALNT0290220 HSALNG0142335 RP4-575N6.5 NA NA pathogenic process lung adenocarcinoma
HSALNT0290226 HSALNG0142341 RP5-826L7.1 NA NA pathogenic process lung adenocarcinoma
HSALNT0290378 HSALNG0142493 XLOC_003286 NA NA pathogenic process lung adenocarcinoma
HSALNT0290379 HSALNG0142494 XLOC_003405 NA NA pathogenic process lung adenocarcinoma
HSALNT0290389 HSALNG0142504 XLOC_012255 NA NA pathogenic process lung adenocarcinoma
HSALNT0290056 HSALNG0142171 MIR21 NA NA pathogenic process laryngeal squamous cell cancer
HSALNT0289621 HSALNG0141736 ASncmtRNAs NA transcriptional regulation pathogenic process cancer
HSALNT0289316 HSALNG0022090 LINC01614 LCAL4,TCONS_00003105 NA pathogenic process lung cancer
HSALNT0289982 HSALNG0142097 lncRNA-FER1L4 NA ceRNA pathogenic process gastric cancer
HSALNT0290016 HSALNG0142131 LOC283177 NA NA pathogenic process diffuse large B-cell lymphoma
HSALNT0289003 HSALNG0134860 HORMAD2-AS1 MTMR3-AS1,NONHSAG033653 NA pathogenic process type 1 diabetes;bowel disease
HSALNT0290372 HSALNG0142487 WNT4 NA NA pathogenic process endometriosis
HSALNT0289540 HSALNG0141655 AB074278 NA NA pathogenic process bladder cancer
HSALNT0290166 HSALNG0142281 RCCRT1 NA NA pathogenic process renal cell cancer
HSALNT0289043 HSALNG0043862 LINC00491 BC008363 NA pathogenic process pancreatic ductal adenocarcinoma
HSALNT0289632 HSALNG0141747 BC008363 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0289858 HSALNG0141973 H1.3 NA NA pathogenic process ovarian cancer
HSALNT0289896 HSALNG0142011 LINC00582 NA NA pathogenic process endometrial cancer
HSALNT0289301 HSALNG0141635 LINC01537 RP11-169D4.1-001 NA pathogenic process laryngeal squamous cell cancer
HSALNT0289551 HSALNG0141666 AC026166.2 MTCO1P5 NA pathogenic process laryngeal squamous cell cancer
HSALNT0290184 HSALNG0142299 RP11-169D4.1-001 NA NA pathogenic process laryngeal squamous cell cancer
HSALNT0289545 HSALNG0141660 AC006050.3 NA NA pathogenic process lung squamous cell cancer
HSALNT0289556 HSALNG0141671 AC138128.1 NA NA pathogenic process gastric cancer
HSALNT0289818 HSALNG0141933 ERCC1 NA NA pathogenic process gastric cancer
HSALNT0290061 HSALNG0142176 MT1DP MT1DP NA pathogenic process liver cancer
HSALNT0289578 HSALNG0141693 AK023096 NA NA pathogenic process Wilms’ tumor;uterine leiomyomas
HSALNT0289112 HSALNG0003560 LINC01562 RP11-296A18.3 transcriptional regulation pathogenic process intervertebral disc degeneration
HSALNT0289567 HSALNG0141682 AK000974 NA NA pathogenic process breast cancer
HSALNT0289579 HSALNG0141694 AK024118 NA NA pathogenic process breast cancer
HSALNT0289645 HSALNG0141760 BC040204 NA NA pathogenic process breast cancer
HSALNT0290321 HSALNG0142436 U79277 NA NA pathogenic process breast cancer
HSALNT0289869 HSALNG0141984 HOST2 NA ceRNA pathogenic process epithelial ovarian cancer
HSALNT0289368 HSALNG0135509 MGAT3-AS1 TapSAKI NA pathogenic process acute kidney injury
HSALNT0289624 HSALNG0141739 ATXN7L3B NA NA pathogenic process spinocerebellar ataxia
HSALNT0289990 HSALNG0142105 lnc-SCA7 NA ceRNA pathogenic process spinocerebellar ataxia
HSALNT0290004 HSALNG0142119 LOC100287482 NA NA pathogenic process prostate cancer
HSALNT0290383 HSALNG0142498 XLOC_007697 NA NA pathogenic process prostate cancer
HSALNT0290384 HSALNG0142499 XLOC_008559 NA NA pathogenic process prostate cancer
HSALNT0290385 HSALNG0142500 XLOC_009911 NA NA pathogenic process prostate cancer
HSALNT0289813 HSALNG0141928 ENST00000480739 RPL13AP23 NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290111 HSALNG0142226 OS9 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0290324 HSALNG0142439 uc.283-plus NA NA pathogenic process glioma
HSALNT0289117 HSALNG0051652 LINC01611 RP1-90L14.1,TCONS_l2_00025430 NA pathogenic process diabetic retinopathy
HSALNT0289529 HSALNG0141644 2900055J20Rik 2900055J20Rik NA pathogenic process left ventricular hypertrophy
HSALNT0289792 HSALNG0141907 ENSG00000261777 AC012184.3 NA pathogenic process prostate cancer
HSALNT0289618 HSALNG0141733 Asb3 NA NA pathogenic process cardiovascular and renal disease
HSALNT0289703 HSALNG0141818 Chac2 NA NA pathogenic process cardiovascular and renal disease
HSALNT0290139 HSALNG0142254 Pex11b NA NA pathogenic process cardiovascular and renal disease
HSALNT0290255 HSALNG0142370 Sp5 NA NA pathogenic process cardiovascular and renal disease
HSALNT0211639 HSALNG0101614 PSMA3-AS1 FLJ31306 NA pathogenic process NA
HSALNT0289319 HSALNG0141639 LINC00493 LOC388789 NA pathogenic process NA
HSALNT0288903 HSALNG0126842 CARD8-AS1 LOC100505812 transcriptional regulation pathogenic process leukemia and neuroblastoma
HSALNT0064729 HSALNG0030929 KCNMB2-AS1 RP11-385J1.2 NA pathogenic process non-small cell lung cancer
HSALNT0289548 HSALNG0141663 AC013264.2 NA NA pathogenic process non-small cell lung cancer
HSALNT0289857 HSALNG0141972 GUCY1B2 NA NA pathogenic process non-small cell lung cancer
HSALNT0290190 HSALNG0142305 RP11-385J1.2 NA NA pathogenic process non-small cell lung cancer
HSALNT0290216 HSALNG0142331 RP1-317E23.3 NA NA pathogenic process non-small cell lung cancer
HSALNT0290317 HSALNG0142432 TUBA4B NA NA pathogenic process non-small cell lung cancer
HSALNT0290375 HSALNG0142490 XLOC_000371 NA NA pathogenic process non-small cell lung cancer
HSALNT0290397 HSALNG0142512 Z82214.3 NA NA pathogenic process non-small cell lung cancer
HSALNT0289735 HSALNG0141850 DALIR DALI transcriptional regulation NA NA
HSALNT0290376 HSALNG0142491 XLOC_000620 NA NA pathogenic process H. pylori-related diseases
HSALNT0290380 HSALNG0142495 XLOC_004122 NA NA pathogenic process H. pylori-related diseases
HSALNT0290381 HSALNG0142496 XLOC_004562 NA NA pathogenic process H. pylori-related diseases
HSALNT0290382 HSALNG0142497 XLOC_005912 NA NA pathogenic process H. pylori-related diseases
HSALNT0290391 HSALNG0142506 XLOC_014388 NA NA pathogenic process H. pylori-related diseases
HSALNT0290028 HSALNG0142143 LOC652276 NA NA pathogenic process colorectal cancer
HSALNT0290162 HSALNG0142277 R05532 NA NA pathogenic process colorectal cancer
HSALNT0098175 HSALNG0046752 LINC01411 RP11-267A15.1 NA pathogenic process prostate cancer
HSALNT0290025 HSALNG0142140 LOC401317 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289726 HSALNG0141841 CTD-2574D22.4 AC120114.2 NA pathogenic process osteoarthritis
HSALNT0290141 HSALNG0142256 PMS2L2 NA NA pathogenic process osteoarthritis
HSALNT0289974 HSALNG0142089 lncRNA-422 NA NA pathogenic process colorectal cancer
HSALNT0289520 HSALNG0133454 AATBC NA NA pathogenic process bladder cancer
HSALNT0289311 HSALNG0141637 LINC00974 NA ceRNA pathogenic process hepatocellular cancer
HSALNT0089943 HSALNG0042820 ZBED3-AS1 NA NA developmental process NA
HSALNT0289116 HSALNG0135958 LINC01589 CTA-941F9.9,TCONS_00029353 NA pathogenic process NA
HSALNT0289910 HSALNG0142025 LINC01426 NA NA pathogenic process esophageal squamous cell cancer
HSALNT0290341 HSALNG0142456 uc002yug.2 NA splicing regulation pathogenic process esophageal squamous cell cancer
HSALNT0290250 HSALNG0142365 SNCG NA NA pathogenic process gastric cancer
HSALNT0289949 HSALNG0142064 lnc-AF085935 NA NA pathogenic process hepatocelluar cancer
HSALNT0289996 HSALNG0142111 lnc-uc003wbd NA NA pathogenic process hepatocelluar cancer
HSALNT0289559 HSALNG0141674 AF085935 NA NA pathogenic process hepatocellular cancer
HSALNT0290347 HSALNG0142462 uc003wbd NA NA pathogenic process hepatocellular cancer
HSALNT0290098 HSALNG0142213 NR_001284 TNXA NA pathogenic process chronic thromboembolic pulmonary hypertension
HSALNT0290327 HSALNG0142442 uc.343 NA NA pathogenic process osteoarthritis
HSALNT0289196 HSALNG0094525 NRAV DYNLL1-AS1 transcriptional regulation pathogenic process influenza A virus
HSALNT0290140 HSALNG0142255 PLEC NA NA pathogenic process chronic obstructive pulmonary disease
HSALNT0290172 HSALNG0142287 UCSC-2000-3182 NA NA pathogenic process chronic obstructive pulmonary disease
HSALNT0290173 HSALNG0142288 UCSC-9199-1005 NA NA pathogenic process chronic obstructive pulmonary disease
HSALNT0290174 HSALNG0142289 CombinedLit_316_550 NA NA pathogenic process chronic obstructive pulmonary disease
HSALNT0289714 HSALNG0141829 CR613944 NA NA pathogenic process hepatocelluar cancer
HSALNT0289933 HSALNG0142048 lincRNA-CALCA NA NA pathogenic process hepatocelluar cancer
HSALNT0290200 HSALNG0142315 RP11-501G6.1 NA NA pathogenic process hepatocelluar cancer
HSALNT0290208 HSALNG0142323 RP11-672F9.1 NA NA pathogenic process hepatocelluar cancer
HSALNT0290405 HSALNG0142520 C14orf132 NA NA pathogenic process hepatocelluar cancer
HSALNT0289937 HSALNG0142052 lincRNA-TSPAN8 NA NA pathogenic process hepatocellular cancer
HSALNT0290225 HSALNG0142340 RP5-1014O16.1 AC244098.1 NA pathogenic process hepatocellular cancer
HSALNT0290275 HSALNG0142390 TCONS_00026102 NA NA pathogenic process atrial fibrillation
HSALNT0290277 HSALNG0142392 TCONS_00032546 NA NA pathogenic process atrial fibrillation
HSALNT0289037 HSALNG0096978 LINC00441 RB1-DT,ncRNA-RB1 NA pathogenic process NA
HSALNT0289661 HSALNG0141776 C1401f132 NA NA pathogenic process non-small cell lung cancer
HSALNT0289141 HSALNG0039030 LINC02365 LVCAT8 NA pathogenic process NA
HSALNT0288885 HSALNG0095161 ADGRD1-AS1 LACAT8 NA NA NA
HSALNT0289142 HSALNG0034152 LINC02475 LVCAT1 NA NA NA
HSALNT0289542 HSALNG0141657 Abhd11os NA NA pathogenic process neurodegenerative diseases
HSALNT0288895 HSALNG0124521 BISPR NA NA pathogenic process virus infection
HSALNT0233975 HSALNG0112910 MAFTRR linc-MAF-4 transcriptional regulation NA NA
HSALNT0290058 HSALNG0142173 MRAK052686 NA NA pathogenic process nonalcoholic fatty liver disease
HSALNT0290221 HSALNG0142336 RP4-583P15.10 AL121845.1 NA pathogenic process breast cancer
HSALNT0211341 HSALNG0101470 KTN1-AS1 C14orf33,MYCLo-3 NA pathogenic process colorectal cancer
HSALNT0266752 HSALNG0129835 DLGAP4-AS1 CCAT7 NA pathogenic process colorectal cancer
HSALNT0289682 HSALNG0141797 CCAT3 NA NA pathogenic process colorectal cancer
HSALNT0289684 HSALNG0141799 CCAT8 NA NA pathogenic process colorectal cancer
HSALNT0289898 HSALNG0142013 LINC00659 NA NA pathogenic process colorectal cancer
HSALNT0289683 HSALNG0141798 CCAT7 NA NA pathogenic process NA
HSALNT0289627 HSALNG0141742 BALR-2 NA NA pathogenic process B cell acute lymphoblastic leukemia
HSALNT0289948 HSALNG0142063 lnc-ACACA-1 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289953 HSALNG0142068 lnc-BMP2-2 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289955 HSALNG0142070 lnc-CPN2-1 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289958 HSALNG0142073 lnc-FOXG1-2 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289960 HSALNG0142075 lnc-FZD1-2 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289962 HSALNG0142077 lnc-ITPR2-3 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289965 HSALNG0142080 lnc-LCP2-2 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289988 HSALNG0142103 lnc-RP3-368B9 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289991 HSALNG0142106 lnc-SLC30A4-1 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289992 HSALNG0142107 lnc-SPAM1-6 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289995 HSALNG0142110 lnc-TTC34-3 NA NA pathogenic process clear cell renal cell cancer
HSALNT0222064 HSALNG0106856 DRAIC NA NA pathogenic process prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
HSALNT0005037 HSALNG0002618 LINC01137 LOC728431 NA pathogenic process NA
HSALNT0290390 HSALNG0142505 XLOC_014172 NA NA pathogenic process hepatocelluar cancer
HSALNT0290014 HSALNG0142129 LOC149086 NA NA pathogenic process hepatocellular cancer
HSALNT0290183 HSALNG0142298 RP11-160H22.5 AL121983.2 NA pathogenic process hepatocellular cancer
HSALNT0289945 HSALNG0142060 LNC00964-3 NA NA pathogenic process colorectal cancer
HSALNT0289616 HSALNG0141731 Arid2-IR NA NA pathogenic process renal inflammation
HSALNT0289716 HSALNG0141831 CR619813 NA NA pathogenic process pancreatic cancer
HSALNT0289739 HSALNG0141854 DDX6P1 NA NA pathogenic process pancreatic cancer
HSALNT0289938 HSALNG0142053 lincRNA-ZNF532 NA NA pathogenic process pancreatic cancer
HSALNT0290011 HSALNG0142126 LOC105372753 NA NA pathogenic process pancreatic cancer
HSALNT0290013 HSALNG0142128 LOC105377769 NA NA pathogenic process pancreatic cancer
HSALNT0290205 HSALNG0142320 RP11-58D2.1 NA NA pathogenic process pancreatic cancer
HSALNT0288946 HSALNG0105101 ENST00000434223 NA NA pathogenic process lung adenocarcinoma
HSALNT0288947 HSALNG0082178 ENST00000442037 NA NA pathogenic process lung adenocarcinoma
HSALNT0288953 HSALNG0088449 ENST00000540136 NA NA pathogenic process lung adenocarcinoma
HSALNT0290103 HSALNG0142218 NR_038125 NA NA pathogenic process lung adenocarcinoma
HSALNT0290136 HSALNG0142251 PDLIM3 NA NA pathogenic process lung adenocarcinoma
HSALNT0290335 HSALNG0142450 uc001gch.1 NA NA pathogenic process lung adenocarcinoma
HSALNT0290336 HSALNG0142451 uc001gzl.3 NA NA pathogenic process lung adenocarcinoma
HSALNT0290351 HSALNG0142466 uc004bbl.1 NA NA pathogenic process lung adenocarcinoma
HSALNT0290369 HSALNG0142484 VNN2 NA NA pathogenic process lung adenocarcinoma
HSALNT0289577 HSALNG0141692 AK022798 NA NA pathogenic process gastric cancer
HSALNT0289663 HSALNG0141778 C1orf74 NA NA pathogenic process gastric cancer
HSALNT0289602 HSALNG0141717 AKR7L NA NA pathogenic process gastric cancer
HSALNT0289711 HSALNG0141826 COL3A1 NA NA pathogenic process gastric cancer
HSALNT0289878 HSALNG0141993 KCNE2 NA NA pathogenic process gastric cancer
HSALNT0289636 HSALNG0141751 BC015134 NA NA pathogenic process gastric cancer
HSALNT0289713 HSALNG0141828 CR594506 NA NA pathogenic process gastric cancer
HSALNT0289928 HSALNG0142043 lincRNA-BBOX1-2 NA NA pathogenic process gastric cancer
HSALNT0271719 HSALNG0132223 LINC00320 PRED14,FLJ37539 NA pathogenic process;developmental process cortical white matter
HSALNT0289823 HSALNG0141938 EVADR NA NA pathogenic process pancreatic cancer;lung cancer;colorectal cancer;rectal cancer
HSALNT0289944 HSALNG0142059 Lnc_bc060912 NA NA pathogenic process lung cancer
HSALNT0289952 HSALNG0142067 lnc-bc060912 NA NA pathogenic process lung cancer
HSALNT0289613 HSALNG0141728 APF NA ceRNA pathogenic process myocardial infarction
HSALNT0289617 HSALNG0141732 AS Uchl1 NA NA pathogenic process Parkinson's disease
HSALNT0289104 HSALNG0099739 LINC01296 FLJ39632 NA pathogenic process colorectal cancer
HSALNT0290403 HSALNG0142518 ZXF2 NA NA pathogenic process lung adenocarcinoma
HSALNT0290113 HSALNG0142228 P14695 NA NA pathogenic process hepatocelluar cancer
HSALNT0290114 HSALNG0142229 P16984 NA NA pathogenic process hepatocelluar cancer
HSALNT0290115 HSALNG0142230 P19780 NA NA pathogenic process hepatocelluar cancer
HSALNT0290116 HSALNG0142231 P23099 NA NA pathogenic process hepatocelluar cancer
HSALNT0290117 HSALNG0142232 P24363 NA NA pathogenic process hepatocelluar cancer
HSALNT0290118 HSALNG0142233 P28210 NA NA pathogenic process hepatocelluar cancer
HSALNT0290120 HSALNG0142235 P33863 NA NA pathogenic process hepatocelluar cancer
HSALNT0290121 HSALNG0142236 P4091 NA NA pathogenic process hepatocelluar cancer
HSALNT0290122 HSALNG0142237 P6391 NA NA pathogenic process hepatocelluar cancer
HSALNT0290123 HSALNG0142238 P6488 NA NA pathogenic process hepatocelluar cancer
HSALNT0290124 HSALNG0142239 P700 NA NA pathogenic process hepatocelluar cancer
HSALNT0290125 HSALNG0142240 P8611 NA NA pathogenic process hepatocelluar cancer
HSALNT0290126 HSALNG0142241 P8725 NA NA pathogenic process hepatocelluar cancer
HSALNT0290127 HSALNG0142242 P8860 NA NA pathogenic process hepatocelluar cancer
HSALNT0290128 HSALNG0142243 P9745 NA NA pathogenic process hepatocelluar cancer
HSALNT0289269 HSALNG0044864 TH2LCRR TH2-LCR transcriptional regulation pathogenic process allergic asthma
HSALNT0289964 HSALNG0142079 lnc-LCE5A-1 NA NA pathogenic process laryngeal cancer;head and neck squamous cell cancer
HSALNT0055198 HSALNG0026441 FAM3D-AS1 lnc-KCTD6-3 NA pathogenic process tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer
HSALNT0289843 HSALNG0141958 FRLnc1 NA NA pathogenic process gastric cancer
HSALNT0242005 HSALNG0117109 ENST00000575202 NA NA pathogenic process colorectal cancer
HSALNT0288952 HSALNG0089220 ENST00000539009 NA NA pathogenic process colorectal cancer
HSALNT0288954 HSALNG0089242 ENST00000544591 NA NA pathogenic process colorectal cancer
HSALNT0289752 HSALNG0141867 EHHADH-AS1 NA NA pathogenic process colorectal cancer
HSALNT0289812 HSALNG0141927 ENST00000468960 NA NA pathogenic process colorectal cancer
HSALNT0290276 HSALNG0142391 TCONS_00026506 NA NA pathogenic process colorectal cancer
HSALNT0189952 HSALNG0091595 LRP1-AS NA transcriptional regulation pathogenic process Alzheimer's disease
HSALNT0032045 HSALNG0015125 LINC01122 FLJ30838,AC007092.1 NA NA NA
HSALNT0289565 HSALNG0141680 AI364715 NA NA pathogenic process gastric cancer
HSALNT0289921 HSALNG0142036 LINC0949 NA NA pathogenic process systemic lupus erythematosus
HSALNT0289680 HSALNG0141795 CCAL NA NA pathogenic process colorectal cancer
HSALNT0289079 HSALNG0077354 LINC00993 NA NA pathogenic process breast cancer
HSALNT0289811 HSALNG0141926 ENST00000460164 NA NA pathogenic process triple-negative breast cancer
HSALNT0290282 HSALNG0142397 TCONS_l2_00003938 NA NA pathogenic process triple-negative breast cancer
HSALNT0289888 HSALNG0142003 LGALS3 NA NA pathogenic process papillary thyroid cancer
HSALNT0289963 HSALNG0142078 lnc-KCMF1-2:1 NA NA pathogenic process papillary thyroid cancer
HSALNT0289967 HSALNG0142082 lnc-LLPH-2:1 NA NA pathogenic process papillary thyroid cancer
HSALNT0289971 HSALNG0142086 lnc-PLA2R1-1:1 NA NA pathogenic process papillary thyroid cancer
HSALNT0289972 HSALNG0142087 lnc-PSD4-1:14 NA NA pathogenic process papillary thyroid cancer
HSALNT0290066 HSALNG0142181 n335550 NA NA pathogenic process papillary thyroid cancer
HSALNT0290070 HSALNG0142185 n340790 NA NA pathogenic process papillary thyroid cancer
HSALNT0290072 HSALNG0142187 n386477 NA NA pathogenic process papillary thyroid cancer
HSALNT0290286 HSALNG0142401 TCONS_l2_00010365 NA NA pathogenic process papillary thyroid cancer
HSALNT0288944 HSALNG0129184 ENST00000422494 NA NA NA NA
HSALNT0289118 HSALNG0038513 LINC01612 RP11-789C1.1,TCONS_00008319 NA pathogenic process gastric cancer
HSALNT0289610 HSALNG0141725 AP001439.2 NA NA pathogenic process gastric cancer
HSALNT0289671 HSALNG0141786 CACNAICAS3 NA NA pathogenic process gastric cancer
HSALNT0289853 HSALNG0141968 GS1-5L10.1 NA NA pathogenic process gastric cancer
HSALNT0289875 HSALNG0141990 INTS7 NA NA pathogenic process gastric cancer
HSALNT0290065 HSALNG0142180 MYLK-AS1 NA NA pathogenic process gastric cancer
HSALNT0290157 HSALNG0142272 PRSS21 NA NA pathogenic process gastric cancer
HSALNT0290202 HSALNG0142317 RP11-528G1.2 NA NA pathogenic process gastric cancer
HSALNT0290207 HSALNG0142322 RP11-643M14.1 NA NA pathogenic process gastric cancer
HSALNT0290209 HSALNG0142324 RP11-789C1.1 LINC01612 NA pathogenic process gastric cancer
HSALNT0290314 HSALNG0142429 TSNAX-DISC1 NA NA pathogenic process gastric cancer
HSALNT0290386 HSALNG0142501 XLOC_010235 NA NA pathogenic process gastric cancer
HSALNT0289558 HSALNG0141673 AF075041 NA NA pathogenic process pancreatic cancer
HSALNT0289564 HSALNG0141679 AF339813 NA NA pathogenic process pancreatic cancer
HSALNT0289575 HSALNG0141690 AK022029 NA NA pathogenic process pancreatic cancer
HSALNT0289576 HSALNG0141691 AK022159 NA NA pathogenic process pancreatic cancer
HSALNT0289604 HSALNG0141719 AL389956 NA NA pathogenic process pancreatic cancer
HSALNT0289640 HSALNG0141755 BC023629 NA NA pathogenic process pancreatic cancer
HSALNT0290096 HSALNG0142211 NONHSAT125629 NA NA pathogenic process breast cancer
HSALNT0290393 HSALNG0142508 XR_250621.1 NA NA pathogenic process breast cancer
HSALNT0288951 HSALNG0033002 ENST00000503938 NA NA pathogenic process triple-negative breast cancer
HSALNT0290085 HSALNG0142200 NONHSAT012762 NA NA pathogenic process triple-negative breast cancer
HSALNT0289151 HSALNG0023952 LMCD1-AS1 NA NA pathogenic process acute kidney injury
HSALNT0289926 HSALNG0142041 linc-PXN-1 NA NA pathogenic process prostate cancer
HSALNT0290281 HSALNG0142396 TCONS_l2_00001418 NA NA pathogenic process prostate cancer
HSALNT0290285 HSALNG0142400 TCONS_l2_00008237 NA NA pathogenic process prostate cancer
HSALNT0290287 HSALNG0142402 TCONS_l2_00011130 NA NA pathogenic process prostate cancer
HSALNT0290288 HSALNG0142403 TCONS_l2_00013175 NA NA pathogenic process prostate cancer
HSALNT0290294 HSALNG0142409 TCONS_l2_00022611 NA NA pathogenic process prostate cancer
HSALNT0290295 HSALNG0142410 TCONS_l2_00022670 NA NA pathogenic process prostate cancer
HSALNT0290352 HSALNG0142467 uc004bdv.3 NA NA pathogenic process hepatocelluar cancer
HSALNT0290363 HSALNG0142478 ULK4P2 NA NA pathogenic process hepatocelluar cancer
HSALNT0289942 HSALNG0142057 LK4P2 NA NA pathogenic process hepatocellular cancer
HSALNT0289538 HSALNG0141653 AB019562 NA NA pathogenic process hypopharyngeal squamous cell cancer
HSALNT0091661 HSALNG0043585 ENST00000503710 NA NA pathogenic process endometrial cancer
HSALNT0289806 HSALNG0141921 ENST00000445734 NA NA pathogenic process endometrial cancer
HSALNT0289807 HSALNG0141922 ENST00000448093 NA NA pathogenic process endometrial cancer
HSALNT0289815 HSALNG0141930 ENST00000502941 NA NA pathogenic process endometrial cancer
HSALNT0290340 HSALNG0142455 uc002nbr.3 NA NA pathogenic process endometrial cancer
HSALNT0290348 HSALNG0142463 uc003xut. NA NA pathogenic process endometrial cancer
HSALNT0290356 HSALNG0142471 uc021re1.1 NA NA pathogenic process endometrial cancer
HSALNT0289549 HSALNG0141664 AC016745.3 AC016745.1 NA pathogenic process glioma
HSALNT0290180 HSALNG0142295 RP11-128A17.1 AC078909.1 NA pathogenic process glioma
HSALNT0290377 HSALNG0142492 XLOC_001711 NA NA pathogenic process glioma
HSALNT0289975 HSALNG0142090 lncRNA-AK058003 NA NA pathogenic process breast cancer
HSALNT0289061 HSALNG0034072 LINC00682 NA NA pathogenic process hepatocellular cancer
HSALNT0289305 HSALNG0089456 LINC01559 FLJ33810 NA pathogenic process Huntington disease
HSALNT0289854 HSALNG0141969 GSTT1-AS1 NA transcriptional regulation pathogenic process mycobacterium tuberculosis infection
HSALNT0289978 HSALNG0142093 lncRNA-CD244 NA transcriptional regulation pathogenic process tuberculosis infection
HSALNT0289237 HSALNG0068014 SAMD12-AS1 NA NA pathogenic process neuroblastoma
HSALNT0290179 HSALNG0142294 RP11-119F7.4 NA NA pathogenic process gastric cancer
HSALNT0290278 HSALNG0142393 TCONS_00068220 NA NA pathogenic process gastric cancer
HSALNT0285573 HSALNG0139654 DANT1 NA transcriptional regulation NA NA
HSALNT0288926 HSALNG0139662 DANT2 NA transcriptional regulation NA NA
HSALNT0290399 HSALNG0142514 ZMAT1 NA NA pathogenic process gastric cancer
HSALNT0289554 HSALNG0141669 AC100865.1 NA NA pathogenic process coronary artery disease
HSALNT0289228 HSALNG0105273 RAD51-AS1 TODRA transcriptional regulation pathogenic process breast cancer
HSALNT0289743 HSALNG0141858 DKFZP434K028 NA NA pathogenic process gastric cancer
HSALNT0289630 HSALNG0141745 BC002811 NA NA pathogenic process astrocytoma
HSALNT0290387 HSALNG0142502 XLOC_010967 NA NA pathogenic process astrocytoma
HSALNT0288955 HSALNG0084672 ENST00000545440 NA NA pathogenic process pediatric acute myeloid leukemia
HSALNT0288981 HSALNG0133391 FRGCA LncRNA-AP001631.9 NA pathogenic process gastric cancer
HSALNT0289611 HSALNG0141726 AP001631.9 NA NA pathogenic process gastric cancer
HSALNT0289976 HSALNG0142091 LncRNA-AP001631.9 NA NA pathogenic process gastric cancer
HSALNT0289686 HSALNG0141801 CD99P1 NA ceRNA pathogenic process idiopathic pulmonary fibrosis
HSALNT0289119 HSALNG0074097 LINC01613 n341773 NA pathogenic process idiopathic pulmonary fibrosis
HSALNT0289844 HSALNG0141959 FTH1P3 FTH1P3 NA pathogenic process oral squamous cell cancer
HSALNT0289855 HSALNG0141970 GTF2IRD2P1 GTF2IRD2P1 NA pathogenic process oral squamous cell cancer
HSALNT0290135 HSALNG0142250 PDIA3F NA NA pathogenic process oral squamous cell cancer
HSALNT0289329 HSALNG0026562 LINC00994 NA NA pathogenic process inflammatory bowel disease
HSALNT0289208 HSALNG0077290 PCAT5 LINC01452,TPCAT-10-36067 NA pathogenic process prostate cancer
HSALNT0114870 HSALNG0054158 LUADT1 NA transcriptional regulation pathogenic process lung adenocarcinoma
HSALNT0289154 HSALNG0107133 LOXL1-AS1 NA NA pathogenic process exfoliation syndrome
HSALNT0289734 HSALNG0141849 DACOR1 TCONS_00023265 transcriptional regulation pathogenic process colorectal cancer
HSALNT0289060 HSALNG0114548 LINC00675 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0288889 HSALNG0070759 B4GALT1-AS1 NA transcriptional regulation pathogenic process NA
HSALNT0289348 HSALNG0083371 LINC01616 n341006 NA pathogenic process Alzheimer's disease
HSALNT0290068 HSALNG0142183 n336934 NA NA pathogenic process Alzheimer's disease
HSALNT0290240 HSALNG0142355 SIRT1-AS NA NA pathogenic process hepatocellular cancer
HSALNT0290198 HSALNG0142313 RP11-457M11.2 NA ceRNA pathogenic process lung adenocarcinoma
HSALNT0150768 HSALNG0072141 LINC01507 XLOC_000303 NA pathogenic process colorectal cancer
HSALNT0289903 HSALNG0142018 LINC01057 NA NA pathogenic process colorectal cancer
HSALNT0289914 HSALNG0142029 LINC01617 C8orf23,NCRNA00249,XLOC_006844 NA pathogenic process colorectal cancer
HSALNT0290015 HSALNG0142130 LOC152578 NA NA pathogenic process colorectal cancer
HSALNT0072252 HSALNG0034426 LINC01618 LOC152578 NA pathogenic process NA
HSALNT0156870 HSALNG0075266 NALT1 MIR4674HG,LINC01573,TCONS_l2_00029132 transcriptional regulation pathogenic process acute lymphoblastic leukemia
HSALNT0289083 HSALNG0045290 MALINC1 LINC01024,MA-linc1 NA pathogenic process human breast and lung cancer
HSALNT0289902 HSALNG0142017 LINC01024 MA-linc1 NA pathogenic process osteosarcoma;lung cancer
HSALNT0289120 HSALNG0071043 LINC01627 RP11-397D12.4 NA pathogenic process non-small cell lung cancer
HSALNT0289121 HSALNG0015617 LINC01628 AC007403.1 NA pathogenic process non-small cell lung cancer
HSALNT0289820 HSALNG0141935 ERICH1-AS1 NA NA pathogenic process non-small cell lung cancer
HSALNT0290193 HSALNG0142308 RP11-397D12.4 LINC01627 NA pathogenic process non-small cell lung cancer
HSALNT0289122 HSALNG0102605 LINC01629 linc-KIAA1737-2 transcriptional regulation pathogenic process hypoxic and inflammatory renal epithelial injury
HSALNT0290161 HSALNG0142276 PTPRG-AS1 NA NA pathogenic process breast cancer
HSALNT0289980 HSALNG0142095 lncRNA-DLEU1 NA ceRNA pathogenic process breast cancer
HSALNT0289983 HSALNG0142098 lncRNA-Hh NA NA pathogenic process breast cancer
HSALNT0288986 HSALNG0072437 GAS1RR LncRNA-Hh NA pathogenic process breast cancer
HSALNT0288908 HSALNG0005250 CCDC18-AS1 ENST00000440778.1 NA pathogenic process adolescent idiopathic scoliosis
HSALNT0289055 HSALNG0132813 LINC00649 TCONS_00028768 NA pathogenic process adolescent idiopathic scoliosis
HSALNT0289219 HSALNG0075966 PRKCQ-AS1 ENST00000414894.1 NA pathogenic process adolescent idiopathic scoliosis
HSALNT0290203 HSALNG0142318 RP11-567G11.1 LINC02041 NA pathogenic process pancreatic cancer
HSALNT0289805 HSALNG0141920 ENST00000438550 RPS24P1 NA pathogenic process nasopharyngeal cancer
HSALNT0290083 HSALNG0142198 NONHSAG011351 NA NA pathogenic process type 1 diabetes
HSALNT0290049 HSALNG0142164 MCHR2-AS1 NA NA pathogenic process psychiatric disease
HSALNT0289799 HSALNG0141914 ENST00000414355 NA NA pathogenic process cadmium toxicology
HSALNT0290241 HSALNG0142356 SKP2 NA NA pathogenic process non-small cell lung cancer
HSALNT0289837 HSALNG0141952 FLJ90757 NA ceRNA pathogenic process hepatocellular cancer
HSALNT0290017 HSALNG0142132 LOC283663 NA ceRNA pathogenic process hepatocellular cancer
HSALNT0290019 HSALNG0142134 LOC338651 NA ceRNA pathogenic process hepatocellular cancer
HSALNT0290132 HSALNG0142247 PCATs NA NA pathogenic process prostate cancer
HSALNT0086786 HSALNG0041277 EGFLAM-AS1 lncRNA-LOWEG NA pathogenic process gastric cancer
HSALNT0290031 HSALNG0142146 LOWEG NA NA pathogenic process gastric cancer
HSALNT0289635 HSALNG0141750 BC014579 NA NA pathogenic process hepatocelluar cancer
HSALNT0289721 HSALNG0141836 CTB-167B5.2 NA NA pathogenic process hepatocelluar cancer
HSALNT0289863 HSALNG0141978 HELLS NA NA pathogenic process leukemia
HSALNT0290195 HSALNG0142310 RP11-401P9.4 NA NA pathogenic process hepatocelluar cancer
HSALNT0290252 HSALNG0142367 SNHG19 NA NA pathogenic process hepatocelluar cancer
HSALNT0289557 HSALNG0141672 AF070632 NA NA pathogenic process hepatocellular cancer
HSALNT0289569 HSALNG0141684 AK021443 NA NA pathogenic process hepatocellular cancer
HSALNT0289728 HSALNG0141843 CTD-3080P12.3 NA ceRNA pathogenic process gastric cancer
HSALNT0289987 HSALNG0142102 lncRNA-n336928 NA NA pathogenic process bladder cancer
HSALNT0289723 HSALNG0141838 CTC-523E23.5 AC008555.2 NA pathogenic process intervertebral disc degeneration
HSALNT0289724 HSALNG0141839 CTD-2246P4.1 NA NA pathogenic process intervertebral disc degeneration
HSALNT0290055 HSALNG0142170 MIR132 MIRN132,miRNA132,mir-132 NA pathogenic process intervertebral disc degeneration
HSALNT0290189 HSALNG0142304 RP11-363G2.4 NA NA pathogenic process intervertebral disc degeneration
HSALNT0290191 HSALNG0142306 RP11-38F22.1 LINC02424 NA pathogenic process intervertebral disc degeneration
HSALNT0290223 HSALNG0142338 RP4-639J15.1 AC006967.2 NA pathogenic process intervertebral disc degeneration
HSALNT0290233 HSALNG0142348 RUNX1-IT1 C21orf96 NA pathogenic process gastric cancer
HSALNT0288943 HSALNG0053446 ENST00000415964 NA NA pathogenic process pediatric acute myeloid leukemia
HSALNT0290009 HSALNG0142124 LOC101927497 NA NA pathogenic process gastric cancer
HSALNT0289956 HSALNG0142071 lnc-CYP4A22-2/3 NA NA pathogenic process clear cell renal cell cancer
HSALNT0289999 HSALNG0142114 lnc-ZNF180-2 NA NA pathogenic process renal clear cell cancer
HSALNT0290086 HSALNG0142201 NONHSAT037832 NA NA pathogenic process papillary thyroid cancer
HSALNT0289658 HSALNG0141773 BX647187 NA NA pathogenic process prostate cancer
HSALNT0288920 HSALNG0017086 CNNM3-DT LOC100506036 NA NA NA
HSALNT0289584 HSALNG0141699 AK056155 NA NA pathogenic process Loeys-Dietz syndrome
HSALNT0290057 HSALNG0142172 MR1 NA NA pathogenic process Loeys-Dietz syndrome
HSALNT0289543 HSALNG0141658 AC002454.1 AC002454.1 NA pathogenic process endometriosis
HSALNT0289909 HSALNG0142024 LINC01420 NA NA pathogenic process systemic lupus erythematosus
HSALNT0289531 HSALNG0141646 53BP1 NA NA pathogenic process breast cancer
HSALNT0290101 HSALNG0142216 NR_024118 NA NA pathogenic process rheumatoid arthritis
HSALNT0290239 HSALNG0142354 SGO1-AS1 SGOL1-AS1 NA pathogenic process lung cancer
HSALNT0289293 HSALNG0127764 ZNF667-AS1 MORT NA pathogenic process breast cancer
HSALNT0289984 HSALNG0142099 lncRNA-HIF2PUT NA NA pathogenic process colorectal cancer
HSALNT0288945 HSALNG0018617 ENST00000433673 AC068282.1 NA pathogenic process polycystic ovary syndrome
HSALNT0288948 HSALNG0008353 ENST00000454271 AL021940.1 NA pathogenic process polycystic ovary syndrome
HSALNT0289495 HSALNG0141606 ENST00000432431 AC023128.1 NA pathogenic process polycystic ovary syndrome
HSALNT0289918 HSALNG0142033 LINC01828 NA NA pathogenic process polycystic ovary syndrome
HSALNT0290388 HSALNG0142503 XLOC_011402 NA NA pathogenic process polycystic ovary syndrome
HSALNT0289873 HSALNG0141988 ICAM-1 NA NA pathogenic process hepatocellular cancer
HSALNT0289668 HSALNG0141783 C5T1lncRNA NA transcriptional regulation pathogenic process rheumatoid arthritis
HSALNT0289667 HSALNG0141782 C5T1 NA NA pathogenic process NA
HSALNT0289666 HSALNG0141781 C5-OT1 C5T1lncRNA NA pathogenic process rheumatoid arthritis
HSALNT0289626 HSALNG0141741 AX800134 NA NA pathogenic process hepatocellular cancer
HSALNT0290338 HSALNG0142453 uc001ncr NA NA pathogenic process hepatocellular cancer
HSALNT0290330 HSALNG0142445 uc.48+ NA NA pathogenic process diabetic neuropathic pain
HSALNT0289098 HSALNG0038313 LINC01207 NA transcriptional regulation pathogenic process lung adenocarcinoma
HSALNT0289628 HSALNG0141743 BALR-6 NA transcriptional regulation pathogenic process B-lymphoblastic leukemia
HSALNT0290022 HSALNG0142137 LOC389641 NA NA pathogenic process Pancreatic ductal adenocarcinoma
HSALNT0289725 HSALNG0141840 CTD-2541M15 NA NA pathogenic process gastric cancer
HSALNT0289940 HSALNG0142055 LINK-A NA NA pathogenic process triple-negative breast cancer
HSALNT0290107 HSALNG0142222 NUTF2P3 NUTF2P3 NA pathogenic process pancreatic cancer
HSALNT0290095 HSALNG0142210 NONHSAT123350 NA NA pathogenic process renal clear cell cancer
HSALNT0290362 HSALNG0142477 UHRF1 NA NA pathogenic process colorectal cancer
HSALNT0290366 HSALNG0142481 UPAT NA NA pathogenic process colorectal cancer
HSALNT0289307 HSALNG0114404 LINC00324 FLJ34790,MGC104931 NA pathogenic process NA
HSALNT0289969 HSALNG0142084 lnc-MX1-1 NA NA pathogenic process prostate cancer
HSALNT0290024 HSALNG0142139 LOC400891 NA NA pathogenic process prostate cancer
HSALNT0289883 HSALNG0141998 LA16c-313D11.11 NA ceRNA pathogenic process endometrial cancer
HSALNT0290192 HSALNG0142307 RP11-395G23.3 AC027031.2 NA pathogenic process endometrial cancer
HSALNT0289742 HSALNG0141857 DILC NA transcriptional regulation pathogenic process liver cancer
HSALNT0289957 HSALNG0142072 lnc-DILC NA transcriptional regulation pathogenic process liver cancer
HSALNT0289581 HSALNG0141696 AK027294 NA NA pathogenic process colorectal cancer
HSALNT0290371 HSALNG0142486 WISP1 NA NA pathogenic process colorectal cancer
HSALNT0206117 HSALNG0099020 FGF14-AS2 NA NA pathogenic process breast cancer
HSALNT0290131 HSALNG0142246 PCAT2 CARLo-4,PCA2,TCONS_00015167 NA pathogenic process prostate cancer
HSALNT0289528 HSALNG0141643 2700086A05Rik 2700086A05Rik NA pathogenic process idiopathic pulmonary fibrosis
HSALNT0290251 HSALNG0142366 SNED1 NA NA pathogenic process Idiopathic pulmonary fibrosis
HSALNT0290333 HSALNG0142448 uc.77 NA NA pathogenic process idiopathic pulmonary fibrosis
HSALNT0289816 HSALNG0141931 ENST00000537266 NA NA pathogenic process papillary thyroid cancer
HSALNT0289860 HSALNG0141975 HAGLROS NA NA pathogenic process papillary thyroid cancer
HSALNT0289881 HSALNG0141996 KRT18P55 KRT18P55 NA pathogenic process gastric cancer
HSALNT0229266 HSALNG0110450 IL21R-AS1 NA NA pathogenic process coronary artery disease
HSALNT0290112 HSALNG0142227 OTTHUMT00000387022 NA NA pathogenic process coronary artery disease
HSALNT0000551 HSALNG0000226 PRKCZ-AS1 RP11-181G12.2 NA pathogenic process lung adenocarcinoma
HSALNT0030981 HSALNG0014612 LINC01833 RP11-89,K21.1 NA pathogenic process lung adenocarcinoma
HSALNT0290214 HSALNG0142329 RP11-89K21 NA NA pathogenic process lung adenocarcinoma
HSALNT0165271 HSALNG0079188 LINC00857 NA NA pathogenic process lung cancer
HSALNT0290109 HSALNG0142224 OR3A4 NA NA pathogenic process gastric cancer
HSALNT0290046 HSALNG0142161 MAGI1-IT1 NA ceRNA pathogenic process cardiac hypertrophy
HSALNT0290242 HSALNG0142357 SLC26A4-AS1 NA ceRNA pathogenic process cardiac hypertrophy
HSALNT0289302 HSALNG0141636 KRT7-AS NA NA pathogenic process gastric cancer
HSALNT0218672 HSALNG0105101 LINC01852 ENST00000434223 NA pathogenic process non-small cell lung cancer
HSALNT0290178 HSALNG0142293 RP11-1008C21.2 NA NA pathogenic process non-small cell lung cancer
HSALNT0289592 HSALNG0141707 AK123072 NA NA pathogenic process gastric cancer
HSALNT0289573 HSALNG0141688 AK021954 NA NA pathogenic process atherosclerosis
HSALNT0288916 HSALNG0105961 CERNA1 LOC100129973 ceRNA pathogenic process cardiovascular disease
HSALNT0018525 HSALNG0008959 LAMC1-AS1 lnc-LAMC2-1:1 NA pathogenic process colorectal cancer
HSALNT0290087 HSALNG0142202 NONHSAT040387 NA NA pathogenic process atrial fibrillation
HSALNT0290092 HSALNG0142207 NONHSAT098586 NA NA pathogenic process atrial fibrillation
HSALNT0289213 HSALNG0108626 PCSK6-AS1 NA NA NA NA
HSALNT0289637 HSALNG0141752 BC016831 NA NA pathogenic process breast cancer
HSALNT0289874 HSALNG0141989 IGKV NA NA pathogenic process breast cancer
HSALNT0290196 HSALNG0142311 RP11-434D9.1 AC112206.2 NA pathogenic process breast cancer
HSALNT0289885 HSALNG0142000 LCAL6 NA NA pathogenic process lung adenocarcinoma
HSALNT0289650 HSALNG0141765 BC088254 NA NA pathogenic process myocardial hypertrophy
HSALNT0289596 HSALNG0141711 AK124454 NA NA pathogenic process breast cancer
HSALNT0289731 HSALNG0141846 CYP4B1-PS1 NA NA pathogenic process diabetic nephropathy
HSALNT0289106 HSALNG0094020 LINC01405 NA NA pathogenic process breast cancer
HSALNT0290259 HSALNG0142374 ST8SIA6-AS1 NA NA pathogenic process breast cancer
HSALNT0289278 HSALNG0047244 TRIM52-AS1 NA NA pathogenic process renal cell cancer
HSALNT0289634 HSALNG0141749 BC012900 NA NA pathogenic process ulcerative colitis
HSALNT0274011 HSALNG0133283 UMODL1-AS1 FLJ33471 NA pathogenic process breast cancer
HSALNT0289454 HSALNG0075449 ARRDC1-AS1 NA NA pathogenic process breast cancer
HSALNT0289456 HSALNG0071200 FAM74A3 OTTHUMG00000067149 NA pathogenic process breast cancer
HSALNT0289834 HSALNG0141949 FH NA NA pathogenic process Fumarase deficiency
HSALNT0289961 HSALNG0142076 lnc-HOXC4-3:1 NA NA pathogenic process breast cancer
HSALNT0289994 HSALNG0142109 lnc-TEAD4-1:1 NA NA pathogenic process breast cancer
HSALNT0290270 HSALNG0142385 TCONS_00003876 NA NA pathogenic process breast cancer
HSALNT0289825 HSALNG0141940 EVI1 NA transcriptional regulation pathogenic process hepatocellular cancer
HSALNT0290235 HSALNG0142350 SARCC NA NA pathogenic process renal cell cancer
HSALNT0290360 HSALNG0142475 ucoo2kmd.1 NA ceRNA pathogenic process colorectal cancer
HSALNT0289015 HSALNG0001020 KAZN-AS1 NA NA pathogenic process breast cancer
HSALNT0289722 HSALNG0141837 CTB-89H12.4 AC021078.1 ceRNA pathogenic process prostate cancer
HSALNT0289496 HSALNG0141607 EPB41L4A-AS2 FLJ11235 NA pathogenic process lung cancer;breast cancer;kidney cancer
HSALNT0289146 HSALNG0004554 LINC02567 ENST00000427806 NA pathogenic process attention deficit hyperactivity disorder
HSALNT0289833 HSALNG0141948 FGFR3-AS1 NA NA pathogenic process osteosarcoma
HSALNT0289707 HSALNG0141822 CILinc01 NA NA pathogenic process osteoarthritis
HSALNT0289708 HSALNG0141823 CILinc02 NA NA pathogenic process osteoarthritis
HSALNT0286597 HSALNG0140235 LINC00629 LINC00629AB,LINC00629C,LINC00629D,LINC00629 NA pathogenic process choriocarcinoma
HSALNT0289665 HSALNG0141780 C2dat1 NA NA pathogenic process ischemic brain injury
HSALNT0289217 HSALNG0057357 POU6F2-AS2 FLJ12971 protein localization pathogenic process oesophageal squamous cell cancer
HSALNT0289946 HSALNG0142061 lnc13 NA NA pathogenic process celiac disease
HSALNT0289729 HSALNG0141844 CTD903 NA NA pathogenic process colorectal cancer
HSALNT0290093 HSALNG0142208 NONHSAT104436 NA NA pathogenic process esophageal squamous cell cancer
HSALNT0289550 HSALNG0141665 AC024560.2 AC024560.1 NA pathogenic process cervical cancer
HSALNT0289483 HSALNG0134219 ENST00000436681 AP000552.1 NA pathogenic process congenital heart defect
HSALNT0289536 HSALNG0141651 AA584040 NA NA pathogenic process congenital heart defect
HSALNT0289537 HSALNG0141652 AA709223 NA NA pathogenic process congenital heart defect
HSALNT0289657 HSALNG0141772 BX478947 NA NA pathogenic process congenital heart defect
HSALNT0247515 HSALNG0119819 LINC00668 NA NA pathogenic process gastric cancer
HSALNT0289719 HSALNG0141834 CRNDE-h NA NA pathogenic process colorectal cancer
HSALNT0142879 HSALNG0068121 SMILR NA NA pathogenic process vascular pathologies
HSALNT0290396 HSALNG0142511 Z38 NA NA pathogenic process breast cancer
HSALNT0197213 HSALNG0095037 LINC00507 NA NA developmental process NA
HSALNT0289086 HSALNG0113270 LINC01082 TCONSNA00024492 NA pathogenic process alveolar capillary dysplasia with misalignment of pulmonary veins
HSALNT0289094 HSALNG0015253 LINC01185 FLJ16341 NA pathogenic process NA
HSALNT0290160 HSALNG0142275 PTPRD-AS1 NA NA pathogenic process ovarian cancer
HSALNT0290186 HSALNG0142301 RP11-254I22.1 MIR583HG NA pathogenic process ovarian cancer
HSALNT0290204 HSALNG0142319 RP11-57P19.1 AC009432.1 NA pathogenic process ovarian cancer
HSALNT0290211 HSALNG0142326 RP11-80H5.7 AL157400.4 NA pathogenic process ovarian cancer
HSALNT0290215 HSALNG0142330 RP1-223E5.4 AL441883.1 NA pathogenic process ovarian cancer
HSALNT0290224 HSALNG0142339 RP4-799P18.3 AL122008.4 NA pathogenic process ovarian cancer
HSALNT0289126 HSALNG0045514 LINC01844 LOC101926975 NA pathogenic process hirschsprung disease
HSALNT0289947 HSALNG0142062 Lnc34a NA transcriptional regulation pathogenic process colorectal cancer
HSALNT0289150 HSALNG0075977 LINP1 NA NA pathogenic process breast cancer
HSALNT0289951 HSALNG0142066 lncARSR NA ceRNA pathogenic process renal cell cancer
HSALNT0289392 HSALNG0005967 RBM15-AS1 AS-RBM15 translational control pathogenic process acute megakaryocytic leukemia
HSALNT0290089 HSALNG0142204 NONHSAT073641 NA NA pathogenic process vascular diseases
HSALNT0290027 HSALNG0142142 LOC572558 NA NA pathogenic process bladder cancer
HSALNT0289582 HSALNG0141697 AK033210 NA NA pathogenic process;developmental process bronchopulmonary dysplasia
HSALNT0289848 HSALNG0141963 GClnc1 NA transcriptional regulation pathogenic process gastric cancer
HSALNT0289572 HSALNG0141687 AK021630 NA NA pathogenic process Parkinson's disease
HSALNT0289603 HSALNG0141718 AL049437 NA NA pathogenic process Parkinson's disease
HSALNT0290007 HSALNG0142122 LOC100507661 NA NA pathogenic process thyroid cancer
HSALNT0289084 HSALNG0122663 LINC01029 NA NA pathogenic process cognitive functions and neuronal plasticity
HSALNT0290169 HSALNG0142284 RMEL3 NA NA pathogenic process melanoma
HSALNT0289959 HSALNG0142074 lnc-FRG2C-3 NA NA pathogenic process ankylosing spondylitis
HSALNT0289966 HSALNG0142081 lnc-LIN54-1 NA NA pathogenic process ankylosing spondylitis
HSALNT0289997 HSALNG0142112 lnc-USP50-2 NA NA pathogenic process ankylosing spondylitis
HSALNT0290000 HSALNG0142115 lnc-ZNF354A-1 NA NA pathogenic process ankylosing spondylitis
HSALNT0288949 HSALNG0017887 ENST00000455309 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0289920 HSALNG0142035 LINC02384 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0289998 HSALNG0142113 Lnc-UTS2D-1:1 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0290067 HSALNG0142182 n336161 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0290069 HSALNG0142184 n340599 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0290099 HSALNG0142214 NR_002712 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0290290 HSALNG0142405 TCONS_l2_00014794 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0290170 HSALNG0142285 RMRP CHH,NME1R,RRP2,RMRP ceRNA pathogenic process gastric cancer
HSALNT0289900 HSALNG0142015 LINC00961 NA NA pathogenic process ovarian cancer
HSALNT0289077 HSALNG0068551 LINC00977 NA NA pathogenic process primary spontaneous pneumothorax
HSALNT0289560 HSALNG0141675 AF085995 NA NA pathogenic process lung cancer
HSALNT0289566 HSALNG0141681 AK000053 NA NA pathogenic process lung cancer
HSALNT0289571 HSALNG0141686 AK021595 NA NA pathogenic process lung cancer
HSALNT0289574 HSALNG0141689 AK022024 NA NA pathogenic process lung cancer
HSALNT0289595 HSALNG0141710 AK124307 NA NA pathogenic process lung cancer
HSALNT0289639 HSALNG0141754 BC020384 NA NA pathogenic process lung cancer
HSALNT0289642 HSALNG0141757 BC030759 NA NA pathogenic process lung cancer
HSALNT0289715 HSALNG0141830 CR615992 NA NA pathogenic process lung cancer
HSALNT0289954 HSALNG0142069 lnc-CC3 NA NA pathogenic process cervical cancer
HSALNT0289614 HSALNG0141729 APOC1P1-3 NA transcriptional regulation pathogenic process breast cancer
HSALNT0290365 HSALNG0142480 UNMIBC NA transcriptional regulation pathogenic process bladder cancer
HSALNT0290323 HSALNG0142438 uc.167 NA NA pathogenic process ventricular septal defects
HSALNT0290212 HSALNG0142327 RP11-838N2.4 GAPLINC ceRNA pathogenic process glioblastoma
HSALNT0289109 HSALNG0121223 LINC01478 NA NA pathogenic process blood pressure
HSALNT0289313 HSALNG0016990 LINC00342 NA NA pathogenic process non-small cell lung cancer
HSALNT0289677 HSALNG0141792 CAR10 NA NA pathogenic process lung cancer
HSALNT0289365 HSALNG0141638 MAPT-AS1 NA transcriptional regulation pathogenic process Parkinson's disease
HSALNT0289679 HSALNG0141794 CAT104 NA ceRNA pathogenic process breast cancer
HSALNT0290260 HSALNG0142375 STXBP5-AS1 NA ceRNA pathogenic process breast cancer
HSALNT0289861 HSALNG0141976 HAR1 NA NA pathogenic process Huntington disease
HSALNT0290359 HSALNG0142474 UCHL1-AS1 NA translational control pathogenic process Parkinson's disease
HSALNT0290238 HSALNG0142353 SCAANT1-AS NA NA pathogenic process spinocerebellar ataxia
HSALNT0289648 HSALNG0141763 BC041488 NA transcriptional regulation pathogenic process bladder cancer
HSALNT0290188 HSALNG0142303 RP11-359E19.2 AC022733.1 transcriptional regulation pathogenic process bladder cancer
HSALNT0289669 HSALNG0141784 C6orf176-TV1 NA NA pathogenic process non-small cell lung cancer
HSALNT0289670 HSALNG0141785 C6orf176-TV2 NA NA pathogenic process non-small cell lung cancer
HSALNT0289851 HSALNG0141966 GIHCG NA transcriptional regulation pathogenic process hepatocellular cancer
HSALNT0289649 HSALNG0141764 BC087858 NA NA pathogenic process non-small cell lung cancer
HSALNT0290353 HSALNG0142468 uc004cov.4 NA NA pathogenic process hypertrophic cardiomyopathy
HSALNT0290357 HSALNG0142472 uc022bqu.1 NA NA pathogenic process hypertrophic cardiomyopathy
HSALNT0127837 HSALNG0060796 CFTR-AS1 BGas transcriptional regulation pathogenic process cystic fibrosis
HSALNT0046367 HSALNG0021858 MYOSLID NA NA pathogenic process vascular smooth muscle cell (VSMC) contractile phenotype
HSALNT0290331 HSALNG0142446 uc.63 NA NA pathogenic process breast cancer
HSALNT0290106 HSALNG0142221 numb NA NA pathogenic process uveal melanoma
HSALNT0289847 HSALNG0141962 GCASPC TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 NA pathogenic process gallbladder cancer
HSALNT0289568 HSALNG0141683 AK001094 NA NA pathogenic process gastric cancer
HSALNT0289588 HSALNG0141703 AK093735 NA NA pathogenic process gastric cancer
HSALNT0289631 HSALNG0141746 BC003519 NA NA pathogenic process gastric cancer
HSALNT0290100 HSALNG0142215 NR_003573 ANXA2P2 NA pathogenic process gastric cancer
HSALNT0290119 HSALNG0142234 P2RX7-V3 NA NA pathogenic process uveal melanoma
HSALNT0290308 HSALNG0142423 TMSB4 NA ceRNA pathogenic process osteoarthritis
HSALNT0288928 HSALNG0090163 DDX11-AS1 CONCR NA pathogenic process NA
HSALNT0290052 HSALNG0142167 MELOE NA NA pathogenic process melanoma
HSALNT0290231 HSALNG0142346 RSU1P2 RSU1P2 ceRNA pathogenic process cervical cancer
HSALNT0290165 HSALNG0142280 RBMY2FP RBMY2FP NA NA hepatocellular cancer
HSALNT0290071 HSALNG0142186 n375709 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289748 HSALNG0141863 DUXAP8 DUXAP8 NA NA gastric cancer
HSALNT0290030 HSALNG0142145 LOC729966 NA NA pathogenic process papillary thyroid cancer
HSALNT0290143 HSALNG0142258 POIR NA ceRNA pathogenic process periodontitis
HSALNT0067481 HSALNG0031988 MELTF-AS1 MFI2-AS1,AC068302.3 NA pathogenic process osteosarcoma
HSALNT0290053 HSALNG0142168 MFI2 NA NA pathogenic process osteosarcoma
HSALNT0289922 HSALNG0142037 linc-223 NA ceRNA pathogenic process acute myeloid leukemia
HSALNT0014603 HSALNG0006859 LINC01138 LINC00875,FLJ39739 NA pathogenic process prostate cancer
HSALNT0290262 HSALNG0142377 SUZ12P1 SUZ12P1 NA pathogenic process prostate cancer
HSALNT0290005 HSALNG0142120 LOC100505976 NA NA pathogenic process laryngeal squamous cell cancer
HSALNT0290392 HSALNG0142507 XLOC_l2_010636 NA NA pathogenic process laryngeal squamous cell cancer
HSALNT0090295 HSALNG0043014 RASGRF2-AS1 CTC-459I6.1 NA pathogenic process sepsis-induced endothelial dysfunction
HSALNT0289852 HSALNG0141967 GPC3-AS1 NA transcriptional regulation pathogenic process hepatocellular cancer
HSALNT0189472 HSALNG0091321 HOXC-AS1 NA transcriptional regulation pathogenic process atherosclerosis
HSALNT0289157 HSALNG0057557 LUARIS lncRNA#32 transcriptional regulation NA NA
HSALNT0289371 HSALNG0044828 MIR3936HG LOC553103,SLC22A5-AS1 NA pathogenic process gastric cancer;nasopharyngeal cancer
HSALNT0290148 HSALNG0142263 Ppp1r1b NA transcriptional regulation pathogenic process congenital heart defect
HSALNT0289038 HSALNG0099182 LINC00460 NA NA pathogenic process colorectal cancer
HSALNT0290194 HSALNG0142309 RP1-13P20.6 NA NA pathogenic process colorectal cancer
HSALNT0290364 HSALNG0142479 Unigene56159 NA ceRNA pathogenic process hepatocellular cancer
HSALNT0290355 HSALNG0142470 uc009yby.1 NA NA pathogenic process renal cell cancer
HSALNT0289406 HSALNG0048011 TFAP2A-AS2 HIPSTR NA developmental process NA
HSALNT0289704 HSALNG0141819 Chaer NA transcriptional regulation pathogenic process cardiac hypertrophy
HSALNT0289865 HSALNG0141980 HIF-2α NA NA pathogenic process NA
HSALNT0211378 HSALNG0101489 LINC00520 C14orf34 NA pathogenic process breast cancer
HSALNT0087374 HSALNG0041561 MRPS30-DT BRCAT54 NA pathogenic process breast cancer
HSALNT0289388 HSALNG0092662 PPP1R12A-AS1 R12A-AS1 translational control NA NA
HSALNT0289013 HSALNG0088600 ITFG2-AS1 NA NA NA NA
HSALNT0290088 HSALNG0142203 NONHSAT041499 NA NA pathogenic process schizophrenia
HSALNT0290091 HSALNG0142206 NONHSAT089447 NA NA pathogenic process schizophrenia
HSALNT0289970 HSALNG0142085 lnc-NKX2-3-1 NA transcriptional regulation pathogenic process acute lymphoblastic leukemia
HSALNT0289989 HSALNG0142104 lnc-RTN4R-1 NA transcriptional regulation pathogenic process acute lymphoblastic leukemia
HSALNT0289821 HSALNG0141936 ERL NA NA pathogenic process Marek's disease
HSALNT0192459 HSALNG0092867 LINC02258 RP11-248E9.5 NA pathogenic process pneumonia
HSALNT0241871 HSALNG0117085 SKAP1-AS1 RP11-456D7.1 NA pathogenic process pneumonia
HSALNT0289439 HSALNG0049760 DINOL DINO NA NA NA
HSALNT0288901 HSALNG0000547 CAMTA1-DT lncCAMTA1 transcriptional regulation pathogenic process liver cancer
HSALNT0290328 HSALNG0142443 uc.345 NA transcriptional regulation pathogenic process pancreatic cancer
HSALNT0290060 HSALNG0142175 MSNP1AS NA translational control pathogenic process autism spectrum disorder
HSALNT0289376 HSALNG0004596 NEXN-AS1 C1orf118,FLJ90637 NA pathogenic process lung cancer
HSALNT0183194 HSALNG0088083 LINC02098 RP11-702B10.1 NA pathogenic process esophageal cancer
HSALNT0198055 HSALNG0095473 PSPC1-AS2 RP11-523H24.3 NA pathogenic process esophageal cancer
HSALNT0289155 HSALNG0114857 LRRC75A-AS1 C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 NA pathogenic process rheumatoid arthritis
HSALNT0289220 HSALNG0077999 PRKG1-AS1 RP11-573I11.2 NA pathogenic process rheumatoid arthritis
HSALNT0289262 HSALNG0076970 SVIL-AS1 RP11-534G20.3 NA pathogenic process rheumatoid arthritis
HSALNT0289281 HSALNG0108169 VPS33B-DT NA NA pathogenic process rheumatoid arthritis
HSALNT0289804 HSALNG0141919 ENST00000438399 NA NA pathogenic process rheumatoid arthritis
HSALNT0290228 HSALNG0142343 RPKG1-AS1 NA NA pathogenic process rheumatoid arthritis
HSALNT0290350 HSALNG0142465 uc004afb.1 NA NA pathogenic process rheumatoid arthritis
HSALNT0289398 HSALNG0135015 SLC5A4-AS1 RP1-90G24.10 NA pathogenic process gastric cancer
HSALNT0289411 HSALNG0063964 TNFRSF10A-AS1 RP11-1149O23.2 NA pathogenic process gastric cancer
HSALNT0289727 HSALNG0141842 CTD-2616J11.14 AC008750.7 NA pathogenic process gastric cancer
HSALNT0290182 HSALNG0142297 RP11-150O12.3 AC124067.4 NA pathogenic process gastric cancer
HSALNT0289730 HSALNG0141845 CXCL1P1 CXCL1P1 NA pathogenic process hepatocellular cancer
HSALNT0289803 HSALNG0141918 ENST00000438347 CCND3P1 NA pathogenic process hepatocellular cancer
HSALNT0289897 HSALNG0142012 LINC00601 NA NA pathogenic process hepatocellular cancer
HSALNT0289503 HSALNG0141614 KIAA0087 NA NA pathogenic process endometrial cancer
HSALNT0289827 HSALNG0141942 FAM212B-AS1 NA NA pathogenic process endometrial cancer
HSALNT0290010 HSALNG0142125 LOC102723552 NA NA pathogenic process endometrial cancer
HSALNT0290181 HSALNG0142296 RP11-140I24 LINC01568 NA pathogenic process endometrial cancer
HSALNT0290201 HSALNG0142316 RP11-501O2 LINC02046 NA pathogenic process endometrial cancer
HSALNT0290206 HSALNG0142321 RP11-600K151 NA NA pathogenic process endometrial cancer
HSALNT0290084 HSALNG0142199 NONHSAG051968 NA NA pathogenic process papillary thyroid cancer
HSALNT0290090 HSALNG0142205 NONHSAT076747 NA NA pathogenic process papillary thyroid cancer
HSALNT0290094 HSALNG0142209 NONHSAT122730 NA NA pathogenic process papillary thyroid cancer
HSALNT0138768 HSALNG0066240 MIR2052HG NA transcriptional regulation pathogenic process breast cancer
HSALNT0289096 HSALNG0096884 LINC01198 NA NA pathogenic process glioma
HSALNT0289274 HSALNG0096821 TPT1-AS1 NA NA pathogenic process glioma
HSALNT0289924 HSALNG0142039 linc-cdh4-2 NA NA pathogenic process hepatocellular cancer
HSALNT0144641 HSALNG0068878 LINC02055 RP1130-1 NA pathogenic process hepatocellular cancer
HSALNT0289737 HSALNG0141852 DBCCR1 NA transcriptional regulation pathogenic process bladder cancer
HSALNT0289547 HSALNG0141662 AC012065.7 NA NA pathogenic process chronic lymphocytic leukemia
HSALNT0289229 HSALNG0116565 RAMP2-AS1 NA NA pathogenic process glioblastoma
HSALNT0289591 HSALNG0141706 AK098081 NA NA pathogenic process colorectal cancer
HSALNT0289644 HSALNG0141759 BC037331 NA NA pathogenic process colorectal cancer
HSALNT0289646 HSALNG0141761 BC040303 NA NA pathogenic process colorectal cancer
HSALNT0289717 HSALNG0141832 CR749831 NA NA pathogenic process colorectal cancer
HSALNT0289250 HSALNG0040073 SNHG18 NA NA pathogenic process glioma
HSALNT0106140 HSALNG0050030 FOXP4-AS1 NA NA pathogenic process colorectal cancer
HSALNT0026202 HSALNG0012584 RNASEH1-AS1 LOC100506054 NA pathogenic process colorectal cancer
HSALNT0288993 HSALNG0088026 GSEC ST3GAL4-AS1,DCPS-AS1,FLJ39051 NA pathogenic process colorectal cancer
HSALNT0060264 HSALNG0028799 DNAJB8-AS1 NA NA NA NA
HSALNT0248137 HSALNG0120059 CHMP1B-AS1 NA NA NA NA
HSALNT0021970 HSALNG0010602 TGFB2-AS1 NR_046268 NA pathogenic process early-onset preeclampsia
HSALNT0078323 HSALNG0037356 SLC7A11-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0134663 HSALNG0064248 INTS9-AS1 ENST00000520055 NA pathogenic process early-onset preeclampsia
HSALNT0231572 HSALNG0111641 MMP2-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0267869 HSALNG0130456 SLC12A5-AS1 RP11-465L10.10 NA pathogenic process early-onset preeclampsia
HSALNT0288921 HSALNG0002415 CSMD2-AS1 ENST00000434181 NA pathogenic process early-onset preeclampsia
HSALNT0288997 HSALNG0052934 HDAC2-AS2 ENST00000421891 NA pathogenic process early-onset preeclampsia
HSALNT0289012 HSALNG0105327 INO80-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0289140 HSALNG0075065 LINC02247 NA NA pathogenic process early-onset preeclampsia
HSALNT0289161 HSALNG0059170 MAGI2-AS3 NA NA pathogenic process early-onset preeclampsia
HSALNT0289188 HSALNG0062699 MNX1-AS2 NA NA pathogenic process early-onset preeclampsia
HSALNT0289245 HSALNG0140277 SMIM10L2B-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0289407 HSALNG0102543 TGFB3-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0289457 HSALNG0073036 HSD17B3-AS1 NA NA pathogenic process early-onset preeclampsia
HSALNT0289919 HSALNG0142034 LINC02246 NA NA pathogenic process early-onset preeclampsia
HSALNT0289288 HSALNG0100050 ZNF710-AS1 ENST00000558334 NA pathogenic process early-onset preeclampsia
HSALNT0289266 HSALNG0007188 TDRKH-AS1 RP11-98D18.9 NA pathogenic process NA
HSALNT0289128 HSALNG0057684 LINC01952 AC004854.4 NA pathogenic process recurrent miscarriage
HSALNT0290075 HSALNG0142190 NCF4-AS1 CTA-833B7.2 NA pathogenic process recurrent miscarriage
HSALNT0289360 HSALNG0029603 LNCSRLR lncRNA-SRLR transcriptional regulation pathogenic process renal cell cancer
HSALNT0288918 HSALNG0021529 CFLAR-AS1 ALS2CR10 NA pathogenic process esophageal squamous cell cancer
HSALNT0289710 HSALNG0141825 COL1A2-AS1 TCONS_00013888,lncRNA8975-1 transcriptional regulation pathogenic process hypertrophic scar
HSALNT0075075 HSALNG0035847 LNCPRESS2 lncPRESS2 transcriptional regulation NA NA
HSALNT0011289 HSALNG0005432 LINC01930 EU358092 NA pathogenic process schizophrenia
HSALNT0097120 HSALNG0046325 HMMR-AS1 NA NA pathogenic process basal-like breast cancer
HSALNT0184498 HSALNG0088703 CCND2-AS1 CCND2-AS2 NA pathogenic process glioma
HSALNT0289045 HSALNG0030884 LINC00578 NA NA pathogenic process major depression disorder
HSALNT0288884 HSALNG0026576 ADAMTS9-AS1 NA NA pathogenic process epithelial ovarian cancer
HSALNT0080041 HSALNG0038152 FAM198B-AS1 NA NA pathogenic process NA
HSALNT0103007 HSALNG0048820 LINC00240 C6orf41,NCRNA00240,bA373D17.1 ceRNA pathogenic process esophageal squamous cell cancer
HSALNT0289071 HSALNG0122453 LINC00909 NA NA NA NA
HSALNT0289509 HSALNG0141620 LINC00680 NA NA NA NA
HSALNT0129070 HSALNG0061394 LINC00513 AC016831.7 NA NA NA
HSALNT0289129 HSALNG0115960 LINC02001 RP11-1094M14.11 NA NA NA
HSALNT0289215 HSALNG0092950 POC1B-AS1 RP11-734K2.4 NA NA NA
HSALNT0289241 HSALNG0060049 SLC12A9-AS1 RP11-126L15.4 NA NA NA
HSALNT0289275 HSALNG0050617 TRAM2-AS1 NA NA NA NA
HSALNT0002243 HSALNG0001176 LINC01772 ENSG00000226029 ceRNA pathogenic process oesophageal cancer
HSALNT0288941 HSALNG0009693 ELF3-AS1 ENST00000415582 NA pathogenic process papillary thyroid cancer
HSALNT0289134 HSALNG0025450 LINC02158 NA NA pathogenic process breast cancer
HSALNT0289350 HSALNG0133329 LINC01671 BC041455 NA pathogenic process breast cancer
HSALNT0289124 HSALNG0132343 LINC01684 lnc-JAM2-6 NA pathogenic process nonalcoholic fatty liver disease
HSALNT0289036 HSALNG0096092 LINC00365 NA NA pathogenic process esophageal cancer
HSALNT0289111 HSALNG0043625 LINC01554 C5orf27,FLJ38821,FIS NA pathogenic process esophageal cancer
HSALNT0289132 HSALNG0136701 LINC02154 GS1-600G8.5 NA pathogenic process esophageal cancer
HSALNT0137721 HSALNG0065704 LINC02155 RP11-705O24.1 NA pathogenic process esophageal cancer
HSALNT0225363 HSALNG0108398 LINC02157 RP11-327J17.1 NA pathogenic process esophageal cancer
HSALNT0289133 HSALNG0090758 LINC02156 RP1-90J4.1 NA pathogenic process esophageal cancer
HSALNT0133924 HSALNG0063832 LINC02153 NA NA pathogenic process major depression disorder
HSALNT0181656 HSALNG0087394 LINC02151 TCONS_00019174 NA pathogenic process major depression disorder
HSALNT0227367 HSALNG0109385 LINC02152 NA NA pathogenic process major depression disorder
HSALNT0029246 HSALNG0013844 BRE-AS1 NA NA NA NA
HSALNT0289251 HSALNG0056623 SNHG26 AC005682.5 NA pathogenic process bladder urothelial cancer
HSALNT0252719 HSALNG0122284 LIVAR lnc18q22.2 NA pathogenic process nonalcoholic steatohepatiti
HSALNT0289074 HSALNG0031832 LINC00969 ENST00000453324 NA pathogenic process lung squamous cell cancer
HSALNT0289138 HSALNG0140259 LINC02243 ENST00000441841 NA pathogenic process lung squamous cell cancer
HSALNT0289399 HSALNG0039449 SLC9A3-AS1 UC011CLY.2 NA pathogenic process lung squamous cell cancer
HSALNT0288934 HSALNG0126602 DM1-AS NA NA pathogenic process myotonic dystrophy type 1
HSALNT0009014 HSALNG0004475 LINC02238 RP4-788P17.1 NA pathogenic process B cell lymphoma
HSALNT0289163 HSALNG0043374 MEF2C-AS2 CTC-467M3.1 NA pathogenic process diffuse large B-cell lymphoma
HSALNT0289181 HSALNG0003824 MIR4422HG RP11-101C11.1 NA pathogenic process diffuse large B-cell lymphoma
HSALNT0289403 HSALNG0082800 SPON1-AS1 RP11-21,L19.1 NA pathogenic process diffuse large B-cell lymphoma
HSALNT0289461 HSALNG0083610 CD44-AS1 RP1-68D18.4 NA pathogenic process diffuse large B-cell lymphoma
HSALNT0262277 HSALNG0127560 LILRB1-AS1 AC009892.10 NA pathogenic process NA
HSALNT0289546 HSALNG0141661 AC009892.10 LILRB1-AS1 NA NA B cell lymphoma
HSALNT0282241 HSALNG0137635 LINC01186 NA NA pathogenic process lung cancer
HSALNT0289168 HSALNG0131657 MHENCR NA ceRNA pathogenic process melanoma
HSALNT0072994 HSALNG0034801 LINC02232 RP11-707A18.1 NA pathogenic process NA
HSALNT0080161 HSALNG0038220 LINC02233 RP11-6C14.1 NA pathogenic process NA
HSALNT0084027 HSALNG0039930 LINC02236 RP11-332J15.1 NA pathogenic process NA
HSALNT0091870 HSALNG0043678 LINC02234 RP11-455B3.1 NA pathogenic process NA
HSALNT0139521 HSALNG0066607 LINC02235 RP11-354A14.1 NA pathogenic process NA
HSALNT0142040 HSALNG0067779 LINC02237 RP11-1101K5.1 NA pathogenic process NA
HSALNT0289135 HSALNG0111295 LINC02179 RP11-189E14.4 NA pathogenic process NA
HSALNT0289351 HSALNG0132340 LINC01689 AP000469.2 NA pathogenic process NA
HSALNT0289137 HSALNG0091963 LINC02231 RP11-766N7.4 NA pathogenic process Esophageal squamous cell cancer
HSALNT0220239 HSALNG0105903 MIR4713HG RP11-108K3.1 NA pathogenic process colorectal cancer
HSALNT0288967 HSALNG0037858 FAM160A1-DT RP11-610P16.1 NA pathogenic process colorectal cancer
HSALNT0289239 HSALNG0021423 SATB2-AS1 NA translational control pathogenic process osteosarcoma
HSALNT0289512 HSALNG0141623 LINC01826 lnc-MKI67IP-3 ceRNA pathogenic process atherosclerosis
HSALNT0289024 HSALNG0104253 LINC00226 C14orf97,NCRNA00226 NA pathogenic process pancreatic ductaladenocarcinoma
HSALNT0082192 HSALNG0039173 F11-AS1 NA NA NA NA
HSALNT0219108 HSALNG0105295 SPINT1-AS1 RP11-532F12.5 NA pathogenic process melanoma
HSALNT0289177 HSALNG0088950 MIR200CHG U47924.27 NA pathogenic process melanoma
HSALNT0289328 HSALNG0031153 LINC00888 NA NA pathogenic process melanoma
HSALNT0289309 HSALNG0116205 LINC00672 NA transcriptional regulation pathogenic process endometrial cancer
HSALNT0289198 HSALNG0085691 P4HA3-AS1 NA NA pathogenic process parkinson's disease
HSALNT0197312 HSALNG0095075 TMEM132D-AS1 LOC283352 NA pathogenic process human dermal fibroblasts
HSALNT0289472 HSALNG0113128 ATP2C2-AS1 RP11-517C16.2-001 NA NA NA
HSALNT0233849 HSALNG0112863 WWOX-AS1 RP11-190D6.2 NA pathogenic process epithelial ovarian cancer
HSALNT0128829 HSALNG0061246 FLNC-AS1 NA NA pathogenic process cervical squamous cancer
HSALNT0289889 HSALNG0142004 LIF-AS1 Lnc-LIF-AS NA pathogenic process cervical squamous cancer
HSALNT0011283 HSALNG0005428 DPYD-AS2 NA NA pathogenic process cervical squamous cancer
HSALNT0289836 HSALNG0141951 FLICR NA transcriptional regulation pathogenic process autoimmune diabete
HSALNT0289356 HSALNG0090563 LINC02402 ENST00000550337.1 NA pathogenic process diabetes
HSALNT0137118 HSALNG0065453 CERNA3 CTA ceRNA pathogenic process osteosarcoma
HSALNT0090838 HSALNG0043312 LINC02488 CTD-2316B1 NA pathogenic process NA
HSALNT0174947 HSALNG0083979 LINC02489 CTD-2589M5 NA pathogenic process NA
HSALNT0220441 HSALNG0105991 LINC02490 RP11-209E8 NA pathogenic process NA
HSALNT0289260 HSALNG0045650 STK32A-AS1 CTC-255N20 NA pathogenic process NA
HSALNT0289143 HSALNG0055190 LINC02487 NA NA pathogenic process squamous cell cancer
HSALNT0095585 HSALNG0045503 SPRY4-AS1 THCAT68 NA pathogenic process bladder cancer
HSALNT0288927 HSALNG0090908 DDN-AS1 CAT1507 NA pathogenic process bladder cancer
HSALNT0012862 HSALNG0006150 SLC16A1-AS1 NA NA pathogenic process acute myocardial infarction
HSALNT0289412 HSALNG0000276 TNFRSF14-AS1 ENST00000416860.2 NA pathogenic process acute myocardial infarction
HSALNT0259139 HSALNG0125745 LINC00665 NA NA NA NA
HSALNT0040268 HSALNG0019085 DARS-AS1 NA NA pathogenic process renal disease
HSALNT0288913 HSALNG0125425 CEBPA-AS1 CEBPA-DT NA pathogenic process gastric cancer
HSALNT0289011 HSALNG0057479 INHBA-AS1 NA NA pathogenic process gastric cancer
HSALNT0288988 HSALNG0067472 GASAL1 GASL1 NA pathogenic process liver cancer
HSALNT0289127 HSALNG0021881 LINC01857 AC079767.4 NA pathogenic process tuberculosis
HSALNT0289091 HSALNG0004949 LINC01140 FLJ41676 NA NA NA
HSALNT0281957 HSALNG0137521 PINCR NA transcriptional regulation pathogenic process colorectal cancer
HSALNT0289344 HSALNG0139543 LINC00890 NA NA pathogenic process leiomyoma
HSALNT0019828 HSALNG0009573 LINC00862 C1orf98,SMIM16 NA pathogenic process cystic fibrosis
HSALNT0073790 HSALNG0035237 LINC02562 RP11-44F21.5 NA pathogenic process cystic fibrosis
HSALNT0263101 HSALNG0127961 LINC02560 CTD-2619J13.13 NA pathogenic process cystic fibrosis
HSALNT0289144 HSALNG0088252 LINC02551 RP11-890B15.2 NA pathogenic process cystic fibrosis
HSALNT0289458 HSALNG0078773 DDIT4-AS1 RP11-442H21.2 NA pathogenic process cystic Fibrosis
HSALNT0288992 HSALNG0089423 GPRC5D-AS1 RP11-392P7.6 NA pathogenic process colorectal cancer
HSALNT0289386 HSALNG0015768 PCBP1-AS1 NA NA pathogenic process NA
HSALNT0289405 HSALNG0044141 STARD4-AS1 NA NA pathogenic process NA
HSALNT0201547 HSALNG0097004 LINC00462 NA NA pathogenic process hepatocellular cancer
HSALNT0207103 HSALNG0099453 SOX1-OT LINC00403 NA pathogenic process NA
HSALNT0002131 HSALNG0001107 SLC25A34-AS1 RP11-169K16.4 NA NA NA
HSALNT0289218 HSALNG0075163 PPP1R26-AS1 NA NA pathogenic process breast cancer
HSALNT0289047 HSALNG0064310 LINC00589 C8orf75,TSLNC8 NA pathogenic process hepatocellular cancer
HSALNT0289516 HSALNG0141627 TPM1-AS TPM1-AS1 splicing regulation pathogenic process esophageal cancer
HSALNT0289314 HSALNG0141631 LINC01101 FLJ14816 NA pathogenic process HPV-induced cervical neoplasia
HSALNT0289147 HSALNG0018748 LINC02572 AC079776.2 NA pathogenic process epithelial ovarian cancer
HSALNT0096804 HSALNG0046188 LINC02202 NA NA NA NA
HSALNT0289076 HSALNG0027511 LINC00973 CTD-2021J15.2 NA pathogenic process colorectal cancer
HSALNT0288625 HSALNG0141401 TTTY10 NCRNA00133 NA pathogenic process colorectal cancer
HSALNT0289323 HSALNG0133418 LINC00319 C21orf125,NCRNA00319,PRED49,FLJ38036 ceRNA pathogenic process lung cancer
HSALNT0015533 HSALNG0007394 IL6R-AS1 RP11-350G8.5 NA NA NA
HSALNT0090330 HSALNG0043020 CKMT2-AS1 NA NA NA NA
HSALNT0012995 HSALNG0006203 HIPK1-AS1 NA NA NA NA
HSALNT0289216 HSALNG0050214 POLH-AS1 RP3-337H4.8 NA NA NA
HSALNT0289276 HSALNG0053237 TRDN-AS1 HRAT13 NA NA NA
HSALNT0289159 HSALNG0069213 LY6E-DT LOC100133669 NA pathogenic process ovarian cancer
HSALNT0289434 HSALNG0040409 BASP1-AS1 LOC285696 NA pathogenic process NA
HSALNT0288991 HSALNG0069691 GLIS3-AS1 C9orf70,MGC16153 NA NA NA
HSALNT0288896 HSALNG0070213 BNC2-AS1 RP11-62F24.2 NA pathogenic process gastric cancer
HSALNT0289292 HSALNG0078947 ZNF503-AS1 NA NA pathogenic process age-related macular degeneration
HSALNT0159506 HSALNG0076434 VIM-AS1 NA NA pathogenic process endometrial cancer
HSALNT0288882 HSALNG0011058 ACBD3-AS1 RP11-275I14.4 NA pathogenic process endometrial cancer
HSALNT0289156 HSALNG0005074 LRRC8C-DT FLJ27354 NA pathogenic process endometrial cancer
HSALNT0289447 HSALNG0058889 ELN-AS1 CTB-51J22.1 NA pathogenic process endometrial cancer
HSALNT0076712 HSALNG0036645 LINC02264 NA NA pathogenic process gastric cancer
HSALNT0093666 HSALNG0044495 LINC02201 NA NA pathogenic process gastric cancer
HSALNT0271685 HSALNG0132198 LINC02573 NA NA pathogenic process gastric cancer
HSALNT0289125 HSALNG0015785 LINC01816 LOC100133985 NA pathogenic process gastric cancer
HSALNT0289355 HSALNG0091335 LINC02381 LOC400043 NA pathogenic process gastric cancer
HSALNT0289366 HSALNG0029874 MBNL1-AS1 LOC401093 NA pathogenic process gastric cancer
HSALNT0289513 HSALNG0141624 MIR4697HG LINC00947,LOC283174 NA pathogenic process gastric cancer
HSALNT0289073 HSALNG0065480 LINC00968 NA NA pathogenic process non-small cell lung cancer
HSALNT0114453 HSALNG0053963 NMBR-AS1 RP11-137J7.2 NA pathogenic process non-melanoma skin cancer
HSALNT0289300 HSALNG0077499 LINC01518 NA NA pathogenic process non-melanoma skin cancer
HSALNT0003783 HSALNG0002009 LINC02574 RP11-288L9.1 transcriptional regulation pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0032721 HSALNG0015486 LINC02579 AC007365.1 NA pathogenic process NA
HSALNT0030828 HSALNG0014519 LINC02580 AC093609.1 NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0032808 HSALNG0015519 LINC02576 NA NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0127022 HSALNG0060386 LINC02577 NA NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0154722 HSALNG0074062 LINC02578 RP11-127L21.1 NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0288962 HSALNG0084388 FAM111A-DT NA NA pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0289148 HSALNG0133545 LINC02575 AP001065.15 transcriptional regulation pathogenic process UVB-irradiated KC & non-melanoma skin cancer
HSALNT0025249 HSALNG0012143 KIF26B-AS1 RP11-62I21.1 NA NA NA
HSALNT0177212 HSALNG0085146 RPS6KB2-AS1 AP003419.16 NA pathogenic process aging‑associated idiopathic pulmonary fibrosis
HSALNT0289072 HSALNG0090150 LINC00941 lncRNA-MUF ceRNA pathogenic process hepatocellular cancer
HSALNT0289338 HSALNG0075045 LINC00094 FLJ35348,bA374P20.3 NA pathogenic process lung squamous cell cancer
HSALNT0114192 HSALNG0053894 FILNC1 NA translational control pathogenic process renal tumor
HSALNT0289199 HSALNG0128600 PARAL1 NA ceRNA pathogenic process obesity
HSALNT0244832 HSALNG0118528 SOX9-AS1 FLJ37644 transcriptional regulation NA NA
HSALNT0289236 HSALNG0118528 ROCR LINC02095 transcriptional regulation NA NA
HSALNT0056667 HSALNG0027060 LINC02027 LOC728290 NA pathogenic process hepatocellular cancer
HSALNT0289424 HSALNG0141124 TTTY22 NCRNA00147 NA NA NA
HSALNT0289069 HSALNG0030090 LINC00880 NA NA NA NA
HSALNT0252974 HSALNG0122396 LINC02582 CTD-2354A18.1 NA pathogenic process colorectal cancer
HSALNT0289035 HSALNG0097712 LINC00364 LncRNA00364 NA pathogenic process hepatocellular cancer
HSALNT0060981 HSALNG0029189 NCK1-DT NCK1-AS1,SLC35G2-AS1 ceRNA pathogenic process cervical cancer
HSALNT0288890 HSALNG0067505 BAALC-AS1 lncFZD6,FZD6-DT transcriptional regulation pathogenic process liver cancer
HSALNT0046602 HSALNG0021972 CPS1-IT1 CPS1-IT,CPS1IT,CPS1IT1,PRO0132 NA pathogenic process hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma
HSALNT0289445 HSALNG0059740 DLX6-AS1 DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 transcriptional regulation pathogenic process split hand/split foot malformation disorder;lung adenocarcinoma
HSALNT0289891 HSALNG0142006 LINC00114 NA NA NA NA
HSALNT0289415 HSALNG0138601 TSIX LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS transcriptional regulation pathogenic process systemic sclerosis
HSALNT0217334 HSALNG0104503 MKRN3-AS1 ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS NA pathogenic process Prader-Willi syndrome
HSALNT0290256 HSALNG0142371 SRA lnc-SRA1-1:1,SRA1,ENSG00000213523 transcriptional regulation pathogenic process nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer
HSALNT0289442 HSALNG0049271 HCP5 6S2650E,D6S2650E,P5-1 NA pathogenic process AIDS
HSALNT0289284 HSALNG0083476 WT1-AS WIT1,WIT-1,WT1A, WT1-AS1 transcriptional regulation pathogenic process gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia
HSALNT0289421 HSALNG0082235 KCNQ1OT1 KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 transcriptional regulation pathogenic process prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer
HSALNT0263784 HSALNG0128372 PCNA-AS1 PCNAA, PCNA-AS transcriptional regulation pathogenic process gastric cancer;hepatocelluar cancer
HSALNT0289524 HSALNG0049107 HCG9 PERB11,HCGIX,HCGIX4,HCGIX-4 NA NA NA
HSALNT0289264 HSALNG0103448 TCL6 TCL6e1,TNG2,TNG1 NA pathogenic process;developmental process renal cell cancer;leukemia
HSALNT0289203 HSALNG0072040 PCA3 DD3,NCRNA00019,PCAT3 transcriptional regulation;ceRNA pathogenic process prostate cancer
HSALNT0289462 HSALNG0082178 H19 ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 transcriptional regulation;ceRNA developmental process;pathogenic process prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor
HSALNT0288932 HSALNG0097105 DLEU1 BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 transcriptional regulation;ceRNA pathogenic process lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer
HSALNT0289493 HSALNG0141604 DBH-AS1 NCRNA00118,BPR NA pathogenic process hepatocellular cancer
HSALNT0088415 HSALNG0042101 PART1 DKFZP586D0823,NCRNA00206 NA pathogenic process prostate cancer;glioblastoma
HSALNT0289463 HSALNG0082197 IGF2-AS IGF2A,PEG8,IGF2-AS1 transcriptional regulation pathogenic process liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer
HSALNT0269786 HSALNG0131285 GNAS-AS1 GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 transcriptional regulation pathogenic process non-small cell lung cancer;pseudohypoparathyroidism type Ib
HSALNT0289252 HSALNG0051709 SNHG5 C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 NA pathogenic process gastric cancer;lymphoma;melanoma
HSALNT0023827 HSALNG0011462 DISC2 DISC1-AS1,DISC1O, NCRNA00015 transcriptional regulation pathogenic process bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression
HSALNT0203415 HSALNG0097806 ATXN8OS SCA8,KLHL1A,NCRNA00003 transcriptional regulation pathogenic process spinocerebellar ataxia;spinocerebellar ataxia
HSALNT0290312 HSALNG0142427 TRAF3IP2-AS1 C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 transcriptional regulation pathogenic process schizophrenia;cocaine abuse
HSALNT0289008 HSALNG0054049 HYMAI NCRNA00020 NA pathogenic process transient neonatal diabetes
HSALNT0288968 HSALNG0071146 FAM201A C9orf122 NA pathogenic process leukemia
HSALNT0288969 HSALNG0093910 FAM222A-AS1 NA NA pathogenic process NA
HSALNT0289484 HSALNG0138575 FAM226A CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 NA pathogenic process NA
HSALNT0289497 HSALNG0141608 FAM215A C17orf88,APR-2,LINC00530 NA pathogenic process ovarian cancer;leukemia
HSALNT0289230 HSALNG0025991 RBM5-AS1 LUST transcriptional regulation pathogenic process tumor
HSALNT0002923 HSALNG0001554 LINC00339 NCRNA00339,HSPC157 NA pathogenic process;developmental process Pancreatic ductal adenocarcinoma
HSALNT0144027 HSALNG0068615 ASAP1-IT1 ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 NA pathogenic process ovarian cancer
HSALNT0289212 HSALNG0021208 PCGEM1 NCRNA00071,LINC00071,PCAT9 transcriptional regulation;ceRNA pathogenic process osteoarthritis;prostate cancer;glioma
HSALNT0289016 HSALNG0082243 KCNQ1DN BWRT,HSA404617 NA pathogenic process aging;Wilms' tumor
HSALNT0288933 HSALNG0097101 DLEU2 DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG transcriptional regulation pathogenic process lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer
HSALNT0217624 HSALNG0104558 PWAR4 PAR4,PAR-4 NA pathogenic process Prader-Willi syndrome and Angelman syndrome
HSALNT0289165 HSALNG0103778 MEG8 SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC NA pathogenic process Prader-Willi syndrome and Angelman syndrome;temple syndrome
HSALNT0289482 HSALNG0133856 CECR7 SAHL1 NA pathogenic process hepatocellular cancer;cat eye syndrome
HSALNT0074223 HSALNG0035451 PCAT4 GDEP,PCAN1,PCA4 NA pathogenic process prostate cancer
HSALNT0061175 HSALNG0029318 PISRT1 NCRNA00195 transcriptional regulation developmental process;pathogenic process blepharophimosis syndrome
HSALNT0190912 HSALNG0092137 IFNG-AS1 Tmevpg1,LincR-Ifng-3'A, NEST transcriptional regulation pathogenic process Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome
HSALNT0038178 HSALNG0018067 FAM138B F379 NA NA NA
HSALNT0145703 HSALNG0069515 FAM138C F379 NA NA NA
HSALNT0288963 HSALNG0000006 FAM138A F379 NA NA NA
HSALNT0183947 HSALNG0088434 FAM138D F379 NA NA NA
HSALNT0226092 HSALNG0108677 FAM138E F379 NA NA NA
HSALNT0253925 HSALNG0122829 FAM138F F379 NA NA NA
HSALNT0289326 HSALNG0141632 LINC00312 LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN transcriptional regulation pathogenic process nasopharyngeal cancer;bladder cancer;non-small cell lung cancer
HSALNT0288886 HSALNG0054798 AIRN AIR,NCRNA00088,IGF2RA, IGF2R-AS1 transcriptional regulation pathogenic process NA
HSALNT0254857 HSALNG0123415 MIR7-3HG C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 NA pathogenic process liver cancer;hepatocelluar cancer
HSALNT0185751 HSALNG0089375 LOH12CR2 LOH2CR12 NA pathogenic process pre-B acute lymphoblastic leukaemia
HSALNT0289479 HSALNG0133055 DSCR8 C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b NA pathogenic process Down syndrome;melanoma
HSALNT0289030 HSALNG0133422 LINC00313 C21orf84,NCRNA00313, NA pathogenic process lung cancer
HSALNT0289029 HSALNG0132830 LINC00310 C21orf82,NCRNA00310 NA pathogenic process NA
HSALNT0272435 HSALNG0132500 LINC00161 C21orf100,NCRNA00161 ceRNA pathogenic process osteosarcoma
HSALNT0289184 HSALNG0132027 MIR99AHG C21orf35,FLJ38295,C21orf34,LINC00478,MONC NA pathogenic process myeloid leukemia
HSALNT0289005 HSALNG0056865 HOXA11-AS HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 ceRNA pathogenic process uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer
HSALNT0193654 HSALNG0093342 RMST NCRM, NCRNA00054,LINC00054 transcriptional regulation developmental process;pathogenic process breast cancer;rhabdomyosarcoma
HSALNT0290079 HSALNG0142194 ncR-PAR NCRUPAR,ENSG00000225407 transcriptional regulation developmental process;pathogenic process gastric cancer;colorectal cancer
HSALNT0289167 HSALNG0061370 MESTIT1 MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS NA pathogenic process Silver-Russell syndrome
HSALNT0273791 HSALNG0133168 DSCAM-AS1 M41 NA pathogenic process adolescent idiopathic scoliosis;breast cancer
HSALNT0289391 HSALNG0104546 PWARSN PAR-SN,PARSN NA pathogenic process NA
HSALNT0127791 HSALNG0060774 ST7-AS1 ST7OT1,ST7AS1 NA pathogenic process glioma;autism
HSALNT0206298 HSALNG0099122 DAOA-AS1 DAOAA, DAOA-A,G30 NA pathogenic process panic disorder;schizophrenia;bipolar disorder
HSALNT0167060 HSALNG0080104 OLMALINC C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 NA pathogenic process type 2 diabetes
HSALNT0026878 HSALNG0012802 LINC00299 C2orf46,NCRNA00299,FLJ45673 NA pathogenic process;developmental process intellectual and developmental disability;neurodevelopmental disabilities
HSALNT0289081 HSALNG0039816 LINC01020 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0101186 HSALNG0048016 LINC00518 C6orf218,MGC40222 NA pathogenic process NA
HSALNT0083960 HSALNG0039909 LINC01018 SRHC NA pathogenic process hepatocellular cancer
HSALNT0289361 HSALNG0031463 LPP-AS2 MYCLo-5,MYCLo-6 NA NA NA
HSALNT0143233 HSALNG0068292 LINC00964 NA NA pathogenic process colorectal cancer
HSALNT0289364 HSALNG0094063 MAPKAPK5-AS1 C12orf47,FLJ39616 NA pathogenic process hepatocellular cancer
HSALNT0289053 HSALNG0027872 LINC00635 NA NA pathogenic process lung cancer
HSALNT0289327 HSALNG0141633 LINC00636 NA NA pathogenic process breast cancer
HSALNT0262657 HSALNG0127758 ZNF582-AS1 NA NA pathogenic process colorectal cancer
HSALNT0289020 HSALNG0000022 LINC00115 NCRNA00115,FLJ22639 ceRNA pathogenic process lung adenocarcinoma
HSALNT0289254 HSALNG0075291 SNHG7 MGC16037,NCRNA00061 NA pathogenic process lung cancer
HSALNT0289162 HSALNG0020412 MAP3K20-AS1 MLK7-AS1 NA pathogenic process gastric cancer
HSALNT0145357 HSALNG0069280 RHPN1-AS1 C8orf51,MGC3113 NA NA NA
HSALNT0289343 HSALNG0138602 XIST DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 transcriptional regulation;ceRNA pathogenic process non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis
HSALNT0289389 HSALNG0128330 PRNT M8 NA pathogenic process NA
HSALNT0288942 HSALNG0080912 EMX2OS NCRNA00045,EMX2-AS1 transcriptional regulation pathogenic process NA
HSALNT0200443 HSALNG0096546 LINC00598 TTL NA pathogenic process NA
HSALNT0289517 HSALNG0141628 TTTY17A NCRNA00140 NA NA NA
HSALNT0027901 HSALNG0013206 MYCNOS NCYM,N-CYM,MYCN-AS1 transcriptional regulation pathogenic process neuroblastoma
HSALNT0047175 HSALNG0022192 DIRC3 FLJ14199 NA pathogenic process familial renal cell cancer;breast cancer
HSALNT0289363 HSALNG0084905 MALAT1 PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA pathogenic process prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis
HSALNT0289744 HSALNG0141859 DLG2-AS1 DLG2A, DLG2-A,PSZA11q14,SZ-1 NA pathogenic process schizophrenia;myotonic dystrophy type 1;heart failure
HSALNT0289164 HSALNG0103778 MEG3 FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 translational control;transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor
HSALNT0290298 HSALNG0142413 TERC DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR NA pathogenic process prostate cancer;dyskeratosis congenita;lung squamous cell cancer
HSALNT0288907 HSALNG0080948 CASC2 NA ceRNA pathogenic process colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma
HSALNT0205332 HSALNG0098601 MIR17HG C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 NA pathogenic process diffuse large B-cell lymphoma;syndromic developmental defect;cancer
HSALNT0288716 HSALNG0141456 TTTY6 TTY6,TTTY6A,LINC00127 NA NA NA
HSALNT0288731 HSALNG0141468 TTTY4 TTY4,TTTY4A,LINC00123 NA NA NA
HSALNT0288815 HSALNG0141548 TTTY3 TTY3,TTTY3A,LINC00121 NA NA NA
HSALNT0288703 HSALNG0141450 TTTY5 TTY5,LINC00126 NA NA NA
HSALNT0289255 HSALNG0036656 SNHG8 NCRNA00060,LINC00060 NA pathogenic process gastric cancer;malignant pleural mesothelioma
HSALNT0289486 HSALNG0141597 BCYRN1 BC200,BC200a,NCRNA00004,LINC00004 splicing regulation;translational control pathogenic process aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer
HSALNT0144426 HSALNG0068805 ZFAT-AS1 ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 NA pathogenic process autoimmune disease
HSALNT0289285 HSALNG0077083 ZEB1-AS1 NA NA pathogenic process esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer
HSALNT0289185 HSALNG0135987 MIRLET7BHG linc-Ppara NA developmental process NA
HSALNT0289374 HSALNG0116616 NBR2 NCRNA00192 transcriptional regulation pathogenic process gastric cancer;breast cancer;cancer
HSALNT0289417 HSALNG0134930 TUG1 FLJ20618,NCRNA00080,LINC00080 transcriptional regulation;ceRNA pathogenic process osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer
HSALNT0288973 HSALNG0079552 FAS-AS1 FASA, FAS-A,SAF transcriptional regulation pathogenic process ataxia telangiectasia
HSALNT0288996 HSALNG0068110 HAS2-AS1 HAS2A, HAS2-A,HASNT,NCRNA00077 transcriptional regulation NA NA
HSALNT0289390 HSALNG0049245 PSORS1C3 NCRNA00196 NA pathogenic process rheumatoid arthritis;psoriasis
HSALNT0289868 HSALNG0141983 HLA-AS1 NA NA pathogenic process psoriasis;liver injury;multiple sclerosis;AIDS
HSALNT0290154 HSALNG0142269 PRINS NCRNA00074 transcriptional regulation pathogenic process psoriasis;prostate cancer
HSALNT0262809 HSALNG0127790 PEG3-AS1 PEG3AS,PEG3-AS,APEG3,NCRNA00155 NA NA NA
HSALNT0289533 HSALNG0141648 7SL 7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 protein localization pathogenic process AIDS;Leishmaniasis;dermatomyositis;polymyositis
HSALNT0290081 HSALNG0142196 NDM29 29A,lnc-C11orf16-1:1 NA pathogenic process neuroblastoma
HSALNT0289382 HSALNG0074439 NRON NCRNA00194 NA pathogenic process AIDS;Down syndrome;HIV
HSALNT0289253 HSALNG0065926 SNHG6 U87HG,HBII-276HG,NCRNA00058 translational control;ceRNA pathogenic process hepatocellular cancer;hereditary haemorrhagic telangiectasia
HSALNT0289653 HSALNG0141768 Beta-globin transcript AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 NA NA NA
HSALNT0290398 HSALNG0142513 Zfhx2as Zfh-5AS,ENSG00000157306,ENST00000554403.1 NA NA NA
HSALNT0011306 HSALNG0005433 MIR137HG NA NA pathogenic process schizophrenia;lung cancer;malignant lymphoma
HSALNT0289449 HSALNG0056858 HOXA-AS3 HOXA6as NA pathogenic process glioma
HSALNT0289451 HSALNG0068551 CCDC26 MGC27434,RAM transcriptional regulation pathogenic process hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer
HSALNT0289893 HSALNG0142008 LINC00271 C6orf217,NCRNA00271 NA pathogenic process type 2 diabetes;schizophrenia
HSALNT0288892 HSALNG0109621 BCAR4 NA transcriptional regulation pathogenic process osteosarcoma;breast cancer;colorectal cancer
HSALNT0289890 HSALNG0142005 LINC00032 C9orf14,NCRNA00032 NA pathogenic process narcolepsy;melanoma
HSALNT0274572 HSALNG0133591 PICSAR C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 transcriptional regulation pathogenic process testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer
HSALNT0256354 HSALNG0124398 UCA1 CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 transcriptional regulation;ceRNA developmental process;pathogenic process oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer
HSALNT0003871 HSALNG0002066 SNHG3 NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB NA pathogenic process ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease
HSALNT0289475 HSALNG0131591 HAR1A HAR1F,NCRNA00064,LINC00064 transcriptional regulation pathogenic process Huntington disease;Alzheimer's disease
HSALNT0288995 HSALNG0131589 HAR1B HAR1R,NCRNA00065,LINC00065 transcriptional regulation pathogenic process Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease
HSALNT0288958 HSALNG0044150 EPB41L4A-AS1 C5orf26,NCRNA00219,TIGA1 NA pathogenic process lung cancer;cancer
HSALNT0289170 HSALNG0134655 MIAT C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT splicing regulation;ceRNA pathogenic process prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease
HSALNT0289007 HSALNG0047947 HULC NCRNA00078,LINC00078,HCCAT1 transcriptional regulation;ceRNA pathogenic process prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer
HSALNT0288940 HSALNG0023880 EGOT EGO,NCRNA00190 NA pathogenic process;developmental process prostate cancer;breast cancer
HSALNT0289387 HSALNG0001461 PINK1-AS PINK1-AS1,FLJ00387,PINK1A, naPINK1 transcriptional regulation pathogenic process glucose metabolism disorder;Parkinson's disease;diabetes
HSALNT0289225 HSALNG0068477 PVT1 NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT transcriptional regulation;translational control pathogenic process murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer
HSALNT0289189 HSALNG0073233 NAMA NA NA pathogenic process papillary thyroid cancer
HSALNT0246525 HSALNG0119442 NARF-AS1 NA NA pathogenic process hepatocellular cancer
HSALNT0147433 HSALNG0070397 CDKN2B-AS1 CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 siRNA;transcriptional regulation;ceRNA pathogenic process glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis
HSALNT0050854 HSALNG0024099 GHRLOS NCRNA00068,GHRL-AS1 transcriptional regulation NA NA
HSALNT0288959 HSALNG0026279 ESRG HESRG NA pathogenic process embryonal cancer
HSALNT0287173 HSALNG0140560 FMR1-AS1 FMR1A, FMR1-A,ASFMR1,FMR4 transcriptional regulation pathogenic process fragile X syndrome;neurological disorder
HSALNT0289499 HSALNG0141610 HCG4 HCGIV-10,HCGIV.9 NA pathogenic process NA
HSALNT0288994 HSALNG0038609 HAND2-AS1 DEIN,NBLA00301,FLJ11539 NA pathogenic process neuroblastoma
HSALNT0289286 HSALNG0019362 ZEB2-AS1 ZEB2A, ZEB2-A,ZEB2NAT splicing regulation pathogenic process bladder cancer;hepatocellular cancer
HSALNT0017702 HSALNG0008545 GAS5 SNHG2,NCRNA00030 transcriptional regulation;ceRNA pathogenic process varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer
HSALNT0288891 HSALNG0087449 BACE1-AS BACE1A,FJ573250,NCRNA00177,BACE1-AS1 translational control;transcriptional regulation pathogenic process ovarian cancer;colorectal cancer;Alzheimer's disease
HSALNT0289414 HSALNG0133533 TRPM2-AS TRPM2-AS1 NA pathogenic process melanoma;prostate cancer
HSALNT0288935 HSALNG0008462 DNM3OS DNM3-AS1,MIR199A2HG NA pathogenic process epithelial ovarian cancer
HSALNT0288930 HSALNG0133982 DGCR5 NCRNA00037,LINC00037 transcriptional regulation pathogenic process Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer
HSALNT0288893 HSALNG0083307 BDNF-AS BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS siRNA;transcriptional regulation developmental process;pathogenic process Huntington disease;schizophrenia;psychiatric disease;obesity
HSALNT0120317 HSALNG0056850 HOTAIRM1 HOXA-AS1,NCRNA00179,HOXA1-AS1 transcriptional regulation pathogenic process;developmental process colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma
HSALNT0290158 HSALNG0142273 PTCSC1 PTCSC,AK023948,NCRNA00197 NA pathogenic process papillary thyroid cancer
HSALNT0289004 HSALNG0091318 HOTAIR HOXC-AS4,HOXC11-AS1,NCRNA00072 siRNA;transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer
HSALNT0289192 HSALNG0084892 NEAT1 NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC transcriptional regulation;ceRNA pathogenic process oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer
HSALNT0095094 HSALNG0045213 SNHG4 U19H,NCRNA00059 NA pathogenic process myelodysplastic syndrome
HSALNT0245443 HSALNG0118855 SNHG16 ncRAN,Nbla12061,Nbla10727 NA pathogenic process bladder cancer;bladder cancer;colorectal cancer;neuroblastoma
HSALNT0288897 HSALNG0023698 BOK-AS1 BOKA,NCRNA00151,NAToB NA pathogenic process esophageal squamous cell cancer;testicular cancer;cancer
HSALNT0289532 HSALNG0141647 7SK 7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 transcriptional regulation developmental process;pathogenic process cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma
HSALNT0289182 HSALNG0017872 MIR4435-2HG MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID NA pathogenic process lung cancer
HSALNT0289200 HSALNG0016500 PARTICL PARTICLE transcriptional regulation pathogenic process low-dose irradiation
HSALNT0289172 HSALNG0069266 MINCR LINC01604,TCONS_00015189 transcriptional regulation;ceRNA pathogenic process gallbladder cancer;Burkitt lymphoma
HSALNT0001792 HSALNG0000905 NPPA-AS1 NPPAA, NPPA-AS splicing regulation pathogenic process cardiovascular disease
HSALNT0290230 HSALNG0142345 RRP1B NA transcriptional regulation pathogenic process spinocerebellar ataxia;laryngeal squamous cell cancer;cancer
HSALNT0289467 HSALNG0093062 CLLU1 NA NA NA NA
HSALNT0289173 HSALNG0087764 MIR100HG AGD1,lncRNA-N2,linc-NeD125 NA developmental process;pathogenic process myeloid leukemia;myopia;cervical cancer;neuroblastoma
HSALNT0059175 HSALNG0028235 TUSC7 LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 transcriptional regulation;ceRNA pathogenic process glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer
HSALNT0289647 HSALNG0141762 BC040587 NA NA pathogenic process osteosarcoma;breast cancer
HSALNT0059186 HSALNG0028242 LINC00901 LSAMP-AS4,TCONS_00005428,BC040587 NA pathogenic process osteosarcoma;gastric cancer;breast cancer
HSALNT0233366 HSALNG0112604 HCCAT5 HTA,FJ222407 NA pathogenic process hepatocellular cancer
HSALNT0290040 HSALNG0142155 LSINCT5 NA NA pathogenic process chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer
HSALNT0179611 HSALNG0086377 DISC1FP1 Boymaw transcriptional regulation pathogenic process schizophrenia
HSALNT0217643 HSALNG0104567 SNHG14 115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS ceRNA pathogenic process Angelman syndrome;cerebral infarction;Prader-Willi syndrome
HSALNT0289273 HSALNG0000343 TP73-AS1 KIAA0495,PDAM NA pathogenic process esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma
HSALNT0290311 HSALNG0142426 TP53COR1 Trp53cor1 transcriptional regulation pathogenic process prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer
HSALNT0289221 HSALNG0068414 PRNCR1 CARLo-3,PCAT8 transcriptional regulation pathogenic process gastric cancer;prostate cancer;glioma;colorectal cancer
HSALNT0020131 HSALNG0009743 PCAT6 KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 transcriptional regulation pathogenic process prostate cancer;triple-negative breast cancer;lung cancer
HSALNT0289277 HSALNG0130723 TRERNA1 LINC00651,ncRNA-a7,treRNA transcriptional regulation NA NA
HSALNT0014972 HSALNG0007045 FALEC LINC00568,ncRNA-a1,FAL1 transcriptional regulation pathogenic process ovarian cancer;thyroid cancer
HSALNT0290008 HSALNG0142123 LOC100887755 Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 transcriptional regulation pathogenic process hepatocellular cancer
HSALNT0290248 HSALNG0142363 snaR EU035784.1,lnc-BSPH1-1:1 transcriptional regulation NA NA
HSALNT0289342 HSALNG0138609 JPX NCRNA00183,ENOX,LINC00183,DCBALD06 transcriptional regulation pathogenic process hepatocellular cancer
HSALNT0289231 HSALNG0001716 RCAN3AS TCONS_00001428 NA NA NA
HSALNT0289280 HSALNG0069631 VLDLR-AS1 lincRNA-VLDLR NA pathogenic process hepatocelluar cancer
HSALNT0288982 HSALNG0138614 FTX NCRNA00182,MIR374AHG,LINC00182,FLJ33139 transcriptional regulation pathogenic process hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer
HSALNT0091079 HSALNG0043383 MEF2C-AS1 NA NA pathogenic process gastric cancer;Prader-Willi syndrome and Angelman syndrome
HSALNT0189341 HSALNG0091277 PCBP2-OT1 TUC338 NA pathogenic process hepatocellular cancer;tongue squamous cell cancer
HSALNT0290373 HSALNG0142488 WRAP53 NA NA pathogenic process hepatocellular cancer;cancer;dyskeratosis congenita
HSALNT0289265 HSALNG0049949 TDRG1 LINC00532,lincRNA-NRNA024015 NA pathogenic process esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia
HSALNT0289175 HSALNG0132382 MIR155HG MIRHG2,BIC,NCRNA00172 NA pathogenic process B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma
HSALNT0289051 HSALNG0024293 LINC00620 NA NA pathogenic process cervical cancer
HSALNT0120390 HSALNG0056871 HOTTIP NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 transcriptional regulation pathogenic process hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma
HSALNT0289287 HSALNG0130661 ZFAS1 C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 transcriptional regulation;ceRNA pathogenic process gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer
HSALNT0289259 HSALNG0045502 SPRY4-IT1 SPRIGHTLY transcriptional regulation pathogenic process prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer
HSALNT0105595 HSALNG0049759 PANDAR PANDA transcriptional regulation pathogenic process colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer
HSALNT0068185 HSALNG0032415 HTT-AS HTT-AS1,HTTAS NA pathogenic process Huntington disease
HSALNT0099036 HSALNG0047200 HEIH LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 NA pathogenic process hepatocelluar cancer
HSALNT0222533 HSALNG0107117 NPTN-IT1 lncRNA-LET NA pathogenic process gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer
HSALNT0289747 HSALNG0141862 DQ786243 NA transcriptional regulation pathogenic process crohn's disease;colorectal cancer;hepatocelluar cancer
HSALNT0289204 HSALNG0068414 PCAT1 PCAT-1,PCA1 transcriptional regulation;ceRNA pathogenic process prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer
HSALNT0275894 HSALNG0134403 PCAT14 NA NA pathogenic process prostate cancer
HSALNT0211999 HSALNG0101780 HIF1A-AS2 3'aHIF-1A,aHIF translational control pathogenic process bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer
HSALNT0288999 HSALNG0101776 HIF1A-AS1 5'aHIF-1A,5'aHIF1alpha NA pathogenic process acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer
HSALNT0289258 HSALNG0031034 SOX2-OT SOX2OT,DKFZp761J1324,NCRNA00043 transcriptional regulation pathogenic process colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease
HSALNT0289700 HSALNG0141815 CDR1-AS CDR1NAT,ciRS-7,CDR1as ceRNA NA NA
HSALNT0289149 HSALNG0050599 LINCMD1 MIR133BHG,LINC-MD1 ceRNA developmental process;pathogenic process Duchenne muscular dystrophy
HSALNT0288894 HSALNG0082362 BGLT3 LINC01083,BGL3,lncRNA-BGL3 ceRNA pathogenic process chronic myeloid leukemia
HSALNT0289042 HSALNG0055058 LINC00473 C6orf176,bA142J11.1 transcriptional regulation pathogenic process non-small cell lung cancer;renal cell cancer
HSALNT0101681 HSALNG0048223 LINC01108 LncRNA-ES1 NA developmental process NA
HSALNT0289418 HSALNG0103465 TUNAR LINC00617,TUNA,HI-LNC78 transcriptional regulation developmental process;pathogenic process breast cancer
HSALNT0289197 HSALNG0105343 OIP5-AS1 cyrano,linc-OIP5 NA developmental process NA
HSALNT0289046 HSALNG0048515 LINC00581 NA NA pathogenic process West Syndrome;West syndrome
HSALNT0289656 HSALNG0141771 BX118339 NA NA pathogenic process West syndrome
HSALNT0021726 HSALNG0010465 LINC00538 Yiya,PROX1UT NA pathogenic process colorectal cancer;cancer
HSALNT0273249 HSALNG0132926 CBR3-AS1 PlncRNA-1,PlncRNA1 ceRNA pathogenic process esophageal squamous cell cancer;hepatocellular cancer;prostate cancer
HSALNT0289179 HSALNG0070363 MIR31HG LOC554202,hsa-lnc-31,LncHIFCAR ceRNA pathogenic process bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma
HSALNT0288925 HSALNG0034419 DANCR KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR transcriptional regulation developmental process;pathogenic process prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer
HSALNT0290329 HSALNG0142444 uc.388 NA NA pathogenic process colorectal cancer
HSALNT0289842 HSALNG0141957 FR0348383 NA NA pathogenic process prostate cancer
HSALNT0289279 HSALNG0141211 TTTY15 DKFZP434I143,NCRNA00138 NA pathogenic process NA
HSALNT0289718 HSALNG0141833 CRNDE LOC643911,LINC00180,CRNDEP transcriptional regulation;ceRNA pathogenic process gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma
HSALNT0289685 HSALNG0141800 CCND1 NA NA pathogenic process tumor;cervical cancer
HSALNT0289935 HSALNG0142050 lincRNA-p21 NA transcriptional regulation pathogenic process lung cancer;cancer
HSALNT0290134 HSALNG0142249 PCNCR1 NA NA pathogenic process prostate cancer
HSALNT0289492 HSALNG0141603 DBET DBE-T,DUX4L30 transcriptional regulation developmental process;pathogenic process facioscapulohumeral muscular dystrophy
HSALNT0289455 HSALNG0071734 BANCR LINC00586 transcriptional regulation pathogenic process osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer
HSALNT0209589 HSALNG0100636 PTCSC3 NA ceRNA pathogenic process papillary thyroid cancer;thyroid cancer
HSALNT0290063 HSALNG0142178 MVIH NA ceRNA pathogenic process hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer
HSALNT0289103 HSALNG0052921 LINC01268 LOC285758 NA pathogenic process NA
HSALNT0289070 HSALNG0031716 LINC00887 linc-ATP13A4-8,HEIRCC transcriptional regulation pathogenic process hypoxic and inflammatory renal epithelial injury;renal clear cell cancer
HSALNT0288931 HSALNG0100075 DHRS4-AS1 C14orf167,PRO1488,AS1DHRS4 transcriptional regulation NA NA
HSALNT0288974 HSALNG0113304 FENDRR FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 transcriptional regulation developmental process;pathogenic process osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer
HSALNT0106473 HSALNG0050235 LINC01512 LOC100132354,TCONS_00011120,HI-LNC77 NA pathogenic process lung adenocarcinoma;type 2 diabetes
HSALNT0289059 HSALNG0118547 LINC00673 HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 transcriptional regulation pathogenic process pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma
HSALNT0289107 HSALNG0128306 LINC01433 LOC728228 NA pathogenic process lung cancer
HSALNT0143571 HSALNG0068424 CCAT1 CARLo-5,onco-lncRNA-40 ceRNA pathogenic process gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer
HSALNT0289408 HSALNG0123467 TINCR ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 translational control pathogenic process;developmental process bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer
HSALNT0289152 HSALNG0060113 LNCPRESS1 lncPRESS1 translational control NA NA
HSALNT0289145 HSALNG0075843 LINC02561 RP11-445P17.8 NA pathogenic process cystic fibrosis
HSALNT0289065 HSALNG0140616 LINC00850 KUCG1 NA pathogenic process Duchenne muscular dystrophy
HSALNT0289431 HSALNG0032699 AFAP1-AS1 AFAP1A, AFAP1-A,MGC10981 NA pathogenic process non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer
HSALNT0289519 HSALNG0141630 XACT NA NA NA NA
HSALNT0248684 HSALNG0120344 GATA6-AS1 locus5689,BM742401 NA pathogenic process gastric cancer;chronic lymphocytic leukemia
HSALNT0289222 HSALNG0073144 PTCSC2 NA transcriptional regulation pathogenic process papillary thyroid cancer
HSALNT0289655 HSALNG0141770 BTG3-AS1 ASBEL translational control pathogenic process ovarian cancer;colorectal cancer
HSALNT0289224 HSALNG0070801 PTENP1 NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 transcriptional regulation;ceRNA pathogenic process gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer
HSALNT0290129 HSALNG0142244 PAN NA transcriptional regulation pathogenic process Kaposi's sarcoma
HSALNT0289939 HSALNG0142054 LINC-ROR lincRNA-RoR,lincRNA-ST8SIA3,ROR transcriptional regulation;ceRNA pathogenic process gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer
HSALNT0290322 HSALNG0142437 UBE3A-ATS NA NA pathogenic process Angelman syndrome
HSALNT0091004 HSALNG0043367 LINC00461 EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 NA pathogenic process;developmental process retinal and visual function
HSALNT0289491 HSALNG0141602 CTBP1-AS PCAT10 transcriptional regulation pathogenic process chronic hepatitis C;prostate cancer;polycystic ovary syndrome
HSALNT0037401 HSALNG0017694 GACAT1 LINC00876,AC096655.1-002 NA pathogenic process gastric cancer
HSALNT0120344 HSALNG0056854 HOXA-AS2 HOXA3as transcriptional regulation pathogenic process promyelocytic leukemia;gastric cancer
HSALNT0091313 HSALNG0043441 LUCAT1 SCAL1 transcriptional regulation pathogenic process non-small cell lung cancer;lung cancer
HSALNT0289425 HSALNG0009941 BLACAT1 linc-UBC1,LINC00912,onco-lncRNA-30 transcriptional regulation pathogenic process bladder cancer;gastric cancer
HSALNT0149012 HSALNG0071221 GLIDR LINC01172,MGC21881,TCONS_00015562 NA pathogenic process glioblastoma
HSALNT0217561 HSALNG0104548 PWAR5 PAR5,PAR-5 NA pathogenic process glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome
HSALNT0289272 HSALNG0059377 TP53TG1 TP53AP1,H_RG012D21.9,LINC00096 NA pathogenic process non-small cell lung cancer;ataxia telangiectasia
HSALNT0289598 HSALNG0141713 AK126698 NA NA pathogenic process non-small cell lung cancer
HSALNT0217598 HSALNG0104558 IPW NCRNA00002 transcriptional regulation pathogenic process Prader-Willi syndrome
HSALNT0143633 HSALNG0068443 CCAT2 NCCP1,LINC00873 transcriptional regulation pathogenic process non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer
HSALNT0289026 HSALNG0129180 LINC00261 C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 NA pathogenic process pancreatic cancer;non-small cell lung cancer;gastric cancer
HSALNT0289078 HSALNG0000303 LINC00982 FLJ42875 NA pathogenic process gastric cancer
HSALNT0290082 HSALNG0142197 NEAT1_2 NEAT1_2 protein localization pathogenic process amyotrophic lateral sclerosis
HSALNT0288989 HSALNG0076040 GATA3-AS1 NA transcriptional regulation pathogenic process renal cell cancer
HSALNT0289427 HSALNG0004297 GNG12-AS1 NA transcriptional regulation NA NA
HSALNT0290395 HSALNG0142510 YAM1 Yam-1 transcriptional regulation pathogenic process;developmental process skeletal myogenesis
HSALNT0289202 HSALNG0018036 PAX8-AS1 NA NA pathogenic process malignant pleural mesothelioma;cervical cancer
HSALNT0054469 HSALNG0026023 RASSF1-AS1 ANRASSF1 transcriptional regulation pathogenic process breast cancer
HSALNT0290261 HSALNG0142376 SUMO1P3 SUMO1P3 NA pathogenic process bladder cancer;gastric cancer
HSALNT0289002 HSALNG0094549 HNF1A-AS1 C12orf27,NCRNA00262,FLJ38690,HAS1 ceRNA pathogenic process esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer
HSALNT0289377 HSALNG0041218 NIPBL-AS1 NIPBL-DT,NIPBL-AS NA pathogenic process autism spectrum disorder
HSALNT0289249 HSALNG0057702 SNHG15 C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g NA pathogenic process gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia
HSALNT0235898 HSALNG0113835 MIR22HG C17orf91,MGC14376,DKFZp686O06159 NA pathogenic process ovarian cancer
HSALNT0235898 HSALNG0113835 MIR22HG C17orf91,MGC14376,DKFZp686O06159 NA NA NA
HSALNT0288984 HSALNG0119881 GACAT2 MTCL1-AS1,HMlincRNA717 NA pathogenic process pancreatic cancer;non-small cell lung cancer;gastric cancer
HSALNT0289369 HSALNG0134448 MIF-AS1 LOC284889,MIF-AS transcriptional regulation pathogenic process malaria;nephrolithiasis
HSALNT0129086 HSALNG0061385 LINC-PINT MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint transcriptional regulation pathogenic process colorectal cancer;heart failure
HSALNT0289240 HSALNG0020769 SCHLAP1 LINC00913,SChLAP1,PCAT11 transcriptional regulation pathogenic process bladder cancer;prostate cancer
HSALNT0193241 HSALNG0093119 SOCS2-AS1 NA transcriptional regulation pathogenic process prostate cancer
HSALNT0138824 HSALNG0066261 CASC9 ESCCAL-1,ESSCAL1,LINC00981 NA pathogenic process esophageal squamous cell cancer;esophageal cancer
HSALNT0267627 HSALNG0130306 HNF4A-AS1 uc002xlx NA pathogenic process lung adenocarcinoma
HSALNT0289194 HSALNG0131196 NKILA NA NA pathogenic process nasopharyngeal cancer;breast cancer;tongue squamous cell cancer
HSALNT0289304 HSALNG0088539 LINC00942 NA NA pathogenic process ovarian cancer;autism spectrum disorder
HSALNT0289187 HSALNG0062700 MNX1-AS1 CCAT5,LOC645249 NA pathogenic process ovarian cancer;colorectal cancer
HSALNT0289518 HSALNG0141629 VPS9D1-AS1 MYU NA pathogenic process ovarian cancer;colorectal cancer
HSALNT0290266 HSALNG0142381 TC0101441 NA NA pathogenic process epithelial ovarian cancer
HSALNT0289426 HSALNG0009856 ERLNC1 TC0101441,ElncRNA1 NA pathogenic process ovarian cancer
HSALNT0290050 HSALNG0142165 Mdgt NA NA NA NA
HSALNT0043560 HSALNG0020594 HAGLR HOXD-AS1,Mdgt NA pathogenic process bladder cancer;neuroblastoma
HSALNT0289092 HSALNG0017541 LINC01158 PANTR1,linc-Brn1a,linc-POU3F3 transcriptional regulation pathogenic process;developmental process esophageal squamous cell cancer;gastric cancer;glioma
HSALNT0289448 HSALNG0062110 GHET1 lncRNA-GHET1 NA pathogenic process bladder cancer;gastric cancer;colorectal cancer
HSALNT0289514 HSALNG0141625 PEG13 NA transcriptional regulation pathogenic process intellectual disabilities
HSALNT0289183 HSALNG0140233 MIR503HG MGC16121,H19X NA pathogenic process choriocarcinoma
HSALNT0289201 HSALNG0083445 PAUPAR NA transcriptional regulation pathogenic process;developmental process uveal melanoma
HSALNT0288956 HSALNG0094171 LINC01234 LCAL84,onco-lncRNA-32 ceRNA pathogenic process oesophageal squamous cell cancer;breast cancer
HSALNT0289021 HSALNG0016642 CYTOR C2orf59,NCRNA00152,MGC4677 transcriptional regulation;ceRNA pathogenic process colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer
HSALNT0289706 HSALNG0141821 CHRF NA ceRNA pathogenic process cardiac hypertrophy;silicosis
HSALNT0143635 HSALNG0068436 CASC8 LINC00860,CARLo-1 NA pathogenic process lung cancer
HSALNT0143672 HSALNG0068465 CASC11 TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 transcriptional regulation pathogenic process hepatocellular cancer;colorectal cancer
HSALNT0289032 HSALNG0133191 LINC00323 PRED42,FLJ37173 NA pathogenic process breast cancer;hereditary haemorrhagic telangiectasia
HSALNT0024655 HSALNG0011845 LINC01139 LINK-A,TCONS_00000027 NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0289018 HSALNG0036270 LEF1-AS1 NA NA pathogenic process hereditary haemorrhagic telangiectasia;colorectal cancer
HSALNT0247326 HSALNG0119753 LINC00667 NA NA pathogenic process hereditary haemorrhagic telangiectasia
HSALNT0290145 HSALNG0142260 POU3F3 NA transcriptional regulation pathogenic process esophageal squamous cell cancer;glioma
HSALNT0199349 HSALNG0096112 LINC00426 NA NA pathogenic process primary Sjögren's syndrome
HSALNT0155974 HSALNG0074744 LINC00963 MetaLnc9 NA pathogenic process prostate cancer;renal cell cancer
HSALNT0289211 HSALNG0086124 PCF11-AS1 NA NA pathogenic process hepatocellular cancer;adolescent idiopathic scoliosis
HSALNT0289534 HSALNG0141649 91H NA transcriptional regulation pathogenic process osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer
HSALNT0289446 HSALNG0055679 ELFN1-AS1 MYCLo-2 transcriptional regulation pathogenic process colorectal cancer
HSALNT0288883 HSALNG0079547 ACTA2-AS1 uc001kfo.1,ZXF1 NA pathogenic process lung adenocarcinoma
HSALNT0289443 HSALNG0059132 APTR RSBN1L-AS1 transcriptional regulation pathogenic process liver fibrosis;glioblastoma
HSALNT0289986 HSALNG0142101 lncRNA-MVIH NA NA pathogenic process hepatocellular cancer;non-small cell lung cancer
HSALNT0289977 HSALNG0142092 lncRNA-ATB NA ceRNA pathogenic process colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis
HSALNT0289622 HSALNG0141737 ATB NA ceRNA pathogenic process prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer
HSALNT0289586 HSALNG0141701 AK057054 NA NA pathogenic process gastric cancer
HSALNT0278370 HSALNG0135702 LINC01315 lnc-C22orf32-1,C22orf32-1 NA pathogenic process nasopharyngeal cancer
HSALNT0055601 HSALNG0026583 ADAMTS9-AS2 NA NA pathogenic process non-small cell lung cancer;glioma
HSALNT0289383 HSALNG0009103 PACERR PACER,PTGS2-AS1 transcriptional regulation pathogenic process osteosarcoma;osteoarthritis;inflammation and cancer
HSALNT0289268 HSALNG0010604 TGFB2-OT1 FLJ11812 ceRNA NA NA
HSALNT0288938 HSALNG0027860 DUBR LINC00883 ceRNA pathogenic process asthma and chronic obstructive pulmonary disease
HSALNT0290147 HSALNG0142262 POXCUT TCONS_00011636 NA NA NA
HSALNT0289440 HSALNG0047407 FOXCUT LINC01379,TCONS_00011636 transcriptional regulation pathogenic process esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer
HSALNT0288924 HSALNG0059521 CYP51A1-AS1 ENST00000453068,LRRD1-AS1 NA pathogenic process renal cell cancer
HSALNT0289395 HSALNG0036288 RPL34-AS1 FLJ37673,RP11-462C24.1 NA pathogenic process gastric cancer;colorectal cancer
HSALNT0289435 HSALNG0045015 C5orf66-AS1 CTC-276P9.1,Epist NA pathogenic process esophageal squamous cell cancer;bladder cancer
HSALNT0289052 HSALNG0006924 LINC00623 NA NA pathogenic process nasopharyngeal cancer
HSALNT0289831 HSALNG0141946 FER1L4 FER1L4 ceRNA pathogenic process gastric cancer;endometrial cancer;colorectal cancer
HSALNT0288985 HSALNG0013215 GACAT3 LINC01458,lncRNA-AC130710 NA pathogenic process ovarian cancer;gastric cancer
HSALNT0288881 HSALNG0058863 ABHD11-AS1 WBSCR26,LINC00035,NCRNA00035 NA pathogenic process gastric cancer;mutant huntingtin
HSALNT0282263 HSALNG0137651 ZNF674-AS1 NA NA pathogenic process hepatocellular cancer
HSALNT0289207 HSALNG0106864 PCAT29 NA NA pathogenic process prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
HSALNT0289672 HSALNG0141787 CADM1 NA NA NA NA
HSALNT0289297 HSALNG0007253 LINC01527 lnc-SPRR2D-1,RP1-13P20.6 NA pathogenic process squamous cell cancer
HSALNT0289158 HSALNG0108520 LUNAR1 NA transcriptional regulation pathogenic process diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia
HSALNT0289830 HSALNG0141945 FAR2P1 NA NA pathogenic process lung adenocarcinoma;non-small cell lung cancer
HSALNT0289263 HSALNG0053580 TARID EYA4-AS1 transcriptional regulation pathogenic process kidney clear cell sarcoma
HSALNT0145373 HSALNG0069286 MAFA-AS1 RP11-909N17.3,TCONS_00014882 NA pathogenic process lung adenocarcinoma;non-small cell lung cancer
HSALNT0290229 HSALNG0142344 RPLP0P2 RPLP0P2 NA pathogenic process lung adenocarcinoma
HSALNT0289291 HSALNG0133273 ZNF295-AS1 C21orf121,NCRNA00318,PRED87 NA pathogenic process lung adenocarcinoma;epithelial ovarian cancer
HSALNT0084473 HSALNG0040150 LINC01513 RP11-1C1.7,TCONS_00009352 NA pathogenic process NA
HSALNT0289471 HSALNG0108507 IRAIN IGF1R-AS transcriptional regulation pathogenic process pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer
HSALNT0290402 HSALNG0142517 ZNRD1-AS1 NA NA pathogenic process hepatocellular cancer;lung cancer;cervical cancer
HSALNT0289504 HSALNG0141615 LCAL1 onco-lncRNA-27 NA pathogenic process lung cancer
HSALNT0289169 HSALNG0100038 MHRT Myheart transcriptional regulation pathogenic process heart hypertrophy;acute myocardial infarction
HSALNT0289859 HSALNG0141974 HA117 NA NA pathogenic process hirschsprung disease
HSALNT0026673 HSALNG0012722 NRIR lncRNA-CMPK2 transcriptional regulation pathogenic process chronic hepatitis C;HCV
HSALNT0289887 HSALNG0142002 LET NA NA pathogenic process gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer
HSALNT0007921 HSALNG0004023 NFIA-AS1 RP5-833A20.1 transcriptional regulation pathogenic process atherosclerosis;glioma
HSALNT0247156 HSALNG0119710 GAPLINC LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 siRNA pathogenic process gastric cancer;colorectal cancer
HSALNT0288917 HSALNG0079313 CERNA2 HOST2,lncRNA-HOST2 ceRNA pathogenic process hepatocellular cancer;epithelial ovarian cancer
HSALNT0289113 HSALNG0050689 LINC01564 TCONS_00011314 NA pathogenic process prostate cancer
HSALNT0289088 HSALNG0012685 LINC01105 FLJ30594,LOC150622 NA pathogenic process gastric cancer;leukemia and neuroblastoma
HSALNT0289464 HSALNG0091650 AGAP2-AS1 LOC100130776,PUNISHER transcriptional regulation pathogenic process non-small cell lung cancer;glioma;leukemia and neuroblastoma
HSALNT0288960 HSALNG0106834 EWSAT1 TMEM84,NCRNA00277,LINC00277,FLJ33768 transcriptional regulation pathogenic process Ewing sarcoma
HSALNT0289242 HSALNG0074573 SLC25A25-AS1 NA NA pathogenic process colorectal cancer
HSALNT0289317 HSALNG0130331 KCNK15-AS1 RP11-445H22.4 NA pathogenic process osteoarthritis;breast cancer
HSALNT0289864 HSALNG0141979 HIF2PUT NA NA pathogenic process osteosarcoma;colorectal cancer
HSALNT0289267 HSALNG0019370 TEX41 DKFZp686O1327,LINC00953 transcriptional regulation NA NA
HSALNT0290361 HSALNG0142476 UFC1 NA transcriptional regulation;ceRNA pathogenic process osteoarthritis;hepatocellular cancer
HSALNT0289886 HSALNG0142001 LEIGC NA NA pathogenic process gastric cancer
HSALNT0289367 HSALNG0049188 MDC1-AS1 MDC1-AS NA pathogenic process bladder cancer;glioma
HSALNT0289190 HSALNG0048542 NBAT1 CASC14,NBAT-1 transcriptional regulation pathogenic process breast cancer;renal clear cell cancer;neuroblastoma
HSALNT0234826 HSALNG0113287 LINC00917 NA NA pathogenic process intervertebral disc degeneration;breast cancer
HSALNT0289419 HSALNG0094327 LINC00173 NCRNA00173,FLJ42957 NA pathogenic process HIV-1-infected;hepatocelluar cancer
HSALNT0290138 HSALNG0142253 PEG10 NA NA pathogenic process diffuse large B-cell lymphoma;esophageal cancer
HSALNT0289136 HSALNG0041549 LINC02224 BRCAT107,ENST00000505706 NA pathogenic process active tuberculosis
HSALNT0289866 HSALNG0141981 HIT NA transcriptional regulation pathogenic process non-small cell lung cancer;breast cancer
HSALNT0003927 HSALNG0002075 SNHG12 ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 NA pathogenic process osteosarcoma;endometrial cancer
HSALNT0289099 HSALNG0002236 LINC01225 NA NA pathogenic process hepatocelluar cancer
HSALNT0290047 HSALNG0142162 MALAT2 NA NA pathogenic process gastric cancer
HSALNT0176345 HSALNG0084672 SNHG1 LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 NA pathogenic process astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma
HSALNT0094592 HSALNG0044933 WSPAR TCONS_00009511-XLOC_004555,lncTCF7 transcriptional regulation pathogenic process hepatocellular cancer;liver cancer
HSALNT0289308 HSALNG0118552 LINC00511 onco-lncRNA-12 NA pathogenic process lung adenocarcinoma;breast cancer
HSALNT0289452 HSALNG0069321 FAM83H-AS1 onco-lncRNA-3 NA pathogenic process NA
HSALNT0289041 HSALNG0051162 LINC00472 C6orf155,dJ288M22.3,FLJ13189 NA pathogenic process ovarian cancer;breast cancer
HSALNT0289925 HSALNG0142040 linc-ITGB1 NA NA pathogenic process gallbladder cancer;breast cancer
HSALNT0016239 HSALNG0007801 LINC01133 lncRNA-PAGBC transcriptional regulation pathogenic process non-small cell lung cancer;colorectal cancer;lung squamous cell cancer
HSALNT0289489 HSALNG0141600 CCEPR CCHE1,lncRNA-CCHE1 transcriptional regulation pathogenic process hepatocellular cancer;cervical cancer
HSALNT0289402 HSALNG0098682 SOX21-AS1 NA NA pathogenic process lung adenocarcinoma;oral squamous cell cancer
HSALNT0288905 HSALNG0048533 CASC15 LINC00340,lnc-SOX4-1 NA pathogenic process basal cell cancer;melanoma;neuroblastoma
HSALNT0289555 HSALNG0141670 AC104699.1 NA NA pathogenic process gastric cancer
HSALNT0096322 HSALNG0045923 CLMAT3 SPARC-AS1 NA pathogenic process colorectal cancer
HSALNT0289233 HSALNG0043698 RGMB-AS1 NA NA pathogenic process lung adenocarcinoma;non-small cell lung cancer
HSALNT0289908 HSALNG0142023 LINC01419 LVCAT7,TCONS_00014497 NA pathogenic process hepatocelluar cancer
HSALNT0289541 HSALNG0141656 AB209630 NA NA pathogenic process hypopharyngeal squamous cell cancer
HSALNT0289608 HSALNG0141723 AOC4P AOC4P NA pathogenic process colorectal cancer;hepatocelluar cancer
HSALNT0289082 HSALNG0040781 PURPL LINC01021,LOC643401,RP11-46C20.1 NA pathogenic process NA
HSALNT0196121 HSALNG0094605 LINC01089 LIMT NA pathogenic process breast cancer;astrocytoma
HSALNT0123080 HSALNG0058166 EGFR-AS1 NA NA pathogenic process hepatocellular cancer
HSALNT0289539 HSALNG0141654 AB073614 NA NA pathogenic process ovarian cancer;glioma
HSALNT0242418 HSALNG0117322 CACNA1G-AS1 NA NA pathogenic process keloid
HSALNT0170814 HSALNG0081992 MIR210HG NA transcriptional regulation pathogenic process hypoxic and inflammatory stress
HSALNT0288979 HSALNG0113319 FOXC2-AS1 ODRUL NA pathogenic process osteosarcoma
HSALNT0289022 HSALNG0132865 LINC00160 C21orf52,NCRNA00160 NA pathogenic process breast cancer
HSALNT0105274 HSALNG0049582 LINC01016 NA NA pathogenic process breast cancer
HSALNT0288904 HSALNG0045753 CARMN MIR143HG,CARMEN transcriptional regulation pathogenic process cardiac differentiation
HSALNT0289123 HSALNG0121579 LINC01630 LOC100287225 NA pathogenic process colorectal cancer
HSALNT0288971 HSALNG0104253 FAM30A C14orf110,KIAA0125,HSPC053 NA pathogenic process gallbladder cancer
HSALNT0289506 HSALNG0141617 LINC00346 C13orf29,NCRNA00346 NA pathogenic process hepatocellular cancer;breast cancer
HSALNT0289643 HSALNG0141758 BC032469 NA ceRNA pathogenic process esophageal squamous cell cancer;gastric cancer
HSALNT0289580 HSALNG0141695 AK024171 NA NA pathogenic process intervertebral disc degeneration;gastric cancer
HSALNT0290187 HSALNG0142302 RP11-284N8.3.1 NA NA pathogenic process ovarian cancer
HSALNT0289839 HSALNG0141954 FMR6 NA NA pathogenic process fragile X syndrome;fragile X-associated premature ovarian insufficiency
HSALNT0290152 HSALNG0142267 PRAL lncRNA-PRAL NA pathogenic process hepatocellular cancer;lung cancer
HSALNT0289380 HSALNG0129818 NORAD LINC00657 transcriptional regulation;translational control pathogenic process breast cancer
HSALNT0086803 HSALNG0041283 LIFR-AS1 NA NA pathogenic process preterm
HSALNT0076183 HSALNG0036373 PANCR NA NA pathogenic process atrial fibrillation
HSALNT0288975 HSALNG0060982 FEZF1-AS1 NA transcriptional regulation pathogenic process gastric cancer;colorectal cancer
HSALNT0238475 HSALNG0115230 CCDC144NL-AS1 NA ceRNA pathogenic process ovarian cancer;cardiac hypertrophy
HSALNT0290102 HSALNG0142217 NR_026689 NA NA pathogenic process ovarian cancer;lung cancer
HSALNT0289522 HSALNG0075559 ADARB2-AS1 C10orf109,NCRNA00168,bA466B20.1 NA pathogenic process breast cancer;pancreatic ductal adenocarcinoma
HSALNT0288936 HSALNG0018139 DPP10-AS1 BC032913 NA pathogenic process breast cancer;colorectal cancer
HSALNT0289474 HSALNG0113682 GAS8-AS1 C16orf3 NA pathogenic process papillary thyroid cancer;breast cancer
HSALNT0289063 HSALNG0075802 MANCR LINC00704 NA pathogenic process NA
HSALNT0289238 HSALNG0026715 SAMMSON LINC01212 NA pathogenic process melanoma
HSALNT0289027 HSALNG0007238 LINC00302 C1orf46,NCRNA00302,XP33 NA developmental process NA
HSALNT0245543 HSALNG0118895 SNHG20 C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG transcriptional regulation pathogenic process hepatocellular cancer;colorectal cancer
HSALNT0015631 HSALNG0007463 DCST1-AS1 RP11-307C12.11 NA pathogenic process ovarian cancer
HSALNT0149810 HSALNG0071682 PGM5-AS1 FAM233A,LOC572558 NA pathogenic process bladder cancer
HSALNT0290236 HSALNG0142351 SBF2-AS1 NA transcriptional regulation pathogenic process non-small cell lung cancer
HSALNT0290325 HSALNG0142440 uc.338 NA transcriptional regulation pathogenic process hepatocellular cancer;lung cancer
HSALNT0289973 HSALNG0142088 LNCRI lnc-RI ceRNA NA NA
HSALNT0290002 HSALNG0142117 LOC100130476 NA NA pathogenic process esophageal squamous cell cancer;gastric cardia adenocarcinoma
HSALNT0289049 HSALNG0063356 LINC00599 Rncr3 NA pathogenic process diabetes
HSALNT0020406 HSALNG0009871 LINC00628 NA transcriptional regulation pathogenic process gastric cancer
HSALNT0289478 HSALNG0133031 DSCR4 DCRB NA pathogenic process Down syndrome
HSALNT0017675 HSALNG0008546 GAS5-AS1 NA NA pathogenic process oral submucous fibrosis;non-small cell lung cancer
HSALNT0289523 HSALNG0048782 HCG11 bK14H9.3,FLJ14049,FLJ30357 NA pathogenic process prostate cancer
HSALNT0134828 HSALNG0064314 LINC02099 AC145110.1 NA pathogenic process rheumatoid arthritis;breast cancer
HSALNT0209098 HSALNG0100348 G2E3-AS1 CAT1647 NA pathogenic process bladder cancer
HSALNT0289139 HSALNG0015506 LINC02245 lnc-SERTAD2-3,AC007386.2 NA pathogenic process ovarian cancer
HSALNT0008167 HSALNG0004109 FOXD3-AS1 pasFOXD3 transcriptional regulation pathogenic process glioma
HSALNT0289335 HSALNG0060638 LINC00998 NA NA pathogenic process major depression disorder
HSALNT0289379 HSALNG0041522 NNT-AS1 NA NA pathogenic process colorectal cancer
HSALNT0055497 HSALNG0026555 PSMD6-AS1 ENST00000462717,lnc00462717 NA pathogenic process papillary thyroid cancer;glioma
HSALNT0289130 HSALNG0119047 LINC02081 CTD-2357A8.3,XLOC_012582 NA pathogenic process esophageal cancer
HSALNT0289306 HSALNG0107939 LINC00052 TMEM83,NCRNA00052,FLJ31461 ceRNA pathogenic process hepatocellular cancer;breast cancer
HSALNT0199070 HSALNG0095970 PLUT PDX1-AS1,PLUTO,HI-LNC71 transcriptional regulation pathogenic process type 2 diabetes
HSALNT0289341 HSALNG0073476 LINC01505 RP11-308N19.1 NA pathogenic process NA
HSALNT0289315 HSALNG0020625 LINC01116 TALNEC2 transcriptional regulation pathogenic process prostate cancer;glioblastoma
HSALNT0006439 HSALNG0003395 FOXD2-AS1 MGC12982 NA pathogenic process lung cancer
HSALNT0252387 HSALNG0122085 LINC00305 C18orf20,NCRNA00305,MGC39571,HsT1235 NA NA NA
HSALNT0289473 HSALNG0110794 FBXL19-AS1 NCRNA00095,MGC125469,MGC125470,MGC125472 NA pathogenic process colorectal cancer
HSALNT0187807 HSALNG0090479 LINC02555 AC079630.2 NA pathogenic process papillary thyroid cancer
HSALNT0251493 HSALNG0121679 LINC01929 CTD-2171N6.1 NA pathogenic process papillary thyroid cancer
HSALNT0244776 HSALNG0118529 LINC01152 TCONS_00025128,CMPD NA pathogenic process NA
HSALNT0284591 HSALNG0139113 DIAPH2-AS1 NA NA pathogenic process Hodgkin's disease
HSALNT0289226 HSALNG0104558 PWAR1 PAR1,PAR-1 NA pathogenic process Prader-Willi syndrome and Angelman syndrome
HSALNT0289339 HSALNG0070961 LINC00950 FP588 NA NA NA
HSALNT0289740 HSALNG0141855 DGCR12 DGS-E NA pathogenic process;developmental process DiGeorge syndrome
HSALNT0275220 HSALNG0133987 DGCR9 DGS-A,POM121L5P NA pathogenic process DiGeorge syndrome
HSALNT0288929 HSALNG0133982 DGCR10 DGS-B NA pathogenic process NA
HSALNT0289494 HSALNG0141605 DGCR11 DGS-D NA pathogenic process NA
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:Featured&oldid=1276563"